{ "version": "2.2", "instance": { "vsee10k123125.htm": { "nsprefix": "vsee", "nsuri": "http://vseehealth.com/20251231", "dts": { "schema": { "local": [ "vsee-20251231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd", "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd", "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd", "https://xbrl.sec.gov/country/2025/country-2025.xsd", "https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd", "https://xbrl.sec.gov/cyd/2025/cyd-af-2025.xsd", "https://xbrl.sec.gov/dei/2025/dei-2025.xsd", "https://xbrl.sec.gov/dei/2025/dei-2025_def.xsd", "https://xbrl.sec.gov/dei/2025/dei-2025_lab.xsd", "https://xbrl.sec.gov/dei/2025/dei-2025_pre.xsd", "https://xbrl.sec.gov/dei/2025/dei-sub-2025.xsd", "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd", "https://xbrl.sec.gov/ecd/2025/ecd-sub-2025.xsd", "https://xbrl.sec.gov/sic/2025/sic-2025.xsd", "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd" ] }, "calculationLink": { "local": [ "vsee-20251231_cal.xml" ] }, "definitionLink": { "local": [ "vsee-20251231_def.xml" ] }, "labelLink": { "local": [ "vsee-20251231_lab.xml" ] }, "presentationLink": { "local": [ "vsee-20251231_pre.xml" ] }, "inline": { "local": [ "vsee10k123125.htm" ] } }, "keyStandard": 439, "keyCustom": 322, "axisStandard": 46, "axisCustom": 2, "memberStandard": 58, "memberCustom": 149, "hidden": { "total": 27, "http://vseehealth.com/20251231": 15, "http://fasb.org/us-gaap/2025": 9, "http://xbrl.sec.gov/dei/2025": 3 }, "contextCount": 836, "entityCount": 1, "segmentCount": 253, "elementCount": 1418, "unitCount": 10, "baseTaxonomies": { "http://fasb.org/us-gaap/2025": 1507, "http://xbrl.sec.gov/dei/2025": 43, "http://xbrl.sec.gov/cyd/2025": 9, "http://xbrl.sec.gov/ecd/2025": 4 }, "report": { "R1": { "role": "http://xbrl.sec.gov/dei/role/document/Cover", "longName": "995100 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c0", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "b", "span", "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "b", "span", "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R2": { "role": "http://xbrl.sec.gov/dei/role/document/AuditInformation", "longName": "995300 - Document - Audit Information", "shortName": "Audit Information", "isDefault": "false", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "2", "firstAnchor": { "contextRef": "c0", "name": "dei:AuditorName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "dei:AuditorName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R3": { "role": "http://vseehealth.com/role/ConsolidatedBalanceSheet", "longName": "995301 - Statement - CONSOLIDATED BALANCE SHEETS", "shortName": "CONSOLIDATED BALANCE SHEETS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c5", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c5", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R4": { "role": "http://vseehealth.com/role/ConsolidatedBalanceSheet_Parentheticals", "longName": "995302 - Statement - CONSOLIDATED BALANCE SHEETS (Parentheticals)", "shortName": "CONSOLIDATED BALANCE SHEETS (Parentheticals)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c5", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c5", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R5": { "role": "http://vseehealth.com/role/ConsolidatedIncomeStatement", "longName": "995303 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R6": { "role": "http://vseehealth.com/role/ShareholdersEquityType2or3", "longName": "995304 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 (DEFICIT) EQUITY", "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 (DEFICIT) EQUITY", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c32", "name": "us-gaap:SharesIssued", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c32", "name": "us-gaap:SharesIssued", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R7": { "role": "http://vseehealth.com/role/ShareholdersEquityType2or3_Parentheticals", "longName": "995305 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 (DEFICIT) EQUITY (Parentheticals)", "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 (DEFICIT) EQUITY (Parentheticals)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c41", "name": "us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true }, "uniqueAnchor": null }, "R8": { "role": "http://vseehealth.com/role/ConsolidatedCashFlow", "longName": "995306 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "8", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "unique": true } }, "R9": { "role": "http://vseehealth.com/role/ConsolidatedCashFlow_Parentheticals", "longName": "995307 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parentheticals)", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS (Parentheticals)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "9", "firstAnchor": { "contextRef": "c41", "name": "us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true }, "uniqueAnchor": null }, "R10": { "role": "http://vseehealth.com/role/OrganizationandDescriptionofBusiness", "longName": "995308 - Disclosure - Organization and Description of Business", "shortName": "Organization and Description of Business", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R11": { "role": "http://vseehealth.com/role/SummaryofSignificantAccountingPolicies", "longName": "995309 - Disclosure - Summary of Significant Accounting Policies", "shortName": "Summary of Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R12": { "role": "http://vseehealth.com/role/BusinessCombination", "longName": "995310 - Disclosure - Business Combination", "shortName": "Business Combination", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R13": { "role": "http://vseehealth.com/role/FixedAssets", "longName": "995311 - Disclosure - Fixed Assets", "shortName": "Fixed Assets", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R14": { "role": "http://vseehealth.com/role/Leases", "longName": "995312 - Disclosure - Leases", "shortName": "Leases", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c0", "name": "vsee:LeaseDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "vsee:LeaseDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R15": { "role": "http://vseehealth.com/role/AccountsPayableandAccruedLiabilities", "longName": "995313 - Disclosure - Accounts Payable and Accrued Liabilities", "shortName": "Accounts Payable and Accrued Liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R16": { "role": "http://vseehealth.com/role/FactoringPayable", "longName": "995314 - Disclosure - Factoring Payable", "shortName": "Factoring Payable", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c0", "name": "vsee:FactoringPayableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "vsee:FactoringPayableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R17": { "role": "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscount", "longName": "995315 - Disclosure - Line of Credit and Notes Payable, net of discount", "shortName": "Line of Credit and Notes Payable, net of discount", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R18": { "role": "http://vseehealth.com/role/RelatedParty", "longName": "995316 - Disclosure - Related Party", "shortName": "Related Party", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R19": { "role": "http://vseehealth.com/role/CommitmentsandContingencies", "longName": "995317 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c0", "name": "vsee:CommitmentsContingenciesAndConcentrationRiskDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "vsee:CommitmentsContingenciesAndConcentrationRiskDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R20": { "role": "http://vseehealth.com/role/IncomeTaxes", "longName": "995318 - Disclosure - Income Taxes", "shortName": "Income Taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R21": { "role": "http://vseehealth.com/role/Equity", "longName": "995319 - Disclosure - Equity", "shortName": "Equity", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R22": { "role": "http://vseehealth.com/role/Warrants", "longName": "995320 - Disclosure - Warrants", "shortName": "Warrants", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "c0", "name": "vsee:WarrantsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "vsee:WarrantsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R23": { "role": "http://vseehealth.com/role/Reportablesegments", "longName": "995321 - Disclosure - Reportable segments", "shortName": "Reportable segments", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R24": { "role": "http://vseehealth.com/role/FairValueMeasurements", "longName": "995322 - Disclosure - Fair Value Measurements", "shortName": "Fair Value Measurements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R25": { "role": "http://vseehealth.com/role/SubsequentEvents", "longName": "995323 - Disclosure - Subsequent Events", "shortName": "Subsequent Events", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "25", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R26": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "26", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true }, "uniqueAnchor": null }, "R27": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "27", "firstAnchor": { "contextRef": "c835", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:NonRule10b51ArrAdoptedFlag", "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c835", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:NonRule10b51ArrAdoptedFlag", "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R28": { "role": "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure", "longName": "995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure", "shortName": "Cybersecurity Risk Management and Strategy Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "28", "firstAnchor": { "contextRef": "c0", "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R29": { "role": "http://vseehealth.com/role/AccountingPoliciesByPolicy", "longName": "996000 - Disclosure - Accounting Policies, by Policy (Policies)", "shortName": "Accounting Policies, by Policy (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "29", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R30": { "role": "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesTables", "longName": "996001 - Disclosure - Summary of Significant Accounting Policies (Tables)", "shortName": "Summary of Significant Accounting Policies (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R31": { "role": "http://vseehealth.com/role/BusinessCombinationTables", "longName": "996002 - Disclosure - Business Combination (Tables)", "shortName": "Business Combination (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R32": { "role": "http://vseehealth.com/role/FixedAssetsTables", "longName": "996003 - Disclosure - Fixed Assets (Tables)", "shortName": "Fixed Assets (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R33": { "role": "http://vseehealth.com/role/LeasesTables", "longName": "996004 - Disclosure - Leases (Tables)", "shortName": "Leases (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "c0", "name": "vsee:LesseeOperatingLeaseRightOfUseAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "vsee:LeaseDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "vsee:LesseeOperatingLeaseRightOfUseAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "vsee:LeaseDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R34": { "role": "http://vseehealth.com/role/AccountsPayableandAccruedLiabilitiesTables", "longName": "996005 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)", "shortName": "Accounts Payable and Accrued Liabilities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R35": { "role": "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountTables", "longName": "996006 - Disclosure - Line of Credit and Notes Payable, net of discount (Tables)", "shortName": "Line of Credit and Notes Payable, net of discount (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R36": { "role": "http://vseehealth.com/role/IncomeTaxesTables", "longName": "996007 - Disclosure - Income Taxes (Tables)", "shortName": "Income Taxes (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R37": { "role": "http://vseehealth.com/role/EquityTables", "longName": "996008 - Disclosure - Equity (Tables)", "shortName": "Equity (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "37", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R38": { "role": "http://vseehealth.com/role/WarrantsTables", "longName": "996009 - Disclosure - Warrants (Tables)", "shortName": "Warrants (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "38", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "vsee:WarrantsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "vsee:WarrantsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R39": { "role": "http://vseehealth.com/role/ReportablesegmentsTables", "longName": "996010 - Disclosure - Reportable segments (Tables)", "shortName": "Reportable segments (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "39", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R40": { "role": "http://vseehealth.com/role/FairValueMeasurementsTables", "longName": "996011 - Disclosure - Fair Value Measurements (Tables)", "shortName": "Fair Value Measurements (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "40", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R41": { "role": "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "longName": "996012 - Disclosure - Organization and Description of Business (Details)", "shortName": "Organization and Description of Business (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "c103", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "usdPershares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true }, "uniqueAnchor": { "contextRef": "c104", "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "unique": true } }, "R42": { "role": "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails", "longName": "996013 - Disclosure - Summary of Significant Accounting Policies (Details)", "shortName": "Summary of Significant Accounting Policies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:BusinessCombinationAcquisitionRelatedCosts", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true }, "uniqueAnchor": { "contextRef": "c5", "name": "us-gaap:CashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "unique": true } }, "R43": { "role": "http://vseehealth.com/role/ScheduleofDisaggregatedRevenuebyTimingofRevenueRecognitionTable", "longName": "996014 - Disclosure - Summary of Significant Accounting Policies - Schedule of Disaggregated Revenue by Timing of Revenue Recognition (Details)", "shortName": "Summary of Significant Accounting Policies - Schedule of Disaggregated Revenue by Timing of Revenue Recognition (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:Revenues", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R44": { "role": "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable", "longName": "996015 - Disclosure - Summary of Significant Accounting Policies - Schedule of Net Loss Per Common Share (Details)", "shortName": "Summary of Significant Accounting Policies - Schedule of Net Loss Per Common Share (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true }, "uniqueAnchor": { "contextRef": "c157", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "unique": true } }, "R45": { "role": "http://vseehealth.com/role/ScheduleofAllowanceforCreditLossesTable", "longName": "996016 - Disclosure - Summary of Significant Accounting Policies - Schedule of Allowance for Credit Losses (Details)", "shortName": "Summary of Significant Accounting Policies - Schedule of Allowance for Credit Losses (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "c6", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true }, "uniqueAnchor": { "contextRef": "c0", "name": "vsee:AccountsReceivableWriteOffIncludedInAllowanceForCreditLosses", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "unique": true } }, "R46": { "role": "http://vseehealth.com/role/ScheduleofDeferredRevenueActivitiesTable", "longName": "996017 - Disclosure - Summary of Significant Accounting Policies - Schedule of Deferred Revenue Activities (Details)", "shortName": "Summary of Significant Accounting Policies - Schedule of Deferred Revenue Activities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "c6", "name": "us-gaap:DeferredRevenueCurrent", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:DeferredRevenueByArrangementDisclosureTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true }, "uniqueAnchor": { "contextRef": "c37", "name": "us-gaap:DeferredRevenueCurrent", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:DeferredRevenueByArrangementDisclosureTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "unique": true } }, "R47": { "role": "http://vseehealth.com/role/ScheduleofFixedAssetsareDepreciatedUsingtheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable", "longName": "996018 - Disclosure - Summary of Significant Accounting Policies - Schedule of Fixed Assets are Depreciated Using the Straight-Line Method Over the Estimated Useful Lives of the Assets (Details)", "shortName": "Summary of Significant Accounting Policies - Schedule of Fixed Assets are Depreciated Using the Straight-Line Method Over the Estimated Useful Lives of the Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "c181", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "td", "tr", "table", "ix:continuation", "vsee:ScheduleOfFixedAssetsAreDepreciatedUsingTheStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssets", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c181", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "td", "tr", "table", "ix:continuation", "vsee:ScheduleOfFixedAssetsAreDepreciatedUsingTheStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssets", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R48": { "role": "http://vseehealth.com/role/ScheduleofIdentifiableIntangibleAssetsSubjecttoAmortizationTable", "longName": "996019 - Disclosure - Summary of Significant Accounting Policies - Schedule of Identifiable Intangible Assets Subject to Amortization (Details)", "shortName": "Summary of Significant Accounting Policies - Schedule of Identifiable Intangible Assets Subject to Amortization (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "c5", "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c5", "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R49": { "role": "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable", "longName": "996020 - Disclosure - Summary of Significant Accounting Policies - Schedule of Expected Amortization Expense (Details)", "shortName": "Summary of Significant Accounting Policies - Schedule of Expected Amortization Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "c5", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c5", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R50": { "role": "http://vseehealth.com/role/BusinessCombinationDetails", "longName": "996021 - Disclosure - Business Combination (Details)", "shortName": "Business Combination (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "c103", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "usdPershares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true }, "uniqueAnchor": { "contextRef": "c139", "name": "vsee:EstimatedValueOfSharesAndOptionsGranted", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "-4", "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "unique": true } }, "R51": { "role": "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable", "longName": "996022 - Disclosure - Business Combination - Schedule of Purchase Consideration (Details)", "shortName": "Business Combination - Schedule of Purchase Consideration (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "c193", "name": "vsee:BusinessAcquisitionCommonStockIssuedOrIssuableValueAssigned", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c193", "name": "vsee:BusinessAcquisitionCommonStockIssuedOrIssuableValueAssigned", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R52": { "role": "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable_Parentheticals", "longName": "996023 - Disclosure - Business Combination - Schedule of Purchase Consideration (Parentheticals) (Details)", "shortName": "Business Combination - Schedule of Purchase Consideration (Parentheticals) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "c193", "name": "vsee:BusinessAcquisitionCommonStockIssuedOrIssuableNumberOfShares", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true }, "uniqueAnchor": null }, "R53": { "role": "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable", "longName": "996024 - Disclosure - Business Combination - Schedule of Allocation of Total Purchase Consideration (Details)", "shortName": "Business Combination - Schedule of Allocation of Total Purchase Consideration (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "c193", "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c193", "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R54": { "role": "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable_Parentheticals", "longName": "996025 - Disclosure - Business Combination - Schedule of Allocation of Total Purchase Consideration (Parentheticals) (Details)", "shortName": "Business Combination - Schedule of Allocation of Total Purchase Consideration (Parentheticals) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "c193", "name": "us-gaap:CashAcquiredFromAcquisition", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c193", "name": "us-gaap:CashAcquiredFromAcquisition", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R55": { "role": "http://vseehealth.com/role/ScheduleofProformaFinancialInformationTable", "longName": "996026 - Disclosure - Business Combination - Schedule of Pro forma Financial Information (Details)", "shortName": "Business Combination - Schedule of Pro forma Financial Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "c31", "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c31", "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R56": { "role": "http://vseehealth.com/role/ScheduleofCommonStockBusinessCombinationTable", "longName": "996027 - Disclosure - Business Combination - Schedule of Common Stock Business Combination (Details)", "shortName": "Business Combination - Schedule of Common Stock Business Combination (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "c103", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "vsee:ScheduleOfNumberOfCommonStockOutstandingAfterBusinessCombinationTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true }, "uniqueAnchor": { "contextRef": "c214", "name": "us-gaap:StockIssuedDuringPeriodSharesAcquisitions", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "vsee:ScheduleOfNumberOfCommonStockOutstandingAfterBusinessCombinationTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "unique": true } }, "R57": { "role": "http://vseehealth.com/role/ScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationTable", "longName": "996028 - Disclosure - Business Combination - Schedule of the Recapitalization and Net Equity Impact on Business Combination (Details)", "shortName": "Business Combination - Schedule of the Recapitalization and Net Equity Impact on Business Combination (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "c130", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "vsee:SummaryOfRecapitalizationAndEquityImpactTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c130", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "vsee:SummaryOfRecapitalizationAndEquityImpactTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R58": { "role": "http://vseehealth.com/role/FixedAssetsDetails", "longName": "996029 - Disclosure - Fixed Assets (Details)", "shortName": "Fixed Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:Depreciation", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:Depreciation", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R59": { "role": "http://vseehealth.com/role/ScheduleofComponentsofFixedAssetsTable", "longName": "996030 - Disclosure - Fixed Assets - Schedule of Components of Fixed Assets (Details)", "shortName": "Fixed Assets - Schedule of Components of Fixed Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "c5", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c5", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R60": { "role": "http://vseehealth.com/role/LeasesDetails", "longName": "996031 - Disclosure - Leases (Details)", "shortName": "Leases (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "c5", "name": "us-gaap:OperatingLeaseLiability", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "vsee:LesseeOperatingLeaseLiabilitiesTableTextBlock", "vsee:LeaseDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true }, "uniqueAnchor": { "contextRef": "c230", "name": "us-gaap:LiabilitiesSubjectToCompromiseEarlyContractTerminationFees", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "vsee:LeaseDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "unique": true } }, "R61": { "role": "http://vseehealth.com/role/ScheduleofOperatingLeaseRightofUseAssetsTable", "longName": "996032 - Disclosure - Leases - Schedule of Operating Lease Right-of-Use Assets (Details)", "shortName": "Leases - Schedule of Operating Lease Right-of-Use Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "c5", "name": "vsee:OperatingLeaseRightOfUseAssetBeforeAccumulatedAmortization", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "vsee:LesseeOperatingLeaseRightOfUseAssetsTableTextBlock", "vsee:LeaseDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c5", "name": "vsee:OperatingLeaseRightOfUseAssetBeforeAccumulatedAmortization", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "vsee:LesseeOperatingLeaseRightOfUseAssetsTableTextBlock", "vsee:LeaseDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R62": { "role": "http://vseehealth.com/role/ScheduleofOperatingLeaseLiabilitiesTable", "longName": "996033 - Disclosure - Leases - Schedule of Operating Lease Liabilities (Details)", "shortName": "Leases - Schedule of Operating Lease Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "c5", "name": "us-gaap:OperatingLeaseLiability", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "vsee:LesseeOperatingLeaseLiabilitiesTableTextBlock", "vsee:LeaseDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true }, "uniqueAnchor": null }, "R63": { "role": "http://vseehealth.com/role/ScheduleofFutureMinimumRentPaymentsUndertheOperatingLeaseTable", "longName": "996034 - Disclosure - Leases - Schedule of Future Minimum Rent Payments Under the Operating Lease (Details)", "shortName": "Leases - Schedule of Future Minimum Rent Payments Under the Operating Lease (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "c5", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c5", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R64": { "role": "http://vseehealth.com/role/ScheduleofExpensesIncurredforOperatingLeasesTable", "longName": "996035 - Disclosure - Leases - Schedule of Expenses Incurred for Operating Leases (Details)", "shortName": "Leases - Schedule of Expenses Incurred for Operating Leases (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:OperatingLeaseCost", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:OperatingLeaseCost", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R65": { "role": "http://vseehealth.com/role/ScheduleofWeightedAverageRemainingLeaseTermandDiscountRateonFinanceLeasesTable", "longName": "996036 - Disclosure - Leases - Schedule of Weighted Average Remaining Lease Term and Discount Rate on Finance Leases (Details)", "shortName": "Leases - Schedule of Weighted Average Remaining Lease Term and Discount Rate on Finance Leases (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "c5", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "vsee:LesseeFinanceLeaseSupplementalInformationTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c5", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "td", "tr", "table", "vsee:LesseeFinanceLeaseSupplementalInformationTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R66": { "role": "http://vseehealth.com/role/ScheduleofFinanceLeasedEquipmentTable", "longName": "996037 - Disclosure - Leases - Schedule of Finance Leased Equipment (Details)", "shortName": "Leases - Schedule of Finance Leased Equipment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "c5", "name": "us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "vsee:LesseeFinanceLeaseRightOfUseAssetsTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c5", "name": "us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "vsee:LesseeFinanceLeaseRightOfUseAssetsTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R67": { "role": "http://vseehealth.com/role/ScheduleofFinanceLeaseLiabilitiesTable", "longName": "996038 - Disclosure - Leases - Schedule of Finance Lease Liabilities (Details)", "shortName": "Leases - Schedule of Finance Lease Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "c5", "name": "us-gaap:FinanceLeaseLiability", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "vsee:LesseeFinanceLeaseLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true }, "uniqueAnchor": { "contextRef": "c5", "name": "us-gaap:FinanceLeaseLiabilityNoncurrent", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "vsee:LesseeFinanceLeaseLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "unique": true } }, "R68": { "role": "http://vseehealth.com/role/ScheduleofFutureMinimumPaymentsUnderFinanceLeaseTable", "longName": "996039 - Disclosure - Leases - Schedule of Future Minimum Payments Under Finance Lease (Details)", "shortName": "Leases - Schedule of Future Minimum Payments Under Finance Lease (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "c5", "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c5", "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R69": { "role": "http://vseehealth.com/role/ScheduleofExpensesIncurredwithRespecttoFinanceLeasesTable", "longName": "996040 - Disclosure - Leases - Schedule of Expenses Incurred with Respect to Finance Leases (Details)", "shortName": "Leases - Schedule of Expenses Incurred with Respect to Finance Leases (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:FinanceLeaseRightOfUseAssetAmortization", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:FinancingInterestExpense", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "vsee:FinanceLeaseCostTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "unique": true } }, "R70": { "role": "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable", "longName": "996041 - Disclosure - Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details)", "shortName": "Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "c5", "name": "us-gaap:AccountsPayableCurrent", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c5", "name": "us-gaap:AccountsPayableCurrent", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R71": { "role": "http://vseehealth.com/role/FactoringPayableDetails", "longName": "996042 - Disclosure - Factoring Payable (Details)", "shortName": "Factoring Payable (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "c0", "name": "vsee:FutureReceiptsSaleAgreementInterestRate", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "span", "p", "vsee:FactoringPayableTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "vsee:FutureReceiptsSaleAgreementInterestRate", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "span", "p", "vsee:FactoringPayableTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R72": { "role": "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "longName": "996043 - Disclosure - Line of Credit and Notes Payable, net of discount (Details)", "shortName": "Line of Credit and Notes Payable, net of discount (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "c6", "name": "us-gaap:DebtInstrumentInterestRateEffectivePercentage", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "span", "p", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true }, "uniqueAnchor": { "contextRef": "c0", "name": "vsee:DebtInstrumentPercentageOfPrepaymentPenaltyInCaseOfDefault", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "unique": true } }, "R73": { "role": "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable", "longName": "996044 - Disclosure - Line of Credit and Notes Payable, net of discount - Schedule of Line of Credit and Notes Payable, Net of Discount (Details)", "shortName": "Line of Credit and Notes Payable, net of discount - Schedule of Line of Credit and Notes Payable, Net of Discount (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "c5", "name": "us-gaap:LongTermDebt", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true }, "uniqueAnchor": { "contextRef": "c5", "name": "us-gaap:LongTermDebtCurrent", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "unique": true } }, "R74": { "role": "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable", "longName": "996045 - Disclosure - Line of Credit and Notes Payable, net of discount - Schedule of Required Principal Payments (Details)", "shortName": "Line of Credit and Notes Payable, net of discount - Schedule of Required Principal Payments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "c5", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c5", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R75": { "role": "http://vseehealth.com/role/RelatedPartyDetails", "longName": "996046 - Disclosure - Related Party (Details)", "shortName": "Related Party (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "c6", "name": "us-gaap:CommonStockSharesIssued", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "us-gaap:CommonStockSharesOutstanding", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true }, "uniqueAnchor": { "contextRef": "c504", "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "unique": true } }, "R76": { "role": "http://vseehealth.com/role/CommitmentsandContingenciesDetails", "longName": "996047 - Disclosure - Commitments and Contingencies (Details)", "shortName": "Commitments and Contingencies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "76", "firstAnchor": { "contextRef": "c562", "name": "us-gaap:DebtInstrumentFaceAmount", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true }, "uniqueAnchor": { "contextRef": "c5", "name": "vsee:PurchaseCommitmentAdjustmentsAndPaymentsMade", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "unique": true } }, "R77": { "role": "http://vseehealth.com/role/IncomeTaxesDetails", "longName": "996048 - Disclosure - Income Taxes (Details)", "shortName": "Income Taxes (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "77", "firstAnchor": { "contextRef": "c5", "name": "us-gaap:DeferredTaxAssetsOther", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c5", "name": "us-gaap:DeferredTaxAssetsOther", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R78": { "role": "http://vseehealth.com/role/ScheduleofIncomeTaxProvisionTable", "longName": "996049 - Disclosure - Income Taxes - Schedule of Income Tax Provision (Details)", "shortName": "Income Taxes - Schedule of Income Tax Provision (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "78", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R79": { "role": "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable", "longName": "996050 - Disclosure - Income Taxes - Schedule of Reconciliation of Federal Income Tax Rate to Company's Effective Tax Rate (Details)", "shortName": "Income Taxes - Schedule of Reconciliation of Federal Income Tax Rate to Company's Effective Tax Rate (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "79", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R80": { "role": "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable", "longName": "996051 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)", "shortName": "Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "80", "firstAnchor": { "contextRef": "c5", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c5", "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R81": { "role": "http://vseehealth.com/role/EquityDetails", "longName": "996052 - Disclosure - Equity (Details)", "shortName": "Equity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "81", "firstAnchor": { "contextRef": "c5", "name": "us-gaap:PreferredStockSharesAuthorized", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true }, "uniqueAnchor": { "contextRef": "c0", "name": "vsee:ConversionOfStockEquivalentCommonStockSharesUponConversion", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "unique": true } }, "R82": { "role": "http://vseehealth.com/role/ScheduleofStockOptionsTable", "longName": "996053 - Disclosure - Equity - Schedule of Stock Options (Details)", "shortName": "Equity - Schedule of Stock Options (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "82", "firstAnchor": { "contextRef": "c6", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c6", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R83": { "role": "http://vseehealth.com/role/ScheduleofKeyAssumptionsUsedinValuingUnvestedOptionsTable", "longName": "996054 - Disclosure - Equity - Schedule of Key Assumptions Used in Valuing Unvested Options (Details)", "shortName": "Equity - Schedule of Key Assumptions Used in Valuing Unvested Options (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "83", "firstAnchor": { "contextRef": "c103", "name": "us-gaap:SharePrice", "unitRef": "usdPershares", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c103", "name": "us-gaap:SharePrice", "unitRef": "usdPershares", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R84": { "role": "http://vseehealth.com/role/WarrantsDetails", "longName": "996055 - Disclosure - Warrants (Details)", "shortName": "Warrants (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "84", "firstAnchor": { "contextRef": "c5", "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "unitRef": "usdPershares", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "vsee:WarrantsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true }, "uniqueAnchor": { "contextRef": "c602", "name": "vsee:SecuritiesSoldCombinedPurchasePrice", "unitRef": "usdPershares", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "unique": true } }, "R85": { "role": "http://vseehealth.com/role/ScheduleofWarrantsIssuedandoutstandingTable", "longName": "996056 - Disclosure - Warrants - Schedule of Warrants Issued and outstanding (Details)", "shortName": "Warrants - Schedule of Warrants Issued and outstanding (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "85", "firstAnchor": { "contextRef": "c6", "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "vsee:WarrantsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true }, "uniqueAnchor": { "contextRef": "c31", "name": "vsee:ClassOfWarrantOrRightAssumed", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "vsee:WarrantsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "unique": true } }, "R86": { "role": "http://vseehealth.com/role/ReportablesegmentsDetails", "longName": "996057 - Disclosure - Reportable segments (Details)", "shortName": "Reportable segments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "86", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:NumberOfReportableSegments", "unitRef": "segment", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true }, "uniqueAnchor": { "contextRef": "c0", "name": "vsee:NumberOfLegacyOperatingEntities", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "us-gaap:SegmentReportingDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "unique": true } }, "R87": { "role": "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable", "longName": "996058 - Disclosure - Reportable segments - Schedule of Reconciliation of Consolidated Segment (Details)", "shortName": "Reportable segments - Schedule of Reconciliation of Consolidated Segment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "87", "firstAnchor": { "contextRef": "c656", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c656", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R88": { "role": "http://vseehealth.com/role/ScheduleofTotalAssetsbySegmentTable", "longName": "996059 - Disclosure - Reportable segments - Schedule of Total Assets by Segment (Details)", "shortName": "Reportable segments - Schedule of Total Assets by Segment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "88", "firstAnchor": { "contextRef": "c5", "name": "us-gaap:Assets", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "b", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true }, "uniqueAnchor": { "contextRef": "c684", "name": "us-gaap:Assets", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "unique": true } }, "R89": { "role": "http://vseehealth.com/role/ScheduleofReportableSegmentDepreciationandAmortizationandCapitalExpendituresTable", "longName": "996060 - Disclosure - Reportable segments - Schedule of Reportable Segment Depreciation and Amortization and Capital Expenditures (Details)", "shortName": "Reportable segments - Schedule of Reportable Segment Depreciation and Amortization and Capital Expenditures (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "89", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:DepreciationAndAmortization", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:PaymentsToAcquireProductiveAssets", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "unique": true } }, "R90": { "role": "http://vseehealth.com/role/FairValueMeasurementsDetails", "longName": "996061 - Disclosure - Fair Value Measurements (Details)", "shortName": "Fair Value Measurements (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "90", "firstAnchor": { "contextRef": "c0", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "p", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R91": { "role": "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable", "longName": "996062 - Disclosure - Fair Value Measurements - Schedule of Fair Value Information on Recurring Basis (Details)", "shortName": "Fair Value Measurements - Schedule of Fair Value Information on Recurring Basis (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "91", "firstAnchor": { "contextRef": "c690", "name": "us-gaap:FinancialLiabilitiesFairValueDisclosure", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c690", "name": "us-gaap:FinancialLiabilitiesFairValueDisclosure", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R92": { "role": "http://vseehealth.com/role/ScheduleofKeyInputsTable", "longName": "996063 - Disclosure - Fair Value Measurements - Schedule of Key Inputs (Details)", "shortName": "Fair Value Measurements - Schedule of Key Inputs (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "92", "firstAnchor": { "contextRef": "c723", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c723", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R93": { "role": "http://vseehealth.com/role/ScheduleofKeyInputsTable0", "longName": "996064 - Disclosure - Fair Value Measurements - Schedule of Key Inputs (Details)", "shortName": "Fair Value Measurements - Schedule of Key Inputs (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "93", "firstAnchor": { "contextRef": "c734", "name": "us-gaap:EmbeddedDerivativeLiabilityMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c734", "name": "us-gaap:EmbeddedDerivativeLiabilityMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R94": { "role": "http://vseehealth.com/role/ScheduleofKeyInputsTable1", "longName": "996065 - Disclosure - Fair Value Measurements - Schedule of Key Inputs (Details)", "shortName": "Fair Value Measurements - Schedule of Key Inputs (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "94", "firstAnchor": { "contextRef": "c736", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c736", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R95": { "role": "http://vseehealth.com/role/ScheduleofKeyInputsTable2", "longName": "996066 - Disclosure - Fair Value Measurements - Schedule of Key Inputs (Details)", "shortName": "Fair Value Measurements - Schedule of Key Inputs (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "95", "firstAnchor": { "contextRef": "c752", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c752", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R96": { "role": "http://vseehealth.com/role/ScheduleofKeyInputsTable3", "longName": "996067 - Disclosure - Fair Value Measurements - Schedule of Key Inputs (Details)", "shortName": "Fair Value Measurements - Schedule of Key Inputs (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "96", "firstAnchor": { "contextRef": "c763", "name": "us-gaap:EmbeddedDerivativeLiabilityMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c763", "name": "us-gaap:EmbeddedDerivativeLiabilityMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R97": { "role": "http://vseehealth.com/role/ScheduleofKeyInputsTable4", "longName": "996068 - Disclosure - Fair Value Measurements - Schedule of Key Inputs (Details)", "shortName": "Fair Value Measurements - Schedule of Key Inputs (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "97", "firstAnchor": { "contextRef": "c772", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c772", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R98": { "role": "http://vseehealth.com/role/ScheduleofKeyInputsTable5", "longName": "996069 - Disclosure - Fair Value Measurements - Schedule of Key Inputs (Details)", "shortName": "Fair Value Measurements - Schedule of Key Inputs (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "98", "firstAnchor": { "contextRef": "c783", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c783", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R99": { "role": "http://vseehealth.com/role/ScheduleofKeyInputsTable6", "longName": "996070 - Disclosure - Fair Value Measurements - Schedule of Key Inputs (Details)", "shortName": "Fair Value Measurements - Schedule of Key Inputs (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "99", "firstAnchor": { "contextRef": "c792", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c792", "name": "us-gaap:DebtInstrumentMeasurementInput", "unitRef": "pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R100": { "role": "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable", "longName": "996071 - Disclosure - Fair Value Measurements - Schedule of Changes in the Fair Value of Financial Liabilities (Details)", "shortName": "Fair Value Measurements - Schedule of Changes in the Fair Value of Financial Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "100", "firstAnchor": { "contextRef": "c807", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c807", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "unitRef": "usd", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true, "unique": true } }, "R101": { "role": "http://vseehealth.com/role/SubsequentEventsDetails", "longName": "996072 - Disclosure - Subsequent Events (Details)", "shortName": "Subsequent Events (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "101", "firstAnchor": { "contextRef": "c5", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "usdPershares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "first": true }, "uniqueAnchor": { "contextRef": "c830", "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction", "unitRef": "shares", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:SubsequentEventsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "vsee10k123125.htm", "unique": true } } }, "tag": { "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 }, "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total accounts payable and accrued liabilities", "terseLabel": "Accounts payable and accrued liabilities", "label": "Accounts Payable and Accrued Liabilities, Current", "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits." } } }, "auth_ref": [ "r47", "r48" ] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "presentation": [ "http://vseehealth.com/role/AccountsPayableandAccruedLiabilities" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts Payable and Accrued Liabilities", "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]", "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period." } } }, "auth_ref": [ "r46", "r48", "r52", "r1471" ] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccountsPayableAndAccruedLiabilitiesMember", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts Payable and Accrued Liabilities [Member]", "label": "Accounts Payable and Accrued Liabilities [Member]", "documentation": "Primary financial statement caption encompassing accounts payable and accrued liabilities." } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable": { "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable", "label": "Accounts Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r46", "r1110" ] }, "vsee_AccountsReceivableAllowanceForCreditLossIncreaseFromAcquisition": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "AccountsReceivableAllowanceForCreditLossIncreaseFromAcquisition", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofAllowanceforCreditLossesTable", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Add: Allowance for credit losses, due to acquisition", "verboseLabel": "Allowance for credit losses, due to acquisition", "documentation": "Amount of allowance for credit loss on accounts receivable raised from business acquisition.", "label": "Accounts Receivable Allowance For Credit Loss Increase From Acquisition" } } }, "auth_ref": [] }, "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Allowance for Credit Losses", "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]", "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable." } } }, "auth_ref": [ "r1404" ] }, "us-gaap_AccountsReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccountsReceivableMember", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts Receivable [Member]", "label": "Accounts Receivable [Member]", "documentation": "Due from customers or clients for goods or services that have been delivered or sold." } } }, "auth_ref": [ "r973", "r1383" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable, net of allowance for credit losses of $835,007 and $2,393,033 as of December 31, 2025, and 2024, respectively", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r1394" ] }, "vsee_AccountsReceivableWriteOffIncludedInAllowanceForCreditLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "AccountsReceivableWriteOffIncludedInAllowanceForCreditLosses", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofAllowanceforCreditLossesTable" ], "lang": { "en-us": { "role": { "negatedLabel": "(Less)/Add: Accounts receivable write-off included in allowance for credit losses above", "documentation": "Accounts receivable write-off included in allowance for credit losses.", "label": "Accounts Receivable Write Off Included In Allowance For Credit Losses" } } }, "auth_ref": [] }, "vsee_AccruedLiabilitiesCommonStockIssuableToRelatedParty": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "AccruedLiabilitiesCommonStockIssuableToRelatedParty", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock issuances to the related party", "documentation": "Carrying amount as of the balance sheet date relating to future stock issuances to the related party as part of the consulting agreement.", "label": "Accrued Liabilities Common Stock Issuable To Related Party" } } }, "auth_ref": [] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofComponentsofFixedAssetsTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: Accumulated depreciation", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r32", "r135", "r819" ] }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems", "presentation": [ "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable" ], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r331", "r332", "r333", "r335", "r855", "r986" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure [Text Block]", "terseLabel": "Additional 402(v) Disclosure" } } }, "auth_ref": [ "r1207" ] }, "vsee_AdditionalAdvanceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "AdditionalAdvanceAmount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional advance amount", "documentation": "Additional advance amount.", "label": "Additional Advance Amount" } } }, "auth_ref": [] }, "vsee_AdditionalBridgeNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "AdditionalBridgeNotesMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/FairValueMeasurementsTables", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable", "http://vseehealth.com/role/ScheduleofKeyInputsTable1", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Additional Bridge Notes", "verboseLabel": "Additional Bridge Notes [Member]", "documentation": "Represents information pertaining to additional bridge note.", "label": "Additional Bridge Notes Member" } } }, "auth_ref": [] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in capital", "label": "Additional Paid in Capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r59", "r1110", "r1587" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Additional Paid- In Capital", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r873", "r1375", "r1376", "r1377", "r1378", "r1512", "r1592" ] }, "dei_AdditionalSecurities462b": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AdditionalSecurities462b", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Additional Securities. 462(b)" } } }, "auth_ref": [ "r1270" ] }, "dei_AdditionalSecurities462bFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AdditionalSecurities462bFileNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Additional Securities, 462(b), File Number" } } }, "auth_ref": [ "r1270" ] }, "dei_AdditionalSecuritiesEffective413b": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AdditionalSecuritiesEffective413b", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Additional Securities Effective, 413(b)" } } }, "auth_ref": [ "r1268" ] }, "dei_AddressTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AddressTypeDomain", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Address Type [Domain]", "documentation": "An entity may have several addresses for different purposes and this domain represents all such types." } } }, "auth_ref": [] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation Amount", "terseLabel": "Adjustment to Compensation, Amount" } } }, "auth_ref": [ "r1220" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]", "terseLabel": "Adjustment to Compensation:" } } }, "auth_ref": [ "r1220" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]", "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote" } } }, "auth_ref": [ "r1220" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote [Text Block]", "terseLabel": "Adjustment To PEO Compensation, Footnote" } } }, "auth_ref": [ "r1220" ] }, "vsee_AdjustmentToIncreaseCompensationAndRelatedBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "AdjustmentToIncreaseCompensationAndRelatedBenefits", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation and related benefits", "documentation": "Amount of expense for employee benefit and equity-based compensation.", "label": "Adjustment To Increase Compensation And Related Benefits" } } }, "auth_ref": [] }, "vsee_AdjustmentsToAdditionalPaidInCapitalConversionOfDebtGainLossOnRestructuring": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "AdjustmentsToAdditionalPaidInCapitalConversionOfDebtGainLossOnRestructuring", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additional reduction in the carrying value representing as gain on restructuring", "verboseLabel": "Additional reduction in the carrying value representing as gain on restructuring (in Dollars)", "documentation": "Amount of increase (decrease) in adjustments to additional paid-in capital (APIC) resulting from the gain (loss) on restructuring.", "label": "Adjustments To Additional Paid In Capital Conversion Of Debt Gain Loss On Restructuring" } } }, "auth_ref": [] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from pre-funded warrants, net of issuance cost", "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs", "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration." } } }, "auth_ref": [ "r7", "r89" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:", "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]" } } }, "auth_ref": [] }, "vsee_AdministratorMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "AdministratorMember", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Administrator [Member]", "documentation": "Represents the member information pertaining to administrator.", "label": "Administrator Member" } } }, "auth_ref": [] }, "vsee_AffiliateOfSponsorMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "AffiliateOfSponsorMember", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Affiliate Of The Sponsor [Member]", "documentation": "This member stands for an affiliate of the sponsor.", "label": "Affiliate Of Sponsor Member" } } }, "auth_ref": [] }, "vsee_AggregateAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "AggregateAmount", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate amount (in Dollars)", "documentation": "The amount of aggregate amount.", "label": "Aggregate Amount" } } }, "auth_ref": [] }, "vsee_AggregateShares": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "AggregateShares", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate shares", "documentation": "Shares of aggregate.", "label": "Aggregate Shares" } } }, "auth_ref": [] }, "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]", "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table" } } }, "auth_ref": [ "r1261" ] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount", "terseLabel": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r1170", "r1181", "r1197", "r1232" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]", "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined" } } }, "auth_ref": [ "r1173", "r1184", "r1200", "r1235" ] }, "ecd_AggtPnsnAdjsSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AggtPnsnAdjsSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Pension Adjustments Service Cost [Member]", "terseLabel": "Aggregate Pension Adjustments Service Cost" } } }, "auth_ref": [ "r1262" ] }, "vsee_AgreedToPurchaseSharesOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "AgreedToPurchaseSharesOfCommonStock", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Agreed to purchase shares of common stock", "documentation": "Agreed to purchase shares of common stock.", "label": "Agreed To Purchase Shares Of Common Stock" } } }, "auth_ref": [] }, "vsee_AgreementTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "AgreementTypeAxis", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Agreement Type [Axis]", "label": "Agreement Type Axis" } } }, "auth_ref": [] }, "vsee_AgreementTypeDomainDomain": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "AgreementTypeDomainDomain", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "label": "AgreementTypeDomain [Domain]" } } }, "auth_ref": [] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Adjustments to Compensation [Member]", "terseLabel": "All Adjustments to Compensation" } } }, "auth_ref": [ "r1220" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Executive Categories [Member]", "terseLabel": "All Executive Categories" } } }, "auth_ref": [ "r1227" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "All Individuals [Member]", "terseLabel": "All Individuals" } } }, "auth_ref": [ "r1174", "r1185", "r1201", "r1227", "r1236", "r1240", "r1248" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "All Trading Arrangements [Member]", "terseLabel": "All Trading Arrangements" } } }, "auth_ref": [ "r1246" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation", "verboseLabel": "Share-based compensation expense (in Dollars)", "netLabel": "Share-based compensation expense", "label": "Share-Based Payment Arrangement, Expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r493", "r496", "r505" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AllowanceForDoubtfulAccountsReceivable", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofAllowanceforCreditLossesTable", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning allowance for credit losses", "periodEndLabel": "Ending allowance for credit losses", "terseLabel": "Allowance for credit losses", "label": "Accounts Receivable, Allowance for Credit Loss", "documentation": "Amount of allowance for credit loss on accounts receivable." } } }, "auth_ref": [ "r144", "r264", "r301", "r304", "r306", "r1554" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Allowance for credit losses", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current." } } }, "auth_ref": [ "r144", "r264", "r301" ] }, "vsee_AltaMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "AltaMember", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Alta [Member]", "label": "Alta Member" } } }, "auth_ref": [] }, "vsee_AltaWarrantsExercisableCommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "AltaWarrantsExercisableCommonStockMember", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Alta warrants Exercisable Common Stock [Member]", "label": "Alta Warrants Exercisable Common Stock Member" } } }, "auth_ref": [] }, "vsee_AmendedAndRestatedConversionSecuritiesPurchaseAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "AmendedAndRestatedConversionSecuritiesPurchaseAgreementsMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amended And Restated Conversion Securities Purchase Agreements [Member]", "documentation": "Represents information related to amended and restated conversion conversion securities purchase agreement.", "label": "Amended And Restated Conversion Securities Purchase Agreements Member" } } }, "auth_ref": [] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AmendmentDescription", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AmendmentFlag", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfDebtDiscountPremium": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AmortizationOfDebtDiscountPremium", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of discount on note payable", "label": "Amortization of Debt Discount (Premium)", "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense." } } }, "auth_ref": [ "r4", "r72", "r392", "r1531" ] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization expense", "label": "Amortization of Intangible Assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets." } } }, "auth_ref": [ "r4", "r159", "r330", "r337", "r991", "r996", "r997", "r999", "r1001" ] }, "vsee_AmortizationOfRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "AmortizationOfRightOfUseAsset", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of right-of-use assets", "documentation": "Amount of amortization expense attributable to right-of-use asset.", "label": "Amortization Of Right Of Use Asset" } } }, "auth_ref": [] }, "vsee_AmountPaidByInvestor": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "AmountPaidByInvestor", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount paid by investor", "documentation": "The amount paid by an accredited investor in a partnership agreement with the company.", "label": "Amount Paid By Investor" } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AnnualInformationForm", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r1177" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable" ], "lang": { "en-us": { "role": { "terseLabel": "Anti-dilutive shares outstanding", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r207" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "presentation": [ "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities [Axis]", "documentation": "Information by type of antidilutive security." } } }, "auth_ref": [ "r207" ] }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AntidilutiveSecuritiesNameDomain", "presentation": [ "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities, Name [Domain]", "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "auth_ref": [ "r207" ] }, "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": { "xbrltype": "dateOrAsapItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Approximate Date of Commencement of Proposed Sale to Public", "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings." } } }, "auth_ref": [] }, "vsee_April2025PromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "April2025PromissoryNoteMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "April 2025 Promissory Note [Member]", "label": "April2025 Promissory Note Member" } } }, "auth_ref": [] }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ArrangementsAndNonarrangementTransactionsMember", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]", "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r613" ] }, "us-gaap_AssetAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AssetAcquisitionAxis", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Asset Acquisition [Axis]", "documentation": "Information by asset acquisition." } } }, "auth_ref": [ "r327", "r331", "r332", "r333", "r334", "r335", "r855", "r1501" ] }, "us-gaap_AssetAcquisitionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AssetAcquisitionDomain", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Asset Acquisition [Domain]", "documentation": "Asset acquisition." } } }, "auth_ref": [ "r327", "r331", "r332", "r333", "r334", "r335", "r855", "r1501" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "Assets", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ScheduleofTotalAssetsbySegmentTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "terseLabel": "Total assets", "label": "Assets", "documentation": "Amount of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r94", "r107", "r138", "r169", "r172", "r173", "r210", "r224", "r250", "r254", "r298", "r359", "r360", "r362", "r363", "r364", "r365", "r366", "r368", "r369", "r615", "r620", "r677", "r798", "r799", "r808", "r913", "r1014", "r1015", "r1028", "r1110", "r1129", "r1130", "r1142", "r1429", "r1430", "r1542" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AssetsAbstract", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "ASSETS", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Amount of asset recognized for present right to economic benefit, classified as current." } } }, "auth_ref": [ "r131", "r145", "r169", "r172", "r173", "r298", "r359", "r360", "r362", "r363", "r364", "r365", "r366", "r368", "r369", "r615", "r620", "r677", "r1110", "r1429", "r1430", "r1542" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AssetsCurrentAbstract", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Current assets", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AssetsNoncurrentAbstract", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Non-current assets", "label": "Assets, Noncurrent [Abstract]" } } }, "auth_ref": [] }, "vsee_AssignmentOfALoanLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "AssignmentOfALoanLiability", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assignment of a loan liability", "documentation": "Assignment of a loan liability.", "label": "Assignment Of ALoan Liability" } } }, "auth_ref": [] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r1177" ] }, "dei_AuditorFirmId": { "xbrltype": "nonemptySequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AuditorFirmId", "presentation": [ "http://xbrl.sec.gov/dei/role/document/AuditInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Firm ID", "documentation": "PCAOB issued Audit Firm Identifier" } } }, "auth_ref": [ "r1155", "r1158", "r1177" ] }, "dei_AuditorLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AuditorLineItems", "lang": { "en-us": { "role": { "label": "Auditor [Line Items]" } } }, "auth_ref": [] }, "dei_AuditorLocation": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AuditorLocation", "presentation": [ "http://xbrl.sec.gov/dei/role/document/AuditInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "auth_ref": [ "r1155", "r1158", "r1177" ] }, "dei_AuditorName": { "xbrltype": "internationalNameItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AuditorName", "presentation": [ "http://xbrl.sec.gov/dei/role/document/AuditInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "auth_ref": [ "r1155", "r1158", "r1177" ] }, "dei_AuditorOpinionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AuditorOpinionTextBlock", "presentation": [ "http://xbrl.sec.gov/dei/role/document/AuditInformation" ], "lang": { "en-us": { "role": { "label": "Auditor Opinion [Text Block]" } } }, "auth_ref": [ "r1266" ] }, "dei_AuditorTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "AuditorTable", "presentation": [ "http://xbrl.sec.gov/dei/role/document/AuditInformation" ], "lang": { "en-us": { "role": { "label": "Auditor [Table]" } } }, "auth_ref": [] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Exercise Price", "terseLabel": "Exercise Price" } } }, "auth_ref": [ "r1243" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Grant Date Fair Value", "terseLabel": "Fair Value as of Grant Date" } } }, "auth_ref": [ "r1244" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]", "terseLabel": "Award Timing Disclosures" } } }, "auth_ref": [ "r1239" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered [Text Block]", "terseLabel": "Award Timing, How MNPI Considered" } } }, "auth_ref": [ "r1239" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Method [Text Block]", "terseLabel": "Award Timing Method" } } }, "auth_ref": [ "r1239" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered [Flag]", "terseLabel": "Award Timing MNPI Considered" } } }, "auth_ref": [ "r1239" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure [Text Block]", "terseLabel": "Award Timing MNPI Disclosure" } } }, "auth_ref": [ "r1239" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined [Flag]", "terseLabel": "Award Timing Predetermined" } } }, "auth_ref": [ "r1239" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "AwardTypeAxis", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/EquityDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "terseLabel": "Award Type", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r464", "r465", "r466", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r488", "r489", "r490", "r491", "r492" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Underlying Securities Amount", "terseLabel": "Underlying Securities" } } }, "auth_ref": [ "r1242" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r1241" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]", "terseLabel": "Awards Close in Time to MNPI Disclosures" } } }, "auth_ref": [ "r1240" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]", "terseLabel": "Awards Close in Time to MNPI Disclosures, Table" } } }, "auth_ref": [ "r1240" ] }, "vsee_BidPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BidPricePerShare", "presentation": [ "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Bid price per share (in Dollars per share)", "documentation": "It represents the bid price per share regained by the entity.", "label": "Bid Price Per Share" } } }, "auth_ref": [] }, "vsee_BridgeExchangeAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BridgeExchangeAgreementMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Bridge Exchange Agreement", "verboseLabel": "Bridge Exchange Agreement [Member]", "documentation": "Represents the information pertaining to bridge exchange agreement.", "label": "Bridge Exchange Agreement Member" } } }, "auth_ref": [] }, "vsee_BridgeInvestorMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BridgeInvestorMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/ScheduleofCommonStockBusinessCombinationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Bridge Investor [Member]", "documentation": "Represents information related to Bridge Investor.", "label": "Bridge Investor Member" } } }, "auth_ref": [] }, "vsee_BridgeNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BridgeNotesMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Bridge Notes [Member]", "documentation": "Represents information relating to the bridge notes issued by the entity.", "label": "Bridge Notes Member" } } }, "auth_ref": [] }, "vsee_BridgeSecuritiesPurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BridgeSecuritiesPurchaseAgreementMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Bridge Securities Purchase Agreement [Member]", "documentation": "It represents bridge securities purchase agreement.", "label": "Bridge Securities Purchase Agreement Member" } } }, "auth_ref": [] }, "vsee_BridgeWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BridgeWarrantsMember", "presentation": [ "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable", "http://vseehealth.com/role/ScheduleofWarrantsIssuedandoutstandingTable", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Bridge Warrants [Member]", "verboseLabel": "Bridge [Member]", "documentation": "Represents information pertaining to Bridge Warrants.", "label": "Bridge Warrants Member" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/BusinessCombinationTables", "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofCommonStockBusinessCombinationTable", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "label": "Business Combination [Domain]", "documentation": "Business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r327", "r331", "r332", "r333", "r334", "r335", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r585", "r586", "r587", "r588", "r589", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r607", "r608", "r609", "r855", "r1044", "r1045", "r1488", "r1493", "r1495" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/BusinessCombinationTables", "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/ConsolidatedCashFlow_Parentheticals", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable", "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable_Parentheticals", "http://vseehealth.com/role/ScheduleofCommonStockBusinessCombinationTable", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable_Parentheticals", "http://vseehealth.com/role/ScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationTable", "http://vseehealth.com/role/ShareholdersEquityType2or3", "http://vseehealth.com/role/ShareholdersEquityType2or3_Parentheticals" ], "lang": { "en-us": { "role": { "label": "Business Combination [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r327", "r331", "r332", "r333", "r334", "r335", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r585", "r586", "r587", "r588", "r589", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r607", "r608", "r609", "r855", "r1044", "r1045", "r1488", "r1493", "r1495" ] }, "vsee_BusinessAcquisitionCommonStockIssuedOrIssuableNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessAcquisitionCommonStockIssuedOrIssuableNumberOfShares", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares of common stock issued to seller (in Shares)", "verboseLabel": "Number of shares of common stock issued to seller", "documentation": "Number of common shares of equity interests issued or issuable to acquire entity.", "label": "Business Acquisition Common Stock Issued Or Issuable Number Of Shares" } } }, "auth_ref": [] }, "vsee_BusinessAcquisitionCommonStockIssuedOrIssuableUponDebtConversionNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessAcquisitionCommonStockIssuedOrIssuableUponDebtConversionNumberOfShares", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares of common stock issued upon conversion of debt (in Shares)", "verboseLabel": "Number of shares of common stock issued upon conversion of debt", "documentation": "Number of common shares of equity interests issued or issuable upon debt conversion to acquire entity.", "label": "Business Acquisition Common Stock Issued Or Issuable Upon Debt Conversion Number Of Shares" } } }, "auth_ref": [] }, "vsee_BusinessAcquisitionCommonStockIssuedOrIssuableUponDebtConversionValueAssigned": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessAcquisitionCommonStockIssuedOrIssuableUponDebtConversionValueAssigned", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "292,500 shares of common stock issued upon conversion of debt at $12.11 per share", "documentation": "Amount of common stock issued or issuable upon debt conversion in consideration for the business combination.", "label": "Business Acquisition Common Stock Issued Or Issuable Upon Debt Conversion Value Assigned" } } }, "auth_ref": [] }, "vsee_BusinessAcquisitionCommonStockIssuedOrIssuableValueAssigned": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessAcquisitionCommonStockIssuedOrIssuableValueAssigned", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "4,950,000 shares of common stock issued to sellers at $12.11 per share", "documentation": "Amount of common stock issued or issuable in consideration for the business combination.", "label": "Business Acquisition Common Stock Issued Or Issuable Value Assigned" } } }, "auth_ref": [] }, "vsee_BusinessAcquisitionEquityInterestConvertedValue": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessAcquisitionEquityInterestConvertedValue", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Notes converted (in Dollars)", "documentation": "Value of equity interests (such as common shares, preferred shares, or partnership interest) converted to acquire the entity.", "label": "Business Acquisition Equity Interest Converted Value" } } }, "auth_ref": [] }, "vsee_BusinessAcquisitionEquityInterestIssuableNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessAcquisitionEquityInterestIssuableNumberOfShares", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity interests issuable", "documentation": "Number of shares of equity interests issuable to acquire entity.", "label": "Business Acquisition Equity Interest Issuable Number Of Shares" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Total purchase consideration", "verboseLabel": "Total purchase consideration (in Dollars)", "label": "Business Combination, Consideration Transferred, Equity Interest, Share Issued, Value", "documentation": "Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity." } } }, "auth_ref": [ "r1498", "r1499" ] }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares issued for business combination", "label": "Business Combination, Consideration Transferred, Equity Interest, Share Issued, Number of Shares", "documentation": "Number of shares of equity interest issued or issuable by acquirer as part of consideration transferred in business combination." } } }, "auth_ref": [ "r1049", "r1054", "r1055", "r1089", "r1090" ] }, "us-gaap_BusinessAcquisitionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessAcquisitionLineItems", "presentation": [ "http://vseehealth.com/role/BusinessCombinationTables", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable_Parentheticals" ], "lang": { "en-us": { "role": { "label": "Business Combination", "terseLabel": "Organization and Description of Business", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r327", "r549", "r550", "r551", "r552", "r558", "r559", "r560", "r561", "r567", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r585", "r586", "r587", "r588", "r589", "r592", "r593", "r594", "r595", "r596", "r597", "r603", "r604", "r605", "r609", "r1049", "r1059", "r1488", "r1493", "r1495" ] }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Business acquisition percentage of voting interests acquired", "label": "Business Combination, Voting Equity Interest Acquired, Percentage", "documentation": "Percentage of voting equity interest acquired in business combination." } } }, "auth_ref": [ "r551", "r1049", "r1052" ] }, "vsee_BusinessAcquisitionPreferredStockIssuedOrIssuableUponDebtConversionSharesAssigned": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessAcquisitionPreferredStockIssuedOrIssuableUponDebtConversionSharesAssigned", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock issuable upon conversion (in Shares)", "verboseLabel": "Common stock issuable upon conversion", "documentation": "Shares of preferred stock issued or issuable to acquire the entity.", "label": "Business Acquisition Preferred Stock Issued Or Issuable Upon Debt Conversion Shares Assigned" } } }, "auth_ref": [] }, "vsee_BusinessAcquisitionPreferredStockIssuedOrIssuableUponDebtConversionValueAssigned": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessAcquisitionPreferredStockIssuedOrIssuableUponDebtConversionValueAssigned", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "300 shares of series A preferred stock issued upon conversion of debt, of which upon conversion, 150,000 shares of common stock are issuable, at $12.11 per share", "documentation": "Amount of preferred stock issued or issuable upon debt conversion in consideration for the business combination.", "label": "Business Acquisition Preferred Stock Issued Or Issuable Upon Debt Conversion Value Assigned" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessAcquisitionProFormaEarningsPerShareBasic", "presentation": [ "http://vseehealth.com/role/ScheduleofProformaFinancialInformationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Net loss per share, basic (in Dollars per share)", "label": "Business Combination, Pro Forma Information, Pro Forma Earnings Per Share, Basic", "documentation": "Per basic share amount, after tax, of pro forma income (loss) of combined entity as if acquisition date of business combination occurred as of beginning of period." } } }, "auth_ref": [ "r1286", "r1287", "r1489" ] }, "us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessAcquisitionProFormaEarningsPerShareDiluted", "presentation": [ "http://vseehealth.com/role/ScheduleofProformaFinancialInformationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Net loss per share, diluted (in Dollars per share)", "label": "Business Combination, Pro Forma Information, Pro Forma Earnings Per Share, Diluted", "documentation": "Per diluted share amount, after tax, of pro forma income (loss) of combined entity as if acquisition date of business combination occurred as of beginning of period." } } }, "auth_ref": [ "r1286", "r1287", "r1489" ] }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessAcquisitionProFormaInformationTextBlock", "presentation": [ "http://vseehealth.com/role/BusinessCombinationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Pro forma Financial Information", "label": "Business Combination, Pro Forma Information [Table Text Block]", "documentation": "Tabular disclosure of pro forma revenue and earnings for business combination or aggregate of series of individually immaterial business combinations." } } }, "auth_ref": [ "r1049", "r1060", "r1286", "r1287", "r1489" ] }, "vsee_BusinessAcquisitionProFormaOperatingLeaseExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessAcquisitionProFormaOperatingLeaseExpense", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofProformaFinancialInformationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease expense", "documentation": "The pro forma operating lease expense.", "label": "Business Acquisition Pro Forma Operating Lease Expense" } } }, "auth_ref": [] }, "vsee_BusinessAcquisitionProFormaTransactionExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessAcquisitionProFormaTransactionExpenses", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofProformaFinancialInformationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Transaction expenses", "documentation": "The pro forma transaction expenses for a period as if the business combination or combinations had been completed at the beginning of the period.", "label": "Business Acquisition Pro Forma Transaction Expenses" } } }, "auth_ref": [] }, "vsee_BusinessAcquisitionProFormaWeightedAverageSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessAcquisitionProFormaWeightedAverageSharesOutstandingBasic", "presentation": [ "http://vseehealth.com/role/ScheduleofProformaFinancialInformationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average shares, basic (in Shares)", "documentation": "The pro forma basic weighted average shares outstanding for a period as if the business combination or combinations had been completed at the beginning of a period.", "label": "Business Acquisition Pro Forma Weighted Average Shares Outstanding Basic" } } }, "auth_ref": [] }, "vsee_BusinessAcquisitionProFormaWeightedAverageSharesOutstandingDiluted": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessAcquisitionProFormaWeightedAverageSharesOutstandingDiluted", "presentation": [ "http://vseehealth.com/role/ScheduleofProformaFinancialInformationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average shares, diluted (in Shares)", "documentation": "The pro forma diluted weighted average shares outstanding for a period as if the business combination or combinations had been completed at the beginning of a period.", "label": "Business Acquisition Pro Forma Weighted Average Shares Outstanding Diluted" } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionSharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessAcquisitionSharePrice", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Share price per share (in Dollars per share)", "label": "Business Combination, Price Per Share", "documentation": "Per share price of saleable stock paid or offered to be paid by acquirer in business combination." } } }, "auth_ref": [ "r1091", "r1491", "r1492", "r1498", "r1499" ] }, "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessAcquisitionsProFormaNetIncomeLoss", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofProformaFinancialInformationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Net loss", "label": "Business Combination, Pro Forma Information, Pro Forma Income (Loss), after Tax", "documentation": "Amount, after tax, of pro forma income (loss) of combined entity as if acquisition date of business combination occurred as of beginning of period." } } }, "auth_ref": [ "r564", "r565", "r567", "r1049", "r1060", "r1061" ] }, "us-gaap_BusinessAcquisitionsProFormaRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessAcquisitionsProFormaRevenue", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofProformaFinancialInformationTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total revenues", "label": "Business Combination, Pro Forma Information, Pro Forma Revenue", "documentation": "Amount of pro forma revenue of combined entity as if acquisition date of business combination occurred as of beginning of period." } } }, "auth_ref": [ "r564", "r565", "r567", "r1049", "r1060" ] }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationAcquisitionRelatedCosts", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Transaction expenses", "label": "Business Combination, Acquisition-Related Cost, Expense", "documentation": "Amount of expense for acquisition-related cost incurred to effect business combination. Includes, but is not limited to, finder's fee; advisory, legal, accounting, valuation, and other professional and consulting fees; and general administrative cost, including cost of maintaining internal acquisition department." } } }, "auth_ref": [ "r1486", "r1490" ] }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationConsiderationTransferred1", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Total purchase price consideration, net of cash acquired of $29,123", "label": "Business Combination, Consideration Transferred", "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer." } } }, "auth_ref": [ "r593", "r605", "r1049", "r1054" ] }, "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate principal amount of outstanding notes (in Dollars)", "label": "Business Combination, Consideration Transferred, Liabilities Incurred", "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination." } } }, "auth_ref": [ "r596", "r1049", "r1054", "r1090" ] }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationContingentConsiderationLiability", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense", "label": "Business Combination, Contingent Consideration, Liability", "documentation": "Amount of liability recognized arising from contingent consideration in a business combination." } } }, "auth_ref": [ "r598", "r605", "r649", "r650", "r651", "r1049", "r1056" ] }, "vsee_BusinessCombinationDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessCombinationDetailsLineItems", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination (Details) [Line Items]" } } }, "auth_ref": [] }, "vsee_BusinessCombinationDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessCombinationDetailsTable", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "label": "Business Combination (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationDisclosureTextBlock", "presentation": [ "http://vseehealth.com/role/BusinessCombination" ], "lang": { "en-us": { "role": { "terseLabel": "Business Combination", "label": "Business Combination [Text Block]", "documentation": "The entire disclosure for business combination." } } }, "auth_ref": [ "r546", "r549", "r553", "r562", "r566", "r567", "r568", "r569", "r570", "r571", "r573", "r574", "r580", "r583", "r584", "r590", "r591", "r592", "r600", "r604", "r605", "r606", "r608", "r610", "r1049", "r1050", "r1051", "r1052", "r1056", "r1057", "r1058" ] }, "vsee_BusinessCombinationNotesAssumedFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessCombinationNotesAssumedFairValue", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate fair value of notes (in Dollars)", "documentation": "Fair value of notes payable assumed which have been recognized as of the acquisition date.", "label": "Business Combination Notes Assumed Fair Value" } } }, "auth_ref": [] }, "vsee_BusinessCombinationNumberOfSharesCalledByEachRightsIssued": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessCombinationNumberOfSharesCalledByEachRightsIssued", "presentation": [ "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares of common stock called by each rights issued", "documentation": "The number of shares or fractional shares that each right entitles the holder, issued pursuant to business combination transaction.", "label": "Business Combination Number Of Shares Called By Each Rights Issued" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net loss since the date of acquisition (in Dollars)", "label": "Business Combination, Acquiree's Earnings (Loss) since Acquisition Date, Actual", "documentation": "Amount of acquiree's earnings (loss) since acquisition date of business combination included in consolidated statement of income." } } }, "auth_ref": [ "r563", "r567", "r1049", "r1060" ] }, "vsee_BusinessCombinationProFormaInformationGoodwillImpairmentChargeOfAcquireeActual": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessCombinationProFormaInformationGoodwillImpairmentChargeOfAcquireeActual", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill impairment since the date of acquisition (in Dollars)", "documentation": "This element represents the amount of goodwill impairment of the acquiree since the acquisition date included in the consolidated income statement for the reporting period.", "label": "Business Combination Pro Forma Information Goodwill Impairment Charge Of Acquiree Actual" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue since the date of acquisition (in Dollars)", "label": "Business Combination, Acquiree's Revenue since Acquisition Date, Actual", "documentation": "Amount of acquiree's revenue since acquisition date of business combination included in consolidated statement of income." } } }, "auth_ref": [ "r563", "r567", "r1049", "r1060" ] }, "vsee_BusinessCombinationPurchaseConsiderationPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessCombinationPurchaseConsiderationPayableCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Encompass Purchase Liability", "verboseLabel": "Encompass purchase liability", "documentation": "Carrying value as of the balance sheet date of business combination purchase consideration due within one year or the operating cycle.", "label": "Business Combination Purchase Consideration Payable Current" } } }, "auth_ref": [] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedFinanceLeaseObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedFinanceLeaseObligation", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Lease liabilities - finance", "documentation": "Amount of finance lease obligation assumed in business combination.", "label": "Business Combination Recognized Identifiable Asset Acquired And Liability Assumed Finance Lease Obligation" } } }, "auth_ref": [] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedOperatingLeaseObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedOperatingLeaseObligation", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Lease liabilities - operating", "documentation": "Amount of operating lease obligation assumed in business combination.", "label": "Business Combination Recognized Identifiable Asset Acquired And Liability Assumed Operating Lease Obligation" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets acquired", "label": "Business Combination, Recognized Asset Acquired, Asset", "documentation": "Amount of asset acquired in business combination and recognized at acquisition date." } } }, "auth_ref": [ "r578", "r583" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Cash - Trust and cash", "label": "Business Combination, Recognized Asset Acquired, Cash and Cash Equivalent", "documentation": "Amount of cash and cash equivalent acquired in business combination and recognized at acquisition date." } } }, "auth_ref": [ "r1494", "r1496" ] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAccountsReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAccountsReceivables", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable, net", "documentation": "Amount of accounts receivables, that have been delivered or sold in the normal course of business, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Accounts Receivables" } } }, "auth_ref": [] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAccountsReceivablesGross": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAccountsReceivablesGross", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross contractual accounts receivable (in Dollars)", "documentation": "Amount of gross accounts receivables, that have been delivered or sold in the normal course of business, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Accounts Receivables Gross" } } }, "auth_ref": [] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAccountsReceivablesNotExpectedToBeCollected": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAccountsReceivablesNotExpectedToBeCollected", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross contractual accounts receivable not expected to be collected (in Dollars)", "documentation": "Amount of gross accounts receivables that are not expected to be collected from customers.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Accounts Receivables Not Expected To Be Collected" } } }, "auth_ref": [] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsNotesReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsNotesReceivables", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Note receivable, related party", "documentation": "Amount of notes receivables, that have been delivered or sold in the normal course of business, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Notes Receivables" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses and other current assets", "label": "Business Combination, Recognized Asset Acquired, Prepaid Expense and Other Asset, Current", "documentation": "Amount of prepaid expense and asset classified as other, acquired in business combination and recognized at acquisition date, classified as current." } } }, "auth_ref": [ "r1494", "r1496" ] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesFromRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesFromRelatedParties", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Due from related party", "documentation": "Amount due from customers or clients for goods or services, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables From Related Parties" } } }, "auth_ref": [] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedLiabilitiesAndOtherLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayableAccruedLiabilitiesAndOtherLiabilities", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable, accrued expenses and other current liabilities", "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, accrued liabilities and other liabilities, assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable Accrued Liabilities And Other Liabilities" } } }, "auth_ref": [] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Accrued Expenses", "documentation": "Amount of expenses of taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. used in an entity's business assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accrued Expenses" } } }, "auth_ref": [] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDerivativeLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDerivativeLiability", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Extension Note - Embedded Derivative", "documentation": "Amount of derivative liability due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Derivative Liability" } } }, "auth_ref": [] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesExchangeNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesExchangeNotesPayable", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Exchange Note", "documentation": "Amount of exchange notes payables due within one year or within the normal operating cycle, if longer assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Exchange Notes Payable" } } }, "auth_ref": [] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLineOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLineOfCredit", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationTable" ], "lang": { "en-us": { "role": { "negatedLabel": "ELOC", "documentation": "Amount of line of credit payables due within one year or within the normal operating cycle, if longer assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Line Of Credit" } } }, "auth_ref": [] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableExtensionLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableExtensionLoan", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Promissory Note - Extension Note", "documentation": "Amount of extension notes payables due within one year or within the normal operating cycle, if longer assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Notes Payable Extension Loan" } } }, "auth_ref": [] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedPartyOther": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedPartyOther", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Promissory Note - SCS Capital Partners LLC", "documentation": "Amount of notes payables to the related party due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Notes Payable Related Party Other" } } }, "auth_ref": [] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedPartySponsor": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedPartySponsor", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Promissory Note - Related Party", "documentation": "Amount of notes payables to the sponsor due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Notes Payable Related Party Sponsor" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Due to Sponsor", "label": "Business Combination, Recognized Liability Assumed, Other Liability, Current", "documentation": "Amount of liability assumed in business combination and recognized at acquisition date, classified as other and current." } } }, "auth_ref": [ "r1494", "r1496" ] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesPromissoryNotesPayableAdditionalBridgeLoans": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesPromissoryNotesPayableAdditionalBridgeLoans", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Additional Bridge Notes", "documentation": "Amount of notes payable related to additional bridge loans due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Promissory Notes Payable Additional Bridge Loans" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax liabilities", "label": "Business Combination, Recognized Liability Assumed, Deferred Tax Liability", "documentation": "Amount of deferred tax liability assumed in business combination and recognized at acquisition date." } } }, "auth_ref": [ "r1494", "r1496" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other intangible assets (in Dollars)", "label": "Business Combination, Recognized Asset Acquired, Identifiable Intangible Asset, Excluding Goodwill", "documentation": "Amount of identifiable intangible asset acquired in business combination and recognized at acquisition date. Excludes goodwill and financial asset." } } }, "auth_ref": [ "r1049", "r1054", "r1057", "r1494", "r1496" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets", "label": "Business Combination, Recognized Asset Acquired, Identifiable Intangible Asset, Finite-Lived", "documentation": "Amount of identifiable finite-lived intangible asset acquired in business combination and recognized at acquisition date." } } }, "auth_ref": [ "r1494", "r1496" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable", "http://vseehealth.com/role/ScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities assumed", "negatedTotalLabel": "Total liabilities assumed", "label": "Business Combination, Recognized Liability Assumed, Liability", "documentation": "Amount of liability assumed in business combination and recognized at acquisition date." } } }, "auth_ref": [ "r578", "r583" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/ScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Net liabilities assumed", "verboseLabel": "Net liabilities assumed (in Dollars)", "label": "Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less)", "documentation": "Amount of asset acquired in excess of (less than) liability assumed in business combination and recognized at acquisition date. Excludes goodwill." } } }, "auth_ref": [ "r1049", "r1054", "r1494", "r1496" ] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesDeferredOfferingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesDeferredOfferingCosts", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Deferred Underwriting Fee Payable", "documentation": "Amount of deferred offering costs due after one year or the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities Deferred Offering Costs" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Line of credit and notes payable", "label": "Business Combination, Recognized Liability Assumed, Long-Term Debt, Noncurrent", "documentation": "Amount of long-term debt assumed in business combination and recognized at acquisition date, classified as noncurrent." } } }, "auth_ref": [ "r1494", "r1496" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/FixedAssetsDetails", "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Fixed assets", "verboseLabel": "Property and equipment", "label": "Business Combination, Recognized Asset Acquired, Property, Plant, and Equipment", "documentation": "Amount of property, plant, and equipment acquired in business combination and recognized at acquisition date." } } }, "auth_ref": [ "r1049", "r1054", "r1494", "r1496" ] }, "vsee_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRightOfUseAssets", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Right-of-use assets", "documentation": "The amount of right of use assets recognized as of the acquisition date.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Right Of Use Assets" } } }, "auth_ref": [] }, "vsee_BusinessCombinationScheduleofAllocationofTotalPurchaseConsiderationDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessCombinationScheduleofAllocationofTotalPurchaseConsiderationDetailsLineItems", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "label": "Business Combination - Schedule of Allocation of Total Purchase Consideration (Details) [Line Items]" } } }, "auth_ref": [] }, "vsee_BusinessCombinationScheduleofAllocationofTotalPurchaseConsiderationDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessCombinationScheduleofAllocationofTotalPurchaseConsiderationDetailsTable", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "label": "Business Combination - Schedule of Allocation of Total Purchase Consideration (Details) [Table]" } } }, "auth_ref": [] }, "vsee_BusinessCombinationScheduleofAllocationofTotalPurchaseConsiderationParentheticalsDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessCombinationScheduleofAllocationofTotalPurchaseConsiderationParentheticalsDetailsLineItems", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable_Parentheticals" ], "lang": { "en-us": { "role": { "label": "Business Combination - Schedule of Allocation of Total Purchase Consideration (Parentheticals) (Details) [Line Items]" } } }, "auth_ref": [] }, "vsee_BusinessCombinationScheduleofAllocationofTotalPurchaseConsiderationParentheticalsDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessCombinationScheduleofAllocationofTotalPurchaseConsiderationParentheticalsDetailsTable", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable_Parentheticals" ], "lang": { "en-us": { "role": { "label": "Business Combination - Schedule of Allocation of Total Purchase Consideration (Parentheticals) (Details) [Table]" } } }, "auth_ref": [] }, "vsee_BusinessCombinationScheduleofCommonStockBusinessCombinationDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessCombinationScheduleofCommonStockBusinessCombinationDetailsLineItems", "presentation": [ "http://vseehealth.com/role/ScheduleofCommonStockBusinessCombinationTable" ], "lang": { "en-us": { "role": { "label": "Business Combination - Schedule of Common Stock Business Combination (Details) [Line Items]" } } }, "auth_ref": [] }, "vsee_BusinessCombinationScheduleofCommonStockBusinessCombinationDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessCombinationScheduleofCommonStockBusinessCombinationDetailsTable", "presentation": [ "http://vseehealth.com/role/ScheduleofCommonStockBusinessCombinationTable" ], "lang": { "en-us": { "role": { "label": "Business Combination - Schedule of Common Stock Business Combination (Details) [Table]" } } }, "auth_ref": [] }, "vsee_BusinessCombinationScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessCombinationScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationDetailsLineItems", "presentation": [ "http://vseehealth.com/role/ScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationTable" ], "lang": { "en-us": { "role": { "label": "Business Combination - Schedule of the Recapitalization and Net Equity Impact on Business Combination (Details) [Line Items]" } } }, "auth_ref": [] }, "vsee_BusinessCombinationScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "BusinessCombinationScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationDetailsTable", "presentation": [ "http://vseehealth.com/role/ScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationTable" ], "lang": { "en-us": { "role": { "label": "Business Combination - Schedule of the Recapitalization and Net Equity Impact on Business Combination (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow_Parentheticals", "http://vseehealth.com/role/ShareholdersEquityType2or3_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of equity interest to obtain in acquisition", "label": "Business Combination, Achieved in Stages, Preacquisition and Acquired Equity Interests in Acquiree, Percentage", "documentation": "Percentage of voting equity interests acquired in a business combination achieved in stages, including equity interests in the acquiree held by the acquirer immediately before the acquisition date and acquired at the acquisition date." } } }, "auth_ref": [ "r1487", "r1488", "r1489" ] }, "us-gaap_BusinessCombinationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationsAbstract", "lang": { "en-us": { "role": { "label": "Business Combination [Abstract]" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "BusinessCombinationsPolicy", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Transaction Expenses", "label": "Business Combination [Policy Text Block]", "documentation": "Disclosure of accounting policy for business combination." } } }, "auth_ref": [ "r547", "r548", "r554", "r556", "r567", "r579", "r583", "r1049", "r1055", "r1089", "r1090" ] }, "dei_BusinessContactMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "BusinessContactMember", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Business Contact [Member]", "documentation": "Business contact for the entity" } } }, "auth_ref": [ "r1158", "r1177" ] }, "vsee_CapitalExpendituresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "CapitalExpendituresAbstract", "presentation": [ "http://vseehealth.com/role/ScheduleofReportableSegmentDepreciationandAmortizationandCapitalExpendituresTable" ], "lang": { "en-us": { "role": { "terseLabel": "Capital Expenditures:", "label": "Capital Expenditures Abstract" } } }, "auth_ref": [] }, "us-gaap_Cash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "Cash", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash", "label": "Cash", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r110", "r812", "r885", "r908", "r1110", "r1129", "r1130", "r1142", "r1301" ] }, "us-gaap_CashAcquiredFromAcquisition": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashAcquiredFromAcquisition", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Cash acquired from Business Combination- iDoc", "verboseLabel": "Cash acquired in Business Combination - iDoc", "label": "Cash Acquired from Acquisition", "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business)." } } }, "auth_ref": [ "r13" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Cash", "label": "Cash and Cash Equivalent", "documentation": "Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate." } } }, "auth_ref": [ "r17", "r133", "r992" ] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Cash", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r18" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash, beginning of year", "periodEndLabel": "CASH, END OF THE YEAR", "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation", "documentation": "Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate." } } }, "auth_ref": [ "r17", "r77", "r166" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "totalLabel": "NET CHANGE IN CASH", "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation", "documentation": "Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate." } } }, "auth_ref": [ "r0", "r77" ] }, "us-gaap_CashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CashEquivalentsAtCarryingValue", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash equivalents", "label": "Cash Equivalents, at Carrying Value", "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r1301", "r1553" ] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote [Text Block]", "terseLabel": "Changed Peer Group, Footnote" } } }, "auth_ref": [ "r1218" ] }, "srt_ChiefExecutiveOfficerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "ChiefExecutiveOfficerMember", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Chief Executive Officer [Member]", "label": "Chief Executive Officer [Member]" } } }, "auth_ref": [ "r1393" ] }, "srt_ChiefFinancialOfficerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "ChiefFinancialOfficerMember", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Chief Financial Officer [Member]", "label": "Chief Financial Officer [Member]" } } }, "auth_ref": [ "r1393" ] }, "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]", "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year" } } }, "auth_ref": [ "r1215" ] }, "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]", "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested" } } }, "auth_ref": [ "r1213" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CityAreaCode", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ClassOfStockDomain", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable_Parentheticals", "http://vseehealth.com/role/ShareholdersEquityType2or3", "http://vseehealth.com/role/WarrantsDetails", "http://xbrl.sec.gov/dei/role/document/AuditInformation", "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r119", "r141", "r142", "r143", "r169", "r173", "r201", "r202", "r204", "r206", "r212", "r213", "r298", "r359", "r362", "r363", "r364", "r368", "r369", "r404", "r405", "r407", "r408", "r410", "r413", "r416", "r417", "r421", "r424", "r431", "r677", "r862", "r863", "r864", "r865", "r873", "r875", "r876", "r877", "r878", "r879", "r880", "r881", "r882", "r883", "r884", "r886", "r900", "r921", "r943", "r960", "r961", "r962", "r963", "r964", "r1278", "r1368", "r1370", "r1379" ] }, "vsee_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnGreaterOfMarketValueAndNewlyShareIssuedPrice": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnGreaterOfMarketValueAndNewlyShareIssuedPrice", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment percentage of Exercise price of warrants", "documentation": "Represents the percentage of adjustment to exercise price of warrants based on the greater of market value and newly issued share price.", "label": "Class Of Warrant Or Right Adjustment Of Exercise Price Of Warrants Or Rights Percent Based On Greater Of Market Value And Newly Share Issued Price" } } }, "auth_ref": [] }, "vsee_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketPrice": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketPrice", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment percentage of Redemption price of warrants", "documentation": "Represents the percentage of adjustment to redemption price of warrants or rights based on market value.", "label": "Class Of Warrant Or Right Adjustment Of Redemption Price Of Warrants Or Rights Percent Based On Market Price" } } }, "auth_ref": [] }, "vsee_ClassOfWarrantOrRightAssumed": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ClassOfWarrantOrRightAssumed", "presentation": [ "http://vseehealth.com/role/ScheduleofWarrantsIssuedandoutstandingTable" ], "lang": { "en-us": { "role": { "terseLabel": "Assumed at June 24, 2024", "documentation": "Number of warrants or rights assumed during the period.", "label": "Class Of Warrant Or Right Assumed" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ClassOfWarrantOrRightAxis", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofWarrantsIssuedandoutstandingTable", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Axis]", "documentation": "Information by type of warrant or right issued." } } }, "auth_ref": [ "r1439" ] }, "us-gaap_ClassOfWarrantOrRightDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ClassOfWarrantOrRightDomain", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofWarrantsIssuedandoutstandingTable", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Domain]", "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/ScheduleofWarrantsIssuedandoutstandingTable", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Exercise Price (in Dollars per share)", "verboseLabel": "Exercise price of warrants (in Dollars per share)", "netLabel": "Warrant shares per share (in Dollars per share)", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "documentation": "Exercise price per share or per unit of warrants or rights outstanding." } } }, "auth_ref": [ "r169", "r175", "r432" ] }, "vsee_ClassOfWarrantOrRightExercisedDuringPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ClassOfWarrantOrRightExercisedDuringPeriod", "presentation": [ "http://vseehealth.com/role/ScheduleofWarrantsIssuedandoutstandingTable" ], "lang": { "en-us": { "role": { "terseLabel": "Exercised", "documentation": "Class of Warrant or right exercised during period.", "label": "Class Of Warrant Or Right Exercised During Period" } } }, "auth_ref": [] }, "vsee_ClassOfWarrantOrRightIssued": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ClassOfWarrantOrRightIssued", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of warrant or right, issued", "documentation": "Number of warrants or rights issued.", "label": "Class Of Warrant Or Right Issued" } } }, "auth_ref": [] }, "vsee_ClassOfWarrantOrRightIssuedDuringPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ClassOfWarrantOrRightIssuedDuringPeriod", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofWarrantsIssuedandoutstandingTable", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Issued", "verboseLabel": "Warrants issued during period (in Shares)", "netLabel": "Warrants issued during period", "documentation": "Number of warrants or rights issued during the period.", "label": "Class Of Warrant Or Right Issued During Period" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ClassOfWarrantOrRightLineItems", "presentation": [ "http://vseehealth.com/role/ScheduleofWarrantsIssuedandoutstandingTable", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Line Items]", "terseLabel": "Warrants", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares of common stock per warrant or right", "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right", "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrants to purchase common stock (in Shares)", "verboseLabel": "Warrant shares", "netLabel": "Purchase an aggregate shares", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares." } } }, "auth_ref": [ "r432" ] }, "vsee_ClassOfWarrantOrRightNumberOfTradingDaysConsideredForDeterminationOfFairMarketValue": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ClassOfWarrantOrRightNumberOfTradingDaysConsideredForDeterminationOfFairMarketValue", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of trading days considered for determination of fair market value of warrants (in tradingdays)", "documentation": "Number of trading days over which average reported last sale price of the shares of common stock is considered for determination of Fair Market Value of warrants.", "label": "Class Of Warrant Or Right Number Of Trading Days Considered For Determination Of Fair Market Value" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ClassOfWarrantOrRightOutstanding", "presentation": [ "http://vseehealth.com/role/ScheduleofWarrantsIssuedandoutstandingTable", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Outstanding, Balance", "periodEndLabel": "Outstanding, Balance", "terseLabel": "Class of warrant or right, outstanding", "label": "Class of Warrant or Right, Outstanding", "documentation": "Number of warrants or rights outstanding." } } }, "auth_ref": [] }, "vsee_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsStockPriceTrigger", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock price trigger for redemption of warrants (in Dollars per share)", "documentation": "Price of the entity's common stock which would be required to be attained for triggering redemption of warrants.", "label": "Class Of Warrant Or Right Redemption Of Warrants Or Rights Stock Price Trigger" } } }, "auth_ref": [] }, "vsee_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdConsecutiveTradingDays", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Threshold consecutive trading days considered for redemption of warrants (in tradingdays)", "documentation": "Represents the threshold consecutive trading days over which the stock price is considered for redemption of warrants.", "label": "Class Of Warrant Or Right Redemption Of Warrants Or Rights Threshold Consecutive Trading Days" } } }, "auth_ref": [] }, "vsee_ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsThresholdTradingDays", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Threshold trading days considered for redemption of warrants (in tradingdays)", "documentation": "Represents the threshold trading days over which the stock price is considered for redemption of warrants.", "label": "Class Of Warrant Or Right Redemption Of Warrants Or Rights Threshold Trading Days" } } }, "auth_ref": [] }, "vsee_ClassOfWarrantOrRightRedemptionPrice": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ClassOfWarrantOrRightRedemptionPrice", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Redemption price of warrants (in Dollars per share)", "documentation": "The redemption price of class of warrant or rights.", "label": "Class Of Warrant Or Right Redemption Price" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ClassOfWarrantOrRightTable", "presentation": [ "http://vseehealth.com/role/ScheduleofWarrantsIssuedandoutstandingTable", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Table]", "documentation": "Disclosure of information about warrant or right issued that give holder right to purchase security from issuer at specific price within certain time frame." } } }, "auth_ref": [ "r1439" ] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount", "terseLabel": "Company Selected Measure Amount" } } }, "auth_ref": [ "r1219" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name", "terseLabel": "Company Selected Measure Name" } } }, "auth_ref": [ "r1219" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies (Note 10)", "label": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r53", "r99", "r811", "r899" ] }, "vsee_CommitmentsContingenciesAndConcentrationRiskDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "CommitmentsContingenciesAndConcentrationRiskDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments Contingencies And Concentration Risk Disclosure Abstract" } } }, "auth_ref": [] }, "vsee_CommitmentsContingenciesAndConcentrationRiskDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "CommitmentsContingenciesAndConcentrationRiskDisclosureTextBlock", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingencies" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies", "documentation": "The entire disclosure for commitments and contingencies and concentration of risks.", "label": "Commitments Contingencies And Concentration Risk Disclosure Text Block" } } }, "auth_ref": [] }, "vsee_CommitmentsandContingenciesDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "CommitmentsandContingenciesDetailsLineItems", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies (Details) [Line Items]" } } }, "auth_ref": [] }, "vsee_CommitmentsandContingenciesDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "CommitmentsandContingenciesDetailsTable", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares issued (in Shares)", "verboseLabel": "Common stock shares", "netLabel": "Issuance of common stock issuable (in Shares)", "label": "Common Stock, Capital Shares Reserved for Future Issuance", "documentation": "Aggregate number of common shares reserved for future issuance." } } }, "auth_ref": [ "r58" ] }, "vsee_CommonStockIssuanceObligationCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "CommonStockIssuanceObligationCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock issuance obligation", "verboseLabel": "Common stock issuance obligation (in Dollars)", "documentation": "Sum of the carrying values as of the balance sheet date of the portions of common stock issuance obligation within one year or the operating cycle if longer, net of discount.", "label": "Common Stock Issuance Obligation Current" } } }, "auth_ref": [] }, "vsee_CommonStockIssuanceObligationMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "CommonStockIssuanceObligationMember", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable", "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock Issuance Obligation [Member]", "verboseLabel": "Common stock issuance obligation [Member]", "documentation": "Represents information pertaining to common stock issuance obligation.", "label": "Common Stock Issuance Obligation Member" } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockMember", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/ShareholdersEquityType2or3", "http://vseehealth.com/role/WarrantsDetails", "http://xbrl.sec.gov/dei/role/document/AuditInformation", "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock [Member]", "verboseLabel": "Common Stock", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r1132", "r1133", "r1134", "r1136", "r1137", "r1138", "r1139", "r1375", "r1376", "r1378", "r1512", "r1585", "r1592" ] }, "vsee_CommonStockNumberOfSharesOwned": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "CommonStockNumberOfSharesOwned", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares of common stock owned by the holder (in Shares)", "documentation": "Number of shares of common stock owned by the holder as of the reporting date.", "label": "Common Stock Number Of Shares Owned" } } }, "auth_ref": [] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, par value (in Dollars per share)", "verboseLabel": "Common stock, par value per share (in Dollars per share)", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r58" ] }, "vsee_CommonStockPercentageOfCapitalSharesReservedForFutureIssuance": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "CommonStockPercentageOfCapitalSharesReservedForFutureIssuance", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of shares reserved for issuance", "documentation": "Percentage of common shares reserved for future issuance.", "label": "Common Stock Percentage Of Capital Shares Reserved For Future Issuance" } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares authorized (in Shares)", "verboseLabel": "Common stock, shares authorized", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r58", "r900" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockSharesIssued", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares issued (in Shares)", "verboseLabel": "Common stock issued shares", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r58" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/ScheduleofCommonStockBusinessCombinationTable", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Common stock outstanding immediately following the closing of the Business Combination", "terseLabel": "Common stock, shares outstanding (in Shares)", "verboseLabel": "Common stock outstanding immediately following the closing of the business combination", "netLabel": "Common stock, shares, outstanding", "label": "Common stock, shares outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r7", "r58", "r900", "r919", "r1592", "r1593" ] }, "vsee_CommonStockSharesSubscribedAndIssuable": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "CommonStockSharesSubscribedAndIssuable", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee subscription of shares (in Shares)", "documentation": "Number of common stock shares subscribed and issuable.", "label": "Common Stock Shares Subscribed And Issuable" } } }, "auth_ref": [] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, $0.0001 par value; 100,000,000 shares authorized; 33,193,140 and 16,297,190 shares issued and outstanding as of December 31, 2025, and 2024, respectively", "verboseLabel": "Common stock, shares issued", "netLabel": "Common stock, value issued", "label": "Shares of common stock (in Dollars)", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r58", "r405", "r412", "r814", "r1110" ] }, "vsee_CommonStockWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "CommonStockWarrantsMember", "presentation": [ "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable", "http://vseehealth.com/role/ScheduleofWarrantsIssuedandoutstandingTable", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock Warrants [Member]", "label": "Common Stock Warrants Member" } } }, "auth_ref": [] }, "vsee_CommonWarrantsForGrossProceeds": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "CommonWarrantsForGrossProceeds", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common warrants, for gross proceeds", "documentation": "Common warrants, for gross proceeds.", "label": "Common Warrants For Gross Proceeds" } } }, "auth_ref": [] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Company Selected Measure" } } }, "auth_ref": [ "r1224" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income [Text Block]", "terseLabel": "Compensation Actually Paid vs. Net Income" } } }, "auth_ref": [ "r1223" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure [Text Block]", "terseLabel": "Compensation Actually Paid vs. Other Measure" } } }, "auth_ref": [ "r1225" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]", "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return" } } }, "auth_ref": [ "r1222" ] }, "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ComponentsOfDeferredTaxAssetsAbstract", "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax assets:", "label": "Components of Deferred Tax Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Domain]", "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r215", "r262", "r856", "r857", "r973", "r1382", "r1383", "r1384", "r1385", "r1386" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r215", "r262", "r856", "r857", "r973", "r1382", "r1383", "r1384", "r1385", "r1386" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r215", "r262", "r856", "r857", "r973", "r1382", "r1383", "r1384", "r1385", "r1386" ] }, "us-gaap_ConcentrationRiskCreditRisk": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ConcentrationRiskCreditRisk", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Risk and Major Customers/Supplier Concentration", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for credit risk. Includes, but is not limited to, policy for entering into master netting arrangement or similar agreement to mitigate credit risk of financial instrument." } } }, "auth_ref": [ "r673", "r674" ] }, "vsee_ConcentrationRiskNumberOfSuppliers": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ConcentrationRiskNumberOfSuppliers", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of suppliers", "documentation": "The total number of suppliers representing the concentration risk for the requisite benchmark.", "label": "Concentration Risk Number Of Suppliers" } } }, "auth_ref": [] }, "vsee_ConcentrationRiskThresholdPercentage": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ConcentrationRiskThresholdPercentage", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration risk percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk Threshold Percentage" } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Domain]", "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r215", "r262", "r856", "r857", "r973", "r1382", "r1383", "r1384", "r1385", "r1386" ] }, "vsee_ConnectionWithTheBridgeInvestorsDescription": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ConnectionWithTheBridgeInvestorsDescription", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Description of connection with the bridge investor", "documentation": "The entire description represents connection with the bridge investor.", "label": "Connection With The Bridge Investors Description" } } }, "auth_ref": [] }, "srt_ConsolidatedEntitiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "ConsolidatedEntitiesAxis", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Axis]" } } }, "auth_ref": [ "r170", "r181", "r615", "r616", "r619", "r620", "r621", "r717", "r802", "r978", "r1428", "r1431", "r1432" ] }, "srt_ConsolidatedEntitiesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "ConsolidatedEntitiesDomain", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "label": "Consolidated Entities [Domain]" } } }, "auth_ref": [ "r170", "r181", "r615", "r616", "r619", "r620", "r621", "r717", "r802", "r978", "r1428", "r1431", "r1432" ] }, "srt_ConsolidationItemsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "ConsolidationItemsAxis", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable", "http://vseehealth.com/role/ScheduleofReportableSegmentDepreciationandAmortizationandCapitalExpendituresTable", "http://vseehealth.com/role/ScheduleofTotalAssetsbySegmentTable" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]" } } }, "auth_ref": [ "r105", "r169", "r170", "r177", "r181", "r210", "r226", "r248", "r249", "r250", "r251", "r252", "r254", "r255", "r256", "r359", "r360", "r361", "r362", "r364", "r365", "r366", "r367", "r368", "r802", "r1014", "r1015", "r1429", "r1430" ] }, "srt_ConsolidationItemsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "ConsolidationItemsDomain", "presentation": [ "http://vseehealth.com/role/ScheduleofReportableSegmentDepreciationandAmortizationandCapitalExpendituresTable", "http://vseehealth.com/role/ScheduleofTotalAssetsbySegmentTable" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Domain]" } } }, "auth_ref": [ "r105", "r169", "r170", "r177", "r181", "r210", "r226", "r248", "r249", "r250", "r251", "r252", "r254", "r255", "r256", "r359", "r360", "r361", "r362", "r364", "r365", "r366", "r367", "r368", "r802", "r1014", "r1015", "r1429", "r1430" ] }, "dei_ContactPersonnelEmailAddress": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "ContactPersonnelEmailAddress", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Contact Personnel Email Address", "documentation": "Email address of contact personnel." } } }, "auth_ref": [] }, "dei_ContactPersonnelFaxNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "ContactPersonnelFaxNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Contact Personnel Fax Number", "documentation": "Fax Number of contact personnel." } } }, "auth_ref": [ "r1158" ] }, "dei_ContactPersonnelName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "ContactPersonnelName", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Contact Personnel Name", "documentation": "Name of contact personnel" } } }, "auth_ref": [] }, "dei_ContainedFileInformationFileDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "ContainedFileInformationFileDescription", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Contained File Information, File Description", "documentation": "The description of the contained file." } } }, "auth_ref": [] }, "dei_ContainedFileInformationFileName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "ContainedFileInformationFileName", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Contained File Information, File Name", "documentation": "The name of the contained file." } } }, "auth_ref": [] }, "dei_ContainedFileInformationFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "ContainedFileInformationFileNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Contained File Information, File Number", "documentation": "The SEC Document Number of the contained file." } } }, "auth_ref": [] }, "dei_ContainedFileInformationFileType": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "ContainedFileInformationFileType", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Contained File Information, File Type", "documentation": "The type or format of the contained file (usually XBRL but may be used for other types such as HTML, Word, PDF, GIF/JPG, etc.)." } } }, "auth_ref": [] }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ContractWithCustomerLiabilityCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred revenue", "verboseLabel": "Contract liabilities", "label": "Contract with Customer, Liability, Current", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r434", "r435", "r436", "r448" ] }, "us-gaap_ContractWithCustomerLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ContractWithCustomerLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred revenue, net of current portion", "label": "Contract with Customer, Liability, Noncurrent", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent." } } }, "auth_ref": [ "r434", "r435", "r436", "r448" ] }, "vsee_ContractWithCustomerLiabilityPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ContractWithCustomerLiabilityPolicyPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred Revenue", "documentation": "Disclosure of accounting policy for contract with customer liability.", "label": "Contract With Customer Liability Policy Policy Text Block" } } }, "auth_ref": [] }, "vsee_ConversionOfStockEquivalentCommonStockSharesUponConversion": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ConversionOfStockEquivalentCommonStockSharesUponConversion", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Conversion of stock, equivalent common stock shares upon conversion", "documentation": "The number of common stock shares equivalent to the shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion Of Stock Equivalent Common Stock Shares Upon Conversion" } } }, "auth_ref": [] }, "us-gaap_ConversionOfStockSharesConverted1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ConversionOfStockSharesConverted1", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Conversion of stock", "label": "Conversion of Stock, Shares Converted", "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r19", "r20", "r21" ] }, "us-gaap_ConversionOfStockSharesIssued1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ConversionOfStockSharesIssued1", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate shares (in Shares)", "verboseLabel": "Conversion of shares issued", "label": "Conversion of Stock, Shares Issued", "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r19", "r20", "r21" ] }, "vsee_ConversionRatePerShares": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ConversionRatePerShares", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Conversion rate per share (in Dollars per share)", "documentation": "Conversion rate per shares.", "label": "Conversion Rate Per Shares" } } }, "auth_ref": [] }, "vsee_ConversionRatePricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ConversionRatePricePerShare", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Conversion rate price per share (in Dollars per share)", "documentation": "Conversion rate price per share.", "label": "Conversion Rate Price Per Share" } } }, "auth_ref": [] }, "vsee_ConversionSecuritiesPurchaseAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ConversionSecuritiesPurchaseAgreementsMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Conversion Securities Purchase Agreements [Member]", "documentation": "Represents information related to conversion securities purchase agreement.", "label": "Conversion Securities Purchase Agreements Member" } } }, "auth_ref": [] }, "vsee_ConvertibleNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ConvertibleNoteMember", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Convertible Note [Member]", "label": "Convertible Note Member" } } }, "auth_ref": [] }, "us-gaap_ConvertibleNotesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ConvertibleNotesPayableCurrent", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Convertible note payable", "label": "Convertible Notes Payable, Current", "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder." } } }, "auth_ref": [ "r48" ] }, "us-gaap_CorporateNonSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CorporateNonSegmentMember", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable", "http://vseehealth.com/role/ScheduleofReportableSegmentDepreciationandAmortizationandCapitalExpendituresTable", "http://vseehealth.com/role/ScheduleofTotalAssetsbySegmentTable" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting, Reconciling Item, Corporate Nonsegment [Member]", "verboseLabel": "Non-operating corporate [Member]", "netLabel": "Non-Operating corporate [Member]", "label": "Segment Reporting, Reconciling Item, Corporate Nonsegment [Member]", "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment." } } }, "auth_ref": [ "r11", "r249", "r250", "r251", "r252", "r255", "r1389" ] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of revenues", "label": "Cost of Product and Service Sold", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r66", "r67", "r758", "r997", "r1002", "r1095", "r1356" ] }, "us-gaap_CostOfRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CostOfRevenue", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of revenues", "label": "Cost of Revenue", "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period." } } }, "auth_ref": [ "r68", "r169", "r172", "r173", "r298", "r359", "r360", "r362", "r363", "r364", "r365", "r366", "r368", "r369", "r677", "r1014", "r1429" ] }, "us-gaap_CostOfSalesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CostOfSalesPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of Revenue", "label": "Cost of Goods and Service [Policy Text Block]", "documentation": "Disclosure of accounting policy for cost of product sold and service rendered." } } }, "auth_ref": [ "r1293" ] }, "srt_CounterpartyNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "CounterpartyNameAxis", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofCommonStockBusinessCombinationTable", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable_Parentheticals", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]" } } }, "auth_ref": [ "r169", "r178", "r179", "r374", "r419", "r715", "r737", "r807", "r993", "r994", "r995", "r1307", "r1308", "r1309", "r1310", "r1311", "r1312", "r1313", "r1314", "r1315", "r1507", "r1508", "r1509", "r1510" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CountryRegion", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_CreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CreditFacilityAxis", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "label": "Credit Facility [Axis]", "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [ "r358", "r1427" ] }, "us-gaap_CreditFacilityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CreditFacilityDomain", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "label": "Credit Facility [Domain]", "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [ "r358", "r1427" ] }, "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CurrentFederalStateAndLocalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofIncomeTaxProvisionTable": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofIncomeTaxProvisionTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total current income tax provision/(benefit)", "label": "Current Federal, State and Local, Tax Expense (Benefit)", "documentation": "Amount of current federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r1291" ] }, "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CurrentFederalStateAndLocalTaxExpenseBenefitAbstract", "presentation": [ "http://vseehealth.com/role/ScheduleofIncomeTaxProvisionTable" ], "lang": { "en-us": { "role": { "terseLabel": "Current income tax provision/(benefit):", "label": "Current Federal, State and Local, Tax Expense (Benefit) [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CurrentFederalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofIncomeTaxProvisionTable": { "parentTag": "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofIncomeTaxProvisionTable" ], "lang": { "en-us": { "role": { "terseLabel": "Federal", "label": "Current Federal Tax Expense (Benefit)", "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r1291", "r1366", "r1372", "r1481" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CurrentStateAndLocalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofIncomeTaxProvisionTable": { "parentTag": "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofIncomeTaxProvisionTable" ], "lang": { "en-us": { "role": { "terseLabel": "State", "label": "Current State and Local Tax Expense (Benefit)", "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r1291", "r1366", "r1372", "r1481" ] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer Concentration Risk [Member]", "label": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r262", "r1383" ] }, "us-gaap_CustomerListsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CustomerListsMember", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer Lists [Member]", "label": "Customer Lists [Member]", "documentation": "Information about customers such as their name and contact information; it may also be an extensive database that includes other information about the customers such as their order history and demographic information." } } }, "auth_ref": [ "r1068", "r1409", "r1410", "r1411", "r1412", "r1413", "r1415", "r1418", "r1419" ] }, "us-gaap_CustomerRelationshipsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "CustomerRelationshipsMember", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable", "http://vseehealth.com/role/ScheduleofIdentifiableIntangibleAssetsSubjecttoAmortizationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Customer relationships [Member]", "verboseLabel": "Customer Relationships [Member]", "label": "Customer Relationships [Member]", "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships." } } }, "auth_ref": [ "r1070", "r1409", "r1410", "r1411", "r1412", "r1413", "r1415", "r1418", "r1419" ] }, "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2025", "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]", "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]" } } }, "auth_ref": [ "r1166", "r1259" ] }, "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2025", "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Cybersecurity Risk Board of Directors Oversight [Text Block]", "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]" } } }, "auth_ref": [ "r1166", "r1259" ] }, "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2025", "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]", "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]" } } }, "auth_ref": [ "r1161", "r1254" ] }, "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2025", "localname": "CybersecurityRiskManagementProcessesIntegratedFlag", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Cybersecurity Risk Management Processes Integrated [Flag]", "label": "Cybersecurity Risk Management Processes Integrated [Flag]" } } }, "auth_ref": [ "r1162", "r1255" ] }, "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2025", "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Cybersecurity Risk Management Processes Integrated [Text Block]", "label": "Cybersecurity Risk Management Processes Integrated [Text Block]" } } }, "auth_ref": [ "r1162", "r1255" ] }, "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cyd/2025", "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract", "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]" } } }, "auth_ref": [ "r1160", "r1253" ] }, "cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cyd/2025", "localname": "CybersecurityRiskManagementStrategyAndGovernanceLineItems", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management, Strategy, and Governance [Line Items]" } } }, "auth_ref": [ "r1160", "r1253" ] }, "cyd_CybersecurityRiskManagementStrategyAndGovernanceTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cyd/2025", "localname": "CybersecurityRiskManagementStrategyAndGovernanceTable", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "label": "Cybersecurity Risk Management, Strategy, and Governance [Table]" } } }, "auth_ref": [ "r1160", "r1253" ] }, "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2025", "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Cybersecurity Risk Management Third Party Engaged [Flag]", "label": "Cybersecurity Risk Management Third Party Engaged [Flag]" } } }, "auth_ref": [ "r1163", "r1256" ] }, "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2025", "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]", "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]" } } }, "auth_ref": [ "r1165", "r1258" ] }, "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cyd/2025", "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]", "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]" } } }, "auth_ref": [ "r1166", "r1259" ] }, "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cyd/2025", "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag", "presentation": [ "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]", "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]" } } }, "auth_ref": [ "r1164", "r1257" ] }, "vsee_DHACAssumedWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DHACAssumedWarrantsMember", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "DHAC Assumed Warrants [Member]", "label": "DHACAssumed Warrants Member" } } }, "auth_ref": [] }, "vsee_DavidL.WickershamMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DavidL.WickershamMember", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "David L. Wickersham [Member]", "documentation": "Represents information pertaining to board of directors of David L. Wickersham.", "label": "David L. Wickersham Member" } } }, "auth_ref": [] }, "us-gaap_DebtConversionByUniqueDescriptionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtConversionByUniqueDescriptionAxis", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "label": "Debt Conversion Description [Axis]", "documentation": "Information by description of debt issuances converted in a noncash or part noncash transaction." } } }, "auth_ref": [ "r19", "r21" ] }, "us-gaap_DebtConversionConvertedInstrumentAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtConversionConvertedInstrumentAmount1", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued as conversion of debt", "label": "Debt Conversion, Converted Instrument, Amount", "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r19", "r21" ] }, "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtConversionConvertedInstrumentSharesIssued1", "presentation": [ "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares issued on conversion of debt", "verboseLabel": "Number of shares issued on conversion of debt (in Shares)", "label": "Debt Conversion, Converted Instrument, Shares Issued", "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period." } } }, "auth_ref": [ "r19", "r21" ] }, "us-gaap_DebtConversionNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtConversionNameDomain", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "label": "Debt Conversion, Name [Domain]", "documentation": "The name of the original debt issue that has been converted in a noncash (or part noncash) transaction during the accounting period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r19", "r21" ] }, "us-gaap_DebtConversionOriginalDebtAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtConversionOriginalDebtAmount1", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt conversion, amount", "verboseLabel": "Principal amount (in Dollars)", "label": "Debt Conversion, Original Debt, Amount", "documentation": "The amount of the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r19", "r21" ] }, "vsee_DebtConversionOriginalDebtFairValueAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtConversionOriginalDebtFairValueAmount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt conversion, fair value", "verboseLabel": "Debt conversion, fair value (in Dollars)", "documentation": "Fair value of the original debt that is being converted in a noncash or part noncash transaction on the conversion date.", "label": "Debt Conversion Original Debt Fair Value Amount" } } }, "auth_ref": [] }, "vsee_DebtConversionRates": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtConversionRates", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt conversion rates (in Dollars per share)", "documentation": "Debt conversion rates.", "label": "Debt Conversion Rates" } } }, "auth_ref": [] }, "vsee_DebtConvertibleOriginalDebtAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtConvertibleOriginalDebtAmount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate amount", "documentation": "The amount of debt convertible into shares of common stock.", "label": "Debt Convertible Original Debt Amount" } } }, "auth_ref": [] }, "vsee_DebtDefaultInterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtDefaultInterestExpense", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Default interest expense", "documentation": "Represents the amount of interest due to default of debt repayment.", "label": "Debt Default Interest Expense" } } }, "auth_ref": [] }, "vsee_DebtDefaultPercentageOfMandatoryPenalty": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtDefaultPercentageOfMandatoryPenalty", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Mandatory default penalty", "documentation": "Represents the percentage of mandatory penalty for debt default.", "label": "Debt Default Percentage Of Mandatory Penalty" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscount" ], "lang": { "en-us": { "role": { "terseLabel": "Line of Credit and Notes Payable, net of discount", "label": "Debt Disclosure [Text Block]", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r84", "r169", "r171", "r346", "r347", "r348", "r349", "r350", "r357", "r358", "r370", "r376", "r377", "r378", "r379", "r380", "r381", "r386", "r393", "r394", "r396", "r628", "r687" ] }, "vsee_DebtInstrumentAdditionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtInstrumentAdditionalAmount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument, additional amount", "documentation": "Debt instrument, additional amount.", "label": "Debt Instrument Additional Amount" } } }, "auth_ref": [] }, "vsee_DebtInstrumentAdditionalInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtInstrumentAdditionalInterestRate", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Rate for additional interest", "documentation": "Percentage of increased interest rate.", "label": "Debt Instrument Additional Interest Rate" } } }, "auth_ref": [] }, "vsee_DebtInstrumentAggregatePrincipalValueAgreedToBePurchasedByCounterparty": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtInstrumentAggregatePrincipalValueAgreedToBePurchasedByCounterparty", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate principal value", "documentation": "The aggregate principal value of debt instrument agreed to be purchased by the counterparty.", "label": "Debt Instrument Aggregate Principal Value Agreed To Be Purchased By Counterparty" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentAxis", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails", "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/FairValueMeasurementsDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofKeyInputsTable", "http://vseehealth.com/role/ScheduleofKeyInputsTable2", "http://vseehealth.com/role/ScheduleofKeyInputsTable4", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r12", "r47", "r48", "r95", "r98", "r371", "r372", "r373", "r374", "r375", "r377", "r382", "r383", "r384", "r385", "r387", "r388", "r389", "r390", "r391", "r392", "r1023", "r1024", "r1025", "r1026", "r1027", "r1108", "r1366", "r1367", "r1369", "r1374", "r1421", "r1422", "r1423", "r1530", "r1532", "r1550" ] }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basis spread on the variable rate", "label": "Debt Instrument, Basis Spread on Variable Rate", "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentCarryingAmount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding principal amount (in Dollars)", "verboseLabel": "Outstanding principal amount", "netLabel": "Principal balance of debt (in Dollars)", "label": "Long-Term Debt, Gross", "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt." } } }, "auth_ref": [ "r12", "r98", "r397" ] }, "vsee_DebtInstrumentCashPaymentFee": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtInstrumentCashPaymentFee", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash payment fee percentage", "documentation": "Percentage of fee chargeable on payments not made via draws on line of credit.", "label": "Debt Instrument Cash Payment Fee" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConversionPricePercentage": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtInstrumentConversionPricePercentage", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument conversion price percentage", "documentation": "Debt instrument conversion price percentage.", "label": "Debt Instrument Conversion Price Percentage" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertibleAveragePriceForStockPriceTriggerForResetOfConversionPrice": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtInstrumentConvertibleAveragePriceForStockPriceTriggerForResetOfConversionPrice", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Average price for share price trigger to determine reset of conversion price (in Dollars per share)", "documentation": "Represents the average price for share price trigger which would be required to be attained for reset of conversion price.", "label": "Debt Instrument Convertible Average Price For Stock Price Trigger For Reset Of Conversion Price" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertibleAveragePriceForStockPriceTriggerForResetOfConversionPriceMinimum": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtInstrumentConvertibleAveragePriceForStockPriceTriggerForResetOfConversionPriceMinimum", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum average price for share price trigger to determine reset of conversion price (in Dollars per share)", "documentation": "Represents the minimum average price for share price trigger which would be required to be attained for reset of conversion price.", "label": "Debt Instrument Convertible Average Price For Stock Price Trigger For Reset Of Conversion Price Minimum" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertibleConversionFloorPrice": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtInstrumentConvertibleConversionFloorPrice", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Floor price (in Dollars per share)", "documentation": "Debt instrument, convertible, conversion floor price.", "label": "Debt Instrument Convertible Conversion Floor Price" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentConvertibleConversionPrice1", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Conversion price (in Dollars per share)", "label": "Debt Instrument, Convertible, Conversion Price", "documentation": "The price per share of the conversion feature embedded in the debt instrument." } } }, "auth_ref": [ "r85", "r373" ] }, "vsee_DebtInstrumentConvertibleMaximumResetOfConversionPrice": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtInstrumentConvertibleMaximumResetOfConversionPrice", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum reset of conversion price (in Dollars per share)", "documentation": "Represents the maximum share price up to which the conversion price of the convertible debt instrument can be reset.", "label": "Debt Instrument Convertible Maximum Reset Of Conversion Price" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertibleMinimumConversionPriceToMakeAmortizationPayment": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtInstrumentConvertibleMinimumConversionPriceToMakeAmortizationPayment", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum conversion price to make amortization payment (in Dollars per share)", "documentation": "Represents the minimum conversion price to make amortization payment on convertible debt instruments.", "label": "Debt Instrument Convertible Minimum Conversion Price To Make Amortization Payment" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertiblePercentageDiscountToVWPUsedToDetermineConversionPrice": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtInstrumentConvertiblePercentageDiscountToVWPUsedToDetermineConversionPrice", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage discount on VWAP", "documentation": "Percentage discount to prior trading day VWAP used to determine conversion price in conversion of debt instrument to equity instrument.", "label": "Debt Instrument Convertible Percentage Discount To VWPUsed To Determine Conversion Price" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertibleQualifiedFinancingPercentageOfEffectivePricePerShare": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtInstrumentConvertibleQualifiedFinancingPercentageOfEffectivePricePerShare", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Effective price per share", "documentation": "Represents the percentage of effective price per share for conversion by holder of debt instrument in qualified financing.", "label": "Debt Instrument Convertible Qualified Financing Percentage Of Effective Price Per Share" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertibleStockPriceTriggerForResetOfConversionPrice": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtInstrumentConvertibleStockPriceTriggerForResetOfConversionPrice", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share price trigger to determine reset of conversion price (in Dollars per share)", "documentation": "Price of the entity's common stock which would be required to be attained for reset of conversion price of the convertible debt instrument.", "label": "Debt Instrument Convertible Stock Price Trigger For Reset Of Conversion Price" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertibleThresholdPercentageOfAverageLowestVolumeWeightedAveragePriceConsideredForAmortizationConversionPriceDetermination": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtInstrumentConvertibleThresholdPercentageOfAverageLowestVolumeWeightedAveragePriceConsideredForAmortizationConversionPriceDetermination", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of average lowest VWAP of common stock considered for determination of amortization conversion price", "documentation": "Threshold minimum percentage of average lowest VWAP of common stock considered to determine the amortization conversion price of convertible debt instruments, if common stock is used to make such amortization payments.", "label": "Debt Instrument Convertible Threshold Percentage Of Average Lowest Volume Weighted Average Price Considered For Amortization Conversion Price Determination" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertibleThresholdPercentageOfAverageLowestVolumeWeightedAveragePriceConsideredForResetOfConversionPrice": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtInstrumentConvertibleThresholdPercentageOfAverageLowestVolumeWeightedAveragePriceConsideredForResetOfConversionPrice", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Threshold percentage", "documentation": "Threshold minimum percentage of average lowest VWAP of common stock considered to determine reset value of conversion price of convertible debt instruments.", "label": "Debt Instrument Convertible Threshold Percentage Of Average Lowest Volume Weighted Average Price Considered For Reset Of Conversion Price" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertibleThresholdPercentageOfLowestVolumeWeightedAveragePriceConsideredForDeterminationOfConversionPrice": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtInstrumentConvertibleThresholdPercentageOfLowestVolumeWeightedAveragePriceConsideredForDeterminationOfConversionPrice", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Threshold percentage of lowest VWAP of common stock to determine conversion price", "documentation": "Threshold percentage of lowest VWAP of common stock considered to determine conversion price of convertible debt instruments.", "label": "Debt Instrument Convertible Threshold Percentage Of Lowest Volume Weighted Average Price Considered For Determination Of Conversion Price" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Convertible note differed by more than percent", "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger", "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentConvertibleThresholdTradingDays", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of trading days (in tradingdays)", "label": "Debt Instrument, Convertible, Threshold Trading Days", "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature." } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertibleThresholdTradingDaysForResetOfConversionPrice": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtInstrumentConvertibleThresholdTradingDaysForResetOfConversionPrice", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of trading days to determine reset of conversion price (in tradingdays)", "documentation": "Threshold number of specified trading days to determine reset of conversion price.", "label": "Debt Instrument Convertible Threshold Trading Days For Reset Of Conversion Price" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertibleThresholdTradingDaysOverWhichAverageDailyVolumeWeightedAveragePriceOfCommonStockConsideredForResetOfConversionPrice": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtInstrumentConvertibleThresholdTradingDaysOverWhichAverageDailyVolumeWeightedAveragePriceOfCommonStockConsideredForResetOfConversionPrice", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Threshold trading days over which the average daily VWAP of common stock is considered for reset of conversion price (in tradingdays)", "documentation": "Threshold number of trading days over which daily average VWAP of common stock is considered to reset the conversion price of convertible debt instruments.", "label": "Debt Instrument Convertible Threshold Trading Days Over Which Average Daily Volume Weighted Average Price Of Common Stock Considered For Reset Of Conversion Price" } } }, "auth_ref": [] }, "vsee_DebtInstrumentConvertibleThresholdTradingDaysOverWhichLowestVolumeWeightedAveragePriceConsideredForDeterminationOfConversionPrice": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtInstrumentConvertibleThresholdTradingDaysOverWhichLowestVolumeWeightedAveragePriceConsideredForDeterminationOfConversionPrice", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Threshold trading days over which the lowest VWAP of common stock is considered to determine conversion price (in tradingdays)", "documentation": "Threshold number of trading days over which lowest VWAP of common stock is considered to determine conversion price of convertible debt instruments.", "label": "Debt Instrument Convertible Threshold Trading Days Over Which Lowest Volume Weighted Average Price Considered For Determination Of Conversion Price" } } }, "auth_ref": [] }, "vsee_DebtInstrumentDefaultInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtInstrumentDefaultInterestRate", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Default interest", "verboseLabel": "Default interest rate", "documentation": "Percentage of interest chargeable on making default in payments on promissory note from the default date.", "label": "Debt Instrument Default Interest Rate" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate principal amount (in Dollars)", "verboseLabel": "Principal amount", "netLabel": "Aggregate principal amount", "label": "Principal amount (in Dollars)", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r371", "r687", "r688", "r1024", "r1025", "r1108" ] }, "us-gaap_DebtInstrumentFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentFairValue", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value exchange note amount", "label": "Debt Instrument, Fair Value Disclosure", "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable." } } }, "auth_ref": [ "r384", "r670", "r671", "r672", "r675", "r1024", "r1025", "r1515", "r1516", "r1517", "r1518", "r1520" ] }, "vsee_DebtInstrumentFairValueGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtInstrumentFairValueGainLoss", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value gain (loss)", "documentation": "Debt instrument, fair value gain (loss)", "label": "Debt Instrument Fair Value Gain Loss" } } }, "auth_ref": [] }, "vsee_DebtInstrumentForbearanceAgreementPaymentsAgreedToBeMade": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtInstrumentForbearanceAgreementPaymentsAgreedToBeMade", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Payments for forbearance", "documentation": "The amount of payments agreed to be made as a consideration for the forbearance of bank on its collection rights.", "label": "Debt Instrument Forbearance Agreement Payments Agreed To Be Made" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentInterestRateDuringPeriod", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest accruing percentage", "label": "Debt Instrument, Interest Rate During Period", "documentation": "The average effective interest rate during the reporting period." } } }, "auth_ref": [ "r50", "r389", "r1530" ] }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentInterestRateEffectivePercentage", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest rate", "label": "Debt Instrument, Interest Rate, Effective Percentage", "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium." } } }, "auth_ref": [ "r50", "r399", "r687", "r688", "r1108" ] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Annual fixed rate percentage", "verboseLabel": "Annual fixed interest rate", "label": "Debt Instrument, Interest Rate, Stated Percentage", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r50", "r372" ] }, "vsee_DebtInstrumentLateFeeEqualPercent": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtInstrumentLateFeeEqualPercent", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Late fee equal percent", "documentation": "Debt instrument, late fee equal percent.", "label": "Debt Instrument Late Fee Equal Percent" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentLineItems", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable" ], "lang": { "en-us": { "role": { "label": "Line of Credit and Notes Payable, Net of Discount", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r371", "r372", "r373", "r374", "r375", "r377", "r382", "r383", "r384", "r385", "r387", "r388", "r389", "r390", "r391", "r392", "r395", "r628", "r802", "r1023", "r1024", "r1025", "r1026", "r1027", "r1108", "r1366", "r1367", "r1369", "r1374", "r1530", "r1532" ] }, "us-gaap_DebtInstrumentMeasurementInput": { "xbrltype": "decimalItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentMeasurementInput", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyInputsTable", "http://vseehealth.com/role/ScheduleofKeyInputsTable1", "http://vseehealth.com/role/ScheduleofKeyInputsTable2", "http://vseehealth.com/role/ScheduleofKeyInputsTable4", "http://vseehealth.com/role/ScheduleofKeyInputsTable5", "http://vseehealth.com/role/ScheduleofKeyInputsTable6" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement input of notes payable", "verboseLabel": "Measurement input", "label": "Debt Instrument, Measurement Input", "documentation": "Value of input used to measure debt instrument, including, but not limited to, convertible and non-convertible debt." } } }, "auth_ref": [ "r1516", "r1517", "r1518" ] }, "vsee_DebtInstrumentModificationMinimumActualChangeInCashFlow": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtInstrumentModificationMinimumActualChangeInCashFlow", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum percentage change to cash flow", "documentation": "Represents the minimum percentage of change in cash flow achieved by the loan modification.", "label": "Debt Instrument Modification Minimum Actual Change In Cash Flow" } } }, "auth_ref": [] }, "vsee_DebtInstrumentModificationMinimumActualChangeInFairValue": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtInstrumentModificationMinimumActualChangeInFairValue", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum percentage change to fair value", "documentation": "Represents the minimum percentage of change in fair value achieved by the loan modification.", "label": "Debt Instrument Modification Minimum Actual Change In Fair Value" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails", "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/FairValueMeasurementsDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r12", "r371", "r372", "r373", "r374", "r375", "r377", "r382", "r383", "r384", "r385", "r387", "r388", "r389", "r390", "r391", "r392", "r1023", "r1024", "r1025", "r1026", "r1027", "r1108", "r1366", "r1367", "r1369", "r1374", "r1421", "r1422", "r1423", "r1530", "r1532", "r1550" ] }, "vsee_DebtInstrumentOutstandingPercentage": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtInstrumentOutstandingPercentage", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument, outstanding percentage", "documentation": "Debt instrument, outstanding percentage.", "label": "Debt Instrument Outstanding Percentage" } } }, "auth_ref": [] }, "vsee_DebtInstrumentPercentageOfInterestRateIncreasesPercentage": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtInstrumentPercentageOfInterestRateIncreasesPercentage", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest rate increases percentage", "documentation": "Debt instrument percentage of interest rate increases percentage.", "label": "Debt Instrument Percentage Of Interest Rate Increases Percentage" } } }, "auth_ref": [] }, "vsee_DebtInstrumentPercentageOfOriginalIssueDiscount": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtInstrumentPercentageOfOriginalIssueDiscount", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Original issue discount", "documentation": "Represents the percentage of debt original issue discount.", "label": "Debt Instrument Percentage Of Original Issue Discount" } } }, "auth_ref": [] }, "vsee_DebtInstrumentPercentageOfOverdueAmountIsAssessed": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtInstrumentPercentageOfOverdueAmountIsAssessed", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of overdue amount is assessed", "documentation": "Percentage of overdue amount is assessed.", "label": "Debt Instrument Percentage Of Overdue Amount Is Assessed" } } }, "auth_ref": [] }, "vsee_DebtInstrumentPercentageOfPrepaymentPenaltyInCaseOfDefault": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtInstrumentPercentageOfPrepaymentPenaltyInCaseOfDefault", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding balance, percentage", "documentation": "Represents the prepayment penalty rate of debt instrument in case of default.", "label": "Debt Instrument Percentage Of Prepayment Penalty In Case Of Default" } } }, "auth_ref": [] }, "vsee_DebtInstrumentPercentageOfPrincipalBalancePercentage": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtInstrumentPercentageOfPrincipalBalancePercentage", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of principal balance", "documentation": "Represents the percentage of debt principal balance.", "label": "Debt Instrument Percentage Of Principal Balance Percentage" } } }, "auth_ref": [] }, "vsee_DebtInstrumentPercentageOfPrincipalEstimatedRecoveredInEventOfDefault": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtInstrumentPercentageOfPrincipalEstimatedRecoveredInEventOfDefault", "presentation": [ "http://vseehealth.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of lender recovery on principal outstanding", "documentation": "Represents the percentage of principal of the debt that is estimated to be recoverable in the event of default.", "label": "Debt Instrument Percentage Of Principal Estimated Recovered In Event Of Default" } } }, "auth_ref": [] }, "vsee_DebtInstrumentPeriodOfGuaranteedInterestPayment": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtInstrumentPeriodOfGuaranteedInterestPayment", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Period of guaranteed interest payment", "documentation": "The period during which payment of interest is guaranteed regardless of early payment or redemption of notes.", "label": "Debt Instrument Period Of Guaranteed Interest Payment" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentPeriodicPayment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentPeriodicPayment", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loan payments amount", "verboseLabel": "Periodic payment", "label": "Debt Instrument, Periodic Payment", "documentation": "Amount of the required periodic payments including both interest and principal payments." } } }, "auth_ref": [ "r12", "r45" ] }, "vsee_DebtInstrumentPeriodicPaymentNumberOfInstallments": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtInstrumentPeriodicPaymentNumberOfInstallments", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of installments", "documentation": "Represents the number of installments for periodic payment of debt instrument.", "label": "Debt Instrument Periodic Payment Number Of Installments" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentPeriodicPaymentPrincipal", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Periodic principal payment", "label": "Debt Instrument, Periodic Payment, Principal", "documentation": "Amount of the required periodic payments applied to principal." } } }, "auth_ref": [ "r12" ] }, "us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "payment to be paid", "verboseLabel": "Periodic payment terms, balloon payment to be paid", "label": "Debt Instrument, Periodic Payment Terms, Balloon Payment to be Paid", "documentation": "Amount of payment greater than the preceding installment payments to be paid at final maturity date of debt." } } }, "auth_ref": [] }, "vsee_DebtInstrumentPrincipalAmountIssuable": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtInstrumentPrincipalAmountIssuable", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Principal amount of debt issuable (in Dollars)", "verboseLabel": "Principal amount of debt issuable", "documentation": "Represents the principal amount of debt issuable.", "label": "Debt Instrument Principal Amount Issuable" } } }, "auth_ref": [] }, "vsee_DebtInstrumentPrincipalAmountNotExchangeable": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtInstrumentPrincipalAmountNotExchangeable", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Principal amount not exchangeable", "documentation": "The principal amount of debt that is non exchangeable.", "label": "Debt Instrument Principal Amount Not Exchangeable" } } }, "auth_ref": [] }, "vsee_DebtInstrumentPrincipalAmountPurchasedOnLaterDate": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtInstrumentPrincipalAmountPurchasedOnLaterDate", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Notes purchased", "documentation": "The principal amount of debt which is purchased on the later date.", "label": "Debt Instrument Principal Amount Purchased On Later Date" } } }, "auth_ref": [] }, "vsee_DebtInstrumentPrincipalAmountPurchasedOnSigningDate": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtInstrumentPrincipalAmountPurchasedOnSigningDate", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Notes purchased", "documentation": "The principal amount of debt which is purchased on the date of signing of the agreement.", "label": "Debt Instrument Principal Amount Purchased On Signing Date" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentRedemptionPeriodAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentRedemptionPeriodAxis", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Redemption, Period [Axis]", "documentation": "Information by period of debt redemption feature under terms of debt agreement." } } }, "auth_ref": [ "r103" ] }, "us-gaap_DebtInstrumentRedemptionPeriodDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentRedemptionPeriodDomain", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "label": "Debt Instrument, Redemption, Period [Domain]", "documentation": "Period as defined under terms of the debt agreement for debt redemption features." } } }, "auth_ref": [ "r103" ] }, "us-gaap_DebtInstrumentRedemptionPeriodOneMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentRedemptionPeriodOneMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Redemption, Period One [Member]", "label": "Debt Instrument, Redemption, Period One [Member]", "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement." } } }, "auth_ref": [ "r103" ] }, "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentRedemptionPeriodTwoMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Redemption, Period Two [Member]", "label": "Debt Instrument, Redemption, Period Two [Member]", "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement." } } }, "auth_ref": [ "r103" ] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentTable", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable" ], "lang": { "en-us": { "role": { "label": "Schedule of Long-Term Debt Instruments [Table]", "documentation": "Disclosure of information about long-term debt instrument or arrangement." } } }, "auth_ref": [ "r12", "r36", "r38", "r44", "r87", "r88", "r371", "r372", "r373", "r374", "r375", "r377", "r382", "r383", "r384", "r385", "r387", "r388", "r389", "r390", "r391", "r392", "r395", "r628", "r802", "r1023", "r1024", "r1025", "r1026", "r1027", "r1108", "r1366", "r1367", "r1369", "r1374", "r1530", "r1532" ] }, "us-gaap_DebtInstrumentTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentTerm", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term of debt", "label": "Debt Instrument, Term", "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "vsee_DebtInstrumentTotalInterestExpenseOverLifeOfLoan": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DebtInstrumentTotalInterestExpenseOverLifeOfLoan", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total interest over entire loan maturity", "documentation": "Total amount, over entire maturity, of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Debt Instrument Total Interest Expense Over Life Of Loan" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentUnamortizedDiscount", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Original issue discount", "verboseLabel": "Unamortized debt discount", "label": "Debt Instrument, Unamortized Discount", "documentation": "Amount, after accumulated amortization, of debt discount." } } }, "auth_ref": [ "r1434", "r1529", "r1530", "r1532" ] }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentUnamortizedDiscountPremiumNet", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net of unamortized debt discount", "label": "Debt Instrument, Unamortized Discount (Premium), Net", "documentation": "Amount, after accumulated amortization, of debt discount (premium)." } } }, "auth_ref": [ "r1434", "r1529", "r1530", "r1532" ] }, "us-gaap_DebtInstrumentVariableInterestRateTypeExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtInstrumentVariableInterestRateTypeExtensibleEnumeration", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument, variable interest rate, type [Extensible enumeration]", "label": "Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration]", "documentation": "Indicates type of variable interest rate on debt instrument." } } }, "auth_ref": [ "r804" ] }, "us-gaap_DebtPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Original Issue Discount on Debt", "label": "Debt, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt." } } }, "auth_ref": [ "r6" ] }, "us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DebtRelatedCommitmentFeesAndDebtIssuanceCosts", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt issuance costs expensed", "label": "Debt Related Commitment Fees and Debt Issuance Costs", "documentation": "Represents the charge against earnings during the period for commitment fees and debt issuance expenses." } } }, "auth_ref": [ "r72" ] }, "vsee_DefaultInterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DefaultInterestExpense", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Default interest expense (in Dollars)", "documentation": "The amount of default interest expense.", "label": "Default Interest Expense" } } }, "auth_ref": [] }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredFederalIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofIncomeTaxProvisionTable": { "parentTag": "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofIncomeTaxProvisionTable" ], "lang": { "en-us": { "role": { "terseLabel": "Federal", "label": "Deferred Federal Income Tax Expense (Benefit)", "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r1366", "r1372", "r1480", "r1481" ] }, "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredFederalStateAndLocalTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofIncomeTaxProvisionTable": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofIncomeTaxProvisionTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total deferred income tax provision/(benefit)", "label": "Deferred Federal, State and Local, Tax Expense (Benefit)", "documentation": "Amount of deferred federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r1472" ] }, "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredFederalStateAndLocalTaxExpenseBenefitAbstract", "presentation": [ "http://vseehealth.com/role/ScheduleofIncomeTaxProvisionTable" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income tax provision/(benefit):", "label": "Deferred Federal, State and Local, Tax Expense (Benefit) [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DeferredFinanceCostsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredFinanceCostsNet", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financing cost", "label": "Debt Issuance Costs, Net", "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r1434", "r1529", "r1530", "r1532" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income taxes", "label": "Deferred Income Tax Expense (Benefit)", "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r4", "r116", "r1366", "r1372" ] }, "us-gaap_DeferredIncomeTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredIncomeTaxLiabilities", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Total deferred tax liabilities", "label": "Deferred Tax Liabilities, Gross", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences." } } }, "auth_ref": [ "r54", "r55", "r96", "r524" ] }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredIncomeTaxLiabilitiesNet", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax liabilities, net", "label": "Deferred Income Tax Liabilities, Net", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting." } } }, "auth_ref": [ "r510", "r511", "r809" ] }, "us-gaap_DeferredRevenueAdditions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredRevenueAdditions", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredRevenueActivitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Additions", "label": "Deferred Revenue, Additions", "documentation": "Amount of deferred revenue recognized for transactions arising during the current reporting period. Deferred revenue is a liability as of the balance sheet date related to a revenue producing activity for which revenue has not yet been recognized. Generally, an Entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP." } } }, "auth_ref": [] }, "us-gaap_DeferredRevenueByArrangementDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredRevenueByArrangementDisclosureTextBlock", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Deferred Revenue Activities", "label": "Deferred Revenue, by Arrangement, Disclosure [Table Text Block]", "documentation": "Tabular disclosure of the type of arrangements and the corresponding amounts that comprise the current and noncurrent balance of deferred revenue as of the balance sheet date." } } }, "auth_ref": [] }, "us-gaap_DeferredRevenueCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredRevenueCurrent", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredRevenueActivitiesTable" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning of year", "periodEndLabel": "End of year", "label": "Deferred Revenue, Current", "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r1302" ] }, "us-gaap_DeferredRevenueNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredRevenueNoncurrent", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred revenue", "label": "Deferred Revenue, Noncurrent", "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent." } } }, "auth_ref": [ "r1303" ] }, "us-gaap_DeferredRevenueRevenueRecognized1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredRevenueRevenueRecognized1", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredRevenueActivitiesTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Revenue recognized", "label": "Deferred Revenue, Revenue Recognized", "documentation": "Amount of revenue recognized that was previously reported as deferred or unearned revenue." } } }, "auth_ref": [] }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofIncomeTaxProvisionTable": { "parentTag": "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofIncomeTaxProvisionTable" ], "lang": { "en-us": { "role": { "terseLabel": "State", "label": "Deferred State and Local Income Tax Expense (Benefit)", "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction." } } }, "auth_ref": [ "r1366", "r1372", "r1480", "r1481" ] }, "vsee_DeferredTaxAssetAccruedInterestRelatedParty": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DeferredTaxAssetAccruedInterestRelatedParty", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued interest, related party", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from accrued interest pertaining to related party.", "label": "Deferred Tax Asset Accrued Interest Related Party" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetInterestCarryforward": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredTaxAssetInterestCarryforward", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Interest payable", "label": "Deferred Tax Asset, Interest Carryforward", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible interest carryforward." } } }, "auth_ref": [ "r1478" ] }, "vsee_DeferredTaxAssetsBadDebtExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DeferredTaxAssetsBadDebtExpense", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Bad debt expense", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from bad debt expense.", "label": "Deferred Tax Assets Bad Debt Expense" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsDeferredIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredTaxAssetsDeferredIncome", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred revenue", "label": "Deferred Tax Assets, Deferred Income", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income." } } }, "auth_ref": [ "r1478" ] }, "us-gaap_DeferredTaxAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredTaxAssetsGross", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total deferred tax assets", "label": "Deferred Tax Assets, Gross", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r525" ] }, "vsee_DeferredTaxAssetsLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DeferredTaxAssetsLeaseLiabilities", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Operating and finance lease liabilities", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from lease liabilities.", "label": "Deferred Tax Assets Lease Liabilities" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredTaxAssetsNet", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredTaxLiabilities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "totalLabel": "Net deferred tax assets", "label": "Deferred Tax Assets, Net of Valuation Allowance", "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards." } } }, "auth_ref": [ "r1476" ] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Net operating loss carryforwards", "label": "Deferred Tax Assets, Operating Loss Carryforwards", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards." } } }, "auth_ref": [ "r1478" ] }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating loss carryforwards, not subject to expiration", "label": "Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates." } } }, "auth_ref": [ "r1478" ] }, "us-gaap_DeferredTaxAssetsOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredTaxAssetsOther", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax assets", "label": "Deferred Tax Assets, Other", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other." } } }, "auth_ref": [ "r1478" ] }, "vsee_DeferredTaxAssetsPayrollLiabilitiesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DeferredTaxAssetsPayrollLiabilitiesPayable", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued payroll", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from payroll liabilities payable.", "label": "Deferred Tax Assets Payroll Liabilities Payable" } } }, "auth_ref": [] }, "vsee_DeferredTaxAssetsStartUpCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DeferredTaxAssetsStartUpCosts", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Start-up costs", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from start-up costs.", "label": "Deferred Tax Assets Start Up Costs" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred compensation", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits", "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs." } } }, "auth_ref": [ "r1478" ] }, "vsee_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable and accrued liabilities", "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from accounts payable and accrued liabilities.", "label": "Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accounts Payable And Accrued Liabilities" } } }, "auth_ref": [] }, "vsee_DeferredTaxAssetsTaxEncompassPurchaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DeferredTaxAssetsTaxEncompassPurchaseLiability", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Encompass Purchase Liability", "documentation": "The amount of encompass purchase liability.", "label": "Deferred Tax Assets Tax Encompass Purchase Liability" } } }, "auth_ref": [] }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredTaxAssetsValuationAllowance", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "negatedLabel": "(Less) valuation allowance", "label": "Deferred Tax Assets, Valuation Allowance", "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized." } } }, "auth_ref": [ "r526" ] }, "us-gaap_DeferredTaxLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredTaxLiabilities", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Total deferred tax liabilities", "label": "Deferred Tax Liabilities, Net", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting." } } }, "auth_ref": [ "r1476" ] }, "us-gaap_DeferredTaxLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DeferredTaxLiabilitiesAbstract", "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred tax liabilities:", "label": "Deferred Tax Liabilities, Gross [Abstract]" } } }, "auth_ref": [] }, "vsee_DeferredTaxLiabilitiesAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DeferredTaxLiabilitiesAccountsReceivable", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from accounts receivable.", "label": "Deferred Tax Liabilities Accounts Receivable" } } }, "auth_ref": [] }, "vsee_DeferredTaxLiabilitiesAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DeferredTaxLiabilitiesAmortization", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Amortization", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from amortization.", "label": "Deferred Tax Liabilities Amortization" } } }, "auth_ref": [] }, "vsee_DeferredTaxLiabilitiesDepreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DeferredTaxLiabilitiesDepreciation", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Depreciation", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from depreciation.", "label": "Deferred Tax Liabilities Depreciation" } } }, "auth_ref": [] }, "vsee_DeferredTaxLiabilitiesPrepaidsAndOtherCurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DeferredTaxLiabilitiesPrepaidsAndOtherCurrentAssets", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable": { "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofDeferredTaxAssetsandLiabilitiesTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaids and other current assets", "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from prepaids and other current assets.", "label": "Deferred Tax Liabilities Prepaids And Other Current Assets" } } }, "auth_ref": [] }, "vsee_DeferredUnderwritingFee": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DeferredUnderwritingFee", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred underwriting fee", "documentation": "The amount of deferred underwriting fee payable by the company.", "label": "Deferred Underwriting Fee" } } }, "auth_ref": [] }, "dei_DelayedOrContinuousOffering": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DelayedOrContinuousOffering", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Delayed or Continuous Offering" } } }, "auth_ref": [ "r1189", "r1190", "r1204" ] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "Depreciation", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/FixedAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation expense", "label": "Depreciation", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r4", "r31", "r158", "r996", "r997", "r999", "r1001" ] }, "us-gaap_DepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DepreciationAndAmortization", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/ScheduleofReportableSegmentDepreciationandAmortizationandCapitalExpendituresTable" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization", "label": "Depreciation, Depletion and Amortization, Nonproduction", "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production." } } }, "auth_ref": [ "r4", "r31" ] }, "us-gaap_DepreciationAndAmortizationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DepreciationAndAmortizationAbstract", "presentation": [ "http://vseehealth.com/role/ScheduleofReportableSegmentDepreciationandAmortizationandCapitalExpendituresTable" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and Amortization:", "label": "Depreciation, Depletion and Amortization [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DerivativesPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Financial Instruments", "label": "Derivatives, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities." } } }, "auth_ref": [ "r169", "r180", "r197", "r622", "r623", "r624", "r625", "r626", "r627", "r629", "r630" ] }, "us-gaap_DevelopedTechnologyRightsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DevelopedTechnologyRightsMember", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Developed Technology Rights [Member]", "label": "Developed Technology Rights [Member]", "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property." } } }, "auth_ref": [ "r1409", "r1410", "r1411", "r1412", "r1413", "r1415", "r1418", "r1419", "r1497" ] }, "vsee_DhacPublicShareholdersMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DhacPublicShareholdersMember", "presentation": [ "http://vseehealth.com/role/ScheduleofCommonStockBusinessCombinationTable" ], "lang": { "en-us": { "role": { "terseLabel": "DHAC Public Shareholders [Member]", "documentation": "Represents the information pertaining to DHAC public shareholders.", "label": "Dhac Public Shareholders Member" } } }, "auth_ref": [] }, "vsee_DhacShareholdersMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DhacShareholdersMember", "presentation": [ "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "DHAC Shareholders [Member]", "documentation": "Represents information pertaining to DHAC shareholders.", "label": "Dhac Shareholders Member" } } }, "auth_ref": [] }, "vsee_DigitalHealthAcquisitionCorpMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DigitalHealthAcquisitionCorpMember", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationTable", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "DHAC", "verboseLabel": "Digital Health Acquisition Corp", "netLabel": "DHAC [Member]", "label": "Digital Health Acquisition Corp [Member]", "documentation": "Represents the information pertaining to Digital Health Acquisition Corp." } } }, "auth_ref": [] }, "srt_DirectorMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "DirectorMember", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Director [Member]", "verboseLabel": "Board of Directors [Member]", "label": "Director [Member]" } } }, "auth_ref": [ "r1393", "r1586" ] }, "us-gaap_DisaggregationOfRevenueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DisaggregationOfRevenueLineItems", "presentation": [ "http://vseehealth.com/role/ScheduleofDisaggregatedRevenuebyTimingofRevenueRecognitionTable" ], "lang": { "en-us": { "role": { "label": "Disaggregation of Revenue [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r446", "r447", "r1032", "r1033", "r1034", "r1035", "r1036", "r1037", "r1038" ] }, "us-gaap_DisaggregationOfRevenueTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DisaggregationOfRevenueTable", "presentation": [ "http://vseehealth.com/role/ScheduleofDisaggregatedRevenuebyTimingofRevenueRecognitionTable" ], "lang": { "en-us": { "role": { "label": "Disaggregation of Revenue [Table]", "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r446", "r447", "r1032", "r1033", "r1034", "r1035", "r1036", "r1037", "r1038" ] }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "DisaggregationOfRevenueTableTextBlock", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Disaggregated Revenue by Timing of Revenue Recognition", "label": "Disaggregation of Revenue [Table Text Block]", "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r1440" ] }, "dei_DividendOrInterestReinvestmentPlanOnly": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DividendOrInterestReinvestmentPlanOnly", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Dividend or Interest Reinvestment Plan Only" } } }, "auth_ref": [ "r1189", "r1190", "r1204" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentAccountingStandard", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r1158" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentAnnualReport", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r1155", "r1158", "r1177" ] }, "dei_DocumentCopyrightInformation": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentCopyrightInformation", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Copyright Information", "documentation": "The copyright information for the document." } } }, "auth_ref": [] }, "dei_DocumentCreationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentCreationDate", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Creation Date", "documentation": "The date the document was made available and submitted, in YYYY-MM-DD format. The date of submission, date of acceptance by the recipient, and the document effective date are all potentially different." } } }, "auth_ref": [] }, "dei_DocumentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentDescription", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Description", "documentation": "The description of the document." } } }, "auth_ref": [] }, "dei_DocumentDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentDomain", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document [Domain]", "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards." } } }, "auth_ref": [] }, "dei_DocumentEffectiveDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentEffectiveDate", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Effective Date", "documentation": "The date when a document, upon receipt and acceptance, becomes officially effective, in YYYY-MM-DD format. Usually it is a system-assigned date time value, but it may be declared by the submitter in some cases." } } }, "auth_ref": [] }, "dei_DocumentFinStmtErrorCorrectionFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentFinStmtErrorCorrectionFlag", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Error Correction [Flag]", "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction." } } }, "auth_ref": [ "r1155", "r1158", "r1177", "r1228" ] }, "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Financial Statement Restatement Recovery Analysis [Flag]", "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)." } } }, "auth_ref": [ "r1155", "r1158", "r1177", "r1228" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentInformationDocumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentInformationDocumentAxis", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Information, Document [Axis]", "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentInformationLineItems", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentInformationTable", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentInformationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentInformationTextBlock", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Information [Text Block]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentName", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Name", "documentation": "Name of the document as assigned by the filer, corresponding to SEC document naming convention standards. Examples appear in the <FILENAME> field of EDGAR filings, such as 'htm_25911.htm', 'exhibit1.htm', 'v105727_8k.txt'." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentPeriodEndDate", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentPeriodStartDate", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentQuarterlyReport", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r1156" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentRegistrationStatement", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r1144" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r1158" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentShellCompanyReport", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r1158" ] }, "dei_DocumentSubtitle": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentSubtitle", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Subtitle", "documentation": "The subtitle given to the document resource by the creator or publisher. An example is 'A New Period of Growth'." } } }, "auth_ref": [] }, "dei_DocumentSynopsis": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentSynopsis", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Synopsis", "documentation": "A synopsis or description of the document provided by the creator or publisher. Examples are 'This is the 2006 annual report for Company. During this period we saw revenue grow by 10% and earnings per share grow by 15% over the prior period'" } } }, "auth_ref": [] }, "dei_DocumentTitle": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentTitle", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Title", "documentation": "The name or title given to the document resource by the creator or publisher. An example is '2002 Annual Report'." } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentTransitionReport", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r1205" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentType", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentVersion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentVersion", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Document Version", "documentation": "The version identifier of the document." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r1147" ] }, "vsee_DominionMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "DominionMember", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Dominion", "verboseLabel": "Dominion [Member]", "documentation": "Represents information pertaining to dominion.", "label": "Dominion Member" } } }, "auth_ref": [] }, "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]", "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year" } } }, "auth_ref": [ "r1217" ] }, "vsee_ELOCAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ELOCAgreementMember", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "ELOC Agreement [Member]", "label": "ELOCAgreement Member" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EarningsPerShareBasic", "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable" ], "lang": { "en-us": { "role": { "terseLabel": "Basic loss per common share (in Dollars per share)", "verboseLabel": "Net loss per share \u2013 basic (in Dollars per share)", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r123", "r153", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r199", "r201", "r204", "r205", "r206", "r209", "r402", "r495", "r544", "r612", "r644", "r645", "r797", "r826", "r1004" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EarningsPerShareDiluted", "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted loss per common share (in Dollars per share)", "verboseLabel": "Net loss per share diluted (in Dollars per share)", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r123", "r153", "r187", "r188", "r189", "r190", "r191", "r192", "r193", "r194", "r201", "r204", "r205", "r206", "r209", "r402", "r495", "r544", "r612", "r644", "r645", "r797", "r826", "r1004" ] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Net Loss per Common Share", "label": "Earnings Per Share, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r22", "r23", "r208" ] }, "dei_EffectiveAfter60Days486a": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EffectiveAfter60Days486a", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Effective after 60 Days, 486(a)" } } }, "auth_ref": [ "r1274" ] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EffectiveIncomeTaxRateContinuingOperations", "calculation": { "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "totalLabel": "Provision for income tax, Percentage", "label": "Effective Income Tax Rate Reconciliation, Percent", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r513", "r1048" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "calculation": { "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "U.S. federal statutory tax, Percentage", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)." } } }, "auth_ref": [ "r169", "r174", "r513", "r534", "r1048" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "calculation": { "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Change in valuation allowance, Percentage", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets." } } }, "auth_ref": [ "r517", "r1048", "r1366", "r1373", "r1473" ] }, "vsee_EffectiveIncomeTaxRateReconciliationExtinguishmentOfDebtAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "EffectiveIncomeTaxRateReconciliationExtinguishmentOfDebtAmount", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Extinguishment of debt, Amount (in Dollars)", "documentation": "The amount of extinguishment of debt.", "label": "Effective Income Tax Rate Reconciliation Extinguishment Of Debt Amount" } } }, "auth_ref": [] }, "vsee_EffectiveIncomeTaxRateReconciliationExtinguishmentOfDebtPercentage": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "EffectiveIncomeTaxRateReconciliationExtinguishmentOfDebtPercentage", "calculation": { "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Extinguishment of debt, Percentage", "documentation": "Percentage of the extinguishment of debt.", "label": "Effective Income Tax Rate Reconciliation Extinguishment Of Debt Percentage" } } }, "auth_ref": [] }, "vsee_EffectiveIncomeTaxRateReconciliationGainlossOnChangeInFairValueOfFinancialInstrumentsAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "EffectiveIncomeTaxRateReconciliationGainlossOnChangeInFairValueOfFinancialInstrumentsAmount", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Gain/loss on change in fair value of financial instruments, Amount (in Dollars)", "documentation": "The amount of gain/loss on change in fair value of financial instruments.", "label": "Effective Income Tax Rate Reconciliation Gainloss On Change In Fair Value Of Financial Instruments Amount" } } }, "auth_ref": [] }, "vsee_EffectiveIncomeTaxRateReconciliationGainlossOnChangeInFairValueOfFinancialInstrumentsPercentage": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "EffectiveIncomeTaxRateReconciliationGainlossOnChangeInFairValueOfFinancialInstrumentsPercentage", "calculation": { "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Gain/loss on change in fair value of financial instruments, Percentage", "documentation": "Percentage of the Gain/loss on change in fair value of financial instruments.", "label": "Effective Income Tax Rate Reconciliation Gainloss On Change In Fair Value Of Financial Instruments Percentage" } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses", "calculation": { "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill impairment, Percentage", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to impairment loss." } } }, "auth_ref": [ "r1048", "r1366", "r1373", "r1473", "r1474" ] }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment", "calculation": { "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Meals and entertainment, Percentage", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to meals and entertainment expense." } } }, "auth_ref": [ "r1366", "r1373", "r1473", "r1474" ] }, "vsee_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePenalties": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpensePenalties", "calculation": { "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Penalties, Percentage", "documentation": "The percentage of effective income tax non-deductible expenses for penalty.", "label": "Effective Income Tax Rate Reconciliation Nondeductible Expense Penalties" } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost", "calculation": { "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation, Percentage", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent", "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement." } } }, "auth_ref": [ "r1048", "r1366", "r1373", "r1473", "r1474" ] }, "vsee_EffectiveIncomeTaxRateReconciliationPermanentDifferencesNetPercentage": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "EffectiveIncomeTaxRateReconciliationPermanentDifferencesNetPercentage", "calculation": { "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Permanent differences, net, Percentage", "documentation": "Percentage of Permanent differences, net.", "label": "Effective Income Tax Rate Reconciliation Permanent Differences Net Percentage" } } }, "auth_ref": [] }, "vsee_EffectiveIncomeTaxRateReconciliationReturnToIncomeTaxProvisionAdjustmentsPercentage": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "EffectiveIncomeTaxRateReconciliationReturnToIncomeTaxProvisionAdjustmentsPercentage", "calculation": { "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Return to income tax provision adjustments, Percentage", "documentation": "Percentage of the return to income tax provision adjustments.", "label": "Effective Income Tax Rate Reconciliation Return To Income Tax Provision Adjustments Percentage" } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "calculation": { "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "State taxes, net of federal tax benefit, Percentage", "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)." } } }, "auth_ref": [ "r516", "r1048", "r1366", "r1373", "r1473" ] }, "vsee_EffectiveIncomeTaxRateReconciliationStatutoryTaxRateDifferenceBetweenForeignAndUnitedStatesAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "EffectiveIncomeTaxRateReconciliationStatutoryTaxRateDifferenceBetweenForeignAndUnitedStatesAmount", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Statutory tax rate difference between Foreign and United States, Amount (in Dollars)", "documentation": "Statutory tax rate difference between Foreign and United States, Amount.", "label": "Effective Income Tax Rate Reconciliation Statutory Tax Rate Difference Between Foreign And United States Amount" } } }, "auth_ref": [] }, "vsee_EffectiveIncomeTaxRateReconciliationStatutoryTaxRateDifferenceBetweenForeignAndUnitedStatesPercentage": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "EffectiveIncomeTaxRateReconciliationStatutoryTaxRateDifferenceBetweenForeignAndUnitedStatesPercentage", "calculation": { "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Statutory tax rate difference between Foreign and United States, Percentage", "documentation": "Percentage of statutory tax rate difference between Foreign and United States.", "label": "Effective Income Tax Rate Reconciliation Statutory Tax Rate Difference Between Foreign And United States Percentage" } } }, "auth_ref": [] }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsOther": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsOther", "calculation": { "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable": { "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Other, Percentage", "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent", "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other tax credits." } } }, "auth_ref": [ "r1048", "r1366", "r1373", "r1473", "r1474" ] }, "vsee_EffectiveIncomeTaxRateReturnToIncomeTaxProvisionAdjustmentsAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "EffectiveIncomeTaxRateReturnToIncomeTaxProvisionAdjustmentsAmount", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Return to income tax provision adjustments, Amount (in Dollars)", "documentation": "The amount of Return to income tax provision adjustments, Amount.", "label": "Effective Income Tax Rate Return To Income Tax Provision Adjustments Amount" } } }, "auth_ref": [] }, "dei_EffectiveOnDate486a": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EffectiveOnDate486a", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Effective on Date, 486(a)" } } }, "auth_ref": [ "r1274" ] }, "dei_EffectiveOnDate486b": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EffectiveOnDate486b", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Effective on Date, 486(b)" } } }, "auth_ref": [ "r1275" ] }, "dei_EffectiveOnSetDate486a": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EffectiveOnSetDate486a", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Effective on Set Date, 486(a)" } } }, "auth_ref": [ "r1274" ] }, "dei_EffectiveOnSetDate486b": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EffectiveOnSetDate486b", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Effective on Set Date, 486(b)" } } }, "auth_ref": [ "r1275" ] }, "dei_EffectiveUponFiling462e": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EffectiveUponFiling462e", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Effective Upon Filing, 462(e)" } } }, "auth_ref": [ "r1273" ] }, "dei_EffectiveUponFiling486b": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EffectiveUponFiling486b", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Effective upon Filing, 486(b)" } } }, "auth_ref": [ "r1275" ] }, "dei_EffectiveWhenDeclaredSection8c": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EffectiveWhenDeclaredSection8c", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Effective when Declared, Section 8(c)" } } }, "auth_ref": [ "r1277" ] }, "us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of the embedded derivative at issuance", "label": "Embedded Derivative, Fair Value of Embedded Derivative Liability", "documentation": "Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability." } } }, "auth_ref": [ "r1505", "r1516", "r1517", "r1518" ] }, "us-gaap_EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Change in fair value on embedded derivative", "label": "Embedded Derivative, Gain (Loss) on Embedded Derivative, Net", "documentation": "Net Increase or Decrease in the fair value of the embedded derivative or group of embedded derivatives included in earnings in the period." } } }, "auth_ref": [ "r1506", "r1511" ] }, "us-gaap_EmbeddedDerivativeLiabilityMeasurementInput": { "xbrltype": "decimalItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EmbeddedDerivativeLiabilityMeasurementInput", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyInputsTable0", "http://vseehealth.com/role/ScheduleofKeyInputsTable3" ], "lang": { "en-us": { "role": { "terseLabel": "CCC bond rates", "verboseLabel": "Measurement input", "label": "Embedded Derivative Liability, Measurement Input", "documentation": "Value of input used to measure embedded derivative liability." } } }, "auth_ref": [ "r649", "r650", "r651" ] }, "vsee_EmbeddedDerivativeLiabilityMeasurementInputTerm": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "EmbeddedDerivativeLiabilityMeasurementInputTerm", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyInputsTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Expected term (years)", "documentation": "Expected term (years).", "label": "Embedded Derivative Liability Measurement Input Term" } } }, "auth_ref": [] }, "vsee_EmergingGrowthCompanyPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "EmergingGrowthCompanyPolicyPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Implications of Being an Emerging Growth Company", "documentation": "Disclosure of accounting policy for emerging growth company.", "label": "Emerging Growth Company Policy Policy Text Block" } } }, "auth_ref": [] }, "us-gaap_EmployeeBenefitsAndShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EmployeeBenefitsAndShareBasedCompensation", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation and related benefits", "label": "Employee Benefits and Share-Based Compensation", "documentation": "Amount of expense for employee benefit and equity-based compensation." } } }, "auth_ref": [ "r1317" ] }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EmployeeRelatedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable": { "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued compensation and benefits", "label": "Employee-related Liabilities, Current", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r48" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized compensation cost (in Dollars)", "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount", "documentation": "Amount of cost to be recognized for option under share-based payment arrangement." } } }, "auth_ref": [ "r1469" ] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EmployeeStockOptionMember", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "verboseLabel": "Share-Based Payment Arrangement, Option [Member]", "label": "Employee Stock Option [Member]", "terseLabel": "Employee Stock Option", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [ "r1442", "r1443", "r1444", "r1445", "r1446", "r1447", "r1448", "r1449", "r1450", "r1451", "r1452", "r1453", "r1454", "r1455", "r1456", "r1457", "r1458", "r1459", "r1460", "r1461", "r1462", "r1464", "r1465", "r1466", "r1467", "r1468" ] }, "vsee_EmployeesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "EmployeesMember", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employees [Member]", "documentation": "Represents the information pertaining to employees.", "label": "Employees Member" } } }, "auth_ref": [] }, "vsee_EncompassHealthcareBillingLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "EncompassHealthcareBillingLlcMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Encompass Healthcare Billing, LLC [Member]", "documentation": "Represents the information pertaining to Encompass Healthcare Billing, LLC.", "label": "Encompass Healthcare Billing Llc Member" } } }, "auth_ref": [] }, "dei_EntitiesTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntitiesTable", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entities [Table]", "documentation": "Container to assemble all relevant information about each entity associated with the document instance" } } }, "auth_ref": [] }, "dei_EntityAccountingStandard": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAccountingStandard", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Accounting Standard", "documentation": "The standardized abbreviation of the accounting standard used by the entity. This can either be US GAAP as promulgated by the FASB or IFRS as promulgated by the IASB. Example: 'US GAAP', 'IFRS'. This is distinct from the Document Accounting Standard element." } } }, "auth_ref": [] }, "dei_EntityAddressAddressDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressAddressDescription", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Description", "documentation": "Description of the kind of address for the entity, if needed to distinguish more finely among mailing, principal, legal, accounting, contact or other addresses." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressAddressLine1", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressAddressLine2", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressAddressLine3", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressCityOrTown", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressCountry", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityAddressesAddressTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressesAddressTypeAxis", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Addresses, Address Type [Axis]", "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table." } } }, "auth_ref": [] }, "dei_EntityAddressesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressesLineItems", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Addresses [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityAddressesTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityAddressesTable", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Addresses [Table]", "documentation": "Container of address information for the entity" } } }, "auth_ref": [ "r1146" ] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r1150" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCentralIndexKey", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1146" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityContactPersonnelLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityContactPersonnelLineItems", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Contact Personnel [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityDomain", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ShareholdersEquityType2or3", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails", "http://xbrl.sec.gov/dei/role/document/AuditInformation", "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1146" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityExTransitionPeriod", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r1276" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityFileNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityFilerCategory", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r1146" ] }, "dei_EntityHomeCountryISOCode": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityHomeCountryISOCode", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Home Country ISO Code", "documentation": "ISO 3166-1 alpha-2 country code for the Entity's home country. If home country is different from country of legal incorporation, then also provide country of legal incorporation in the 'Entity Incorporation, State Country Code' element." } } }, "auth_ref": [] }, "dei_EntityIncorporationDateOfIncorporation": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityIncorporationDateOfIncorporation", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, Date of Incorporation", "documentation": "Date when an entity was incorporated" } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInformationFormerLegalOrRegisteredName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityInformationFormerLegalOrRegisteredName", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Information, Former Legal or Registered Name", "documentation": "Former Legal or Registered Name of an entity" } } }, "auth_ref": [] }, "dei_EntityInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityInformationLineItems", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r1265" ] }, "dei_EntityInvCompanyType": { "xbrltype": "invCompanyType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityInvCompanyType", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Inv Company Type", "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)." } } }, "auth_ref": [ "r1264" ] }, "dei_EntityLegalForm": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityLegalForm", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Legal Form", "documentation": "The details of the entity's legal form. Examples are partnership, limited liability company, trust, etc." } } }, "auth_ref": [] }, "dei_EntityListingDepositoryReceiptRatio": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityListingDepositoryReceiptRatio", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Listing, Depository Receipt Ratio", "documentation": "The number of underlying shares represented by one American Depository Receipt (ADR) or Global Depository Receipt (GDR). A value of '3' means that one ADR represents 3 underlying shares. If one underlying share represents 2 ADR's then the value would be represented as '0.5'." } } }, "auth_ref": [] }, "dei_EntityListingDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityListingDescription", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Listing, Description", "documentation": "Description of the kind of listing the entity has on the exchange, if necessary to further describe different instruments that are already distinguished by Entity, Exchange and Security." } } }, "auth_ref": [] }, "dei_EntityListingForeign": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityListingForeign", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Listing, Foreign", "documentation": "Yes or No value indicating whether this is a listing that is a foreign listing or depository receipt." } } }, "auth_ref": [] }, "dei_EntityListingParValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityListingParValuePerShare", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Listing, Par Value Per Share", "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'." } } }, "auth_ref": [] }, "dei_EntityListingPrimary": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityListingPrimary", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Listing, Primary", "documentation": "Yes or No value indicating whether a listing of an instrument on an exchange is primary for the entity." } } }, "auth_ref": [] }, "dei_EntityListingSecurityTradingCurrency": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityListingSecurityTradingCurrency", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Listing, Security Trading Currency", "documentation": "The three character ISO 4217 code for the currency in which the security is quoted. Example: 'USD'" } } }, "auth_ref": [] }, "dei_EntityListingsExchangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityListingsExchangeAxis", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Listings, Exchange [Axis]", "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table." } } }, "auth_ref": [] }, "dei_EntityListingsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityListingsLineItems", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Listings [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityListingsTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityListingsTable", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Listings [Table]", "documentation": "Container for exchange listing information for an entity" } } }, "auth_ref": [] }, "dei_EntityNumberOfEmployees": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityNumberOfEmployees", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Number of Employees", "documentation": "Number of persons employed by the Entity" } } }, "auth_ref": [] }, "dei_EntityPhoneFaxNumbersLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityPhoneFaxNumbersLineItems", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Phone Fax Numbers [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityPrimarySicNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r1177" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityRegistrantName", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1146" ] }, "dei_EntityReportingCurrencyISOCode": { "xbrltype": "currencyItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityReportingCurrencyISOCode", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Reporting Currency ISO Code", "documentation": "The three character ISO 4217 code for the currency used for reporting purposes. Example: 'USD'." } } }, "auth_ref": [] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityShellCompany", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r1146" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntitySmallBusiness", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r1146" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1146" ] }, "dei_EntityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityTextBlock", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity [Text Block]", "documentation": "Container to serve as parent of six Entity related Table concepts." } } }, "auth_ref": [] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityVoluntaryFilers", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r1267" ] }, "ecd_EqtyAwrdsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "EqtyAwrdsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Awards Adjustments, Footnote [Text Block]", "terseLabel": "Equity Awards Adjustments, Footnote" } } }, "auth_ref": [ "r1211" ] }, "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]", "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table" } } }, "auth_ref": [ "r1260" ] }, "ecd_EqtyAwrdsAdjsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "EqtyAwrdsAdjsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Awards Adjustments [Member]", "terseLabel": "Equity Awards Adjustments" } } }, "auth_ref": [ "r1260" ] }, "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]", "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table" } } }, "auth_ref": [ "r1260" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "EquityComponentDomain", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/ShareholdersEquityType2or3", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r7", "r120", "r122", "r123", "r149", "r150", "r151", "r182", "r183", "r184", "r186", "r193", "r195", "r197", "r211", "r299", "r300", "r344", "r401", "r433", "r495", "r532", "r533", "r541", "r542", "r543", "r545", "r611", "r612", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r643", "r679", "r680", "r681", "r682", "r683", "r684", "r689", "r691", "r708", "r824", "r848", "r849", "r850", "r873", "r943" ] }, "vsee_EquityDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "EquityDetailsLineItems", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "label": "Equity (Details) [Line Items]" } } }, "auth_ref": [] }, "vsee_EquityDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "EquityDetailsTable", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "label": "Equity (Details) [Table]" } } }, "auth_ref": [] }, "vsee_EquityFinancingMaximumRemainingShareCapacityAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "EquityFinancingMaximumRemainingShareCapacityAmount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum remaining availability under the ELOC", "documentation": "Maximum amount of share capacity available for issuance under the equity financing.", "label": "Equity Financing Maximum Remaining Share Capacity Amount" } } }, "auth_ref": [] }, "vsee_EquityIncentivePlan2024Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "EquityIncentivePlan2024Member", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails", "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Incentive Plan 2024 [Member]", "documentation": "Represents information relating to 2024 Equity Incentive Plan.", "label": "Equity Incentive Plan2024 Member" } } }, "auth_ref": [] }, "vsee_EquityLineOfCreditCommitmentFeeNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "EquityLineOfCreditCommitmentFeeNoteMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "ELOC Commitment Fee Note", "verboseLabel": "Equity Line Of Credit", "netLabel": "Equity Line Of Credit, Commitment Fee Note [Member]", "documentation": "Represents information pertaining to equity line of credit commitment fee note.", "label": "Equity Line Of Credit Commitment Fee Note Member" } } }, "auth_ref": [] }, "vsee_EquityLineOfCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "EquityLineOfCreditMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/FairValueMeasurementsTables", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable", "http://vseehealth.com/role/ScheduleofKeyInputsTable3", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Line of Credit", "verboseLabel": "Equity line of credit [Member]", "netLabel": "ELOC Purchase Agreement [Member]", "label": "Equity Line Of Credit [Member]", "documentation": "Represents information pertaining to equity line of credit." } } }, "auth_ref": [] }, "srt_EquityMethodInvesteeNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "EquityMethodInvesteeNameDomain", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Domain]" } } }, "auth_ref": [ "r295", "r296", "r297", "r540", "r677", "r1280", "r1281", "r1282", "r1482", "r1483", "r1484", "r1485" ] }, "vsee_EquityPurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "EquityPurchaseAgreementMember", "presentation": [ "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Purchase Agreement [Member]", "documentation": "Represents the information pertaining to equity purchase agreement.", "label": "Equity Purchase Agreement Member" } } }, "auth_ref": [] }, "vsee_EquityPurchaseCommitmentNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "EquityPurchaseCommitmentNoteMember", "presentation": [ "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Purchase Commitment Note [Member]", "documentation": "Represents information related to Equity Purchase Commitment Note.", "label": "Equity Purchase Commitment Note Member" } } }, "auth_ref": [] }, "vsee_EquityScheduleofKeyAssumptionsUsedinValuingUnvestedOptionsDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "EquityScheduleofKeyAssumptionsUsedinValuingUnvestedOptionsDetailsLineItems", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyAssumptionsUsedinValuingUnvestedOptionsTable" ], "lang": { "en-us": { "role": { "label": "Equity - Schedule of Key Assumptions Used in Valuing Unvested Options (Details) [Line Items]" } } }, "auth_ref": [] }, "vsee_EquityScheduleofKeyAssumptionsUsedinValuingUnvestedOptionsDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "EquityScheduleofKeyAssumptionsUsedinValuingUnvestedOptionsDetailsTable", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyAssumptionsUsedinValuingUnvestedOptionsTable" ], "lang": { "en-us": { "role": { "label": "Equity - Schedule of Key Assumptions Used in Valuing Unvested Options (Details) [Table]" } } }, "auth_ref": [] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote [Text Block]", "terseLabel": "Equity Valuation Assumption Difference, Footnote" } } }, "auth_ref": [ "r1221" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis [Text Block]", "terseLabel": "Erroneous Compensation Analysis" } } }, "auth_ref": [ "r1170", "r1181", "r1197", "r1232" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]", "terseLabel": "Erroneously Awarded Compensation Recovery" } } }, "auth_ref": [ "r1167", "r1178", "r1194", "r1229" ] }, "vsee_EstimatedFairValueOfAssetsAcquiredAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "EstimatedFairValueOfAssetsAcquiredAbstract", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated fair value of assets acquired:", "label": "Estimated Fair Value Of Assets Acquired Abstract" } } }, "auth_ref": [] }, "vsee_EstimatedFairValueOfLiabilitiesAssumedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "EstimatedFairValueOfLiabilitiesAssumedAbstract", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated fair value of liabilities assumed:", "label": "Estimated Fair Value Of Liabilities Assumed Abstract" } } }, "auth_ref": [] }, "vsee_EstimatedValueOfSharesAndOptionsGranted": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "EstimatedValueOfSharesAndOptionsGranted", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares and options granted (in Dollars)", "documentation": "The estimated value of shares and options granted.", "label": "Estimated Value Of Shares And Options Granted" } } }, "auth_ref": [] }, "vsee_ExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ExcessAmount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Excess amount", "documentation": "Excess amount.", "label": "Excess Amount" } } }, "auth_ref": [] }, "vsee_ExchangeAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ExchangeAgreementMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exchange Agreement [Member]", "documentation": "Represents information related to Exchange Agreement.", "label": "Exchange Agreement Member" } } }, "auth_ref": [] }, "dei_ExchangeDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "ExchangeDomain", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Exchange [Domain]", "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383." } } }, "auth_ref": [] }, "vsee_ExchangeNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ExchangeNoteMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Exchange Note", "verboseLabel": "Exchange Note [Member]", "documentation": "Represents information related to Exchange Note.", "label": "Exchange Note Member" } } }, "auth_ref": [] }, "vsee_ExchangeNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ExchangeNotesMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/FairValueMeasurementsTables", "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable", "http://vseehealth.com/role/ScheduleofKeyInputsTable2" ], "lang": { "en-us": { "role": { "terseLabel": "Exchange Note", "verboseLabel": "Exchange Note [Member]", "netLabel": "Exchange Notes [Member]", "documentation": "Represents information pertaining to exchange note.", "label": "Exchange Notes Member" } } }, "auth_ref": [] }, "vsee_ExcludedSecurities1Abstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ExcludedSecurities1Abstract", "presentation": [ "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable" ], "lang": { "en-us": { "role": { "terseLabel": "Excluded securities:(1)", "label": "Excluded Securities1 Abstract" } } }, "auth_ref": [] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]", "terseLabel": "Executive Category:" } } }, "auth_ref": [ "r1227" ] }, "dei_ExhibitsOnly462d": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "ExhibitsOnly462d", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Exhibits Only, 462(d)" } } }, "auth_ref": [ "r1272" ] }, "dei_ExhibitsOnly462dFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "ExhibitsOnly462dFileNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Exhibits Only, 462(d), File Number" } } }, "auth_ref": [ "r1272" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "Extension", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "vsee_ExtensionNoteBifurcatedDerivativeMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ExtensionNoteBifurcatedDerivativeMember", "presentation": [ "http://vseehealth.com/role/FairValueMeasurementsTables", "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable", "http://vseehealth.com/role/ScheduleofKeyInputsTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Extension Note Bifurcated Derivative [Member]", "documentation": "Represents information pertaining to extension note - bifurcated derivative.", "label": "Extension Note Bifurcated Derivative Member" } } }, "auth_ref": [] }, "vsee_ExtensionNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ExtensionNoteMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Extension Note [Member]", "documentation": "Represents information related to Extension Note.", "label": "Extension Note Member" } } }, "auth_ref": [] }, "vsee_ExtensionWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ExtensionWarrantsMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable", "http://vseehealth.com/role/ScheduleofWarrantsIssuedandoutstandingTable", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Extension Warrants [Member]", "verboseLabel": "Extension [Member]", "documentation": "Represents information pertaining to Extension Warrants.", "label": "Extension Warrants Member" } } }, "auth_ref": [] }, "vsee_FactoringPayableAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FactoringPayableAbstract", "lang": { "en-us": { "role": { "label": "Factoring Payable Abstract" } } }, "auth_ref": [] }, "vsee_FactoringPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FactoringPayableCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Factoring payable", "documentation": "Carrying value as of the balance sheet date of factoring payable, classified as current.", "label": "Factoring Payable Current" } } }, "auth_ref": [] }, "vsee_FactoringPayableDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FactoringPayableDetailsLineItems", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "label": "Factoring Payable (Details) [Line Items]" } } }, "auth_ref": [] }, "vsee_FactoringPayableDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FactoringPayableDetailsTable", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "label": "Factoring Payable (Details) [Table]" } } }, "auth_ref": [] }, "vsee_FactoringPayableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FactoringPayableTextBlock", "presentation": [ "http://vseehealth.com/role/FactoringPayable" ], "lang": { "en-us": { "role": { "terseLabel": "Factoring Payable", "documentation": "The entire disclosure of Factoring Payable.", "label": "Factoring Payable Text Block" } } }, "auth_ref": [] }, "vsee_FairValueAdjustmentOfFinancialInstruments": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FairValueAdjustmentOfFinancialInstruments", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Change in fair value of financial instruments", "terseLabel": "Change in fair value of financial instruments", "documentation": "Amount of expense (income) related to adjustment to fair value of financial instruments.", "label": "Fair Value Adjustment Of Financial Instruments" } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "presentation": [ "http://vseehealth.com/role/FairValueMeasurementsTables", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurements", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r647", "r648", "r662", "r1096" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://vseehealth.com/role/FairValueMeasurementsTables", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable" ], "lang": { "en-us": { "role": { "label": "Fair Value, Recurring and Nonrecurring [Table]", "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis." } } }, "auth_ref": [ "r647", "r648", "r662", "r1096" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyInputsTable", "http://vseehealth.com/role/ScheduleofKeyInputsTable0", "http://vseehealth.com/role/ScheduleofKeyInputsTable1", "http://vseehealth.com/role/ScheduleofKeyInputsTable2", "http://vseehealth.com/role/ScheduleofKeyInputsTable3", "http://vseehealth.com/role/ScheduleofKeyInputsTable4", "http://vseehealth.com/role/ScheduleofKeyInputsTable5", "http://vseehealth.com/role/ScheduleofKeyInputsTable6" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]", "terseLabel": "Fair Value Measurements", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r649", "r650", "r651", "r1049", "r1056", "r1100" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyInputsTable", "http://vseehealth.com/role/ScheduleofKeyInputsTable0", "http://vseehealth.com/role/ScheduleofKeyInputsTable1", "http://vseehealth.com/role/ScheduleofKeyInputsTable2", "http://vseehealth.com/role/ScheduleofKeyInputsTable3", "http://vseehealth.com/role/ScheduleofKeyInputsTable4", "http://vseehealth.com/role/ScheduleofKeyInputsTable5", "http://vseehealth.com/role/ScheduleofKeyInputsTable6" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]", "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis." } } }, "auth_ref": [ "r649", "r650", "r651", "r1049", "r1056", "r1100" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "presentation": [ "http://vseehealth.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Key Inputs", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]", "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis." } } }, "auth_ref": [ "r649", "r650", "r1100" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r384", "r450", "r451", "r452", "r453", "r454", "r455", "r457", "r458", "r646", "r648", "r649", "r650", "r651", "r660", "r662", "r664", "r670", "r724", "r725", "r726", "r988", "r1024", "r1025", "r1039", "r1040", "r1041", "r1042", "r1043", "r1096", "r1100", "r1107" ] }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueByMeasurementFrequencyAxis", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable" ], "lang": { "en-us": { "role": { "label": "Measurement Frequency [Axis]", "documentation": "Information by measurement frequency." } } }, "auth_ref": [ "r647", "r648", "r649", "r651", "r1096", "r1517", "r1522" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://vseehealth.com/role/FairValueMeasurements" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measurements", "label": "Fair Value Disclosures [Text Block]", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r649", "r656", "r658", "r659", "r660", "r664", "r665", "r666", "r667", "r668", "r795", "r1096", "r1101" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Inputs, Level 1 [Member]", "verboseLabel": "Level 2 [Member]", "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r384", "r450", "r455", "r457", "r648", "r662", "r670", "r724", "r988", "r1039", "r1040", "r1041", "r1042", "r1043", "r1096", "r1107" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable" ], "lang": { "en-us": { "role": { "terseLabel": "Level 1 [Member]", "verboseLabel": "Level 3 [Member]", "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r384", "r450", "r455", "r457", "r459", "r648", "r649", "r662", "r670", "r725", "r988", "r1024", "r1025", "r1039", "r1040", "r1041", "r1042", "r1043", "r1096", "r1107" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Inputs, Level 3 [Member]", "verboseLabel": "Level 3 [Member]", "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r384", "r450", "r451", "r452", "r453", "r454", "r455", "r457", "r458", "r648", "r649", "r650", "r651", "r662", "r670", "r726", "r988", "r1024", "r1025", "r1039", "r1040", "r1041", "r1042", "r1043", "r1096", "r1100", "r1107" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "presentation": [ "http://vseehealth.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Fair Value Information on Recurring Basis", "label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]", "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset." } } }, "auth_ref": [ "r1514", "r1515" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "presentation": [ "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable" ], "lang": { "en-us": { "role": { "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r652", "r653", "r654", "r655", "r656", "r657" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "presentation": [ "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable" ], "lang": { "en-us": { "role": { "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]", "documentation": "Disclosure of information about financial instrument liability measured at fair value on recurring basis using unobservable input." } } }, "auth_ref": [ "r652", "r653", "r654", "r655", "r656", "r657", "r663" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "presentation": [ "http://vseehealth.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Changes in the Fair Value of Financial Liabilities", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability." } } }, "auth_ref": [ "r652", "r657", "r663" ] }, "us-gaap_FairValueMeasurementFrequencyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueMeasurementFrequencyDomain", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable" ], "lang": { "en-us": { "role": { "label": "Measurement Frequency [Domain]", "documentation": "Measurement frequency." } } }, "auth_ref": [ "r647", "r648", "r649", "r651", "r1096", "r1517", "r1522" ] }, "vsee_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAdditionsToPrincipal": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAdditionsToPrincipal", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Additions to principal", "documentation": "The amount of additions to principal.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Additions To Principal" } } }, "auth_ref": [] }, "vsee_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversion": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversion", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Conversion", "documentation": "The amount of conversion.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Conversion" } } }, "auth_ref": [] }, "vsee_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionIntoEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityConversionIntoEquity", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Shares issued upon conversions of portion of notes", "documentation": "Amount of conversion into equity of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Conversion Into Equity" } } }, "auth_ref": [] }, "vsee_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossFromExtinguishment": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossFromExtinguishment", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "(Gain) Loss due to extinguishment of debt", "documentation": "Amount of gain (loss) recognized from extinguishment of debt measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss From Extinguishment" } } }, "auth_ref": [] }, "vsee_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarning": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarning", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable" ], "lang": { "en-us": { "role": { "negatedLabel": "(Gain) Loss on change in fair value", "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earning" } } }, "auth_ref": [] }, "vsee_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossOnChangeInFairValueAndExtinguishmentOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossOnChangeInFairValueAndExtinguishmentOfDebt", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Gain on change in fair value / extinguishment of debt", "documentation": "Amount of gain (loss) on change in fair value / extinguishment of debt of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss On Change In Fair Value And Extinguishment Of Debt" } } }, "auth_ref": [] }, "vsee_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityInterestAccrued": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityInterestAccrued", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Interest accrued", "documentation": "Amount of interest accrued of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Interest Accrued" } } }, "auth_ref": [] }, "vsee_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssuanceDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssuanceDiscount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance discount", "documentation": "Amount of issuance discount of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issuance Discount" } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Initial fair value at issuance", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances", "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r655", "r661", "r663" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayment on Notes", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Sales", "documentation": "Amount of sales of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r655", "r663" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Settlement of Extension Note", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements", "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r655", "r663" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Transfer liabilities levels", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net", "documentation": "Amount of transfers of financial instrument classified as a liability into (out of) level 3 of the fair value hierarchy." } } }, "auth_ref": [ "r1519", "r1521" ] }, "vsee_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityWriteOff": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityWriteOff", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Write-off", "documentation": "Amount of write-off of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Write Off" } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable" ], "lang": { "en-us": { "role": { "periodStartLabel": "Fair value as of beginning of the year", "periodEndLabel": "Fair value as of end of the year", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r652", "r663" ] }, "vsee_FairValueMeasurementsDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FairValueMeasurementsDetailsLineItems", "presentation": [ "http://vseehealth.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurements (Details) [Line Items]" } } }, "auth_ref": [] }, "vsee_FairValueMeasurementsDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FairValueMeasurementsDetailsTable", "presentation": [ "http://vseehealth.com/role/FairValueMeasurementsDetails" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurements (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r384", "r450", "r451", "r452", "r453", "r454", "r455", "r457", "r458", "r646", "r648", "r649", "r650", "r651", "r660", "r662", "r664", "r670", "r724", "r725", "r726", "r988", "r1024", "r1025", "r1039", "r1040", "r1041", "r1042", "r1043", "r1096", "r1100", "r1107" ] }, "us-gaap_FairValueMeasurementsRecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueMeasurementsRecurringMember", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Recurring [Member]", "label": "Fair Value, Recurring [Member]", "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value." } } }, "auth_ref": [ "r1096", "r1514", "r1515", "r1516", "r1517", "r1518", "r1522" ] }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FairValueOfFinancialInstrumentsPolicy", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value of Financial Instruments", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments." } } }, "auth_ref": [ "r1523" ] }, "vsee_FairValueOfSharesOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FairValueOfSharesOfCommonStock", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of shares issued to vendor for service (in Dollars)", "documentation": "Amounts of fair values of common stock", "label": "Fair Value Of Shares Of Common Stock" } } }, "auth_ref": [] }, "vsee_FederalMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FederalMember", "presentation": [ "http://vseehealth.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Federal [Member]", "label": "Federal Member" } } }, "auth_ref": [] }, "vsee_FinanceLeaseCostTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FinanceLeaseCostTableTextBlock", "presentation": [ "http://vseehealth.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Expenses Incurred with Respect to Finance Leases", "documentation": "Tabular disclosure of lessee's finance lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease.", "label": "Finance Lease Cost Table Text Block" } } }, "auth_ref": [] }, "us-gaap_FinanceLeaseInterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinanceLeaseInterestExpense", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofExpensesIncurredwithRespecttoFinanceLeasesTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/ScheduleofExpensesIncurredwithRespecttoFinanceLeasesTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total Finance lease expense", "label": "Finance Lease, Interest Expense", "documentation": "Amount of interest expense on finance lease liability." } } }, "auth_ref": [ "r695", "r700", "r1109" ] }, "us-gaap_FinanceLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinanceLeaseLiability", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofFinanceLeaseLiabilitiesTable", "http://vseehealth.com/role/ScheduleofFutureMinimumPaymentsUnderFinanceLeaseTable" ], "lang": { "en-us": { "role": { "terseLabel": "Equipment lease", "verboseLabel": "Present value of payments", "label": "Finance Lease, Liability", "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease." } } }, "auth_ref": [ "r694", "r705" ] }, "us-gaap_FinanceLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinanceLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ScheduleofFinanceLeaseLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Financing lease liabilities", "negatedLabel": "Less: current portion", "label": "Finance Lease, Liability, Current", "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current." } } }, "auth_ref": [ "r694" ] }, "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinanceLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://vseehealth.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Future Minimum Payments Under Finance Lease", "label": "Finance Lease, Liability, to be Paid, Maturity [Table Text Block]", "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r1535" ] }, "us-gaap_FinanceLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinanceLeaseLiabilityNoncurrent", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofFinanceLeaseLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term portion", "label": "Finance Lease, Liability, Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent." } } }, "auth_ref": [ "r694" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinanceLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofFutureMinimumPaymentsUnderFinanceLeaseTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/ScheduleofFutureMinimumPaymentsUnderFinanceLeaseTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total future minimum lease payments", "label": "Finance Lease, Liability, to be Paid", "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease." } } }, "auth_ref": [ "r705", "r1367", "r1374", "r1550" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofFutureMinimumPaymentsUnderFinanceLeaseTable": { "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofFutureMinimumPaymentsUnderFinanceLeaseTable" ], "lang": { "en-us": { "role": { "terseLabel": "Year ending December 31, 2026", "label": "Finance Lease, Liability, to be Paid, Year One", "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r705", "r1367", "r1374", "r1550" ] }, "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofFutureMinimumPaymentsUnderFinanceLeaseTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: Imputed interest", "label": "Finance Lease, Liability, Undiscounted Excess Amount", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease." } } }, "auth_ref": [ "r705" ] }, "vsee_FinanceLeasePayableReclassedFromFinancingActivitiesToAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FinanceLeasePayableReclassedFromFinancingActivitiesToAccountsPayable", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Finance lease payable reclassed from financing activities to accounts payable", "documentation": "Finance lease payable reclassed from financing activities to accounts payable.", "label": "Finance Lease Payable Reclassed From Financing Activities To Accounts Payable" } } }, "auth_ref": [] }, "us-gaap_FinanceLeasePrincipalPayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinanceLeasePrincipalPayments", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 15.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments on financing lease liability", "terseLabel": "Finance lease payments", "label": "Finance Lease, Principal Payments", "documentation": "Amount of cash outflow for principal payment on finance lease." } } }, "auth_ref": [ "r696", "r702" ] }, "us-gaap_FinanceLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinanceLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofFinanceLeasedEquipmentTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/ScheduleofFinanceLeasedEquipmentTable" ], "lang": { "en-us": { "role": { "totalLabel": "Leased equipment, net", "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization", "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease." } } }, "auth_ref": [ "r693" ] }, "us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinanceLeaseRightOfUseAssetAccumulatedAmortization", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofFinanceLeasedEquipmentTable": { "parentTag": "us-gaap_FinanceLeaseRightOfUseAsset", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofFinanceLeasedEquipmentTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: Accumulated amortization", "label": "Finance Lease, Right-of-Use Asset, Accumulated Amortization", "documentation": "Amount of accumulated amortization of right-of-use asset from finance lease." } } }, "auth_ref": [ "r1285", "r1289" ] }, "us-gaap_FinanceLeaseRightOfUseAssetAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinanceLeaseRightOfUseAssetAmortization", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofExpensesIncurredwithRespecttoFinanceLeasesTable": { "parentTag": "us-gaap_FinanceLeaseInterestExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/FixedAssetsDetails", "http://vseehealth.com/role/ScheduleofExpensesIncurredwithRespecttoFinanceLeasesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization expense", "verboseLabel": "Finance lease asset amortization", "label": "Finance Lease, Right-of-Use Asset, Amortization", "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease." } } }, "auth_ref": [ "r695", "r700", "r1109" ] }, "us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofFinanceLeasedEquipmentTable": { "parentTag": "us-gaap_FinanceLeaseRightOfUseAsset", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofFinanceLeasedEquipmentTable" ], "lang": { "en-us": { "role": { "terseLabel": "Equipment lease", "label": "Finance Lease, Right-of-Use Asset, before Accumulated Amortization", "documentation": "Amount, before accumulated amortization, of right-of-use asset from finance lease." } } }, "auth_ref": [ "r1284" ] }, "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinanceLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://vseehealth.com/role/ScheduleofWeightedAverageRemainingLeaseTermandDiscountRateonFinanceLeasesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average discount rate", "label": "Finance Lease, Weighted Average Discount Rate, Percent", "documentation": "Weighted average discount rate for finance lease calculated at point in time." } } }, "auth_ref": [ "r704", "r1109" ] }, "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://vseehealth.com/role/ScheduleofWeightedAverageRemainingLeaseTermandDiscountRateonFinanceLeasesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average remaining lease term (years)*", "label": "Finance Lease, Weighted Average Remaining Lease Term", "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r703", "r1109" ] }, "us-gaap_FinancialInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinancialInstrumentAxis", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/FairValueMeasurementsTables", "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable", "http://vseehealth.com/role/ScheduleofKeyInputsTable0", "http://vseehealth.com/role/ScheduleofKeyInputsTable1", "http://vseehealth.com/role/ScheduleofKeyInputsTable3", "http://vseehealth.com/role/ScheduleofKeyInputsTable5", "http://vseehealth.com/role/ScheduleofKeyInputsTable6" ], "lang": { "en-us": { "role": { "label": "Financial Instrument [Axis]", "documentation": "Information by type of financial instrument." } } }, "auth_ref": [ "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r302", "r303", "r307", "r308", "r309", "r310", "r311", "r312", "r395", "r429", "r628", "r641", "r669", "r676", "r678", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r728", "r729", "r730", "r731", "r732", "r733", "r734", "r735", "r738", "r739", "r740", "r741", "r742", "r743", "r744", "r745", "r746", "r747", "r748", "r749", "r750", "r751", "r752", "r806", "r825", "r1021", "r1096", "r1099", "r1100", "r1101", "r1102", "r1103", "r1104", "r1105", "r1106", "r1111", "r1294", "r1295", "r1296", "r1297", "r1298", "r1299", "r1300", "r1398", "r1399", "r1400", "r1401", "r1513", "r1516", "r1517", "r1518", "r1520", "r1522", "r1524", "r1525" ] }, "us-gaap_FinancialLiabilitiesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinancialLiabilitiesFairValueDisclosure", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value", "label": "Financial Liabilities Fair Value Disclosure", "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities." } } }, "auth_ref": [ "r1514", "r1515", "r1520", "r1524", "r1525", "r1526", "r1527" ] }, "us-gaap_FinancingInterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FinancingInterestExpense", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofExpensesIncurredwithRespecttoFinanceLeasesTable": { "parentTag": "us-gaap_FinanceLeaseInterestExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofExpensesIncurredwithRespecttoFinanceLeasesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense", "label": "Financing Interest Expense", "documentation": "This element represents interest incurred for borrowed money which was used to produce goods or render services." } } }, "auth_ref": [ "r68" ] }, "vsee_FinancingLeaseLiabilitiesIncludedInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FinancingLeaseLiabilitiesIncludedInAccountsPayableAndAccruedLiabilities", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable": { "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vseehealth.com/role/LeasesDetails", "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued financing lease", "verboseLabel": "Financing lease liabilities included in accounts payable and accrued liabilities", "documentation": "Amount of financing lease liabilities that are included in accounts payable and accrued liabilities at balance sheet date.", "label": "Financing Lease Liabilities Included In Accounts Payable And Accrued Liabilities" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FiniteLivedIntangibleAssetUsefulLife", "presentation": [ "http://vseehealth.com/role/ScheduleofIdentifiableIntangibleAssetsSubjecttoAmortizationTable", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated useful life", "verboseLabel": "Estimated useful lives, intangible assets", "label": "Finite-Lived Intangible Asset, Useful Life", "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofIdentifiableIntangibleAssetsSubjecttoAmortizationTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Accumulated amortization", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r137", "r313", "r336", "r991" ] }, "us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable", "presentation": [ "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]", "documentation": "Disclosure of information about finite-lived intangible asset acquired in business combination." } } }, "auth_ref": [ "r1411", "r1412", "r1494", "r1496" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable" ], "lang": { "en-us": { "role": { "terseLabel": "Thereafter", "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five", "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r1416", "r1594" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable" ], "lang": { "en-us": { "role": { "terseLabel": "Year ending December 31, 2026", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r338", "r986", "r991" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable" ], "lang": { "en-us": { "role": { "terseLabel": "Year ending December 31, 2030", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r338", "r986", "r991" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable" ], "lang": { "en-us": { "role": { "terseLabel": "Year ending December 31, 2029", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r338", "r986", "r991" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable" ], "lang": { "en-us": { "role": { "terseLabel": "Year ending December 31, 2028", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r338", "r986", "r991" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable" ], "lang": { "en-us": { "role": { "terseLabel": "Year ending December 31, 2027", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r338", "r986", "r991" ] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable", "http://vseehealth.com/role/ScheduleofIdentifiableIntangibleAssetsSubjecttoAmortizationTable" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r329", "r331", "r332", "r333", "r335", "r336", "r340", "r341", "r759", "r760", "r855", "r986", "r991", "r1062", "r1063", "r1064", "r1065", "r1066", "r1067", "r1068", "r1069", "r1070", "r1071", "r1072", "r1073", "r1074", "r1075", "r1076", "r1077", "r1078", "r1079", "r1080", "r1081", "r1082", "r1083", "r1084", "r1085", "r1086", "r1087", "r1088" ] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofIdentifiableIntangibleAssetsSubjecttoAmortizationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets, gross", "label": "Finite-Lived Intangible Assets, Gross", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r313", "r336", "r760", "r991" ] }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FiniteLivedIntangibleAssetsLineItems", "presentation": [ "http://vseehealth.com/role/ScheduleofIdentifiableIntangibleAssetsSubjecttoAmortizationTable" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r329", "r336", "r340", "r341", "r343", "r759", "r986", "r991", "r1062", "r1063", "r1064", "r1065", "r1066", "r1067", "r1068", "r1069", "r1070", "r1071", "r1072", "r1073", "r1074", "r1075", "r1076", "r1077", "r1078", "r1079", "r1080", "r1081", "r1082", "r1083", "r1084", "r1085", "r1086", "r1087", "r1088" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable", "http://vseehealth.com/role/ScheduleofIdentifiableIntangibleAssetsSubjecttoAmortizationTable" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r329", "r331", "r332", "r333", "r335", "r336", "r340", "r341", "r855", "r986", "r991", "r1062", "r1063", "r1064", "r1065", "r1066", "r1067", "r1068", "r1069", "r1070", "r1071", "r1072", "r1073", "r1074", "r1075", "r1076", "r1077", "r1078", "r1079", "r1080", "r1081", "r1082", "r1083", "r1084", "r1085", "r1086", "r1087", "r1088" ] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable", "http://vseehealth.com/role/ScheduleofIdentifiableIntangibleAssetsSubjecttoAmortizationTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "terseLabel": "Intangible assets, net", "label": "Finite-Lived Intangible Assets, Net", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r759", "r1415" ] }, "vsee_FixedAssetRecognitionThreshold": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FixedAssetRecognitionThreshold", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fixed asset recognition threshold", "documentation": "The monetary threshold for which fixed assets are required to be recorded.", "label": "Fixed Asset Recognition Threshold" } } }, "auth_ref": [] }, "vsee_FixedSettlement": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FixedSettlement", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fixed settlement", "documentation": "The amount represents the fixed settlement.", "label": "Fixed Settlement" } } }, "auth_ref": [] }, "vsee_ForeignTaxEffectsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ForeignTaxEffectsAbstract", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign tax effects", "label": "Foreign Tax Effects Abstract" } } }, "auth_ref": [] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r1174", "r1185", "r1201", "r1236" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount", "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r1174", "r1185", "r1201", "r1236" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount", "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r1174", "r1185", "r1201", "r1236" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability [Text Block]", "terseLabel": "Forgone Recovery, Explanation of Impracticability" } } }, "auth_ref": [ "r1174", "r1185", "r1201", "r1236" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r1174", "r1185", "r1201", "r1236" ] }, "dei_FormerAddressMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "FormerAddressMember", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Former Address [Member]", "documentation": "Former address for entity" } } }, "auth_ref": [ "r1157", "r1188" ] }, "dei_FormerFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "FormerFiscalYearEndDate", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Former Fiscal Year End Date", "documentation": "Former end date of previous fiscal years" } } }, "auth_ref": [] }, "vsee_FoundersMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FoundersMember", "presentation": [ "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/ScheduleofCommonStockBusinessCombinationTable" ], "lang": { "en-us": { "role": { "terseLabel": "DHAC founders [Member]", "verboseLabel": "Founders [Member]", "documentation": "Represents information pertaining to founders.", "label": "Founders Member" } } }, "auth_ref": [] }, "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]", "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year" } } }, "auth_ref": [ "r1216" ] }, "us-gaap_FurnitureAndFixturesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "FurnitureAndFixturesMember", "presentation": [ "http://vseehealth.com/role/FixedAssetsDetails", "http://vseehealth.com/role/ScheduleofComponentsofFixedAssetsTable", "http://vseehealth.com/role/ScheduleofFixedAssetsareDepreciatedUsingtheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Furniture [Member]", "verboseLabel": "Furniture [Member", "netLabel": "Furniture and Fixtures [Member]", "label": "Furniture and Fixtures [Member]", "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases." } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreement1Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FutureReceiptsSaleAgreement1Member", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Future Receipts Sale Agreement 1 [Member]", "documentation": "Represents information relating to Future Receipts Sale Agreement 1.", "label": "Future Receipts Sale Agreement1 Member" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreement2Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FutureReceiptsSaleAgreement2Member", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Future Receipts Sale Agreement 2 [Member]", "documentation": "Represents information relating to Future Receipts Sale Agreement 2.", "label": "Future Receipts Sale Agreement2 Member" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreement3Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FutureReceiptsSaleAgreement3Member", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Future Receipts Sale Agreement 3 [Member]", "documentation": "Represents information relating to Future Receipts Sale Agreement 3.", "label": "Future Receipts Sale Agreement3 Member" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreement4Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FutureReceiptsSaleAgreement4Member", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Future Receipts Sale Agreement 4 [Member]", "documentation": "Represents information relating to Future Receipts Sale Agreement 4.", "label": "Future Receipts Sale Agreement4 Member" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreement5Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FutureReceiptsSaleAgreement5Member", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Future Receipts Sale Agreement 5 [Member]", "documentation": "Represents information relating to Future Receipts Sale Agreement 5.", "label": "Future Receipts Sale Agreement5 Member" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreement6Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FutureReceiptsSaleAgreement6Member", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Future Receipts Sale Agreement 6 [Member]", "documentation": "Represents information relating to Future Receipts Sale Agreement 6.", "label": "Future Receipts Sale Agreement6 Member" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreement7Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FutureReceiptsSaleAgreement7Member", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Future Receipts Sale Agreement 7 [Member]", "documentation": "Represents information relating to Future Receipts Sale Agreement 7.", "label": "Future Receipts Sale Agreement7 Member" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreementAmountToBeCollectedByPurchaserDaily": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FutureReceiptsSaleAgreementAmountToBeCollectedByPurchaserDaily", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount to be collected by purchaser daily", "documentation": "Represents the amount to be collected by purchaser daily under the Future Receipts Sale Agreement.", "label": "Future Receipts Sale Agreement Amount To Be Collected By Purchaser Daily" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreementAmountToBeCollectedByPurchaserWeekly": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FutureReceiptsSaleAgreementAmountToBeCollectedByPurchaserWeekly", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount to be collected by purchaser weekly", "documentation": "Represents the amount to be collected by purchaser weekly under the Future Receipts Sale Agreement.", "label": "Future Receipts Sale Agreement Amount To Be Collected By Purchaser Weekly" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreementAxis": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FutureReceiptsSaleAgreementAxis", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Future Receipts Sale Agreement [Axis]", "documentation": "Schedule of information pertaining to Future Receipts Sale Agreement.", "label": "Future Receipts Sale Agreement Axis" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreementBalloonCollectionByPurchaser": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FutureReceiptsSaleAgreementBalloonCollectionByPurchaser", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Balloon collection", "documentation": "Represents the amount to be collected by purchaser as a final payment under the Future Receipts Sale Agreement.", "label": "Future Receipts Sale Agreement Balloon Collection By Purchaser" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreementDomainDomain": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FutureReceiptsSaleAgreementDomainDomain", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "label": "FutureReceiptsSaleAgreementDomain [Domain]" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreementFutureReceiptsSold": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FutureReceiptsSaleAgreementFutureReceiptsSold", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Future receipts sold", "documentation": "Represents the amount of Future receipts sold under the Future Receipts Sale Agreement.", "label": "Future Receipts Sale Agreement Future Receipts Sold" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreementInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FutureReceiptsSaleAgreementInterestRate", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest rate", "documentation": "Represents the interest rate associated with the transactions under Future Receipts Sale Agreement.", "label": "Future Receipts Sale Agreement Interest Rate" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreementNetSalePrice": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FutureReceiptsSaleAgreementNetSalePrice", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net purchase price", "documentation": "Represents the amount of Net sales under the Future Receipts Sale Agreement.", "label": "Future Receipts Sale Agreement Net Sale Price" } } }, "auth_ref": [] }, "vsee_FutureReceiptsSaleAgreementPeriodOverWhichAmountIsToBeCollectedByPurchaserWeekly": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "FutureReceiptsSaleAgreementPeriodOverWhichAmountIsToBeCollectedByPurchaserWeekly", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Period over which amount is to be collected by purchaser weekly", "documentation": "Represents the period over which the amount is to be collected by purchaser weekly under the Future Receipts Sale Agreement.", "label": "Future Receipts Sale Agreement Period Over Which Amount Is To Be Collected By Purchaser Weekly" } } }, "auth_ref": [] }, "vsee_GainLossOnDebtConversion": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "GainLossOnDebtConversion", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gain (loss) on debt conversion", "documentation": "The amount of gain loss recorded during the period on conversion of debt.", "label": "Gain Loss On Debt Conversion" } } }, "auth_ref": [] }, "vsee_GainLossOnExtinguishmentOfELOC": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "GainLossOnExtinguishmentOfELOC", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable" ], "lang": { "en-us": { "role": { "terseLabel": "Gain on extinguishment of ELOC", "documentation": "Gain (loss) on extinguishment of ELOC.", "label": "Gain Loss On Extinguishment Of ELOC" } } }, "auth_ref": [] }, "vsee_GainLossOnIssuanceOfFinancialInstruments": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "GainLossOnIssuanceOfFinancialInstruments", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 4.0 }, "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 14.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Loss on issuance of financial instruments", "negatedLabel": "Loss on issuance of financial instruments", "documentation": "Amount of increase (decrease) in the fair value of financial instruments at issuance recognized in the income statement.", "label": "Gain Loss On Issuance Of Financial Instruments" } } }, "auth_ref": [] }, "us-gaap_GainLossOnTerminationOfLease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GainLossOnTerminationOfLease", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 18.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Loss on termination of lease", "label": "Gain (Loss) on Termination of Lease", "documentation": "Amount of gain (loss) on termination of lease before expiration of lease term." } } }, "auth_ref": [ "r692" ] }, "vsee_GainOnExtinguishmentOfELOC": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "GainOnExtinguishmentOfELOC", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 17.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Gain on extinguishment of ELOC", "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain On Extinguishment Of ELOC" } } }, "auth_ref": [] }, "vsee_GainOnExtinguishmentOfEquityLineOfCreditELOC": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "GainOnExtinguishmentOfEquityLineOfCreditELOC", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Gain on extinguishment of Equity Line of Credit (\u201cELOC\u201d)", "documentation": "Gain on extinguishment of equity line of credit (\u201cELOC\u201d).", "label": "Gain On Extinguishment Of Equity Line Of Credit ELOC" } } }, "auth_ref": [] }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GainsLossesOnExtinguishmentOfDebt", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 3.0 }, "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 16.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable" ], "lang": { "en-us": { "role": { "terseLabel": "Loss on extinguishment of debt", "negatedLabel": "Loss on extinguishment of debt", "verboseLabel": "Loss on extinguishment", "label": "Gain (Loss) on Extinguishment of Debt", "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity." } } }, "auth_ref": [ "r4", "r33", "r34" ] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable" ], "lang": { "en-us": { "role": { "terseLabel": "General and administrative", "verboseLabel": "General and administrative expenses", "label": "General and Administrative Expense", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r70", "r923" ] }, "vsee_GianLossOnIssuanceOfFinancialInstruments": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "GianLossOnIssuanceOfFinancialInstruments", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable" ], "lang": { "en-us": { "role": { "terseLabel": "Loss on issuance of financial instruments", "documentation": "Amount of increase (decrease) in the fair value of financial instruments at issuance recognized in the income statement.", "label": "Gian Loss On Issuance Of Financial Instruments" } } }, "auth_ref": [] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable", "http://vseehealth.com/role/ScheduleofTotalAssetsbySegmentTable" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "verboseLabel": "Total goodwill", "netLabel": "Goodwill (in Dollars)", "label": "Goodwill", "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r136", "r315", "r796", "r1015", "r1022", "r1049", "r1053", "r1054", "r1092", "r1098", "r1110", "r1406", "r1407", "r1500" ] }, "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined." } } }, "auth_ref": [ "r314", "r326", "r1022" ] }, "us-gaap_GoodwillImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GoodwillImpairmentLoss", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 2.0 }, "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill impairment charges", "verboseLabel": "Goodwill impairment", "label": "Goodwill, Impairment Loss", "documentation": "Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r4", "r316", "r322", "r326", "r328", "r609", "r1022", "r1098" ] }, "vsee_GrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "GrantDateFairValue", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Grant date fair value (in Dollars)", "documentation": "The amount of grant date fair value.", "label": "Grant Date Fair Value" } } }, "auth_ref": [] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable" ], "lang": { "en-us": { "role": { "totalLabel": "Gross margin", "terseLabel": "Segment gross margin", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r64", "r68", "r106", "r169", "r172", "r173", "r298", "r359", "r360", "r362", "r363", "r364", "r365", "r366", "r368", "r369", "r677", "r1008", "r1014", "r1381", "r1388", "r1390", "r1391", "r1392", "r1429" ] }, "us-gaap_HealthCarePatientServiceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "HealthCarePatientServiceMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Patient fees", "label": "Health Care, Patient Service [Member]", "documentation": "Service provided to patient for maintenance, diagnosis and treatment of physical and mental health. Excludes service to resident in health care facility." } } }, "auth_ref": [ "r1440", "r1441" ] }, "us-gaap_HomeEquityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "HomeEquityMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Home Equity Line of Credit [Member]", "label": "Home Equity Line of Credit [Member]", "documentation": "Revolving, open-end loan extended under a line of credit and secured by the borrower's residential property." } } }, "auth_ref": [] }, "dei_IcfrAuditorAttestationFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "IcfrAuditorAttestationFlag", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "auth_ref": [ "r1155", "r1158", "r1177" ] }, "vsee_IdocNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "IdocNoteMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "IDoc Note [Member]", "documentation": "Represents information related to iDoc Note.", "label": "Idoc Note Member" } } }, "auth_ref": [] }, "vsee_IdocStockholdersMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "IdocStockholdersMember", "presentation": [ "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "IDoc Stockholders [Member]", "documentation": "Represents information pertaining to iDoc stockholders.", "label": "Idoc Stockholders Member" } } }, "auth_ref": [] }, "vsee_IdocVirtualTelehealthSolutionsIncMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "IdocVirtualTelehealthSolutionsIncMember", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/BusinessCombinationTables", "http://vseehealth.com/role/CommitmentsandContingenciesDetails", "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable", "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable_Parentheticals", "http://vseehealth.com/role/ScheduleofCommonStockBusinessCombinationTable", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable_Parentheticals", "http://vseehealth.com/role/ShareholdersEquityType2or3", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "IDoc Virtual Telehealth Solutions, Inc", "verboseLabel": "iDoc", "netLabel": "IDoc Virtual Telehealth Solutions, Inc [Member]", "label": "iDoc [Member]", "documentation": "Represents the information pertaining to iDoc Virtual Telehealth Solutions, INC." } } }, "auth_ref": [] }, "vsee_IfStockPriceDropsBelow2DollarsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "IfStockPriceDropsBelow2DollarsMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "If stock Price Drops Below 2 Dollars [Member]", "documentation": "Represents scenario information pertaining to stock price drops below $2.", "label": "If Stock Price Drops Below2 Dollars Member" } } }, "auth_ref": [] }, "vsee_ImoAisikuMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ImoAisikuMember", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Imo Aisiku [Member]", "documentation": "Represents information pertaining to Co-CEO Imo Aisiku.", "label": "Imo Aisiku Member" } } }, "auth_ref": [] }, "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment of intangible assets other than goodwill", "label": "Impairment of Intangible Assets (Excluding Goodwill)", "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value." } } }, "auth_ref": [ "r4", "r155", "r330", "r342" ] }, "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ImpairmentOfLongLivedAssetsHeldForUse", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment of long-lived", "label": "Impairment, Long-Lived Asset, Held-for-Use", "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale)." } } }, "auth_ref": [ "r4", "r30", "r83", "r156", "r997", "r1097" ] }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Impairment of Long-Lived and Intangible Assets Other than Goodwill", "label": "Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets." } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable" ], "lang": { "en-us": { "role": { "totalLabel": "Loss before (provision for) benefit from income taxes", "terseLabel": "Loss before (provision) benefit for income taxes", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r65", "r101", "r106", "r798", "r800", "r821", "r998", "r1000", "r1002", "r1008", "r1014", "r1381", "r1388", "r1390", "r1391", "r1392" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxAuthorityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxAuthorityAxis", "presentation": [ "http://vseehealth.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Income Tax Jurisdiction [Axis]", "documentation": "Information by income tax jurisdiction." } } }, "auth_ref": [ "r165", "r513", "r514", "r521", "r529", "r1048", "r1477" ] }, "us-gaap_IncomeTaxAuthorityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxAuthorityDomain", "presentation": [ "http://vseehealth.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Income Tax Jurisdiction [Domain]", "documentation": "Income tax jurisdiction." } } }, "auth_ref": [ "r165", "r513", "r514", "r521", "r529", "r1048", "r1477" ] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://vseehealth.com/role/IncomeTaxes" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes", "label": "Income Tax Disclosure [Text Block]", "documentation": "The entire disclosure for income tax." } } }, "auth_ref": [ "r169", "r174", "r507", "r513", "r518", "r519", "r520", "r522", "r528", "r535", "r537", "r538", "r539", "r805", "r854", "r867", "r1048" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_ProfitLoss", "weight": -1.0, "order": 2.0 }, "http://vseehealth.com/role/ScheduleofIncomeTaxProvisionTable": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofIncomeTaxProvisionTable", "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total income tax provision for (benefit from) continuing operations", "negatedLabel": "(Provision for) benefit from income taxes", "terseLabel": "Provision for income tax, Amount (in Dollars)", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r109", "r117", "r169", "r196", "r197", "r210", "r232", "r254", "r512", "r513", "r536", "r827", "r998", "r1000", "r1002", "r1048" ] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes", "label": "Income Tax, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r148", "r508", "r509", "r522", "r523", "r527", "r531", "r861" ] }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Change in valuation allowance, Amount (in Dollars)", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets." } } }, "auth_ref": [ "r517", "r1048", "r1473" ] }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "U.S. federal statutory tax, Amount (in Dollars)", "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount", "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r513", "r1048" ] }, "us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Meals and entertainment, Amount (in Dollars)", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Amount", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible meals and entertainment expense." } } }, "auth_ref": [ "r1473", "r1474" ] }, "us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxReconciliationNondeductibleExpenseOther", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Other, Amount (in Dollars)", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses." } } }, "auth_ref": [ "r1048", "r1473", "r1474" ] }, "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation, Amount (in Dollars)", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount", "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement." } } }, "auth_ref": [ "r1048", "r1473", "r1474" ] }, "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "State taxes, net of federal tax benefit, Amount (in Dollars)", "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount", "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit)." } } }, "auth_ref": [ "r516", "r1048", "r1473" ] }, "vsee_IncomeTaxReconciliationTaxPenalties": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "IncomeTaxReconciliationTaxPenalties", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable": { "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Penalties, Amount (in Dollars)", "documentation": "The amount of tax penalties during the year.", "label": "Income Tax Reconciliation Tax Penalties" } } }, "auth_ref": [] }, "vsee_IncomeTaxesDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "IncomeTaxesDetailsTable", "presentation": [ "http://vseehealth.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Income Taxes (Details) [Table]" } } }, "auth_ref": [] }, "vsee_IncreaseDecreaseChangeInFairValueOfFinancialInstruments": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "IncreaseDecreaseChangeInFairValueOfFinancialInstruments", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 15.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Change in fair value of financial instruments", "documentation": "The amount of change in fair value of financial instruments.", "label": "Increase Decrease Change In Fair Value Of Financial Instruments" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable and accrued liabilities", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid." } } }, "auth_ref": [ "r3" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 19.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r3" ] }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncreaseDecreaseInContractWithCustomerLiability", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred revenue", "label": "Increase (Decrease) in Contract with Customer, Liability", "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r754", "r1362" ] }, "us-gaap_IncreaseDecreaseInDueFromRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncreaseDecreaseInDueFromRelatedParties", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 20.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Due from related party", "label": "Increase (Decrease) in Due from Related Parties", "documentation": "The increase (decrease) during the reporting period in receivables to be collected from other entities that could exert significant influence over the reporting entity." } } }, "auth_ref": [ "r3" ] }, "us-gaap_IncreaseDecreaseInDueToRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncreaseDecreaseInDueToRelatedParties", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Due to related parties", "label": "Increase (Decrease) in Due to Related Parties", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence." } } }, "auth_ref": [ "r3" ] }, "vsee_IncreaseDecreaseInEncompassPurchaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "IncreaseDecreaseInEncompassPurchaseLiability", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 22.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Encompass Purchase liability", "documentation": "The amount represents the encompass purchase liability.", "label": "Increase Decrease In Encompass Purchase Liability" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in operating assets and liabilities:", "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncreaseDecreaseInOperatingLeaseLiability", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liabilities", "label": "Increase (Decrease) in Operating Lease Liability", "documentation": "Amount of increase (decrease) in obligation for operating lease." } } }, "auth_ref": [ "r1290", "r1362" ] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 21.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaids and other current assets", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r3" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Indefinite-Lived Intangible Assets [Axis]", "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit." } } }, "auth_ref": [ "r329", "r334", "r339", "r991", "r1062", "r1063", "r1064", "r1073", "r1074", "r1088" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company." } } }, "auth_ref": [ "r329", "r334", "r339", "r991", "r1062", "r1063", "r1064", "r1073", "r1074", "r1088" ] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]", "terseLabel": "Individual:" } } }, "auth_ref": [ "r1174", "r1185", "r1201", "r1227", "r1236", "r1240", "r1248" ] }, "vsee_InitialMBLANoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "InitialMBLANoteMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Initial MBLA Note [Member]", "label": "Initial MBLANote Member" } } }, "auth_ref": [] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]", "terseLabel": "Insider Trading Arrangements:" } } }, "auth_ref": [ "r1246" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]", "terseLabel": "Insider Trading Policies and Procedures:" } } }, "auth_ref": [ "r1159", "r1252" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted [Flag]", "terseLabel": "Insider Trading Policies and Procedures Adopted" } } }, "auth_ref": [ "r1159", "r1252" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]", "terseLabel": "Insider Trading Policies and Procedures Not Adopted" } } }, "auth_ref": [ "r1159", "r1252" ] }, "vsee_InstitutionalFeesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "InstitutionalFeesMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable" ], "lang": { "en-us": { "role": { "terseLabel": "Institutional fees", "verboseLabel": "Institutional fees [Member]", "netLabel": "Institutional Fees [Member]", "documentation": "Represents fess relating to institutional activities.", "label": "Institutional Fees Member" } } }, "auth_ref": [] }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IntangibleAssetsFiniteLivedPolicy", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible Assets", "label": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets." } } }, "auth_ref": [ "r755", "r756", "r757", "r759", "r1003", "r1408" ] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets, net", "label": "Intangible Assets, Net (Excluding Goodwill)", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r329", "r1415", "r1417" ] }, "vsee_InterestAccruedPerMonth": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "InterestAccruedPerMonth", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest accrued per month", "documentation": "The amount of interest accrued per month.", "label": "Interest Accrued Per Month" } } }, "auth_ref": [] }, "vsee_InterestAccruesOfImmediatelyGuaranteedPeriod": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "InterestAccruesOfImmediatelyGuaranteedPeriod", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrues immediately and is guaranteed period", "documentation": "Accrues immediately and is guaranteed.", "label": "Interest Accrues Of Immediately Guaranteed Period" } } }, "auth_ref": [] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InterestExpense", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense", "verboseLabel": "Interest amount", "label": "Interest Expense, Operating and Nonoperating", "documentation": "Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense." } } }, "auth_ref": [ "r210", "r224", "r228", "r234", "r254", "r686", "r1014", "r1015", "r1589" ] }, "us-gaap_InterestExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InterestExpenseAbstract", "presentation": [ "http://vseehealth.com/role/ScheduleofReportableSegmentDepreciationandAmortizationandCapitalExpendituresTable" ], "lang": { "en-us": { "role": { "terseLabel": "Interest Expense:", "label": "Interest Expense, Operating and Nonoperating [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InterestExpenseDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InterestExpenseDebt", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest amount", "verboseLabel": "Total interest expense", "label": "Interest Expense, Debt", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt." } } }, "auth_ref": [ "r72", "r390", "r400", "r1026", "r1027", "r1589" ] }, "us-gaap_InterestExpenseNonoperating": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InterestExpenseNonoperating", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofReportableSegmentDepreciationandAmortizationandCapitalExpendituresTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest expense", "terseLabel": "Interest expense", "label": "Interest Expense, Nonoperating", "documentation": "Amount of interest expense classified as nonoperating." } } }, "auth_ref": [ "r228", "r998", "r1002", "r1318" ] }, "us-gaap_InterestExpenseOther": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InterestExpenseOther", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense, other", "label": "Interest Expense, Other", "documentation": "Amount of interest expense classified as other." } } }, "auth_ref": [] }, "us-gaap_InterestPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InterestPaid", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Paid amount", "label": "Interest Paid, Including Capitalized Interest, Operating and Investing Activities", "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities." } } }, "auth_ref": [ "r1364" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Cash paid for interest expense", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activity", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r160", "r163", "r164" ] }, "us-gaap_InterestPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InterestPayableCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable": { "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued interest", "verboseLabel": "Accrued interest (in Dollars)", "netLabel": "Accrued interest payable", "label": "Accrued interest expense (in Dollars)", "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r48" ] }, "us-gaap_InterestPayableCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InterestPayableCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued interest", "label": "Interest Payable", "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables." } } }, "auth_ref": [ "r97", "r1551" ] }, "dei_InvestmentCompanyActFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "InvestmentCompanyActFileNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Investment Company Act File Number" } } }, "auth_ref": [ "r1190", "r1191", "r1192", "r1193" ] }, "dei_InvestmentCompanyActRegistration": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "InvestmentCompanyActRegistration", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Investment Company Act Registration" } } }, "auth_ref": [ "r1206" ] }, "dei_InvestmentCompanyRegistrationAmendment": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "InvestmentCompanyRegistrationAmendment", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Investment Company Registration Amendment" } } }, "auth_ref": [ "r1206" ] }, "dei_InvestmentCompanyRegistrationAmendmentNumber": { "xbrltype": "sequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "InvestmentCompanyRegistrationAmendmentNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Investment Company Registration Amendment Number" } } }, "auth_ref": [ "r1206" ] }, "us-gaap_InvestorMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "InvestorMember", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investor [Member]", "label": "Investor [Member]", "documentation": "Business entity or individual that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value." } } }, "auth_ref": [ "r1537", "r1538" ] }, "vsee_IssuanceOfCompanySharesWithAnAggregateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "IssuanceOfCompanySharesWithAnAggregateFairValue", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of company shares with an aggregate fair value", "documentation": "Issuance of company shares with an aggregate fair value.", "label": "Issuance Of Company Shares With An Aggregate Fair Value" } } }, "auth_ref": [] }, "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued as part of stock grants to vendors", "label": "Issuance of Stock and Warrants for Services or Claims", "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims." } } }, "auth_ref": [ "r4" ] }, "us-gaap_LeaseCostTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LeaseCostTableTextBlock", "presentation": [ "http://vseehealth.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Expenses Incurred for Operating Leases", "label": "Lease, Cost [Table Text Block]", "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income." } } }, "auth_ref": [ "r1534" ] }, "vsee_LeaseDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "LeaseDisclosureTextBlock", "presentation": [ "http://vseehealth.com/role/Leases" ], "lang": { "en-us": { "role": { "terseLabel": "Leases", "documentation": "The entire disclosure of information about leases.", "label": "Lease Disclosure Text Block" } } }, "auth_ref": [] }, "vsee_LeasedEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "LeasedEquipmentMember", "presentation": [ "http://vseehealth.com/role/FixedAssetsDetails", "http://vseehealth.com/role/ScheduleofComponentsofFixedAssetsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Leased Equipment [Member]", "verboseLabel": "Leased equipment [Member", "documentation": "Tangible personal property leased, used to produce goods and services.", "label": "Leased Equipment Member" } } }, "auth_ref": [] }, "us-gaap_LeaseholdImprovementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LeaseholdImprovementsMember", "presentation": [ "http://vseehealth.com/role/FixedAssetsDetails", "http://vseehealth.com/role/ScheduleofComponentsofFixedAssetsTable", "http://vseehealth.com/role/ScheduleofFixedAssetsareDepreciatedUsingtheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Leasehold Improvements [Member]", "verboseLabel": "Leasehold improvements [Member", "label": "Leasehold Improvements [Member]", "documentation": "Additions or improvements to assets held under a lease arrangement." } } }, "auth_ref": [ "r82", "r706" ] }, "us-gaap_LeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LeasesAbstract", "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "auth_ref": [] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "LegalEntityAxis", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ShareholdersEquityType2or3", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails", "http://xbrl.sec.gov/dei/role/document/AuditInformation", "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "dei_LegalEntityIdentifier": { "xbrltype": "legalEntityIdentifierItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "LegalEntityIdentifier", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Legal Entity Identifier", "documentation": "A globally unique ISO 17442 value to identify entities, commonly abbreviated as LEI." } } }, "auth_ref": [ "r1143" ] }, "us-gaap_LegalFees": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LegalFees", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Legal fees (in Dollars)", "label": "Legal Fees", "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings." } } }, "auth_ref": [ "r1292", "r1590", "r1591" ] }, "vsee_LendersUnderARLoanConversionSpasMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "LendersUnderARLoanConversionSpasMember", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "Lenders under A&R Loan Conversion SPAs [Member]", "verboseLabel": "Lenders Under A&R Loan Conversion SPAs [Member]", "documentation": "Represents information pertaining to lenders under A&R Loan Conversion SPAs.", "label": "Lenders Under ARLoan Conversion Spas Member" } } }, "auth_ref": [] }, "vsee_LendersUnderLoanConversionSpasMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "LendersUnderLoanConversionSpasMember", "presentation": [ "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Lenders Under Loan Conversion SPAs [Member]", "documentation": "Represents information pertaining to lenders under Loan Conversion SPAs.", "label": "Lenders Under Loan Conversion Spas Member" } } }, "auth_ref": [] }, "vsee_LesseeFinanceLeaseLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "LesseeFinanceLeaseLiabilitiesTableTextBlock", "presentation": [ "http://vseehealth.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Finance Lease Liabilities", "documentation": "Tabular disclosure of information relating to components of the lessee's finance lease liabilities.", "label": "Lessee Finance Lease Liabilities Table Text Block" } } }, "auth_ref": [] }, "vsee_LesseeFinanceLeaseRightOfUseAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "LesseeFinanceLeaseRightOfUseAssetsTableTextBlock", "presentation": [ "http://vseehealth.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Finance Leased Equipment", "documentation": "Tabular disclosure of information relating to components of the lessee's finance lease right-of-use assets.", "label": "Lessee Finance Lease Right Of Use Assets Table Text Block" } } }, "auth_ref": [] }, "vsee_LesseeFinanceLeaseSupplementalInformationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "LesseeFinanceLeaseSupplementalInformationTableTextBlock", "presentation": [ "http://vseehealth.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Weighted Average Remaining Lease Term and Discount Rate on Finance Leases", "documentation": "Tabular disclosure of the information pertaining to other supplemental information relating to the lessee's finance leases.", "label": "Lessee Finance Lease Supplemental Information Table Text Block" } } }, "auth_ref": [] }, "us-gaap_LesseeLeaseDescriptionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LesseeLeaseDescriptionLineItems", "presentation": [ "http://vseehealth.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "label": "Leases", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r699", "r707" ] }, "us-gaap_LesseeLeaseDescriptionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LesseeLeaseDescriptionTable", "presentation": [ "http://vseehealth.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "label": "Lessee, Lease, Description [Table]", "documentation": "Disclosure of information about lessee's leases." } } }, "auth_ref": [ "r699", "r707" ] }, "us-gaap_LesseeLeasesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LesseeLeasesPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Leases", "label": "Lessee, Leases [Policy Text Block]", "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee." } } }, "auth_ref": [ "r698" ] }, "vsee_LesseeOperatingLeaseLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "LesseeOperatingLeaseLiabilitiesTableTextBlock", "presentation": [ "http://vseehealth.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Operating Lease Liabilities", "documentation": "Tabular disclosure of information relating to components of the lessee's operating lease liabilities.", "label": "Lessee Operating Lease Liabilities Table Text Block" } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "presentation": [ "http://vseehealth.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Future Minimum Rent Payments Under the Operating Lease", "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]", "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position." } } }, "auth_ref": [ "r1535" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofFutureMinimumRentPaymentsUndertheOperatingLeaseTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/ScheduleofFutureMinimumRentPaymentsUndertheOperatingLeaseTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total future minimum lease payments", "label": "Lessee, Operating Lease, Liability, to be Paid", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease." } } }, "auth_ref": [ "r705", "r1367", "r1374", "r1550" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofFutureMinimumRentPaymentsUndertheOperatingLeaseTable": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofFutureMinimumRentPaymentsUndertheOperatingLeaseTable" ], "lang": { "en-us": { "role": { "terseLabel": "Year ending December 31, 2026", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r705", "r1367", "r1374", "r1550" ] }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofFutureMinimumRentPaymentsUndertheOperatingLeaseTable": { "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofFutureMinimumRentPaymentsUndertheOperatingLeaseTable" ], "lang": { "en-us": { "role": { "terseLabel": "Year ending December 31, 2027", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r705", "r1367", "r1374", "r1550" ] }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofFutureMinimumRentPaymentsUndertheOperatingLeaseTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: Imputed interest", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease." } } }, "auth_ref": [ "r705" ] }, "vsee_LesseeOperatingLeaseRightOfUseAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "LesseeOperatingLeaseRightOfUseAssetsTableTextBlock", "presentation": [ "http://vseehealth.com/role/LeasesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Operating Lease Right-of-Use Assets", "documentation": "Tabular disclosure of information relating to components of the lessee's operating lease right-of-use assets.", "label": "Lessee Operating Lease Right Of Use Assets Table Text Block" } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others." } } }, "auth_ref": [ "r12", "r47", "r48", "r49", "r51", "r52", "r53", "r56", "r169", "r172", "r173", "r298", "r359", "r360", "r362", "r363", "r364", "r365", "r366", "r368", "r369", "r616", "r620", "r621", "r677", "r898", "r1007", "r1028", "r1142", "r1429", "r1542", "r1543" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and stockholders\u2019 equity (deficit)", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r63", "r100", "r816", "r1110", "r1129", "r1130", "r1366", "r1371", "r1402", "r1528" ] }, "vsee_LiabilitiesAndStockholdersEquityDeficitAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "LiabilitiesAndStockholdersEquityDeficitAbstract", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY (DEFICIT)", "label": "Liabilities And Stockholders Equity Deficit Abstract" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAssumed1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LiabilitiesAssumed1", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Net liabilities acquired in reverse merger", "label": "Liabilities Assumed", "documentation": "The fair value of liabilities assumed in noncash investing or financing activities." } } }, "auth_ref": [ "r19", "r20", "r21" ] }, "vsee_LiabilitiesAssumedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "LiabilitiesAssumedAbstract", "presentation": [ "http://vseehealth.com/role/ScheduleoftheRecapitalizationandNetEquityImpactonBusinessCombinationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities assumed", "label": "Liabilities Assumed Abstract" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r49", "r132", "r169", "r172", "r173", "r298", "r359", "r360", "r362", "r363", "r364", "r365", "r366", "r368", "r369", "r616", "r620", "r621", "r677", "r1110", "r1429", "r1542", "r1543" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Current liabilities", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LiabilitiesNoncurrentAbstract", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Non-current liabilities", "label": "Liabilities, Noncurrent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesSubjectToCompromiseEarlyContractTerminationFees": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LiabilitiesSubjectToCompromiseEarlyContractTerminationFees", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Early termination fee", "label": "Liabilities Subject to Compromise, Early Contract Termination Fees", "documentation": "The amount of early contract termination fees included in liabilities subject to compromise." } } }, "auth_ref": [ "r1541" ] }, "us-gaap_LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LiabilityForFuturePolicyBenefitExpectedNetPremiumOriginalDiscountRateBeforeCashFlowAndReinsurance", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Original discount", "label": "Liability for Future Policy Benefit, Expected Net Premium, Original Discount Rate, before Cash Flow and Reinsurance", "documentation": "Amount, before effect of reinsurance and current period update of cash flow assumption, of expected net premium component of liability for future policy benefit, discounted at original rate." } } }, "auth_ref": [ "r1122", "r1565", "r1582" ] }, "vsee_LineOfCreditIssuedNovember292021Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "LineOfCreditIssuedNovember292021Member", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line Of Credit Issued November 29, 2021 [Member]", "documentation": "Represents information related to Line of credit issued November 29, 2021", "label": "Line Of Credit Issued November292021 Member" } } }, "auth_ref": [] }, "us-gaap_LineOfCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LineOfCreditMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of Credit [Member]", "label": "Line of Credit [Member]", "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars." } } }, "auth_ref": [] }, "us-gaap_LinesOfCreditCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LinesOfCreditCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Line of credit", "label": "Line of Credit, Current", "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement." } } }, "auth_ref": [ "r47", "r95" ] }, "vsee_LiquidatedDamages": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "LiquidatedDamages", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Liquidated damages", "documentation": "Liquidated damages.", "label": "Liquidated Damages" } } }, "auth_ref": [] }, "us-gaap_LoansPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LoansPayableCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loan payable, related party, net of discount", "verboseLabel": "Loan payable, related party", "label": "Loans Payable, Current", "documentation": "Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer." } } }, "auth_ref": [ "r48" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "LocalPhoneNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LongTermDebt", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable", "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Total notes payable and line of credit", "totalLabel": "Total", "verboseLabel": "Outstanding balance", "label": "Long-Term Debt", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation." } } }, "auth_ref": [ "r12", "r98", "r170", "r181", "r383", "r398", "r802", "r1024", "r1025", "r1108", "r1552" ] }, "us-gaap_LongTermDebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LongTermDebtCurrent", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: Current portion", "label": "Long-Term Debt, Current Maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation." } } }, "auth_ref": [ "r139" ] }, "vsee_LongTermDebtFairValueAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "LongTermDebtFairValueAdjustments", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: Fair value adjustment for debt", "documentation": "The amount of increase (decrease) in long term debt from fair value adjustments.", "label": "Long Term Debt Fair Value Adjustments" } } }, "auth_ref": [] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Thereafter", "label": "Long-Term Debt, Maturity, after Year Five", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r6", "r1367", "r1374", "r1435", "r1550" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Year Ending December 31, 2026", "label": "Long-Term Debt, Maturity, Year One", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r6", "r170", "r181", "r388", "r802" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Year ending December 31, 2030", "label": "Long-Term Debt, Maturity, Year Five", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r6", "r170", "r181", "r388", "r802" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Year ending December 31, 2029", "label": "Long-Term Debt, Maturity, Year Four", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r6", "r170", "r181", "r388", "r802" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Year Ending December 31, 2028", "label": "Long-Term Debt, Maturity, Year Three", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r6", "r170", "r181", "r388", "r802" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable": { "parentTag": "us-gaap_LongTermDebt", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofRequiredPrincipalPaymentsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Year Ending December 31, 2027", "label": "Long-Term Debt, Maturity, Year Two", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r6", "r170", "r181", "r388", "r802" ] }, "us-gaap_LongTermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LongTermDebtNoncurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable" ], "lang": { "en-us": { "role": { "terseLabel": "Notes payable, less current portion, net of discount", "verboseLabel": "Total notes payable, net of current portion", "label": "Long-Term Debt, Excluding Current Maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation." } } }, "auth_ref": [ "r140" ] }, "us-gaap_LongTermPurchaseCommitmentAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LongTermPurchaseCommitmentAmount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total purchase commitment", "label": "Long-Term Purchase Commitment, Amount", "documentation": "The minimum amount the entity agreed to spend under the long-term purchase commitment." } } }, "auth_ref": [] }, "us-gaap_LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LongTermPurchaseCommitmentByCategoryOfItemPurchasedAxis", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Category of Item Purchased [Axis]", "documentation": "Information by category of items purchased under a long-term purchase commitment." } } }, "auth_ref": [] }, "us-gaap_LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "LongTermPurchaseCommitmentCategoryOfItemPurchasedDomain", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "label": "Long-Term Purchase Commitment, Category of Item Purchased [Domain]", "documentation": "General description of the goods or services to be purchased from the counterparty to the long-term purchase commitment." } } }, "auth_ref": [] }, "vsee_LongTermPurchaseCommitmentNumberOfRobotsForWhichLifetimeUsePaymentToBeMade": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "LongTermPurchaseCommitmentNumberOfRobotsForWhichLifetimeUsePaymentToBeMade", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of robots for which lifetime use payments is to be made (in robot)", "documentation": "The total number of robots for which lifetime use payment is required as per the agreement with the vendor.", "label": "Long Term Purchase Commitment Number Of Robots For Which Lifetime Use Payment To Be Made" } } }, "auth_ref": [] }, "vsee_LongTermPurchaseCommitmentNumberOfRobotsToBePurchased": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "LongTermPurchaseCommitmentNumberOfRobotsToBePurchased", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of robots purchased (in robot)", "documentation": "The total number of robots to be purchased as per the agreement with the vendor.", "label": "Long Term Purchase Commitment Number Of Robots To Be Purchased" } } }, "auth_ref": [] }, "vsee_LongTermPurchaseCommitmentUnpaidAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "LongTermPurchaseCommitmentUnpaidAmount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unpaid commitment amount", "documentation": "The unpaid amount of the total amount that the the entity agreed to spend under the long-term purchase commitment.", "label": "Long Term Purchase Commitment Unpaid Amount" } } }, "auth_ref": [] }, "vsee_LossContingencyAndReservePolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "LossContingencyAndReservePolicyPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingencies and Litigation", "documentation": "Disclosure of accounting policy for estimating the loss if an asset has been impaired or liability had been incurred as of the balance sheet date.", "label": "Loss Contingency And Reserve Policy Policy Text Block" } } }, "auth_ref": [] }, "vsee_LossOnConversionOfAccountsPayableToEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "LossOnConversionOfAccountsPayableToEquity", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss on extinguishment of accounts payable (in Dollars)", "documentation": "The amount of loss recognized on the conversion of accounts payable to equity.", "label": "Loss On Conversion Of Accounts Payable To Equity" } } }, "auth_ref": [] }, "stpr_MA": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2025", "localname": "MA", "presentation": [ "http://vseehealth.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "MASSACHUSETTS", "label": "MASSACHUSETTS" } } }, "auth_ref": [] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "MajorCustomersAxis", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "auth_ref": [ "r262", "r1030", "r1034", "r1121", "r1127", "r1555", "r1556", "r1557", "r1559", "r1560", "r1561", "r1562", "r1563", "r1564", "r1565", "r1566", "r1567", "r1568", "r1569", "r1570", "r1571", "r1572", "r1573", "r1574", "r1575", "r1576", "r1577", "r1578", "r1579", "r1580", "r1581", "r1583", "r1584" ] }, "srt_ManagementMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "ManagementMember", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Key Managerial Personnel [Member]", "label": "Management [Member]" } } }, "auth_ref": [ "r1393", "r1539" ] }, "vsee_MandatorilyPrepayableUponChangeOfControlOutstandingBalance": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "MandatorilyPrepayableUponChangeOfControlOutstandingBalance", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Mandatorily prepayable upon change of control outstanding balance, percentage", "documentation": "Mandatorily prepayable upon change of control outstanding balance.", "label": "Mandatorily Prepayable Upon Change Of Control Outstanding Balance" } } }, "auth_ref": [] }, "vsee_March2025ConvertibleNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "March2025ConvertibleNoteMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/FairValueMeasurementsTables", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable", "http://vseehealth.com/role/ScheduleofKeyInputsTable5", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable" ], "lang": { "en-us": { "role": { "terseLabel": "March 2025 convertible Note", "verboseLabel": "May 2025 convertible Note [Member]", "netLabel": "March 2025 Convertible Note [Member]", "label": "March2025 Convertible Note Member" } } }, "auth_ref": [] }, "vsee_MasterBusinessLoanAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "MasterBusinessLoanAgreementMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Master Business Loan Agreement [Member]", "label": "Master Business Loan Agreement Member" } } }, "auth_ref": [] }, "vsee_MaximumBorrowingCapacityOfRelatedPartyPromissoryNote": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "MaximumBorrowingCapacityOfRelatedPartyPromissoryNote", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum borrowing capacity of related party promissory note", "documentation": "Amount of maximum borrowing capacity of related party promissory note.", "label": "Maximum Borrowing Capacity Of Related Party Promissory Note" } } }, "auth_ref": [] }, "vsee_MaximumCalendarYearDaysForSuspensionForUseOfResaleRegistrationStatement": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "MaximumCalendarYearDaysForSuspensionForUseOfResaleRegistrationStatement", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum calendar year days for suspension for use of resale registration statement", "documentation": "Represents the maximum calendar year days for suspension for use of resale registration statement.", "label": "Maximum Calendar Year Days For Suspension For Use Of Resale Registration Statement" } } }, "auth_ref": [] }, "vsee_MaximumConsecutiveDaysForSuspensionForUseOfResaleRegistrationStatement": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "MaximumConsecutiveDaysForSuspensionForUseOfResaleRegistrationStatement", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum consecutive days for suspension for use of resale registration statement", "documentation": "Represents the maximum consecutive days for suspension for use of resale registration statement.", "label": "Maximum Consecutive Days For Suspension For Use Of Resale Registration Statement" } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "MaximumMember", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/CommitmentsandContingenciesDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofFixedAssetsareDepreciatedUsingtheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable", "http://vseehealth.com/role/ScheduleofKeyAssumptionsUsedinValuingUnvestedOptionsTable", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum [Member]", "label": "Maximum [Member]" } } }, "auth_ref": [ "r219", "r353", "r354", "r355", "r356", "r461", "r489", "r490", "r491", "r506", "r651", "r753", "r846", "r847", "r853", "r890", "r891", "r951", "r953", "r955", "r956", "r958", "r968", "r969", "r971", "r972", "r984", "r985", "r1020", "r1029", "r1046", "r1049", "r1056", "r1059", "r1100", "r1101", "r1105", "r1106", "r1123", "r1433", "r1544", "r1545", "r1546", "r1547", "r1548", "r1549" ] }, "vsee_MaximumTermForCarriedForwardOfAdjustmentsFromDateOfFirstEventForWarrants": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "MaximumTermForCarriedForwardOfAdjustmentsFromDateOfFirstEventForWarrants", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum term for carried forward of adjustments from the date of first event for warrants", "documentation": "Represents the maximum term for carried forward of adjustments from the date of first event for warrants.", "label": "Maximum Term For Carried Forward Of Adjustments From Date Of First Event For Warrants" } } }, "auth_ref": [] }, "vsee_MaximumValueOfSharesAgreedToBeIssued": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "MaximumValueOfSharesAgreedToBeIssued", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum amount of shares issuable (in Dollars)", "documentation": "The maximum value of shares agreed to be issued.", "label": "Maximum Value Of Shares Agreed To Be Issued" } } }, "auth_ref": [] }, "vsee_May2025ConvertibleNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "May2025ConvertibleNoteMember", "presentation": [ "http://vseehealth.com/role/FairValueMeasurementsTables", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable", "http://vseehealth.com/role/ScheduleofKeyInputsTable6" ], "lang": { "en-us": { "role": { "terseLabel": "May 2025 Convertible Note [Member]", "label": "May2025 Convertible Note Member" } } }, "auth_ref": [] }, "vsee_May2025ConvertiblePromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "May2025ConvertiblePromissoryNoteMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "May 2025 Convertible Promissory Note [Member]", "label": "May2025 Convertible Promissory Note Member" } } }, "auth_ref": [] }, "vsee_May2025PromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "May2025PromissoryNoteMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "May 2025 Promissory Note [Member]", "label": "May2025 Promissory Note Member" } } }, "auth_ref": [] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]", "terseLabel": "Measure:" } } }, "auth_ref": [ "r1219" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure Name", "terseLabel": "Name" } } }, "auth_ref": [ "r1219" ] }, "vsee_MeasurementInputCccBondRateMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "MeasurementInputCccBondRateMember", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyInputsTable0" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Input CCC Bond Rate [Member]", "documentation": "Represents information pertaining to ccc bond rates.", "label": "Measurement Input Ccc Bond Rate Member" } } }, "auth_ref": [] }, "us-gaap_MeasurementInputDiscountRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "MeasurementInputDiscountRateMember", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyInputsTable", "http://vseehealth.com/role/ScheduleofKeyInputsTable1", "http://vseehealth.com/role/ScheduleofKeyInputsTable2" ], "lang": { "en-us": { "role": { "terseLabel": "Debt discount rate [Member]", "label": "Measurement Input, Discount Rate [Member]", "documentation": "Measurement input using interest rate to determine present value of future cash flows." } } }, "auth_ref": [ "r1049", "r1056", "r1059", "r1516", "r1517", "r1518" ] }, "us-gaap_MeasurementInputExpectedTermMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "MeasurementInputExpectedTermMember", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyInputsTable", "http://vseehealth.com/role/ScheduleofKeyInputsTable1", "http://vseehealth.com/role/ScheduleofKeyInputsTable2", "http://vseehealth.com/role/ScheduleofKeyInputsTable3", "http://vseehealth.com/role/ScheduleofKeyInputsTable4", "http://vseehealth.com/role/ScheduleofKeyInputsTable5", "http://vseehealth.com/role/ScheduleofKeyInputsTable6" ], "lang": { "en-us": { "role": { "terseLabel": "Expected term (years) [Member]", "label": "Measurement Input, Expected Term [Member]", "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date." } } }, "auth_ref": [ "r488", "r1516", "r1517", "r1518" ] }, "us-gaap_MeasurementInputInceptionDiscountRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "MeasurementInputInceptionDiscountRateMember", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyInputsTable4" ], "lang": { "en-us": { "role": { "terseLabel": "Market discount rate [Member]", "label": "Measurement Input, Inception Discount Rate [Member]", "documentation": "Measurement input using interest rate at inception of contract to determine present value of future cash flows." } } }, "auth_ref": [ "r1516", "r1517", "r1518" ] }, "us-gaap_MeasurementInputOptionVolatilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "MeasurementInputOptionVolatilityMember", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyInputsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Volatility [Member]", "label": "Measurement Input, Option Volatility [Member]", "documentation": "Measurement input using rate at which price of option increases (decreases) for given set of returns." } } }, "auth_ref": [ "r1516", "r1517", "r1518" ] }, "us-gaap_MeasurementInputPriceVolatilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "MeasurementInputPriceVolatilityMember", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyInputsTable1", "http://vseehealth.com/role/ScheduleofKeyInputsTable2", "http://vseehealth.com/role/ScheduleofKeyInputsTable3", "http://vseehealth.com/role/ScheduleofKeyInputsTable4", "http://vseehealth.com/role/ScheduleofKeyInputsTable5", "http://vseehealth.com/role/ScheduleofKeyInputsTable6" ], "lang": { "en-us": { "role": { "terseLabel": "Volatility [Member]", "label": "Measurement Input, Price Volatility [Member]", "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns." } } }, "auth_ref": [ "r489", "r1100", "r1516", "r1517", "r1518" ] }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "MeasurementInputRiskFreeInterestRateMember", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyInputsTable", "http://vseehealth.com/role/ScheduleofKeyInputsTable1", "http://vseehealth.com/role/ScheduleofKeyInputsTable2", "http://vseehealth.com/role/ScheduleofKeyInputsTable3", "http://vseehealth.com/role/ScheduleofKeyInputsTable4", "http://vseehealth.com/role/ScheduleofKeyInputsTable5", "http://vseehealth.com/role/ScheduleofKeyInputsTable6" ], "lang": { "en-us": { "role": { "terseLabel": "Risk-free interest rate [Member]", "label": "Measurement Input, Risk Free Interest Rate [Member]", "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss." } } }, "auth_ref": [ "r491", "r1516", "r1517", "r1518" ] }, "us-gaap_MeasurementInputSharePriceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "MeasurementInputSharePriceMember", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyInputsTable", "http://vseehealth.com/role/ScheduleofKeyInputsTable1", "http://vseehealth.com/role/ScheduleofKeyInputsTable2", "http://vseehealth.com/role/ScheduleofKeyInputsTable3", "http://vseehealth.com/role/ScheduleofKeyInputsTable4", "http://vseehealth.com/role/ScheduleofKeyInputsTable5", "http://vseehealth.com/role/ScheduleofKeyInputsTable6" ], "lang": { "en-us": { "role": { "terseLabel": "Stock price [Member]", "label": "Measurement Input, Share Price [Member]", "documentation": "Measurement input using share price of saleable stock." } } }, "auth_ref": [ "r1516", "r1517", "r1518" ] }, "us-gaap_MeasurementInputTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "MeasurementInputTypeAxis", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyInputsTable", "http://vseehealth.com/role/ScheduleofKeyInputsTable0", "http://vseehealth.com/role/ScheduleofKeyInputsTable1", "http://vseehealth.com/role/ScheduleofKeyInputsTable2", "http://vseehealth.com/role/ScheduleofKeyInputsTable3", "http://vseehealth.com/role/ScheduleofKeyInputsTable4", "http://vseehealth.com/role/ScheduleofKeyInputsTable5", "http://vseehealth.com/role/ScheduleofKeyInputsTable6" ], "lang": { "en-us": { "role": { "label": "Measurement Input Type [Axis]", "documentation": "Information by type of measurement input used to determine value of asset and liability." } } }, "auth_ref": [ "r487", "r488", "r489", "r490", "r491", "r492", "r649", "r650", "r651", "r1049", "r1056", "r1059", "r1100" ] }, "vsee_MedicalEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "MedicalEquipmentMember", "presentation": [ "http://vseehealth.com/role/FixedAssetsDetails", "http://vseehealth.com/role/ScheduleofComponentsofFixedAssetsTable", "http://vseehealth.com/role/ScheduleofFixedAssetsareDepreciatedUsingtheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Medical Equipment [Member]", "verboseLabel": "Medical equipment [Member", "documentation": "Tangible personal properties used in the field of medicine that are held by the entity.", "label": "Medical Equipment Member" } } }, "auth_ref": [] }, "vsee_MiltonChenMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "MiltonChenMember", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Milton Chen [Member]", "documentation": "Represents information pertaining to Co-CEO Milton Chen.", "label": "Milton Chen Member" } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "MinimumMember", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/CommitmentsandContingenciesDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofFixedAssetsareDepreciatedUsingtheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable", "http://vseehealth.com/role/ScheduleofKeyAssumptionsUsedinValuingUnvestedOptionsTable", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum [Member]", "label": "Minimum [Member]" } } }, "auth_ref": [ "r219", "r353", "r354", "r355", "r356", "r461", "r489", "r490", "r491", "r506", "r651", "r753", "r846", "r847", "r853", "r890", "r891", "r951", "r953", "r955", "r956", "r958", "r968", "r969", "r971", "r972", "r984", "r985", "r1020", "r1029", "r1046", "r1049", "r1056", "r1059", "r1100", "r1101", "r1105", "r1123", "r1433", "r1544", "r1545", "r1546", "r1547", "r1548", "r1549" ] }, "vsee_MinimumNoticePeriodForRedemptionOfNotes": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "MinimumNoticePeriodForRedemptionOfNotes", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum notice period for redemption of notes", "documentation": "Represents the minimum notice period for redemption of notes.", "label": "Minimum Notice Period For Redemption Of Notes" } } }, "auth_ref": [] }, "vsee_MinimumNoticePeriodForRedemptionOfWarrants": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "MinimumNoticePeriodForRedemptionOfWarrants", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum notice period for redemption of Warrants", "documentation": "Represents the Minimum notice period for redemption of Warrants.", "label": "Minimum Notice Period For Redemption Of Warrants" } } }, "auth_ref": [] }, "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "negatedLabel": "Payment to shareholder", "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders", "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders." } } }, "auth_ref": [ "r89" ] }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "MinorityInterestOwnershipPercentageByParent", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ownership percentage", "label": "Subsidiary, Ownership Percentage, Parent", "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage." } } }, "auth_ref": [] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value [Flag]", "terseLabel": "MNPI Disclosure Timed for Compensation Value" } } }, "auth_ref": [ "r1239" ] }, "vsee_MonthlyRequiredOperatingLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "MonthlyRequiredOperatingLeasePayments", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Monthly required lease payments", "documentation": "Amount of monthly required payments from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Monthly Required Operating Lease Payments" } } }, "auth_ref": [] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement [Text Block]", "terseLabel": "Material Terms of Trading Arrangement" } } }, "auth_ref": [ "r1247" ] }, "vsee_MunroTrustMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "MunroTrustMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Munro Trust [Member]", "documentation": "Represents information related to Munro Trust.", "label": "Munro Trust Member" } } }, "auth_ref": [] }, "dei_NameChangeEventDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "NameChangeEventDateAxis", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Name Change Event Date [Axis]", "documentation": "For a sequence of name change event related facts, use this typed dimension to distinguish them. The axis members are restricted to be a valid for xml schema 'date' or 'datetime' data type." } } }, "auth_ref": [] }, "dei_NameChangeEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "NameChangeEventLineItems", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Name Change Event [Line Items]", "documentation": "Line items represent concepts included in a table. Name change event line item concepts are used for information qualified by domain members of axes in the Name Change Event table." } } }, "auth_ref": [] }, "dei_NameChangeEventTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "NameChangeEventTable", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Name Change Event [Table]", "documentation": "For a set of related facts in a sequence of name change events, use this table when the events occurred within a single reporting period." } } }, "auth_ref": [] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]" } } }, "auth_ref": [ "r262", "r1030", "r1034", "r1121", "r1127", "r1555", "r1556", "r1557", "r1559", "r1560", "r1561", "r1562", "r1563", "r1564", "r1565", "r1566", "r1567", "r1568", "r1569", "r1570", "r1571", "r1572", "r1573", "r1574", "r1575", "r1576", "r1577", "r1578", "r1579", "r1580", "r1581", "r1583", "r1584" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote [Text Block]", "terseLabel": "Named Executive Officers, Footnote" } } }, "auth_ref": [ "r1220" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by financing activities", "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation", "documentation": "Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit." } } }, "auth_ref": [ "r162" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES:", "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities", "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation", "documentation": "Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets." } } }, "auth_ref": [ "r162" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES:", "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in operating activities", "terseLabel": "Net cash used in operating activities (in Dollars)", "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation", "documentation": "Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity." } } }, "auth_ref": [ "r77", "r78", "r79" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES:", "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NetIncomeLoss", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "verboseLabel": "Net loss (in Dollars)", "label": "Net Income (Loss)", "terseLabel": "Net Income (Loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r69", "r79", "r102", "r123", "r130", "r146", "r147", "r151", "r169", "r172", "r173", "r177", "r185", "r189", "r190", "r191", "r192", "r193", "r196", "r197", "r203", "r298", "r359", "r360", "r362", "r363", "r364", "r365", "r366", "r368", "r369", "r402", "r406", "r409", "r414", "r495", "r544", "r612", "r645", "r677", "r823", "r920", "r941", "r942", "r998", "r1000", "r1002", "r1140", "r1429" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Recent Accounting Pronouncements", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "dei_NewEffectiveDateForPreviousFiling": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "NewEffectiveDateForPreviousFiling", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "New Effective Date for Previous Filing" } } }, "auth_ref": [ "r1190", "r1191", "r1192", "r1193" ] }, "dei_NoSubstantiveChanges462c": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "NoSubstantiveChanges462c", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "No Substantive Changes, 462(c)" } } }, "auth_ref": [ "r1271" ] }, "dei_NoSubstantiveChanges462cFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "NoSubstantiveChanges462cFileNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "No Substantive Changes, 462(c), File Number" } } }, "auth_ref": [ "r1271" ] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "NoTradingSymbolFlag", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description [Text Block]", "terseLabel": "Non-GAAP Measure Description" } } }, "auth_ref": [ "r1219" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-NEOs [Member]", "terseLabel": "Non-NEOs" } } }, "auth_ref": [ "r1174", "r1185", "r1201", "r1227", "r1236" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount", "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r1210" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount", "terseLabel": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r1209" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO [Member]", "terseLabel": "Non-PEO NEO" } } }, "auth_ref": [ "r1227" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r1247" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r1247" ] }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NoncashInvestingAndFinancingItemsAbstract", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Non-cash investing and financing activities:", "label": "Noncash Investing and Financing Items [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NoncontrollingInterestMember", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Non- Controlling Interest", "label": "Noncontrolling Interest [Member]", "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest." } } }, "auth_ref": [ "r41", "r433", "r1375", "r1376", "r1377", "r1378", "r1592" ] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "totalLabel": "Total other (expense) income, net", "label": "Nonoperating Income (Expense)", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r71" ] }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NonoperatingIncomeExpenseAbstract", "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Other (expense) income", "label": "Nonoperating Income (Expense) [Abstract]" } } }, "auth_ref": [] }, "vsee_NontaxableOrNondeductibleItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "NontaxableOrNondeductibleItemsAbstract", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofFederalIncomeTaxRatetoCompanysEffectiveTaxRateTable" ], "lang": { "en-us": { "role": { "terseLabel": "Nontaxable or nondeductible items", "label": "Nontaxable Or Nondeductible Items Abstract" } } }, "auth_ref": [] }, "vsee_NoteFairValueAdjustment": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "NoteFairValueAdjustment", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Change in fair value", "documentation": "Amount of expense (income) related to adjustment to fair value of equity contract.", "label": "Note Fair Value Adjustment" } } }, "auth_ref": [] }, "vsee_NotePayableIssuedAugust182023Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "NotePayableIssuedAugust182023Member", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable" ], "lang": { "en-us": { "role": { "terseLabel": "Note Payable Issued August 18, 2023 [Member]", "documentation": "Represents information related to Note Payable issued August 18, 2023", "label": "Note Payable Issued August182023 Member" } } }, "auth_ref": [] }, "vsee_NotePayableIssuedAugust32023Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "NotePayableIssuedAugust32023Member", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Note Payable Issued August 3, 2023 [Member]", "documentation": "Represents information related to Note Payable issued August 3, 2023", "label": "Note Payable Issued August32023 Member" } } }, "auth_ref": [] }, "vsee_NotePayableIssuedDecember12021Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "NotePayableIssuedDecember12021Member", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable" ], "lang": { "en-us": { "role": { "terseLabel": "Note Payable Issued December 1, 2021 [Member]", "documentation": "Represents information related to Note payable issued December 1, 2021", "label": "Note Payable Issued December12021 Member" } } }, "auth_ref": [] }, "vsee_NotePayableIssuedJanuary142024Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "NotePayableIssuedJanuary142024Member", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Note Payable Issued January 14, 2024 [Member]", "documentation": "Represents information related to Note payable issued January 14, 2024", "label": "Note Payable Issued January142024 Member" } } }, "auth_ref": [] }, "vsee_NotePayableIssuedNovember132023Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "NotePayableIssuedNovember132023Member", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Note Payable Issued November 13, 2023 [Member]", "documentation": "Represents information related to Note Payable issued November 13, 2023", "label": "Note Payable Issued November132023 Member" } } }, "auth_ref": [] }, "vsee_NotePayableIssuedNovember292021Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "NotePayableIssuedNovember292021Member", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable" ], "lang": { "en-us": { "role": { "terseLabel": "Note Payable Issued November 29, 2021 [Member]", "documentation": "Represents information related to Note payable issued November 29, 2021", "label": "Note Payable Issued November292021 Member" } } }, "auth_ref": [] }, "vsee_NotePayableIssuedNovember292023Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "NotePayableIssuedNovember292023Member", "presentation": [ "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable" ], "lang": { "en-us": { "role": { "terseLabel": "Note Payable Issued November 29, 2023 [Member]", "documentation": "Represents information related to Note payable issued November 29, 2023", "label": "Note Payable Issued November292023 Member" } } }, "auth_ref": [] }, "us-gaap_NotesAndLoansReceivableGrossNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NotesAndLoansReceivableGrossNoncurrent", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Note receivable with principal balance", "label": "Financing Receivable, before Allowance for Credit Loss, Noncurrent", "documentation": "Amortized cost, before allowance for credit loss, of financing receivable classified as noncurrent. Excludes net investment in lease." } } }, "auth_ref": [ "r967", "r1394", "r1403" ] }, "us-gaap_NotesAndLoansReceivableNetNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NotesAndLoansReceivableNetNoncurrent", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Note receivable, related party", "label": "Financing Receivable, after Allowance for Credit Loss, Noncurrent", "documentation": "Amount, after allowance for credit loss, of financing receivable, classified as noncurrent." } } }, "auth_ref": [ "r1394", "r1403", "r1405" ] }, "us-gaap_NotesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NotesPayableCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Notes payable, current portion", "label": "Notes Payable, Current", "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer." } } }, "auth_ref": [ "r47", "r48" ] }, "vsee_NotesPayableCurrentNetOfDiscount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "NotesPayableCurrentNetOfDiscount", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Notes payable, net of discount", "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer, net of discount.", "label": "Notes Payable Current Net Of Discount" } } }, "auth_ref": [] }, "vsee_NotesReceivableAllowanceForCreditLossWriteoff": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "NotesReceivableAllowanceForCreditLossWriteoff", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Note receivable write-off", "documentation": "Amount of direct write-downs of notes receivable charged against the allowance.", "label": "Notes Receivable Allowance For Credit Loss Writeoff" } } }, "auth_ref": [] }, "us-gaap_NotesReduction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NotesReduction", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued as principal payment of notes", "label": "Notes Reduction", "documentation": "The value of notes retired (or transferred to another entity) in noncash investing or financing transactions." } } }, "auth_ref": [ "r19", "r20", "r21" ] }, "vsee_NumberOfDeployedTelepresenceRobotsRightsConsideredForCalculatingPercentageOfMonthlyRevenueGeneration": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "NumberOfDeployedTelepresenceRobotsRightsConsideredForCalculatingPercentageOfMonthlyRevenueGeneration", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of deployed telepresence robots rights considered for calculating percentage of monthly revenue generation", "verboseLabel": "Telepresence robots deployed (in robot)", "documentation": "Number of deployed telepresence robots rights considered for calculating percentage of monthly revenue generation.", "label": "Number Of Deployed Telepresence Robots Rights Considered For Calculating Percentage Of Monthly Revenue Generation" } } }, "auth_ref": [] }, "vsee_NumberOfDeployedTelepresenceRobotsRightsHeld": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "NumberOfDeployedTelepresenceRobotsRightsHeld", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of deployed telepresence robots rights held", "verboseLabel": "Number of deployed telepresence robots rights held (in robot)", "documentation": "Number of deployed telepresence robots for which rights are held by the related party.", "label": "Number Of Deployed Telepresence Robots Rights Held" } } }, "auth_ref": [] }, "vsee_NumberOfFractionalSharesThatWillBeIssuedUponExerciseOfWarrants": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "NumberOfFractionalSharesThatWillBeIssuedUponExerciseOfWarrants", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of fractional shares that will be issued upon exercise of warrants", "documentation": "Number of fractional shares that will be issued upon exercise of warrants", "label": "Number Of Fractional Shares That Will Be Issued Upon Exercise Of Warrants" } } }, "auth_ref": [] }, "vsee_NumberOfInvestors": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "NumberOfInvestors", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of investors (in investor)", "documentation": "Number Of Investors..", "label": "Number Of Investors" } } }, "auth_ref": [] }, "vsee_NumberOfLegacyOperatingEntities": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "NumberOfLegacyOperatingEntities", "presentation": [ "http://vseehealth.com/role/ReportablesegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of legacy operating entities", "documentation": "Number of legacy operating entities.", "label": "Number Of Legacy Operating Entities" } } }, "auth_ref": [] }, "us-gaap_NumberOfOperatingSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NumberOfOperatingSegments", "presentation": [ "http://vseehealth.com/role/ReportablesegmentsDetails", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of operating segments (in segment)", "verboseLabel": "Number of operating segments", "label": "Number of Operating Segments", "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues." } } }, "auth_ref": [ "r1015", "r1387" ] }, "us-gaap_NumberOfReportableSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NumberOfReportableSegments", "presentation": [ "http://vseehealth.com/role/ReportablesegmentsDetails", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of reportable segments (in segment)", "verboseLabel": "Number of reportable segments", "label": "Number of Reportable Segments", "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements." } } }, "auth_ref": [ "r1009", "r1019", "r1387" ] }, "us-gaap_NumberOfReportingUnits": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "NumberOfReportingUnits", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of reporting units", "label": "Number of Reporting Units", "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment." } } }, "auth_ref": [] }, "vsee_NumberOfSharesCommonStockOutstandingPercentage": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "NumberOfSharesCommonStockOutstandingPercentage", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of shares of the common stock outstanding percent", "documentation": "Number of shares of the common stock outstanding percent.", "label": "Number Of Shares Common Stock Outstanding Percentage" } } }, "auth_ref": [] }, "vsee_NumberOfTopCustomers": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "NumberOfTopCustomers", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of top customers", "documentation": "Number of top customers of the company.", "label": "Number Of Top Customers" } } }, "auth_ref": [] }, "vsee_NumberOfVotesPerShare": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "NumberOfVotesPerShare", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of vote per share", "documentation": "Number of votes that each share entitles the holder.", "label": "Number Of Votes Per Share" } } }, "auth_ref": [] }, "vsee_October2025ConvertibleNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "October2025ConvertibleNoteMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "October 2025 Convertible Note [Member]", "label": "October2025 Convertible Note Member" } } }, "auth_ref": [] }, "vsee_October2025PromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "October2025PromissoryNoteMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "October 2025 Promissory Note [Member]", "label": "October2025 Promissory Note Member" } } }, "auth_ref": [] }, "vsee_October212025ConvertibleNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "October212025ConvertibleNoteMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "October 21, 2025 Convertible Note [Member]", "label": "October212025 Convertible Note Member" } } }, "auth_ref": [] }, "vsee_OctoberPromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "OctoberPromissoryNoteMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "October Promissory Note [Member]", "label": "October Promissory Note Member" } } }, "auth_ref": [] }, "vsee_OctoberPromissoryNoteTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "OctoberPromissoryNoteTwoMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "October Promissory Note Two[Member]", "label": "October Promissory Note Two Member" } } }, "auth_ref": [] }, "vsee_OfficeAndMedicalEquipmentFurnitureMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "OfficeAndMedicalEquipmentFurnitureMember", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Office and Medical Equipment, Furniture [Member]", "documentation": "Tangible personal property used in an office or medical setting as well as furniture.", "label": "Office And Medical Equipment Furniture Member" } } }, "auth_ref": [] }, "us-gaap_OfficeEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OfficeEquipmentMember", "presentation": [ "http://vseehealth.com/role/FixedAssetsDetails", "http://vseehealth.com/role/ScheduleofComponentsofFixedAssetsTable", "http://vseehealth.com/role/ScheduleofFixedAssetsareDepreciatedUsingtheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Office Equipment [Member]", "verboseLabel": "Office equipment [Member]", "label": "Office Equipment [Member]", "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine." } } }, "auth_ref": [] }, "vsee_OfficeSpaceInHoustonMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "OfficeSpaceInHoustonMember", "presentation": [ "http://vseehealth.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Office Space In Houston [Member]", "documentation": "Represents information relating to the office space leased in Houston.", "label": "Office Space In Houston Member" } } }, "auth_ref": [] }, "vsee_OfficeSpaceInTexasMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "OfficeSpaceInTexasMember", "presentation": [ "http://vseehealth.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Office Space In Texas [Member]", "documentation": "Represents information relating to the office space leased in Texas.", "label": "Office Space In Texas Member" } } }, "auth_ref": [] }, "vsee_OnNovember112025PromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "OnNovember112025PromissoryNoteMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "On November 11, 2025 Promissory Note [Member]", "label": "On November112025 Promissory Note Member" } } }, "auth_ref": [] }, "vsee_OneOfLendersUnderArLoanConversionSpasMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "OneOfLendersUnderArLoanConversionSpasMember", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable_Parentheticals" ], "lang": { "en-us": { "role": { "terseLabel": "One of the lenders under A&R Loan Conversion SPAs [Member]", "verboseLabel": "One of The Lenders Under AR Loan Conversion Spas [Member]", "documentation": "Represents information pertaining to one of the lenders under A&R Loan Conversion SPAs.", "label": "One Of Lenders Under Ar Loan Conversion Spas Member" } } }, "auth_ref": [] }, "vsee_OneVendorMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "OneVendorMember", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "One Vendor [Member]", "documentation": "Represents information relating to one vendor.", "label": "One Vendor Member" } } }, "auth_ref": [] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating expenses", "label": "Operating Expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [ "r1002" ] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable" ], "lang": { "en-us": { "role": { "totalLabel": "Net operating loss", "terseLabel": "Segment operating income (loss)", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r106", "r998", "r1002", "r1008", "r1381", "r1388", "r1390", "r1391", "r1392" ] }, "us-gaap_OperatingLeaseCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLeaseCost", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofExpensesIncurredforOperatingLeasesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease expense", "label": "Operating Lease, Cost", "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability." } } }, "auth_ref": [ "r701", "r1109" ] }, "us-gaap_OperatingLeaseExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLeaseExpense", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofExpensesIncurredforOperatingLeasesTable" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating lease expense", "label": "Operating Lease, Expense", "documentation": "Amount of operating lease expense. Excludes sublease income." } } }, "auth_ref": [ "r1533" ] }, "vsee_OperatingLeaseFirstRentalPeriodMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "OperatingLeaseFirstRentalPeriodMember", "presentation": [ "http://vseehealth.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Lease, First Rental Period [Member]", "documentation": "Information pertaining to the first specified rental period under the operating lease.", "label": "Operating Lease First Rental Period Member" } } }, "auth_ref": [] }, "vsee_OperatingLeaseLiabilitiesIncludedInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "OperatingLeaseLiabilitiesIncludedInAccountsPayableAndAccruedLiabilities", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liabilities included in accounts payable and accrued liabilities", "documentation": "Amount of operating lease liabilities that are included in accounts payable and accrued liabilities at balance sheet date.", "label": "Operating Lease Liabilities Included In Accounts Payable And Accrued Liabilities" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLeaseLiability", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofOperatingLeaseLiabilitiesTable": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/LeasesDetails", "http://vseehealth.com/role/ScheduleofFutureMinimumRentPaymentsUndertheOperatingLeaseTable", "http://vseehealth.com/role/ScheduleofOperatingLeaseLiabilitiesTable" ], "lang": { "en-us": { "role": { "totalLabel": "Office lease", "terseLabel": "Present value of payments", "verboseLabel": "Related lease liability", "label": "Operating Lease, Liability", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease." } } }, "auth_ref": [ "r694" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofOperatingLeaseLiabilitiesTable": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0, "order": 1.0 }, "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ScheduleofOperatingLeaseLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liabilities", "negatedLabel": "Less: Current portion", "label": "Operating Lease, Liability, Current", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r694" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofOperatingLeaseLiabilitiesTable": { "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0, "order": 2.0 }, "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ScheduleofOperatingLeaseLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liabilities, less current portion", "verboseLabel": "Long-term portion", "label": "Operating Lease, Liability, Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r694" ] }, "us-gaap_OperatingLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLeasePayments", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Office space lease payments", "label": "Operating Lease, Payments", "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use." } } }, "auth_ref": [ "r697", "r702" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ScheduleofOperatingLeaseRightofUseAssetsTable" ], "lang": { "en-us": { "role": { "totalLabel": "Right-of-use assets, net", "terseLabel": "Right-of-use assets, net", "label": "Operating Lease, Right-of-Use Asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r693" ] }, "vsee_OperatingLeaseRightOfUseAssetAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "OperatingLeaseRightOfUseAssetAccumulatedAmortization", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofOperatingLeaseRightofUseAssetsTable" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: Accumulated amortization", "documentation": "Amount of accumulated amortization of right-of-use asset from operating lease.", "label": "Operating Lease Right Of Use Asset Accumulated Amortization" } } }, "auth_ref": [] }, "vsee_OperatingLeaseRightOfUseAssetBeforeAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "OperatingLeaseRightOfUseAssetBeforeAccumulatedAmortization", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofOperatingLeaseRightofUseAssetsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Office lease", "documentation": "Amount, before accumulated amortization, of right-of-use asset from operating lease.", "label": "Operating Lease Right Of Use Asset Before Accumulated Amortization" } } }, "auth_ref": [] }, "vsee_OperatingLeaseRightOfUseAssetReductionFromContractTermination": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "OperatingLeaseRightOfUseAssetReductionFromContractTermination", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Right of use asset relieved due to termination of lease", "documentation": "Amount of reduction of operating lease right of use asset due to termination of lease.", "label": "Operating Lease Right Of Use Asset Reduction From Contract Termination" } } }, "auth_ref": [] }, "vsee_OperatingLeaseRightOfUseLiabilityReductionFromContractTermination": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "OperatingLeaseRightOfUseLiabilityReductionFromContractTermination", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Right of use liability relieved due to termination of lease", "documentation": "Amount of reduction of operating lease right of use liability due to termination of lease.", "label": "Operating Lease Right Of Use Liability Reduction From Contract Termination" } } }, "auth_ref": [] }, "vsee_OperatingLeaseSecondRentalPeriodMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "OperatingLeaseSecondRentalPeriodMember", "presentation": [ "http://vseehealth.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Lease, Second Rental Period [Member]", "documentation": "Information pertaining to the second specified rental period under the operating lease.", "label": "Operating Lease Second Rental Period Member" } } }, "auth_ref": [] }, "vsee_OperatingLeaseThirdRentalPeriodMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "OperatingLeaseThirdRentalPeriodMember", "presentation": [ "http://vseehealth.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Lease, Third Rental Period [Member]", "documentation": "Information pertaining to the third specified rental period under the operating lease.", "label": "Operating Lease Third Rental Period Member" } } }, "auth_ref": [] }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "presentation": [ "http://vseehealth.com/role/ScheduleofWeightedAverageRemainingLeaseTermandDiscountRateonFinanceLeasesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average discount rate", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "documentation": "Weighted average discount rate for operating lease calculated at point in time." } } }, "auth_ref": [ "r704", "r1109" ] }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "presentation": [ "http://vseehealth.com/role/ScheduleofWeightedAverageRemainingLeaseTermandDiscountRateonFinanceLeasesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average remaining lease term", "label": "Operating Lease, Weighted Average Remaining Lease Term", "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r703", "r1109" ] }, "us-gaap_OperatingLossCarryforwards": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingLossCarryforwards", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating loss carryforwards", "label": "Operating Loss Carryforwards", "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws." } } }, "auth_ref": [ "r530" ] }, "us-gaap_OperatingSegmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OperatingSegmentsMember", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable", "http://vseehealth.com/role/ScheduleofReportableSegmentDepreciationandAmortizationandCapitalExpendituresTable", "http://vseehealth.com/role/ScheduleofTotalAssetsbySegmentTable" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Segments [Member]", "label": "Operating Segments [Member]", "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r248", "r249", "r250", "r251", "r252", "r255", "r1014", "r1015" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "presentation": [ "http://vseehealth.com/role/OrganizationandDescriptionofBusiness" ], "lang": { "en-us": { "role": { "terseLabel": "Organization and Description of Business", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure." } } }, "auth_ref": [ "r93", "r124", "r125", "r127", "r858", "r859" ] }, "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation and Consolidation", "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]", "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles." } } }, "auth_ref": [ "r80", "r93", "r1365" ] }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable": { "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Other accrued liabilities", "label": "Other Accrued Liabilities, Current", "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r48" ] }, "dei_OtherAddressMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "OtherAddressMember", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Other Address [Member]", "documentation": "Other address for entity" } } }, "auth_ref": [] }, "us-gaap_OtherAssetImpairmentCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherAssetImpairmentCharges", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non-cash goodwill impairment charges", "label": "Other Asset Impairment Charges", "documentation": "The charge against earnings resulting from the write down of long lived assets other than goodwill due to the difference between the carrying value and lower fair value." } } }, "auth_ref": [ "r1363", "r1420" ] }, "vsee_OtherCurrentDhacShareholdersMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "OtherCurrentDhacShareholdersMember", "presentation": [ "http://vseehealth.com/role/ScheduleofCommonStockBusinessCombinationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Other Current DHAC Shareholders [Member]", "documentation": "Represents the information pertaining to other current DHAC shareholders.", "label": "Other Current Dhac Shareholders Member" } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due to related parties", "verboseLabel": "Due to related party", "label": "Other Liabilities, Current", "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r48", "r1110" ] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable" ], "lang": { "en-us": { "role": { "terseLabel": "Other income, net", "label": "Other Nonoperating Income (Expense)", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r73", "r1095" ] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure, Amount", "terseLabel": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r1219" ] }, "us-gaap_OtherReceivablesNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "OtherReceivablesNetCurrent", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due from related party", "label": "Other Receivables, Net, Current", "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r1158" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount", "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r1172", "r1183", "r1199", "r1234" ] }, "vsee_OutstandingPrincipalBalanceAnnualRatePercentage": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "OutstandingPrincipalBalanceAnnualRatePercentage", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding Principal balance annual rate percentage", "documentation": "Percentage of outstanding principal balance shall increase to an annual rate.", "label": "Outstanding Principal Balance Annual Rate Percentage" } } }, "auth_ref": [] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery Compensation Amount", "terseLabel": "Compensation Amount" } } }, "auth_ref": [ "r1175", "r1186", "r1202", "r1237" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r1175", "r1186", "r1202", "r1237" ] }, "srt_OwnershipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "OwnershipAxis", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Ownership [Axis]" } } }, "auth_ref": [] }, "srt_OwnershipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "OwnershipDomain", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Ownership [Domain]" } } }, "auth_ref": [] }, "dei_ParentEntityLegalName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "ParentEntityLegalName", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Parent Entity Legal Name", "documentation": "If the entity which the financial information concerns is a subsidiary of another company, then provide to full legal name of the parent entity" } } }, "auth_ref": [] }, "vsee_PatientFeesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PatientFeesMember", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable" ], "lang": { "en-us": { "role": { "terseLabel": "Patient fees [Member]", "label": "Patient Fees Member" } } }, "auth_ref": [] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]", "terseLabel": "Pay vs Performance Disclosure" } } }, "auth_ref": [ "r1208" ] }, "us-gaap_PayablesAndAccrualsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PayablesAndAccrualsAbstract", "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "auth_ref": [] }, "vsee_PaymentOfCash": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PaymentOfCash", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Payment Of Cash (in Dollars)", "documentation": "The amount of payment of cash.", "label": "Payment Of Cash" } } }, "auth_ref": [] }, "us-gaap_PaymentsForLegalSettlements": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PaymentsForLegalSettlements", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash payment", "label": "Payments for Legal Settlements", "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period." } } }, "auth_ref": [ "r2" ] }, "vsee_PaymentsForOptionalPrepaymentAsPercentageOfOutstandingObligationIncludingGuaranteedMinimumInterest": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PaymentsForOptionalPrepaymentAsPercentageOfOutstandingObligationIncludingGuaranteedMinimumInterest", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Payments for optional prepayment as percentage of outstanding obligation including guaranteed minimum interest", "documentation": "Represents the payments for optional prepayment as percentage of outstanding obligation including guaranteed minimum interest.", "label": "Payments For Optional Prepayment As Percentage Of Outstanding Obligation Including Guaranteed Minimum Interest" } } }, "auth_ref": [] }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PaymentsForRepurchaseOfCommonStock", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 14.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments due on acquisition purchase", "label": "Payments for Repurchase of Common Stock", "documentation": "The cash outflow to reacquire common stock during the period." } } }, "auth_ref": [ "r75" ] }, "vsee_PaymentsForSettlementOfFrostBankObligations": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PaymentsForSettlementOfFrostBankObligations", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LeasesDetails", "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Payments for settlement of bank obligations", "verboseLabel": "Payments for settlement of frost bank obligations", "documentation": "Payments for settlement of frost bank obligations.", "label": "Payments For Settlement Of Frost Bank Obligations" } } }, "auth_ref": [] }, "vsee_PaymentsOnExchangeNotes": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PaymentsOnExchangeNotes", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments on Exchange note", "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.", "label": "Payments On Exchange Notes" } } }, "auth_ref": [] }, "vsee_PaymentsOnSeptember2024ConvertibleNote": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PaymentsOnSeptember2024ConvertibleNote", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments on September 2024 Convertible Note", "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.", "label": "Payments On September2024 Convertible Note" } } }, "auth_ref": [] }, "us-gaap_PaymentsToAcquireBusinessesGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PaymentsToAcquireBusinessesGross", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Encompass for a cash payment", "label": "Payments to Acquire Businesses, Gross", "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price." } } }, "auth_ref": [ "r14", "r594", "r1049", "r1054", "r1090" ] }, "us-gaap_PaymentsToAcquireProductiveAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PaymentsToAcquireProductiveAssets", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofReportableSegmentDepreciationandAmortizationandCapitalExpendituresTable" ], "lang": { "en-us": { "role": { "terseLabel": "Capital expenditures", "label": "Payments to Acquire Productive Assets", "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets." } } }, "auth_ref": [ "r108", "r1502", "r1503", "r1504" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchases of fixed assets", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r74" ] }, "us-gaap_PaymentsToMinorityShareholders": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PaymentsToMinorityShareholders", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Payment to shareholder", "label": "Payments to Noncontrolling Interests", "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest." } } }, "auth_ref": [ "r16" ] }, "vsee_PaymentsToRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PaymentsToRelatedParties", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Payments to related parties", "documentation": "Amount of cash outflow to related parties during the period.", "label": "Payments To Related Parties" } } }, "auth_ref": [] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote [Text Block]", "terseLabel": "Peer Group Issuers, Footnote" } } }, "auth_ref": [ "r1218" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount", "terseLabel": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r1218" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount", "terseLabel": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r1210" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO [Member]", "terseLabel": "PEO" } } }, "auth_ref": [ "r1227" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Name", "terseLabel": "PEO Name" } } }, "auth_ref": [ "r1220" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount", "terseLabel": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r1209" ] }, "vsee_PercentageOfAllowableDeductionOfTaxableIncome": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PercentageOfAllowableDeductionOfTaxableIncome", "presentation": [ "http://vseehealth.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of allowable deduction of taxable income", "documentation": "The percentage of allowable deduction of taxable income.", "label": "Percentage Of Allowable Deduction Of Taxable Income" } } }, "auth_ref": [] }, "vsee_PercentageOfEquityInterest": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PercentageOfEquityInterest", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of equity interest", "documentation": "Percentage of equity interest.", "label": "Percentage Of Equity Interest" } } }, "auth_ref": [] }, "vsee_PercentageOfInitialAdvance": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PercentageOfInitialAdvance", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of initial advance", "documentation": "Percentage of initial advance.", "label": "Percentage Of Initial Advance" } } }, "auth_ref": [] }, "vsee_PercentageOfInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PercentageOfInterestRate", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of interest rate", "documentation": "Percentage of interest rate.", "label": "Percentage Of Interest Rate" } } }, "auth_ref": [] }, "vsee_PercentageOfMinimumIncreaseOrDecreaseInAggregateNumberOfCommonSharesPurchasableUponExerciseOfAllWarrantsConsideredForAdjustmentToSharesReceivableUponExerciseOfEachWarrant": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PercentageOfMinimumIncreaseOrDecreaseInAggregateNumberOfCommonSharesPurchasableUponExerciseOfAllWarrantsConsideredForAdjustmentToSharesReceivableUponExerciseOfEachWarrant", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of increase or decrease in aggregate number of common shares purchasable upon exercise of all warrants considered for adjustment to shares receivable upon exercise of each warrant", "documentation": "Represents the percentage of minimum increase or decrease in aggregate number of common shares purchasable upon exercise of all warrants considered for adjustment to shares receivable upon exercise of each warrant.", "label": "Percentage Of Minimum Increase Or Decrease In Aggregate Number Of Common Shares Purchasable Upon Exercise Of All Warrants Considered For Adjustment To Shares Receivable Upon Exercise Of Each Warrant" } } }, "auth_ref": [] }, "vsee_PercentageOfMonthlyRevenueGeneratedFromTelepresenceRobotsConsideredForPaymentsOnPromissoryNote": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PercentageOfMonthlyRevenueGeneratedFromTelepresenceRobotsConsideredForPaymentsOnPromissoryNote", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of monthly revenue generated from telepresence robots, considered for payment", "documentation": "Percentage of monthly revenue generated on eight telepresence robots, based on which company is required to make payments to the related party on promissory note.", "label": "Percentage Of Monthly Revenue Generated From Telepresence Robots Considered For Payments On Promissory Note" } } }, "auth_ref": [] }, "vsee_PercentageOfOutstandingBalance": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PercentageOfOutstandingBalance", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of outstanding balance", "documentation": "Percentage of outstanding balance.", "label": "Percentage Of Outstanding Balance" } } }, "auth_ref": [] }, "vsee_PercentageOfOwnershipInterest": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PercentageOfOwnershipInterest", "presentation": [ "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of ownership interest", "documentation": "Percentage of ownership interest.", "label": "Percentage Of Ownership Interest" } } }, "auth_ref": [] }, "us-gaap_PerformanceSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PerformanceSharesMember", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Performance Shares [Member]", "label": "Performance Shares [Member]", "documentation": "Share-based payment arrangement awarded for meeting performance target." } } }, "auth_ref": [ "r1442", "r1443", "r1444", "r1445", "r1446", "r1447", "r1448", "r1449", "r1450", "r1451", "r1452", "r1453", "r1454", "r1455", "r1456", "r1457", "r1458", "r1459", "r1460", "r1461", "r1462", "r1464", "r1465", "r1466", "r1467", "r1468" ] }, "vsee_PeriodAgreedToFileResaleRegistrationStatement": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PeriodAgreedToFileResaleRegistrationStatement", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Period agreed to file a resale registration statement", "documentation": "Represents the period agreed to file a resale registration statement.", "label": "Period Agreed To File Resale Registration Statement" } } }, "auth_ref": [] }, "vsee_PeriodWithinWhichRegistrationStatementShallBeDeclaredEffective": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PeriodWithinWhichRegistrationStatementShallBeDeclaredEffective", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Period within which registration statement shall be declared effective", "documentation": "Represents the period within which registration statement shall be declared effective.", "label": "Period Within Which Registration Statement Shall Be Declared Effective" } } }, "auth_ref": [] }, "dei_PhoneFaxNumberDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "PhoneFaxNumberDescription", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Phone Fax Number Description", "documentation": "Description of Phone or Fax Number" } } }, "auth_ref": [] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PlanNameAxis", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails", "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r1442", "r1443", "r1444", "r1445", "r1446", "r1447", "r1448", "r1449", "r1450", "r1451", "r1452", "r1453", "r1454", "r1455", "r1456", "r1457", "r1458", "r1459", "r1460", "r1461", "r1462", "r1464", "r1465", "r1466", "r1467", "r1468" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PlanNameDomain", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails", "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "label": "Plan Name [Domain]", "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r1442", "r1443", "r1444", "r1445", "r1446", "r1447", "r1448", "r1449", "r1450", "r1451", "r1452", "r1453", "r1454", "r1455", "r1456", "r1457", "r1458", "r1459", "r1460", "r1461", "r1462", "r1464", "r1465", "r1466", "r1467", "r1468" ] }, "ecd_PnsnAdjsPrrSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PnsnAdjsPrrSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pension Adjustments Prior Service Cost [Member]", "terseLabel": "Pension Adjustments Prior Service Cost" } } }, "auth_ref": [ "r1211" ] }, "ecd_PnsnAdjsSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PnsnAdjsSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pension Adjustments Service Cost [Member]", "terseLabel": "Pension Adjustments Service Cost" } } }, "auth_ref": [ "r1263" ] }, "ecd_PnsnBnftsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PnsnBnftsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pension Benefits Adjustments, Footnote [Text Block]", "terseLabel": "Pension Benefits Adjustments, Footnote" } } }, "auth_ref": [ "r1210" ] }, "dei_PostEffectiveAmendment": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "PostEffectiveAmendment", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Post-Effective Amendment" } } }, "auth_ref": [ "r1144" ] }, "dei_PostEffectiveAmendmentNumber": { "xbrltype": "sequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "PostEffectiveAmendmentNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Post-Effective Amendment Number", "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective." } } }, "auth_ref": [ "r1144" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r1151" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "PreCommencementTenderOffer", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r1153" ] }, "dei_PreEffectiveAmendment": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "PreEffectiveAmendment", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-Effective Amendment" } } }, "auth_ref": [ "r1144" ] }, "dei_PreEffectiveAmendmentNumber": { "xbrltype": "sequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "PreEffectiveAmendmentNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-Effective Amendment Number", "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective." } } }, "auth_ref": [ "r1144" ] }, "vsee_PreFundedWarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PreFundedWarrantMember", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pre Funded Warrants [Member]", "label": "Pre Funded Warrant Member" } } }, "auth_ref": [] }, "vsee_PreFundedWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PreFundedWarrantsMember", "presentation": [ "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-Funded Warrants [Member]", "label": "Pre Funded Warrants Member" } } }, "auth_ref": [] }, "us-gaap_PreferredClassAMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PreferredClassAMember", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred Class A [Member]", "label": "Preferred Class A [Member]", "documentation": "Outstanding nonredeemable preferred class A stock or outstanding convertible preferred class A stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer." } } }, "auth_ref": [] }, "vsee_PreferredSharesIssuedAsConversionOfVSeeDebtAsContemplatedByTheBusinessCombinati": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PreferredSharesIssuedAsConversionOfVSeeDebtAsContemplatedByTheBusinessCombinati", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred shares issued as conversion of VSee debt as contemplated by the business combination transaction", "documentation": "Preferred shares issued as conversion of VSee debt as contemplated by the business combination.", "label": "Preferred Shares Issued As Conversion Of VSee Debt As Contemplated By The Business Combinati" } } }, "auth_ref": [] }, "vsee_PreferredStockConvertibleAlternateConversionMeasuringPeriod": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PreferredStockConvertibleAlternateConversionMeasuringPeriod", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Alternate conversion measuring period", "documentation": "Represents the alternate conversion measuring period for conversion of preferred stock.", "label": "Preferred Stock Convertible Alternate Conversion Measuring Period" } } }, "auth_ref": [] }, "us-gaap_PreferredStockConvertibleConversionPrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PreferredStockConvertibleConversionPrice", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, conversion rate (in Dollars per share)", "label": "Preferred Stock, Convertible, Conversion Price", "documentation": "Per share conversion price of preferred stock." } } }, "auth_ref": [ "r418" ] }, "vsee_PreferredStockConvertibleConversionPricePercentageUsedForCalculation": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PreferredStockConvertibleConversionPricePercentageUsedForCalculation", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage used for calculation of conversion price", "documentation": "Represents the percentage used for calculation of conversion price of convertible preferred stock.", "label": "Preferred Stock Convertible Conversion Price Percentage Used For Calculation" } } }, "auth_ref": [] }, "vsee_PreferredStockConvertibleTerm": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PreferredStockConvertibleTerm", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, convertible term", "documentation": "Period between issuance and conversion of preferred stock, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Preferred Stock Convertible Term" } } }, "auth_ref": [] }, "vsee_PreferredStockConvertibleThresholdConsecutiveTradingDays": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PreferredStockConvertibleThresholdConsecutiveTradingDays", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Threshold period of specified consecutive trading days", "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of preferred stock must exceed threshold percentage for specified number of trading days to trigger conversion feature.", "label": "Preferred Stock Convertible Threshold Consecutive Trading Days" } } }, "auth_ref": [] }, "vsee_PreferredStockConvertibleThresholdTradingDays": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PreferredStockConvertibleThresholdTradingDays", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Threshold number of specified trading days", "documentation": "Threshold number of specified trading days that common stock price to conversion price of preferred stock must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.", "label": "Preferred Stock Convertible Threshold Trading Days" } } }, "auth_ref": [] }, "vsee_PreferredStockIssuedDuringPeriodSharesSettlementOfDebtAsPartOfConsiderationInAcquisitions": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PreferredStockIssuedDuringPeriodSharesSettlementOfDebtAsPartOfConsiderationInAcquisitions", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred shares issued to settle debt as part of the consideration in the acquisition (in Shares)", "verboseLabel": "Preferred shares issued to settle debt as part of the consideration in the acquisition", "documentation": "Number of shares of preferred stock issued as a settlement of debt during the period pursuant to acquisitions.", "label": "Preferred Stock Issued During Period Shares Settlement Of Debt As Part Of Consideration In Acquisitions" } } }, "auth_ref": [] }, "vsee_PreferredStockIssuedDuringPeriodSharesSettlementOfUnderwritingFeeAsPartOfConsiderationInAcquisitions": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PreferredStockIssuedDuringPeriodSharesSettlementOfUnderwritingFeeAsPartOfConsiderationInAcquisitions", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred shares issued as conversion of Underwriting Fee as contemplated by the business combination transaction (in Shares)", "documentation": "Number of shares of preferred stock issued as a settlement of underwriting fee during the period pursuant to acquisitions.", "label": "Preferred Stock Issued During Period Shares Settlement Of Underwriting Fee As Part Of Consideration In Acquisitions" } } }, "auth_ref": [] }, "vsee_PreferredStockIssuedDuringPeriodValueSettlementOfDebtAsPartOfConsiderationInAcquisition": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PreferredStockIssuedDuringPeriodValueSettlementOfDebtAsPartOfConsiderationInAcquisition", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred shares issued to settle debt as part of the consideration in the acquisition", "documentation": "Value of preferred stock issued to settle debt pursuant to consideration in acquisitions during the period.", "label": "Preferred Stock Issued During Period Value Settlement Of Debt As Part Of Consideration In Acquisition" } } }, "auth_ref": [] }, "vsee_PreferredStockIssuedDuringPeriodValueSettlementOfUnderwritingFeeAsPartOfConsiderationInAcquisition": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PreferredStockIssuedDuringPeriodValueSettlementOfUnderwritingFeeAsPartOfConsiderationInAcquisition", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred shares issued as conversion of Underwriting Fee as contemplated by the business combination transaction", "documentation": "Value of preferred stock issued to settle underwriting fee pursuant to consideration in acquisitions during the period.", "label": "Preferred Stock Issued During Period Value Settlement Of Underwriting Fee As Part Of Consideration In Acquisition" } } }, "auth_ref": [] }, "us-gaap_PreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PreferredStockMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred Stock", "verboseLabel": "Preferred Shares", "label": "Preferred Stock [Member]", "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company." } } }, "auth_ref": [ "r1132", "r1133", "r1136", "r1137", "r1138", "r1139", "r1585", "r1592" ] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, par value (in Dollars per share)", "label": "Preferred Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r57", "r416" ] }, "us-gaap_PreferredStockRedemptionPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PreferredStockRedemptionPricePerShare", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Redemption price per share (in Dollars per share)", "label": "Preferred Stock, Redemption Price Per Share", "documentation": "The price per share at which the preferred stock of an entity that has priority over common stock in the distribution of dividends and in the event of liquidation of the entity is redeemed or may be called at. The redemption features of this preferred stock are solely within the control of the issuer." } } }, "auth_ref": [ "r35", "r36", "r37" ] }, "vsee_PreferredStockRedemptionPricePercentage": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PreferredStockRedemptionPricePercentage", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of redemption price", "documentation": "Percentage price of stated value of shares at which preferred stock can be redeemed.", "label": "Preferred Stock Redemption Price Percentage" } } }, "auth_ref": [] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares authorized (in Shares)", "verboseLabel": "Preferred stock, shares authorized", "label": "Preferred Stock, Shares Authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r57", "r900" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PreferredStockSharesIssued", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares issued (in Shares)", "verboseLabel": "Preferred stock, shares issued", "label": "Preferred Stock, Shares Issued", "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt." } } }, "auth_ref": [ "r57", "r416" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares outstanding (in Shares)", "verboseLabel": "Preferred stock, shares outstanding", "label": "Preferred Stock, Shares Outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r57", "r900", "r919", "r1592", "r1593" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, $0.0001 par value, 10,000,000 shares authorized; 1,788 and 6,158 shares issued and outstanding as of December 31, 2025, and December 31, 2024, respectively", "verboseLabel": "Preferred shares (in Dollars)", "label": "Preferred Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r57", "r405", "r411", "r813", "r1110" ] }, "vsee_PrefundedWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PrefundedWarrantsMember", "presentation": [ "http://vseehealth.com/role/ScheduleofWarrantsIssuedandoutstandingTable" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-funded Warrants [Member]", "label": "Prefunded Warrants Member" } } }, "auth_ref": [] }, "vsee_PrepaidAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PrepaidAssetsPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid Assets and Other Current Assets", "documentation": "Disclosure of accounting policy for prepaid assets.", "label": "Prepaid Assets Policy Text Block" } } }, "auth_ref": [] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaids and other current assets", "label": "Prepaid Expense and Other Assets, Current", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r1306" ] }, "vsee_PriorSettlement": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PriorSettlement", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/FactoringPayableDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Prior settlement", "documentation": "The amount represents the prior settlement related to judgment.", "label": "Prior Settlement" } } }, "auth_ref": [] }, "us-gaap_PrivatePlacementMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PrivatePlacementMember", "presentation": [ "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Private Placement Shares [Member]", "label": "Private Placement [Member]", "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts." } } }, "auth_ref": [] }, "vsee_PrivatePlacementWarrantsExpiryTerm": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PrivatePlacementWarrantsExpiryTerm", "presentation": [ "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Private placement warrants expiry term", "documentation": "Private placement warrants expiry term.", "label": "Private Placement Warrants Expiry Term" } } }, "auth_ref": [] }, "vsee_PrivatePlacementWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PrivatePlacementWarrantsMember", "presentation": [ "http://vseehealth.com/role/SubsequentEventsDetails", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Private Placement Warrants [Member]", "documentation": "Represents the information pertaining to private placement warrants.", "label": "Private Placement Warrants Member" } } }, "auth_ref": [] }, "vsee_PrivateWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PrivateWarrantsMember", "presentation": [ "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable", "http://vseehealth.com/role/ScheduleofWarrantsIssuedandoutstandingTable" ], "lang": { "en-us": { "role": { "terseLabel": "Private Warrants [Member]", "verboseLabel": "Private [Member]", "documentation": "Represents the information pertaining to Private warrants.", "label": "Private Warrants Member" } } }, "auth_ref": [] }, "vsee_ProceedsFromCashAdvance": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ProceedsFromCashAdvance", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate advance amount", "documentation": "The cash inflow from cash advance.", "label": "Proceeds From Cash Advance" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromConvertibleDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProceedsFromConvertibleDebt", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from convertible debt", "verboseLabel": "Proceeds from convertible note (in Dollars)", "label": "Proceeds from Convertible Debt", "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder." } } }, "auth_ref": [ "r15" ] }, "vsee_ProceedsFromInitialCashAdvance": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ProceedsFromInitialCashAdvance", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Initial advance amount", "documentation": "The cash inflow from initial cash advance.", "label": "Proceeds From Initial Cash Advance" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProceedsFromIssuanceOfCommonStock", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from issuance of common stock", "label": "Proceeds from Issuance of Common Stock", "documentation": "The cash inflow from the additional capital contribution to the entity." } } }, "auth_ref": [ "r1" ] }, "us-gaap_ProceedsFromIssuanceOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProceedsFromIssuanceOfDebt", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash proceeds received", "label": "Proceeds from Issuance of Debt", "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt." } } }, "auth_ref": [ "r1361" ] }, "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProceedsFromIssuanceOfPrivatePlacement", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross proceeds of before deducting the placement agent\u2019s fees and other estimated offering expenses", "label": "Proceeds from Issuance of Private Placement", "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement." } } }, "auth_ref": [ "r1" ] }, "vsee_ProceedsFromNotesIssuedDuringThePeriod": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ProceedsFromNotesIssuedDuringThePeriod", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from notes issued during the year", "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Proceeds From Notes Issued During The Period" } } }, "auth_ref": [] }, "vsee_ProceedsFromPreFundedWarrantsNetOfIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ProceedsFromPreFundedWarrantsNetOfIssuanceCosts", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from pre-funded warrants, net of issuance costs", "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Proceeds From Pre Funded Warrants Net Of Issuance Costs" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromRelatedPartyDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProceedsFromRelatedPartyDebt", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from loan payable, related party", "label": "Proceeds from Related Party Debt", "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates." } } }, "auth_ref": [ "r15" ] }, "vsee_ProceedsFromReverseRecapitalization": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ProceedsFromReverseRecapitalization", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from reverse recapitalization with DHAC", "documentation": "The cash inflow from a reverse recapitalization.", "label": "Proceeds From Reverse Recapitalization" } } }, "auth_ref": [] }, "vsee_ProceedsFromSaleOfDebtSecuritiesNetOfIssuanceCost": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ProceedsFromSaleOfDebtSecuritiesNetOfIssuanceCost", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from sale of debt securities, net of issuance cost (in Dollars)", "documentation": "Proceeds from sale of debt securities, net of issuance cost.", "label": "Proceeds From Sale Of Debt Securities Net Of Issuance Cost" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProceedsFromStockOptionsExercised", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exchange of recognized proceeds (in Dollars)", "label": "Proceeds from Stock Options Exercised", "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement." } } }, "auth_ref": [ "r1", "r10" ] }, "us-gaap_ProceedsFromSubordinatedShortTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProceedsFromSubordinatedShortTermDebt", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Received on issuance", "label": "Proceeds from Subordinated Short-Term Debt", "documentation": "The cash inflow from an obligation which places a lender in a lien position behind debt having a higher priority of repayment (senior loan) in liquidation of the entity's assets scheduled to be repaid within one year or in the normal operating cycle of the entity, if longer." } } }, "auth_ref": [ "r15" ] }, "vsee_ProceedsFromSubscriptionsOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ProceedsFromSubscriptionsOfCommonStock", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee subscription of shares in cash", "documentation": "The amount of cash inflow received for common stock subscriptions during the period.", "label": "Proceeds From Subscriptions Of Common Stock" } } }, "auth_ref": [] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "ProductOrServiceAxis", "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "auth_ref": [ "r258", "r758", "r839", "r840", "r841", "r842", "r843", "r844", "r845", "r989", "r997", "r1000", "r1002", "r1030", "r1032", "r1120", "r1123", "r1124", "r1128", "r1131", "r1288", "r1319", "r1320", "r1321", "r1322", "r1323", "r1324", "r1325", "r1326", "r1327", "r1328", "r1329", "r1330", "r1331", "r1332", "r1333", "r1334", "r1335", "r1336", "r1337", "r1338", "r1339", "r1340", "r1341", "r1342", "r1343", "r1344", "r1345", "r1346", "r1347", "r1348", "r1349", "r1350", "r1351", "r1352", "r1353", "r1354", "r1355", "r1357", "r1358", "r1359", "r1360", "r1425", "r1426", "r1555", "r1556", "r1557", "r1558", "r1559", "r1560", "r1561", "r1562", "r1563", "r1564", "r1565", "r1566", "r1567", "r1568", "r1569", "r1570", "r1571", "r1572", "r1573", "r1574", "r1575", "r1576", "r1577", "r1578", "r1579", "r1580", "r1581", "r1583", "r1584" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "ProductsAndServicesDomain", "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]" } } }, "auth_ref": [ "r258", "r758", "r839", "r840", "r841", "r842", "r843", "r844", "r845", "r989", "r997", "r1000", "r1002", "r1030", "r1032", "r1120", "r1123", "r1124", "r1128", "r1131", "r1288", "r1319", "r1320", "r1321", "r1322", "r1323", "r1324", "r1325", "r1326", "r1327", "r1328", "r1329", "r1330", "r1331", "r1332", "r1333", "r1334", "r1335", "r1336", "r1337", "r1338", "r1339", "r1340", "r1341", "r1342", "r1343", "r1344", "r1345", "r1346", "r1347", "r1348", "r1349", "r1350", "r1351", "r1352", "r1353", "r1354", "r1355", "r1357", "r1358", "r1359", "r1360", "r1425", "r1426", "r1555", "r1556", "r1557", "r1558", "r1559", "r1560", "r1561", "r1562", "r1563", "r1564", "r1565", "r1566", "r1567", "r1568", "r1569", "r1570", "r1571", "r1572", "r1573", "r1574", "r1575", "r1576", "r1577", "r1578", "r1579", "r1580", "r1581", "r1583", "r1584" ] }, "us-gaap_ProfessionalAndContractServicesExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProfessionalAndContractServicesExpense", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consulting expense recognized (in Dollars)", "label": "Professional and Contract Services Expense", "documentation": "Professional and contract service expense includes cost reimbursements for support services related to contracted projects, outsourced management, technical and staff support." } } }, "auth_ref": [] }, "vsee_ProfessionalServicesAndOtherFeesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ProfessionalServicesAndOtherFeesMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable" ], "lang": { "en-us": { "role": { "terseLabel": "Professional services and other fees", "verboseLabel": "Professional services and other fees [Member]", "netLabel": "Professional Services And Other Fees [Member]", "documentation": "Represents fees relating to professional and other services.", "label": "Professional Services And Other Fees Member" } } }, "auth_ref": [] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 }, "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "totalLabel": "Net loss", "terseLabel": "Net loss", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r123", "r130", "r146", "r147", "r161", "r169", "r172", "r173", "r177", "r185", "r193", "r196", "r197", "r298", "r359", "r360", "r362", "r363", "r364", "r365", "r366", "r368", "r369", "r402", "r495", "r544", "r612", "r614", "r617", "r618", "r645", "r677", "r798", "r800", "r822", "r872", "r920", "r941", "r942", "r1093", "r1094", "r1141", "r1316", "r1429" ] }, "vsee_PromissoryNoteAndLineOfCreditRelatingToForbearanceAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PromissoryNoteAndLineOfCreditRelatingToForbearanceAgreementMember", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Promissory Note and Line of Credit Relating to Forbearance Agreement [Member]", "documentation": "Represents information pertaining to promissory note and line of credit relating to forbearance agreement.", "label": "Promissory Note And Line Of Credit Relating To Forbearance Agreement Member" } } }, "auth_ref": [] }, "vsee_PromissoryNoteCommonSharesValue": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PromissoryNoteCommonSharesValue", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Promissory note common shares value", "documentation": "Promissory note common shares value.", "label": "Promissory Note Common Shares Value" } } }, "auth_ref": [] }, "vsee_PromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PromissoryNoteMember", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Promissory Note [Member]", "documentation": "Promissory Note [Member]", "label": "Promissory Note Member" } } }, "auth_ref": [] }, "vsee_PromissoryNoteWithRelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PromissoryNoteWithRelatedPartyMember", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Promissory Note With Related Party [Member]", "documentation": "This member stands for promissory note with related party.", "label": "Promissory Note With Related Party Member" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PropertyPlantAndEquipmentAbstract", "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://vseehealth.com/role/FixedAssetsDetails", "http://vseehealth.com/role/LeasesDetails", "http://vseehealth.com/role/ScheduleofComponentsofFixedAssetsTable", "http://vseehealth.com/role/ScheduleofFixedAssetsareDepreciatedUsingtheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r5", "r706" ] }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "presentation": [ "http://vseehealth.com/role/FixedAssets" ], "lang": { "en-us": { "role": { "terseLabel": "Fixed Assets", "label": "Property, Plant and Equipment Disclosure [Text Block]", "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r81", "r113", "r114", "r115" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofComponentsofFixedAssetsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Fixed Assets, gross", "label": "Property, Plant and Equipment, Gross", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r82", "r134", "r820" ] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://vseehealth.com/role/FixedAssetsDetails", "http://vseehealth.com/role/ScheduleofComponentsofFixedAssetsTable" ], "lang": { "en-us": { "role": { "label": "Fixed Assets", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r706" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ScheduleofComponentsofFixedAssetsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Fixed assets, net", "label": "Property, Plant and Equipment, Net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r5", "r706", "r803", "r820", "r1110" ] }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Fixed Assets", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r5", "r113", "r114", "r818" ] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://vseehealth.com/role/FixedAssetsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Components of Fixed Assets", "label": "Property, Plant and Equipment [Table Text Block]", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r5" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://vseehealth.com/role/FixedAssetsDetails", "http://vseehealth.com/role/LeasesDetails", "http://vseehealth.com/role/ScheduleofComponentsofFixedAssetsTable", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Domain]", "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r82", "r706" ] }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "PropertyPlantAndEquipmentUsefulLife", "presentation": [ "http://vseehealth.com/role/ScheduleofFixedAssetsareDepreciatedUsingtheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Estimated useful lives of fixed assets", "verboseLabel": "Useful life", "label": "Property, Plant and Equipment, Useful Life", "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment." } } }, "auth_ref": [] }, "us-gaap_ProvisionForDoubtfulAccounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ProvisionForDoubtfulAccounts", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofAllowanceforCreditLossesTable", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Add: Provision for credit losses", "verboseLabel": "Provision for credit losses", "label": "Accounts Receivable, Credit Loss Expense (Reversal)", "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable." } } }, "auth_ref": [ "r154", "r157", "r305" ] }, "vsee_PublicAndPrivateWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PublicAndPrivateWarrantsMember", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Public And Private Warrants [Member]", "documentation": "Represents the information pertaining to public and private warrants.", "label": "Public And Private Warrants Member" } } }, "auth_ref": [] }, "vsee_PublicStockholdersMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PublicStockholdersMember", "presentation": [ "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Public Stockholders [Member]", "documentation": "Represents information pertaining to public stockholders.", "label": "Public Stockholders Member" } } }, "auth_ref": [] }, "vsee_PublicWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PublicWarrantsMember", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable", "http://vseehealth.com/role/ScheduleofWarrantsIssuedandoutstandingTable", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Public Warrants [Member]", "verboseLabel": "Public [Member]", "documentation": "Represents the information pertaining to public warrants.", "label": "Public Warrants Member" } } }, "auth_ref": [] }, "vsee_PurchaseAgreementForTelepresenceRobotsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PurchaseAgreementForTelepresenceRobotsMember", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase Agreement for Telepresence Robots [Member]", "documentation": "Represents information relating to purchase of Telepresence Robots.", "label": "Purchase Agreement For Telepresence Robots Member" } } }, "auth_ref": [] }, "vsee_PurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PurchaseAgreementMember", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase Agreement [Member]", "label": "Purchase Agreement Member" } } }, "auth_ref": [] }, "vsee_PurchaseAgreementPeriod": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PurchaseAgreementPeriod", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase agreement period", "documentation": "Purchase agreement period.", "label": "Purchase Agreement Period" } } }, "auth_ref": [] }, "vsee_PurchaseCommitmentAdjustmentsAndPaymentsMade": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PurchaseCommitmentAdjustmentsAndPaymentsMade", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase commitment amount, payments made", "documentation": "The amount of adjustments and payments made to the purchase commitment.", "label": "Purchase Commitment Adjustments And Payments Made" } } }, "auth_ref": [] }, "vsee_PurchasePricePerPrivatePlacementWarrants": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "PurchasePricePerPrivatePlacementWarrants", "presentation": [ "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Purchase price per private placement warrants (in Dollars per share)", "documentation": "Purchase price per private placement warrants.", "label": "Purchase Price Per Private Placement Warrants" } } }, "auth_ref": [] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]", "terseLabel": "Pay vs Performance Disclosure" } } }, "auth_ref": [ "r1208" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance [Table Text Block]", "terseLabel": "Pay vs Performance Disclosure, Table" } } }, "auth_ref": [ "r1208" ] }, "vsee_QuantumConvertibleNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "QuantumConvertibleNoteMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Quantum Convertible Note", "verboseLabel": "Quantum Convertible Note [Member]", "label": "Quantum Convertible Note Member" } } }, "auth_ref": [] }, "vsee_QuantumConvertibleNoteRelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "QuantumConvertibleNoteRelatedPartyMember", "presentation": [ "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable" ], "lang": { "en-us": { "role": { "terseLabel": "Quantum Convertible Note, related party [Member]", "verboseLabel": "Quantum Convertible Note, Related Party [Member]", "label": "Quantum Convertible Note Related Party Member" } } }, "auth_ref": [] }, "vsee_QuantumInvestorMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "QuantumInvestorMember", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Quantum Investor [Member]", "documentation": "Represents information related to Quantum Investor.", "label": "Quantum Investor Member" } } }, "auth_ref": [] }, "vsee_QuantumNoteConversionMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "QuantumNoteConversionMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Quantum Note Conversion", "label": "Quantum Note Conversion Member" } } }, "auth_ref": [] }, "vsee_QuantumNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "QuantumNoteMember", "presentation": [ "http://vseehealth.com/role/FairValueMeasurementsTables", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofKeyInputsTable", "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable" ], "lang": { "en-us": { "role": { "terseLabel": "Quantum Note [Member]", "verboseLabel": "Quantum Convertible Note [Member]", "documentation": "Represents information related to Quantum Note.", "label": "Quantum Note Member" } } }, "auth_ref": [] }, "vsee_QuantumNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "QuantumNotesMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Quantum Convertible Note, related party at fair value", "verboseLabel": "Quantum Convertible Note [Member]", "documentation": "Represents information pertaining to quantum note.", "label": "Quantum Notes Member" } } }, "auth_ref": [] }, "vsee_QuantumPromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "QuantumPromissoryNoteMember", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Quantum Promissory Note [Member]", "label": "Quantum Promissory Note Member" } } }, "auth_ref": [] }, "vsee_QuantumPromissoryPrincipalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "QuantumPromissoryPrincipalAmount", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Principal amount (in Dollars)", "documentation": "The amount of quantum Promissory note consisting principal amount.", "label": "Quantum Promissory Principal Amount" } } }, "auth_ref": [] }, "vsee_QuantumPurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "QuantumPurchaseAgreementMember", "presentation": [ "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Quantum Purchase Agreement [Member]", "documentation": "Represents the information pertaining to quantum purchase agreement.", "label": "Quantum Purchase Agreement Member" } } }, "auth_ref": [] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "RangeAxis", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/CommitmentsandContingenciesDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofFixedAssetsareDepreciatedUsingtheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable", "http://vseehealth.com/role/ScheduleofKeyAssumptionsUsedinValuingUnvestedOptionsTable", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r219", "r353", "r354", "r355", "r356", "r449", "r461", "r489", "r490", "r491", "r494", "r506", "r651", "r727", "r736", "r753", "r846", "r847", "r853", "r890", "r891", "r951", "r953", "r955", "r956", "r958", "r968", "r969", "r971", "r972", "r984", "r985", "r1020", "r1029", "r1046", "r1049", "r1056", "r1059", "r1100", "r1101", "r1105", "r1106", "r1123", "r1134", "r1424", "r1433", "r1517", "r1545", "r1546", "r1547", "r1548", "r1549" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "RangeMember", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/CommitmentsandContingenciesDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofKeyAssumptionsUsedinValuingUnvestedOptionsTable", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "auth_ref": [ "r219", "r353", "r354", "r355", "r356", "r449", "r461", "r489", "r490", "r491", "r494", "r506", "r651", "r727", "r736", "r753", "r846", "r847", "r853", "r890", "r891", "r951", "r953", "r955", "r956", "r958", "r968", "r969", "r971", "r972", "r984", "r985", "r1020", "r1029", "r1046", "r1049", "r1056", "r1059", "r1100", "r1101", "r1105", "r1106", "r1123", "r1134", "r1424", "r1433", "r1517", "r1545", "r1546", "r1547", "r1548", "r1549" ] }, "vsee_ReceivablesCreditLossExpenseReversal": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ReceivablesCreditLossExpenseReversal", "crdr": "debit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Allowance for expected credit losses", "documentation": "Amount of expense (reversal of expense) for expected credit loss on receivables.", "label": "Receivables Credit Loss Expense Reversal" } } }, "auth_ref": [] }, "us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ReconciliationOfAssetsFromSegmentToConsolidatedTable", "presentation": [ "http://vseehealth.com/role/ScheduleofTotalAssetsbySegmentTable" ], "lang": { "en-us": { "role": { "label": "Reconciliation of Assets from Segment to Consolidated [Table]", "documentation": "Disclosure of information about identification, description, and amounts of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets." } } }, "auth_ref": [ "r28", "r29" ] }, "us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock", "presentation": [ "http://vseehealth.com/role/ReportablesegmentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Total Assets by Segment", "label": "Reconciliation of Assets from Segment to Consolidated [Table Text Block]", "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets." } } }, "auth_ref": [ "r28", "r29" ] }, "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTable", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable" ], "lang": { "en-us": { "role": { "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]", "documentation": "Disclosure of information about the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment." } } }, "auth_ref": [ "r27", "r29" ] }, "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock", "presentation": [ "http://vseehealth.com/role/ReportablesegmentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Reconciliation of Consolidated Segment", "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]", "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment." } } }, "auth_ref": [ "r27", "r29" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]", "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure" } } }, "auth_ref": [ "r1167", "r1178", "r1194", "r1229" ] }, "dei_RegistrationStatementAmendmentNumber": { "xbrltype": "sequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "RegistrationStatementAmendmentNumber", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Registration Statement Amendment Number", "documentation": "Amendment number to registration statement under the Investment Company Act of 1940." } } }, "auth_ref": [ "r1144" ] }, "vsee_RelatedPartyAgreementExtensionTerm": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "RelatedPartyAgreementExtensionTerm", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Extension term", "documentation": "Term of the extension of the agreement with related party.", "label": "Related Party Agreement Extension Term" } } }, "auth_ref": [] }, "vsee_RelatedPartyAgreementTerm": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "RelatedPartyAgreementTerm", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Agreement term", "documentation": "Term of the agreement with related party.", "label": "Related Party Agreement Term" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RelatedPartyDomain", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails", "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "label": "Related and Nonrelated Parties [Domain]", "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest." } } }, "auth_ref": [ "r169", "r176", "r177", "r263", "r456", "r460", "r712", "r713", "r810", "r817", "r893", "r894", "r895", "r896", "r897", "r918", "r950", "r1588" ] }, "us-gaap_RelatedPartyMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RelatedPartyMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Notes payable, net of discount", "verboseLabel": "Related Party [Member]", "label": "Related Party [Member]", "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family." } } }, "auth_ref": [ "r169", "r176", "r177", "r712", "r713", "r714", "r715", "r810", "r817", "r893", "r894", "r895", "r896", "r897", "r918", "r950" ] }, "vsee_RelatedPartyPromissoryNoteOneMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "RelatedPartyPromissoryNoteOneMember", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party Promissory Note One [Member]", "documentation": "Represents information pertaining to Related party promissory note one.", "label": "Related Party Promissory Note One Member" } } }, "auth_ref": [] }, "vsee_RelatedPartyPromissoryNoteThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "RelatedPartyPromissoryNoteThreeMember", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party Promissory Note Three [Member]", "documentation": "Represents information pertaining to Related party promissory note three.", "label": "Related Party Promissory Note Three Member" } } }, "auth_ref": [] }, "vsee_RelatedPartyPromissoryNoteTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "RelatedPartyPromissoryNoteTwoMember", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party Promissory Note Two [Member]", "documentation": "Represents information pertaining to Related party promissory note two.", "label": "Related Party Promissory Note Two Member" } } }, "auth_ref": [] }, "vsee_RelatedPartyTransactionAmountsOfTransactionPerMonth": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "RelatedPartyTransactionAmountsOfTransactionPerMonth", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expense per month", "documentation": "Amount of transactions with related party per month during the financial reporting period.", "label": "Related Party Transaction Amounts Of Transaction Per Month" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RelatedPartyTransactionAxis", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Axis]", "documentation": "Information by type of related party transaction." } } }, "auth_ref": [ "r169", "r176", "r177", "r712", "r713", "r1540" ] }, "us-gaap_RelatedPartyTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RelatedPartyTransactionDomain", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Domain]", "documentation": "Transaction between related party." } } }, "auth_ref": [ "r169", "r176", "r177", "r1540" ] }, "us-gaap_RelatedPartyTransactionLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RelatedPartyTransactionLineItems", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r169", "r176", "r177", "r263", "r712", "r713", "r715", "r924", "r925", "r928" ] }, "us-gaap_RelatedPartyTransactionRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RelatedPartyTransactionRate", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest rate", "label": "Related Party Transaction, Rate", "documentation": "Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties." } } }, "auth_ref": [ "r1536" ] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails", "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofAllocationofTotalPurchaseConsiderationTable" ], "lang": { "en-us": { "role": { "label": "Related and Nonrelated Parties [Axis]", "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest." } } }, "auth_ref": [ "r169", "r176", "r177", "r263", "r456", "r460", "r712", "r713", "r810", "r817", "r893", "r894", "r895", "r896", "r897", "r918", "r950", "r1540", "r1588" ] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://vseehealth.com/role/RelatedParty" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party", "label": "Related Party Transactions Disclosure [Text Block]", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r709", "r710", "r711", "r713", "r716", "r868", "r869", "r870", "r926", "r927", "r928", "r947", "r949" ] }, "vsee_RepaymentOnAdditionalBridgeFinancing": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "RepaymentOnAdditionalBridgeFinancing", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayment on Additional Bridge Financing", "documentation": "Repayment on additional bridge financing.", "label": "Repayment On Additional Bridge Financing" } } }, "auth_ref": [] }, "vsee_RepaymentOnExtensionNote": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "RepaymentOnExtensionNote", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayment on Extension Note", "documentation": "The represent value of repayment on extension note.", "label": "Repayment On Extension Note" } } }, "auth_ref": [] }, "vsee_RepaymentOnFactoringPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "RepaymentOnFactoringPayable", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 13.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Payments on factoring payable", "documentation": "The amount of cash outflow to settle factoring payable during the year.", "label": "Repayment On Factoring Payable" } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RepaymentsOfNotesPayable", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayment of notes payable", "label": "Repayments of Notes Payable", "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation." } } }, "auth_ref": [ "r76" ] }, "vsee_RepaymentsOfNotesPayablePrincipalPortion": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "RepaymentsOfNotesPayablePrincipalPortion", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Repayments of notes payable, principal portion", "documentation": "The cash outflow for the principal portion of a borrowing supported by a written promise to pay an obligation.", "label": "Repayments Of Notes Payable Principal Portion" } } }, "auth_ref": [] }, "vsee_RepaymentsOfNotesPayables": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "RepaymentsOfNotesPayables", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Repayments of notes payable", "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.", "label": "Repayments Of Notes Payables" } } }, "auth_ref": [] }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RepaymentsOfRelatedPartyDebt", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayment on advances of related party", "terseLabel": "Advances repaid", "label": "Repayments of Related Party Debt", "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates." } } }, "auth_ref": [ "r76" ] }, "us-gaap_RepaymentsOfSecuredDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RepaymentsOfSecuredDebt", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate purchase price", "label": "Repayments of Secured Debt", "documentation": "The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt." } } }, "auth_ref": [ "r76" ] }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "RepurchaseAgreementCounterpartyNameDomain", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofCommonStockBusinessCombinationTable", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable_Parentheticals", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]" } } }, "auth_ref": [ "r169", "r178", "r179", "r374", "r419", "r715", "r737", "r807", "r993", "r994", "r995", "r1307", "r1308", "r1309", "r1310", "r1311", "r1312", "r1313", "r1314", "r1315", "r1507", "r1508", "r1509", "r1510" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]", "terseLabel": "Restatement Determination Date:" } } }, "auth_ref": [ "r1168", "r1179", "r1195", "r1230" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date", "terseLabel": "Restatement Determination Date" } } }, "auth_ref": [ "r1169", "r1180", "r1196", "r1231" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Does Not Require Recovery [Text Block]", "terseLabel": "Restatement does not require Recovery" } } }, "auth_ref": [ "r1176", "r1187", "r1203", "r1238" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated deficit", "verboseLabel": "Accumulated deficit (in Dollars)", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r60", "r89", "r815", "r851", "r852", "r866", "r901", "r1110" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RetainedEarningsMember", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Deficit", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r120", "r122", "r123", "r182", "r183", "r184", "r186", "r193", "r195", "r197", "r299", "r300", "r344", "r401", "r495", "r532", "r533", "r541", "r542", "r543", "r545", "r611", "r612", "r631", "r633", "r634", "r636", "r643", "r689", "r691", "r848", "r850", "r873", "r1592" ] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedIncomeStatement": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable" ], "lang": { "en-us": { "role": { "terseLabel": "Total revenues", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r104", "r105", "r210", "r225", "r226", "r248", "r254", "r258", "r260", "r262", "r445", "r446", "r447", "r758", "r998", "r1002" ] }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue Recognition", "label": "Revenue from Contract with Customer [Policy Text Block]", "documentation": "Disclosure of accounting policy for revenue from contract with customer." } } }, "auth_ref": [ "r118", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444", "r987" ] }, "vsee_RevenueRecognitionNoticePeriodForCancelationOfContract": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "RevenueRecognitionNoticePeriodForCancelationOfContract", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Notice period for cancelation of contract", "documentation": "Period within which notice is required for cancellation of contract with customers for generation of revenue.", "label": "Revenue Recognition Notice Period For Cancelation Of Contract" } } }, "auth_ref": [] }, "vsee_RevenueRecognitionTermOfContract": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "RevenueRecognitionTermOfContract", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term of contract", "documentation": "Term of the contract for revenues generated by the company.", "label": "Revenue Recognition Term Of Contract" } } }, "auth_ref": [] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "Revenues", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ScheduleofDisaggregatedRevenuebyTimingofRevenueRecognitionTable" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue", "label": "Revenues", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r104", "r105", "r152", "r169", "r172", "r173", "r210", "r225", "r226", "r248", "r254", "r258", "r260", "r262", "r298", "r359", "r360", "r362", "r363", "r364", "r365", "r366", "r368", "r369", "r677", "r798", "r800", "r1014", "r1095", "r1129", "r1130", "r1429" ] }, "us-gaap_RevenuesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RevenuesAbstract", "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Revenues", "label": "Revenues [Abstract]" } } }, "auth_ref": [] }, "vsee_RevenuesAbstract0": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "RevenuesAbstract0", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable" ], "lang": { "en-us": { "role": { "terseLabel": "Revenues:", "label": "Revenues Abstract0" } } }, "auth_ref": [] }, "us-gaap_RevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "RevolvingCreditFacilityMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "Loan payable, related party, net of discount", "verboseLabel": "Line of credit", "label": "Revolving Credit Facility [Member]", "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount." } } }, "auth_ref": [] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r1247" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated [Flag]", "terseLabel": "Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r1247" ] }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SaleOfStockNameOfTransactionDomain", "presentation": [ "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Domain]", "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "presentation": [ "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate shares of common stock (in Shares)", "label": "Sale of Stock, Number of Shares Issued in Transaction", "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SaleOfStockPricePerShare", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Par value per share (in Dollars per share)", "verboseLabel": "Pre-funded warrants exercisable for per share (in Dollars per share)", "label": "Sale of Stock, Price Per Share", "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction." } } }, "auth_ref": [] }, "us-gaap_SalesAndExciseTaxPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SalesAndExciseTaxPayableCurrent", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Excise tax payable", "label": "Sales and Excise Tax Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r46" ] }, "us-gaap_SalesAndExciseTaxPayableCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SalesAndExciseTaxPayableCurrentAndNoncurrent", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable": { "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://vseehealth.com/role/ScheduleofAccountsPayableandAccruedLiabilitiesTable" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued sales and use tax", "label": "Sales and Excise Tax Payable", "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax." } } }, "auth_ref": [ "r97" ] }, "srt_ScenarioUnspecifiedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "ScenarioUnspecifiedDomain", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://vseehealth.com/role/LeasesDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]" } } }, "auth_ref": [ "r126", "r128", "r198", "r462", "r1279" ] }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "presentation": [ "http://vseehealth.com/role/AccountsPayableandAccruedLiabilitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Accounts Payable and Accrued Liabilities", "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]", "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses." } } }, "auth_ref": [] }, "vsee_ScheduleOfAllocationOfTotalPurchaseConsiderationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ScheduleOfAllocationOfTotalPurchaseConsiderationAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Allocation Of Total Purchase Consideration Abstract" } } }, "auth_ref": [] }, "vsee_ScheduleOfAllowanceForCreditLossesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ScheduleOfAllowanceForCreditLossesAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Allowance For Credit Losses Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTextBlock", "presentation": [ "http://vseehealth.com/role/BusinessCombinationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Purchase Consideration", "label": "Business Combination, Consideration Transferred, Equity Interest [Table Text Block]", "documentation": "Tabular disclosure of equity interest issued or issuable by acquirer as part of consideration transferred in business combination." } } }, "auth_ref": [ "r1498", "r1499" ] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "presentation": [ "http://vseehealth.com/role/BusinessCombinationTables", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable_Parentheticals" ], "lang": { "en-us": { "role": { "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "documentation": "Disclosure of information about business combination. Includes, but is not limited to, recognized asset and liability." } } }, "auth_ref": [ "r327", "r549", "r550", "r551", "r552", "r558", "r559", "r560", "r561", "r567", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r585", "r586", "r587", "r588", "r589", "r592", "r593", "r594", "r595", "r596", "r597", "r603", "r604", "r605", "r609", "r1049", "r1059", "r1488", "r1493", "r1495" ] }, "vsee_ScheduleOfChangesInTheFairValueOfFinancialLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ScheduleOfChangesInTheFairValueOfFinancialLiabilitiesAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Changes In The Fair Value Of Financial Liabilities Abstract" } } }, "auth_ref": [] }, "vsee_ScheduleOfCommonStockBusinessCombinationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ScheduleOfCommonStockBusinessCombinationAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Common Stock Business Combination Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "presentation": [ "http://vseehealth.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Income Tax Provision", "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]", "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years." } } }, "auth_ref": [ "r1479" ] }, "us-gaap_ScheduleOfDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfDebtTableTextBlock", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Line of Credit and Notes Payable, Net of Discount", "label": "Schedule of Debt [Table Text Block]", "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation." } } }, "auth_ref": [] }, "vsee_ScheduleOfDeferredRevenueActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ScheduleOfDeferredRevenueActivitiesAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Deferred Revenue Activities Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "presentation": [ "http://vseehealth.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Deferred Tax Assets and Liabilities", "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]", "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets." } } }, "auth_ref": [ "r1476" ] }, "vsee_ScheduleOfDisaggregatedRevenueByTimingOfRevenueRecognitionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ScheduleOfDisaggregatedRevenueByTimingOfRevenueRecognitionAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Disaggregated Revenue By Timing Of Revenue Recognition Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Net Loss Per Common Share", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r1380" ] }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "presentation": [ "http://vseehealth.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Reconciliation of Federal Income Tax Rate to Company's Effective Tax Rate", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r515", "r1048", "r1473" ] }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]" } } }, "auth_ref": [ "r295", "r296", "r297", "r540", "r677", "r1280", "r1281", "r1282", "r1482", "r1483", "r1484", "r1485" ] }, "vsee_ScheduleOfExpensesIncurredForOperatingLeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ScheduleOfExpensesIncurredForOperatingLeasesAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Expenses Incurred For Operating Leases Abstract" } } }, "auth_ref": [] }, "vsee_ScheduleOfFinanceLeaseLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ScheduleOfFinanceLeaseLiabilitiesAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Finance Lease Liabilities Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "presentation": [ "http://vseehealth.com/role/ScheduleofIdentifiableIntangibleAssetsSubjecttoAmortizationTable" ], "lang": { "en-us": { "role": { "label": "Intangible Asset, Finite-Lived [Table]", "documentation": "Disclosure of information about finite-lived intangible asset. Excludes indefinite-lived intangible asset." } } }, "auth_ref": [ "r329", "r336", "r340", "r341", "r343", "r759", "r986", "r991", "r1062", "r1063", "r1064", "r1065", "r1066", "r1067", "r1068", "r1069", "r1070", "r1071", "r1072", "r1073", "r1074", "r1075", "r1076", "r1077", "r1078", "r1079", "r1080", "r1081", "r1082", "r1083", "r1084", "r1085", "r1086", "r1087", "r1088" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Identifiable Intangible Assets Subject to Amortization", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment." } } }, "auth_ref": [ "r991", "r1414" ] }, "vsee_ScheduleOfFixedAssetsAreDepreciatedUsingTheStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssets": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ScheduleOfFixedAssetsAreDepreciatedUsingTheStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssets", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Fixed Assets are Depreciated Using the Straight-Line Method Over the Estimated Useful Lives of the Assets", "documentation": "Tabular disclosure of fixed assets are depreciated using the straight-line method over the estimated useful lives of the assets.", "label": "Schedule Of Fixed Assets Are Depreciated Using The Straight Line Method Over The Estimated Useful Lives Of The Assets" } } }, "auth_ref": [] }, "vsee_ScheduleOfFixedAssetsAreDepreciatedUsingTheStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ScheduleOfFixedAssetsAreDepreciatedUsingTheStraightLineMethodOverTheEstimatedUsefulLivesOfTheAssetsAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Fixed Assets Are Depreciated Using The Straight Line Method Over The Estimated Useful Lives Of The Assets Abstract" } } }, "auth_ref": [] }, "vsee_ScheduleOfFutureMinimumPaymentsUnderFinanceLeaseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ScheduleOfFutureMinimumPaymentsUnderFinanceLeaseAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Future Minimum Payments Under Finance Lease Abstract" } } }, "auth_ref": [] }, "vsee_ScheduleOfFutureMinimumRentPaymentsUnderTheOperatingLeaseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ScheduleOfFutureMinimumRentPaymentsUnderTheOperatingLeaseAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Future Minimum Rent Payments Under The Operating Lease Abstract" } } }, "auth_ref": [] }, "vsee_ScheduleOfIdentifiableIntangibleAssetsSubjectToAmortizationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ScheduleOfIdentifiableIntangibleAssetsSubjectToAmortizationAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Identifiable Intangible Assets Subject To Amortization Abstract" } } }, "auth_ref": [] }, "vsee_ScheduleOfKeyAssumptionsUsedInValuingUnvestedOptionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ScheduleOfKeyAssumptionsUsedInValuingUnvestedOptionsAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Key Assumptions Used In Valuing Unvested Options Abstract" } } }, "auth_ref": [] }, "vsee_ScheduleOfKeyInputsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ScheduleOfKeyInputsAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Key Inputs Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Required Principal Payments", "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]", "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt." } } }, "auth_ref": [ "r6" ] }, "vsee_ScheduleOfNetLossPerCommonShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ScheduleOfNetLossPerCommonShareAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Net Loss Per Common Share Abstract" } } }, "auth_ref": [] }, "vsee_ScheduleOfNumberOfCommonStockOutstandingAfterBusinessCombinationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ScheduleOfNumberOfCommonStockOutstandingAfterBusinessCombinationTableTextBlock", "presentation": [ "http://vseehealth.com/role/BusinessCombinationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Common Stock Business Combination", "documentation": "Tabular disclosure of common stock outstanding following the consummation of business combination.", "label": "Schedule Of Number Of Common Stock Outstanding After Business Combination Table Text Block" } } }, "auth_ref": [] }, "vsee_ScheduleOfProFormaFinancialInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ScheduleOfProFormaFinancialInformationAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Pro Forma Financial Information Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://vseehealth.com/role/FixedAssetsDetails", "http://vseehealth.com/role/ScheduleofComponentsofFixedAssetsTable" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r5", "r706" ] }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "presentation": [ "http://vseehealth.com/role/BusinessCombinationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Allocation of Total Purchase Consideration", "label": "Business Combination, Recognized Asset Acquired and Liability Assumed [Table Text Block]", "documentation": "Tabular disclosure of asset acquired and liability assumed in business combination and recognized at acquisition date." } } }, "auth_ref": [ "r1494", "r1496" ] }, "vsee_ScheduleOfReconciliationOfConsolidatedSegmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ScheduleOfReconciliationOfConsolidatedSegmentAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Reconciliation Of Consolidated Segment Abstract" } } }, "auth_ref": [] }, "vsee_ScheduleOfReconciliationOfFederalIncomeTaxRateToCompanysEffectiveTaxRateAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ScheduleOfReconciliationOfFederalIncomeTaxRateToCompanysEffectiveTaxRateAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Reconciliation Of Federal Income Tax Rate To Companys Effective Tax Rate Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Table]", "documentation": "Disclosure of information about related party transaction." } } }, "auth_ref": [ "r169", "r176", "r177", "r712", "r713", "r715", "r924", "r925", "r928" ] }, "vsee_ScheduleOfReportableSegmentDepreciationAndAmortizationAndCapitalExpendituresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ScheduleOfReportableSegmentDepreciationAndAmortizationAndCapitalExpendituresAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Reportable Segment Depreciation And Amortization And Capital Expenditures Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "presentation": [ "http://vseehealth.com/role/ScheduleofReportableSegmentDepreciationandAmortizationandCapitalExpendituresTable" ], "lang": { "en-us": { "role": { "label": "Schedule of Segment Reporting Information, by Segment [Table]", "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment." } } }, "auth_ref": [ "r24", "r25", "r26" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://vseehealth.com/role/ReportablesegmentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Reportable Segment Depreciation and Amortization and Capital Expenditures", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r24", "r25", "r26" ] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://vseehealth.com/role/EquityTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Stock Options", "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]", "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value." } } }, "auth_ref": [ "r8", "r9", "r91" ] }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "presentation": [ "http://vseehealth.com/role/EquityTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Key Assumptions Used in Valuing Unvested Options", "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions." } } }, "auth_ref": [ "r92" ] }, "vsee_ScheduleOfStockOptionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ScheduleOfStockOptionsAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Stock Options Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "presentation": [ "http://vseehealth.com/role/WarrantsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Warrants Issued and outstanding", "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]", "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable." } } }, "auth_ref": [ "r1439" ] }, "vsee_ScheduleOfTheRecapitalizationAndNetEquityImpactOnBusinessCombinationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ScheduleOfTheRecapitalizationAndNetEquityImpactOnBusinessCombinationAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of The Recapitalization And Net Equity Impact On Business Combination Abstract" } } }, "auth_ref": [] }, "vsee_ScheduleOfTotalAssetsBySegmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ScheduleOfTotalAssetsBySegmentAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Total Assets By Segment Abstract" } } }, "auth_ref": [] }, "vsee_ScheduleOfWarrantsIssuedAndOutstandingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ScheduleOfWarrantsIssuedAndOutstandingAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Warrants Issued And Outstanding Abstract" } } }, "auth_ref": [] }, "vsee_ScheduleOfWeightedAverageRemainingLeaseTermAndDiscountRateOnFinanceLeasesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ScheduleOfWeightedAverageRemainingLeaseTermAndDiscountRateOnFinanceLeasesAbstract", "lang": { "en-us": { "role": { "label": "Schedule Of Weighted Average Remaining Lease Term And Discount Rate On Finance Leases Abstract" } } }, "auth_ref": [] }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Expected Amortization Expense", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets." } } }, "auth_ref": [ "r991", "r1416" ] }, "vsee_ScsCapitalPartnersLlcMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ScsCapitalPartnersLlcMember", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "SCS Capital Partners LLC [Member]", "documentation": "Represents the information pertaining to SCS Capital Partners LLC .", "label": "Scs Capital Partners Llc Member" } } }, "auth_ref": [] }, "vsee_SecuredPromissoryNoteIssuedOnMarch202025Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "SecuredPromissoryNoteIssuedOnMarch202025Member", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "March 2025 Promissory Note [Member]", "documentation": "Represents information related to secured promissory note issued March 20, 2025.", "label": "Secured Promissory Note Issued On March202025 Member" } } }, "auth_ref": [] }, "vsee_SecuritiesSoldCombinedPurchasePrice": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "SecuritiesSoldCombinedPurchasePrice", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Securities sold combined purchase price (in Dollars per share)", "documentation": "Securities sold combined purchase price.", "label": "Securities Sold Combined Purchase Price" } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "Security12bTitle", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1145" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "Security12gTitle", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r1149" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "SecurityExchangeName", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r1148" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "SecurityReportingObligation", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r1154" ] }, "us-gaap_SegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SegmentDomain", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable", "http://vseehealth.com/role/ScheduleofReportableSegmentDepreciationandAmortizationandCapitalExpendituresTable", "http://vseehealth.com/role/ScheduleofTotalAssetsbySegmentTable" ], "lang": { "en-us": { "role": { "label": "Segments [Domain]", "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r104", "r105", "r106", "r107", "r210", "r221", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r235", "r236", "r238", "r239", "r240", "r248", "r249", "r250", "r251", "r252", "r254", "r255", "r256", "r262", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r343", "r351", "r352", "r602", "r605", "r828", "r829", "r830", "r831", "r832", "r833", "r834", "r835", "r836", "r837", "r838", "r1011", "r1014", "r1015", "r1022", "r1126", "r1555", "r1556", "r1557", "r1558", "r1559", "r1560", "r1561", "r1562", "r1563", "r1564", "r1565", "r1566", "r1567", "r1568", "r1569", "r1570", "r1571", "r1572", "r1573", "r1574", "r1575", "r1576", "r1577", "r1578", "r1579", "r1580", "r1581", "r1583", "r1584" ] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "SegmentGeographicalDomain", "presentation": [ "http://vseehealth.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]" } } }, "auth_ref": [ "r216", "r260", "r261", "r761", "r762", "r763", "r764", "r765", "r766", "r767", "r768", "r769", "r770", "r771", "r772", "r773", "r774", "r775", "r776", "r777", "r778", "r779", "r780", "r781", "r782", "r783", "r784", "r785", "r786", "r787", "r788", "r789", "r790", "r791", "r792", "r793", "r794", "r798", "r799", "r800", "r801", "r887", "r888", "r889", "r952", "r954", "r957", "r959", "r968", "r970", "r971", "r972", "r974", "r975", "r976", "r977", "r979", "r980", "r981", "r982", "r983", "r990", "r1005", "r1030", "r1033", "r1112", "r1113", "r1114", "r1115", "r1116", "r1117", "r1118", "r1119", "r1125", "r1134", "r1555", "r1556", "r1557", "r1559", "r1560", "r1561", "r1562", "r1563", "r1564", "r1565", "r1566", "r1567", "r1568", "r1569", "r1570", "r1571", "r1572", "r1573", "r1574", "r1575", "r1576", "r1577", "r1578", "r1579", "r1580", "r1581", "r1583", "r1584" ] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingAssetReconcilingItemLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SegmentReportingAssetReconcilingItemLineItems", "presentation": [ "http://vseehealth.com/role/ScheduleofTotalAssetsbySegmentTable" ], "lang": { "en-us": { "role": { "label": "Segment Reporting, Asset Reconciling Item [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://vseehealth.com/role/Reportablesegments" ], "lang": { "en-us": { "role": { "terseLabel": "Reportable segments", "label": "Segment Reporting Disclosure [Text Block]", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r107", "r210", "r220", "r221", "r222", "r223", "r224", "r237", "r239", "r240", "r252", "r253", "r254", "r255", "r256", "r258", "r259", "r262", "r1009", "r1012", "r1013", "r1014", "r1016", "r1018", "r1019" ] }, "us-gaap_SegmentReportingInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SegmentReportingInformationLineItems", "presentation": [ "http://vseehealth.com/role/ScheduleofReportableSegmentDepreciationandAmortizationandCapitalExpendituresTable" ], "lang": { "en-us": { "role": { "label": "Segment Reporting Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SegmentReportingPolicyPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Segments", "label": "Segment Reporting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for segment reporting." } } }, "auth_ref": [ "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r257", "r260", "r1010", "r1011", "r1017" ] }, "us-gaap_SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SegmentReportingReconcilingItemForOperatingProfitLossFromSegmentToConsolidatedLineItems", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable" ], "lang": { "en-us": { "role": { "label": "Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_SeniorNotesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SeniorNotesCurrent", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "ELOC commitment fee note", "label": "Senior Notes, Current", "documentation": "Carrying value as of the balance sheet date of the portion of long-term notes having the highest claim on the assets of the issuer in case of bankruptcy or liquidation, due within one year or the normal operating cycle, if longer. Senior note holders are paid off in full before any payments are made to debt holders having a lesser priority of repayment." } } }, "auth_ref": [ "r48", "r1110" ] }, "vsee_September2024ConvertibleNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "September2024ConvertibleNoteMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/FairValueMeasurementsDetails", "http://vseehealth.com/role/FairValueMeasurementsTables", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable", "http://vseehealth.com/role/ScheduleofFairValueInformationonRecurringBasisTable", "http://vseehealth.com/role/ScheduleofKeyInputsTable4", "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable" ], "lang": { "en-us": { "role": { "terseLabel": "September 2024 Convertible Note, at fair value", "verboseLabel": "September 2024 Convertible Note", "netLabel": "September 2024 Convertible Note [Member]", "documentation": "Information pertaining to September 2024 Convertible Note.", "label": "September2024 Convertible Note Member" } } }, "auth_ref": [] }, "vsee_September2024NoteWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "September2024NoteWarrantsMember", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "September 2024 Warrants [Member]", "documentation": "Information pertaining to September 2024 Note Warrants.", "label": "September2024 Note Warrants Member" } } }, "auth_ref": [] }, "vsee_September2024WarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "September2024WarrantsMember", "presentation": [ "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable", "http://vseehealth.com/role/ScheduleofWarrantsIssuedandoutstandingTable" ], "lang": { "en-us": { "role": { "terseLabel": "September 2024 Warrants [Member]", "verboseLabel": "Septemberb 2024 Warrants [Member]", "documentation": "Represents information pertaining to September 2024 Warrants.", "label": "September2024 Warrants Member" } } }, "auth_ref": [] }, "vsee_September2025PromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "September2025PromissoryNoteMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofLineofCreditandNotesPayableNetofDiscountTable" ], "lang": { "en-us": { "role": { "terseLabel": "September 2025 Promissory Note [Member]", "label": "September2025 Promissory Note Member" } } }, "auth_ref": [] }, "vsee_September302024CompanyAndTheBridgeInvestorMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "September302024CompanyAndTheBridgeInvestorMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "September 30, 2024 Company and the Bridge Investor [Member]", "label": "September302024 Company And The Bridge Investor Member" } } }, "auth_ref": [] }, "vsee_SeptemberNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "SeptemberNotesMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "September Notes [Member]", "label": "September Notes Member" } } }, "auth_ref": [] }, "vsee_SeriesA1PreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "SeriesA1PreferredStockMember", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Series A-1 Preferred Stock [Member]", "documentation": "Represents information pertaining to Series A-1 preferred stock.", "label": "Series A1 Preferred Stock Member" } } }, "auth_ref": [] }, "us-gaap_SeriesAPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SeriesAPreferredStockMember", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable_Parentheticals", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Series A", "verboseLabel": "Series A Preferred Stock [Member]", "label": "Series A Preferred Stock [Member]", "documentation": "Series A preferred stock." } } }, "auth_ref": [ "r1304", "r1305", "r1437", "r1438" ] }, "vsee_ServiceContractsWithHospitalsOrHospitalSystemsPhysicianPracticeGroupsAndOtherUsersMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ServiceContractsWithHospitalsOrHospitalSystemsPhysicianPracticeGroupsAndOtherUsersMember", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Service Contracts With Hospitals Or Hospital Systems, Physician Practice Groups, And Other Users [Member]", "documentation": "Represents information pertaining to service contracts with hospitals or hospital systems, physician practice groups, and other users.", "label": "Service Contracts With Hospitals Or Hospital Systems Physician Practice Groups And Other Users Member" } } }, "auth_ref": [] }, "vsee_SettlementAgreementDescription": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "SettlementAgreementDescription", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Settlement agreement description", "documentation": "Settlement agreement description.", "label": "Settlement Agreement Description" } } }, "auth_ref": [] }, "vsee_SettlementOfEncompassPurchaseLiabilityAggregateAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "SettlementOfEncompassPurchaseLiabilityAggregateAmount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Settlement of encompass purchase liability aggregate amount", "documentation": "Settlement of encompass purchase liability aggregate amount.", "label": "Settlement Of Encompass Purchase Liability Aggregate Amount" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensation", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based payment arrangement, noncash expense (in Dollars)", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r3" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Award requisite service period", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period", "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r1047" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Award vesting period", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period", "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition." } } }, "auth_ref": [ "r1047" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyAssumptionsUsedinValuingUnvestedOptionsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise price", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price", "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award." } } }, "auth_ref": [ "r1463" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyAssumptionsUsedinValuingUnvestedOptionsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Volatility", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [ "r489" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyAssumptionsUsedinValuingUnvestedOptionsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Risk-free rate of return", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [ "r491" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "presentation": [ "http://vseehealth.com/role/ScheduleofStockOptionsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Number of Options, Exercisable", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan." } } }, "auth_ref": [ "r470" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "presentation": [ "http://vseehealth.com/role/ScheduleofStockOptionsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Exercise Price, Exercisable", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan." } } }, "auth_ref": [ "r470" ] }, "vsee_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm", "presentation": [ "http://vseehealth.com/role/ScheduleofStockOptionsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Average Remaining Life In Years, Granted", "documentation": "Weighted average remaining contractual term for option awards granted, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/ScheduleofStockOptionsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Number of Options, Granted", "verboseLabel": "Granted", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r472" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average grant date fair value (in Dollars per share)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology." } } }, "auth_ref": [ "r482" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://vseehealth.com/role/ScheduleofStockOptionsTable" ], "lang": { "en-us": { "role": { "periodStartLabel": "Number of Options, Outstanding, Balance", "periodEndLabel": "Number of Options, Outstanding, Balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r468", "r469" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://vseehealth.com/role/ScheduleofStockOptionsTable" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted Average Exercise Price, Outstanding, Balance", "periodEndLabel": "Weighted Average Exercise Price, Outstanding, Balance", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r468", "r469" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based payment award, shares issued in period", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period", "documentation": "Number of shares issued under share-based payment arrangement." } } }, "auth_ref": [ "r39" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/EquityDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "All Award Types", "terseLabel": "All Award Types", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r464", "r465", "r466", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r488", "r489", "r490", "r491", "r492" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/ScheduleofStockOptionsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Exercise Price, Granted", "verboseLabel": "Granted (in Dollars per share)", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r472" ] }, "us-gaap_ShareBasedCompensationAwardTrancheOneMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationAwardTrancheOneMember", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Payment Arrangement, Tranche One [Member]", "label": "Share-Based Payment Arrangement, Tranche One [Member]", "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period." } } }, "auth_ref": [ "r1442", "r1443", "r1444", "r1445", "r1446", "r1447", "r1448", "r1449", "r1450", "r1451", "r1452", "r1453", "r1454", "r1455", "r1456", "r1457", "r1458", "r1459", "r1460", "r1461", "r1462", "r1464", "r1465", "r1466", "r1467", "r1468" ] }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based Compensation", "label": "Share-Based Payment Arrangement [Policy Text Block]", "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost." } } }, "auth_ref": [ "r463", "r467", "r486", "r487", "r488", "r489", "r492", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504" ] }, "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Supplier [Axis]", "documentation": "Information by supplier." } } }, "auth_ref": [] }, "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Supplier [Domain]", "documentation": "Specific identification or general nature of (for example, a construction contractor, a consulting firm) the party from whom the goods or services were or are to be received." } } }, "auth_ref": [] }, "us-gaap_SharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SharePrice", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyAssumptionsUsedinValuingUnvestedOptionsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Stock price", "label": "Share Price", "documentation": "Price of a single share of a number of saleable stocks of a company." } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based payment award, award vesting rights, percentage", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage", "documentation": "Percentage of vesting of award under share-based payment arrangement." } } }, "auth_ref": [ "r1442" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://vseehealth.com/role/ScheduleofKeyAssumptionsUsedinValuingUnvestedOptionsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Expected term (in years)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r488" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "presentation": [ "http://vseehealth.com/role/ScheduleofStockOptionsTable" ], "lang": { "en-us": { "role": { "terseLabel": "Average Remaining Life In Years, Exercisable", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r39" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Non vested", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares", "documentation": "Number of non-vested options outstanding." } } }, "auth_ref": [ "r1470" ] }, "vsee_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm", "presentation": [ "http://vseehealth.com/role/ScheduleofStockOptionsTable" ], "lang": { "en-us": { "role": { "periodStartLabel": "Average Remaining Life In Years, Outstanding, Balance", "periodEndLabel": "Average Remaining Life In Years, Outstanding, Balance", "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Recapitalization value (in Dollars)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value", "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock." } } }, "auth_ref": [ "r483" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vested", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Number of Shares", "documentation": "Number of options vested." } } }, "auth_ref": [ "r1470" ] }, "vsee_SharesAgreedToBeIssuedPeriod": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "SharesAgreedToBeIssuedPeriod", "presentation": [ "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term for shares to be issued", "documentation": "Duration over which shares agreed to be issued.", "label": "Shares Agreed To Be Issued Period" } } }, "auth_ref": [] }, "vsee_SharesAgreedToBePurchasedMaximumValue": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "SharesAgreedToBePurchasedMaximumValue", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum value of shares agreed to be purchased", "documentation": "The maximum value of shares agreed to be purchased.", "label": "Shares Agreed To Be Purchased Maximum Value" } } }, "auth_ref": [] }, "vsee_SharesAgreedToBePurchasedPeriod": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "SharesAgreedToBePurchasedPeriod", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Period to purchase the shares agreed", "documentation": "Period over which shares agreed to be purchased.", "label": "Shares Agreed To Be Purchased Period" } } }, "auth_ref": [] }, "us-gaap_SharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SharesIssued", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance (in Shares)", "periodEndLabel": "Ending balance (in Shares)", "terseLabel": "Shares issued (in Shares)", "label": "Shares, Issued", "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury." } } }, "auth_ref": [ "r7" ] }, "vsee_SharesIssuedAsPartOfStockGrantsToVendors": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "SharesIssuedAsPartOfStockGrantsToVendors", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued as part of stock grants to vendors", "documentation": "The amount of Noncash Financial of Shares Issued as Part of Stock Grants to Vendors.", "label": "Shares Issued As Part Of Stock Grants To Vendors" } } }, "auth_ref": [] }, "vsee_SharesIssuedAsPaymentForMarch2025PromissoryNote": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "SharesIssuedAsPaymentForMarch2025PromissoryNote", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued as payment for March 2025 promissory Note", "documentation": "Shares issued as payment for March 2025 promissory Note.", "label": "Shares Issued As Payment For March2025 Promissory Note" } } }, "auth_ref": [] }, "vsee_SharesIssuedForPriorServicesOfPlacementAgentShares": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "SharesIssuedForPriorServicesOfPlacementAgentShares", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued to placement agent", "documentation": "Number of shares issued in lieu of cash for prior services of placement agent", "label": "Shares Issued For Prior Services Of Placement Agent Shares" } } }, "auth_ref": [] }, "vsee_SharesIssuedOnConversionOfTheExchangeNote": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "SharesIssuedOnConversionOfTheExchangeNote", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued on conversion of the Exchange Note", "documentation": "The shares issued on conversion of the exchange note.", "label": "Shares Issued On Conversion Of The Exchange Note" } } }, "auth_ref": [] }, "vsee_SharesIssuedUponConversionAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "SharesIssuedUponConversionAmount", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued upon conversion", "documentation": "Shares issued upon conversion.", "label": "Shares Issued Upon Conversion Amount" } } }, "auth_ref": [] }, "vsee_SharesOfCommonStockConversion": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "SharesOfCommonStockConversion", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares of common stock conversion (in Shares)", "documentation": "Shares of common stock conversion.", "label": "Shares Of Common Stock Conversion" } } }, "auth_ref": [] }, "us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Due on share purchase", "label": "Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Current", "documentation": "The amount that is required to be paid, determined under the conditions specified in the contract, if as of the reporting date, the holder of the share has exercised the right to or the shares are mandatorily redeemable within one year of the reporting date or operating cycle, if longer." } } }, "auth_ref": [ "r403", "r1436" ] }, "vsee_SharesToBeIssuedAtInceptionAndLaterForConsultingServicesPerAgreement": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "SharesToBeIssuedAtInceptionAndLaterForConsultingServicesPerAgreement", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Value of shares issued and to be issued under the agreement (in Dollars)", "documentation": "Fair value of shares to be issued, at inception and at later date, as share-based compensation for consulting services.", "label": "Shares To Be Issued At Inception And Later For Consulting Services Per Agreement" } } }, "auth_ref": [] }, "us-gaap_ShortTermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShortTermDebtTypeAxis", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "label": "Short-Term Debt, Type [Axis]", "documentation": "Information by type of short-term debt arrangement." } } }, "auth_ref": [ "r47", "r1421", "r1422", "r1423" ] }, "us-gaap_ShortTermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "ShortTermDebtTypeDomain", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "label": "Short-Term Debt, Type [Domain]", "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing." } } }, "auth_ref": [ "r46", "r1421", "r1422", "r1423" ] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of Significant Accounting Policies", "label": "Significant Accounting Policies [Text Block]", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r167", "r168" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "SolicitingMaterial", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r1152" ] }, "vsee_SponsorAffiliateMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "SponsorAffiliateMember", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sponsor Affiliate [Member]", "documentation": "Represents information related to Sponsor Affiliate.", "label": "Sponsor Affiliate Member" } } }, "auth_ref": [] }, "vsee_SponsorAffiliatesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "SponsorAffiliatesMember", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sponsor Affiliates [Member]", "documentation": "Represent information pertains to Sponsor affiliates.", "label": "Sponsor Affiliates Member" } } }, "auth_ref": [] }, "vsee_SponsorMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "SponsorMember", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sponsor [Member]", "documentation": "Represents information pertaining to sponsor.", "label": "Sponsor Member" } } }, "auth_ref": [] }, "us-gaap_StateAndLocalJurisdictionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StateAndLocalJurisdictionMember", "presentation": [ "http://vseehealth.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "State and Local Jurisdiction [Member]", "label": "State and Local Jurisdiction [Member]", "documentation": "Designated state or local jurisdiction entitled to levy and collect income tax." } } }, "auth_ref": [ "r513" ] }, "us-gaap_StatementBusinessSegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementBusinessSegmentsAxis", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable", "http://vseehealth.com/role/ScheduleofReportableSegmentDepreciationandAmortizationandCapitalExpendituresTable", "http://vseehealth.com/role/ScheduleofTotalAssetsbySegmentTable" ], "lang": { "en-us": { "role": { "label": "Segments [Axis]", "documentation": "Information by business segments." } } }, "auth_ref": [ "r104", "r105", "r106", "r107", "r129", "r210", "r221", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r235", "r236", "r238", "r239", "r240", "r248", "r249", "r250", "r251", "r252", "r254", "r255", "r256", "r262", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r343", "r345", "r351", "r352", "r602", "r605", "r828", "r829", "r830", "r831", "r832", "r833", "r834", "r835", "r836", "r837", "r838", "r1011", "r1014", "r1015", "r1022", "r1126", "r1555", "r1556", "r1557", "r1558", "r1559", "r1560", "r1561", "r1562", "r1563", "r1564", "r1565", "r1566", "r1567", "r1568", "r1569", "r1570", "r1571", "r1572", "r1573", "r1574", "r1575", "r1576", "r1577", "r1578", "r1579", "r1580", "r1581", "r1583", "r1584" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementClassOfStockAxis", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofPurchaseConsiderationTable_Parentheticals", "http://vseehealth.com/role/ShareholdersEquityType2or3", "http://vseehealth.com/role/WarrantsDetails", "http://xbrl.sec.gov/dei/role/document/AuditInformation", "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r119", "r141", "r142", "r143", "r169", "r173", "r201", "r202", "r204", "r206", "r212", "r213", "r298", "r359", "r362", "r363", "r364", "r368", "r369", "r404", "r405", "r407", "r408", "r410", "r413", "r416", "r417", "r421", "r424", "r431", "r677", "r862", "r863", "r864", "r865", "r873", "r875", "r876", "r877", "r878", "r879", "r880", "r881", "r882", "r883", "r884", "r886", "r900", "r921", "r943", "r960", "r961", "r962", "r963", "r964", "r1278", "r1368", "r1370", "r1379" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/ShareholdersEquityType2or3", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r7", "r58", "r61", "r62", "r120", "r122", "r123", "r149", "r150", "r151", "r182", "r183", "r184", "r186", "r193", "r195", "r197", "r211", "r299", "r300", "r344", "r401", "r433", "r495", "r532", "r533", "r541", "r542", "r543", "r545", "r611", "r612", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r638", "r639", "r640", "r643", "r679", "r680", "r681", "r682", "r683", "r684", "r689", "r691", "r708", "r824", "r848", "r849", "r850", "r873", "r943" ] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "StatementGeographicalAxis", "presentation": [ "http://vseehealth.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "auth_ref": [ "r216", "r260", "r261", "r761", "r762", "r763", "r764", "r765", "r766", "r767", "r768", "r769", "r770", "r771", "r772", "r773", "r774", "r775", "r776", "r777", "r778", "r779", "r780", "r781", "r782", "r783", "r784", "r785", "r786", "r787", "r788", "r789", "r790", "r791", "r792", "r793", "r794", "r798", "r799", "r800", "r801", "r887", "r888", "r889", "r952", "r954", "r957", "r959", "r968", "r970", "r971", "r972", "r974", "r975", "r976", "r977", "r979", "r980", "r981", "r982", "r983", "r990", "r1005", "r1030", "r1033", "r1112", "r1113", "r1114", "r1115", "r1116", "r1117", "r1118", "r1119", "r1125", "r1134", "r1555", "r1556", "r1557", "r1559", "r1560", "r1561", "r1562", "r1563", "r1564", "r1565", "r1566", "r1567", "r1568", "r1569", "r1570", "r1571", "r1572", "r1573", "r1574", "r1575", "r1576", "r1577", "r1578", "r1579", "r1580", "r1581", "r1583", "r1584" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementLineItems", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/ConsolidatedCashFlow_Parentheticals", "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/IncomeTaxesDetails", "http://vseehealth.com/role/ShareholdersEquityType2or3", "http://vseehealth.com/role/ShareholdersEquityType2or3_Parentheticals" ], "lang": { "en-us": { "role": { "label": "Statement", "terseLabel": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r182", "r183", "r184", "r211", "r404", "r405", "r407", "r410", "r691", "r758", "r860", "r874", "r886", "r892", "r893", "r894", "r895", "r896", "r897", "r900", "r903", "r904", "r905", "r906", "r907", "r909", "r910", "r911", "r912", "r914", "r915", "r916", "r917", "r918", "r922", "r923", "r929", "r930", "r931", "r932", "r933", "r934", "r935", "r936", "r937", "r938", "r939", "r940", "r943", "r1000", "r1002", "r1135", "r1588" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "srt_StatementScenarioAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "StatementScenarioAxis", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://vseehealth.com/role/LeasesDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofExpectedAmortizationExpenseTable" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "auth_ref": [ "r126", "r128", "r198", "r462", "r1279", "r1283" ] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StatementTable", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/ConsolidatedCashFlow_Parentheticals", "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ShareholdersEquityType2or3", "http://vseehealth.com/role/ShareholdersEquityType2or3_Parentheticals" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Presentation of information about comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity." } } }, "auth_ref": [ "r182", "r183", "r184", "r211", "r263", "r404", "r405", "r407", "r410", "r691", "r758", "r860", "r874", "r886", "r892", "r893", "r894", "r895", "r896", "r897", "r900", "r903", "r904", "r905", "r906", "r907", "r909", "r910", "r911", "r912", "r914", "r915", "r916", "r917", "r918", "r922", "r923", "r929", "r930", "r931", "r932", "r933", "r934", "r935", "r936", "r937", "r938", "r939", "r940", "r943", "r1000", "r1002", "r1135", "r1588" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method [Text Block]", "terseLabel": "Stock Price or TSR Estimation Method" } } }, "auth_ref": [ "r1171", "r1182", "r1198", "r1233" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Appreciation Rights (SARs) [Member]", "terseLabel": "Stock Appreciation Rights (SARs)", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [ "r1442", "r1443", "r1444", "r1445", "r1446", "r1447", "r1448", "r1449", "r1450", "r1451", "r1452", "r1453", "r1454", "r1455", "r1456", "r1457", "r1458", "r1459", "r1460", "r1461", "r1462", "r1464", "r1465", "r1466", "r1467", "r1468" ] }, "us-gaap_StockIssued1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssued1", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow", "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued", "verboseLabel": "Estimated the fair value of the shares of common stock issued (in Dollars)", "label": "Stock Issued", "documentation": "The fair value of stock issued in noncash financing activities." } } }, "auth_ref": [ "r19", "r20", "r21" ] }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodSharesAcquisitions", "presentation": [ "http://vseehealth.com/role/ScheduleofCommonStockBusinessCombinationTable", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Shares for iDoc acquisition (in Shares)", "verboseLabel": "Shares for iDoc acquisition", "label": "Stock Issued During Period, Shares, Acquisitions", "documentation": "Number of shares of stock issued during the period pursuant to acquisitions." } } }, "auth_ref": [ "r57", "r58", "r89" ] }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofCommonStockBusinessCombinationTable", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued upon conversion (in Shares)", "verboseLabel": "Conversion of convertible securities", "netLabel": "Shares issued upon conversion", "label": "Conversion of convertible securities (in Shares)", "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities." } } }, "auth_ref": [ "r7", "r36", "r58", "r61", "r89", "r387" ] }, "vsee_StockIssuedDuringPeriodSharesConversionOfWorkingCapitalFundAdvances": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "StockIssuedDuringPeriodSharesConversionOfWorkingCapitalFundAdvances", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued upon conversion of Working Capital Funds Advances (in Shares)", "verboseLabel": "Number of shares of Common Stock upon the settlement in working capital funds advanced", "documentation": "Value of stock issued during period upon conversion of certain working capital funds advanced to the company.", "label": "Stock Issued During Period Shares Conversion Of Working Capital Fund Advances" } } }, "auth_ref": [] }, "vsee_StockIssuedDuringPeriodSharesDebtIssuance": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "StockIssuedDuringPeriodSharesDebtIssuance", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Warrants and commitment shares issued in connection with the September 2024 Note (in Shares)", "verboseLabel": "Warrants and commitment shares issued in connection with the September 2024 Note", "documentation": "Number of shares of stock, including warrants and commitment shares, issued during the period pursuant to debt issuance.", "label": "Stock Issued During Period Shares Debt Issuance" } } }, "auth_ref": [] }, "vsee_StockIssuedDuringPeriodSharesDebtSettlement": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "StockIssuedDuringPeriodSharesDebtSettlement", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued in debt settlement or conversion (in Shares)", "verboseLabel": "Promissory note by issuing shares (in Shares)", "netLabel": "Shares to sponsor debt settlement (in Shares)", "label": "Shares issued in debt settlement or conversion", "documentation": "Number of shares of stock issued during the period pursuant to debt settlement or conversion." } } }, "auth_ref": [] }, "vsee_StockIssuedDuringPeriodSharesEscrowSharesReleasedFromStockPayable": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "StockIssuedDuringPeriodSharesEscrowSharesReleasedFromStockPayable", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Escrow shares released from stock payable (in Shares)", "documentation": "Number\r \nof escrow shares issued from stock payable during the period.", "label": "Stock Issued During Period Shares Escrow Shares Released From Stock Payable" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued as part of stock grants to vendors (in Shares)", "verboseLabel": "Shares issued for services performed by A.G.P.", "netLabel": "Shares issued for services performed by A.G.P. (in Shares)", "label": "Shares issued as part of stock grants to vendors", "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ScheduleofCommonStockBusinessCombinationTable", "http://vseehealth.com/role/ShareholdersEquityType2or3", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued during the year (in Shares)", "verboseLabel": "Number of shares issued", "netLabel": "Pre-funded warrants shares issued (in Shares)", "label": "Number of shares issued (in Shares)", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r7", "r57", "r58", "r89", "r862", "r943", "r961" ] }, "vsee_StockIssuedDuringPeriodSharesReverseRecapitalization": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "StockIssuedDuringPeriodSharesReverseRecapitalization", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Reverse recapitalization (in Shares)", "documentation": "Number of shares of stock issued during the period pursuant to reverse recapitalization.", "label": "Stock Issued During Period Shares Reverse Recapitalization" } } }, "auth_ref": [] }, "vsee_StockIssuedDuringPeriodSharesSettlementOfDebtAsPartOfConsiderationInAcquisitions": { "xbrltype": "sharesItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "StockIssuedDuringPeriodSharesSettlementOfDebtAsPartOfConsiderationInAcquisitions", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued as conversion of iDoc debt as part of the consideration in the acquisition (in Shares)", "documentation": "Number of shares of stock issued as a settlement of debt during the period pursuant to acquisitions.", "label": "Stock Issued During Period Shares Settlement Of Debt As Part Of Consideration In Acquisitions" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Share based compensation issued shares", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r7", "r57", "r58", "r89" ] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationGross", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation (in Shares)", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture", "documentation": "Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r1438" ] }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodValueAcquisitions", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Shares for iDoc acquisition", "label": "Stock Issued During Period, Value, Acquisitions", "documentation": "Value of stock issued pursuant to acquisitions during the period." } } }, "auth_ref": [ "r7", "r58", "r61", "r62", "r89" ] }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued upon conversion", "label": "Stock Issued During Period, Value, Conversion of Convertible Securities", "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities." } } }, "auth_ref": [ "r7", "r58", "r61", "r62", "r89" ] }, "vsee_StockIssuedDuringPeriodValueConversionOfWorkingCapitalFundAdvance": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "StockIssuedDuringPeriodValueConversionOfWorkingCapitalFundAdvance", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued upon conversion of Working Capital Funds Advances", "documentation": "Value of stock issued during period upon conversion of certain working capital funds advanced to the company.", "label": "Stock Issued During Period Value Conversion Of Working Capital Fund Advance" } } }, "auth_ref": [] }, "vsee_StockIssuedDuringPeriodValueConversionOfWorkingCapitalFundAdvances": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "StockIssuedDuringPeriodValueConversionOfWorkingCapitalFundAdvances", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Value of stock issued during the period upon the settlement in working capital funds advanced (in Dollars)", "documentation": "Value of stock issued during period upon conversion of certain working capital funds advanced to the company.", "label": "Stock Issued During Period Value Conversion Of Working Capital Fund Advances" } } }, "auth_ref": [] }, "vsee_StockIssuedDuringPeriodValueConversionOfWorkingCapitalFundAdvancesTroubledDebtRestructuring": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "StockIssuedDuringPeriodValueConversionOfWorkingCapitalFundAdvancesTroubledDebtRestructuring", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Value of stock issued during period upon conversion of certain working capital funds advanced on debt restructuring (in Dollars)", "documentation": "Value of stock issued during period upon conversion of certain working capital funds advanced to the company under troubled debt restructuring.", "label": "Stock Issued During Period Value Conversion Of Working Capital Fund Advances Troubled Debt Restructuring" } } }, "auth_ref": [] }, "vsee_StockIssuedDuringPeriodValueDebtIssuance": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "StockIssuedDuringPeriodValueDebtIssuance", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Warrants and commitment shares issued in connection with the September 2024 Note", "documentation": "Value of stock, including in the form of warrants or commitment shares, issued pursuant to debt issuance during the period.", "label": "Stock Issued During Period Value Debt Issuance" } } }, "auth_ref": [] }, "vsee_StockIssuedDuringPeriodValueDebtSettlement": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "StockIssuedDuringPeriodValueDebtSettlement", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued in debt settlement or conversion", "documentation": "Value of stock issued pursuant to debt settlement or conversion during the period.", "label": "Stock Issued During Period Value Debt Settlement" } } }, "auth_ref": [] }, "vsee_StockIssuedDuringPeriodValueEscrowSharesReleasedFromStockPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "StockIssuedDuringPeriodValueEscrowSharesReleasedFromStockPayable", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Escrow shares released from stock payable", "documentation": "Value of escrow stock issued from stock payable during the period.", "label": "Stock Issued During Period Value Escrow Shares Released From Stock Payable" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodValueIssuedForServices", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued as part of stock grants to vendors", "label": "Stock Issued During Period, Value, Issued for Services", "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued during the year", "verboseLabel": "Stock Issued During Period, Value, New Issues", "label": "Stock Issued During Period, Value, New Issues", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r7", "r57", "r58", "r89", "r873", "r943", "r961", "r1141" ] }, "vsee_StockIssuedDuringPeriodValueSettlementOfDebtAsPartOfConsiderationInAcquisition": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "StockIssuedDuringPeriodValueSettlementOfDebtAsPartOfConsiderationInAcquisition", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued as conversion of iDoc debt as part of the consideration in the acquisition", "documentation": "Value of stock issued to settle debt pursuant to consideration in acquisitions during the period.", "label": "Stock Issued During Period Value Settlement Of Debt As Part Of Consideration In Acquisition" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r40", "r57", "r58", "r89" ] }, "vsee_StockIssuedDuringThePeriodValueReverseRecapitalization": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "StockIssuedDuringThePeriodValueReverseRecapitalization", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "Reverse recapitalization", "documentation": "Value of stock issued pursuant to reverse recapitalization during the period.", "label": "Stock Issued During The Period Value Reverse Recapitalization" } } }, "auth_ref": [] }, "vsee_StockIssuedEscrowSharesReleasedFromStockPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "StockIssuedEscrowSharesReleasedFromStockPayable", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Escrow shares released from stock payable", "documentation": "The fair value of stock issued relating to escrow shares released from notes payable in a non-cash financing activities.", "label": "Stock Issued Escrow Shares Released From Stock Payable" } } }, "auth_ref": [] }, "vsee_StockIssuedForConversionOfUnderwriterFee": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "StockIssuedForConversionOfUnderwriterFee", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred shares issued as conversion of Underwriting Fee as contemplated by the business combination transaction", "documentation": "The value of stock issued during the period for conversion of underwriter fees in a non-cash financing activities.", "label": "Stock Issued For Conversion Of Underwriter Fee" } } }, "auth_ref": [] }, "vsee_StockIssuedForDebtSettlement": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "StockIssuedForDebtSettlement", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued to settled iDoc debt holders", "documentation": "Value of stock issued to settle the debt in a non-cash financing activities.", "label": "Stock Issued For Debt Settlement" } } }, "auth_ref": [] }, "vsee_StockOptionsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "StockOptionsMember", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Options [Member]", "label": "Stock Options Member" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockholdersEquityAbstract", "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet" ], "lang": { "en-us": { "role": { "terseLabel": "STOCKHOLDERS\u2019S EQUITY (DEFICIT)", "label": "Equity, Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://vseehealth.com/role/ConsolidatedBalanceSheet": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://vseehealth.com/role/ConsolidatedBalanceSheet", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "totalLabel": "Total stockholders\u2019 equity (deficit)", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r41", "r42", "r43", "r120", "r121", "r122", "r123", "r150", "r182", "r183", "r184", "r186", "r193", "r195", "r299", "r300", "r344", "r401", "r433", "r495", "r532", "r533", "r541", "r542", "r543", "r545", "r611", "r612", "r631", "r632", "r633", "r634", "r635", "r636", "r643", "r679", "r680", "r684", "r690", "r708", "r849", "r850", "r871", "r902", "r919", "r944", "r945", "r965", "r1129", "r1130", "r1141", "r1366", "r1370", "r1371", "r1402", "r1528", "r1592" ] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://vseehealth.com/role/Equity" ], "lang": { "en-us": { "role": { "terseLabel": "Equity", "label": "Equity [Text Block]", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r86", "r415", "r417", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r430", "r433", "r628", "r642", "r946", "r948", "r966" ] }, "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": { "xbrltype": "pureItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "StockholdersEquityNoteStockSplitConversionRatio1", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exchange ratio", "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio", "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one." } } }, "auth_ref": [ "r90" ] }, "us-gaap_SubscriptionAndCirculationMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubscriptionAndCirculationMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable" ], "lang": { "en-us": { "role": { "terseLabel": "Subscription fees", "verboseLabel": "Subscription fees [Member]", "netLabel": "Subscription and Circulation [Member]", "label": "Subscription and Circulation [Member]", "documentation": "Right to receive or access periodic material for specified period of time." } } }, "auth_ref": [ "r1440", "r1441" ] }, "vsee_SubscriptionProfessionalAndTechnicalEngineeringServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "SubscriptionProfessionalAndTechnicalEngineeringServicesMember", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subscription, Professional And Technical Engineering Services [Member]", "documentation": "Represents the information pertaining to combined member of contract liabilities associated with customer deposits for subscription, professional and technical engineering services.", "label": "Subscription Professional And Technical Engineering Services Member" } } }, "auth_ref": [] }, "vsee_SubscriptionServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "SubscriptionServicesMember", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subscription Services [Member]", "documentation": "Represents information pertaining to subscription services.", "label": "Subscription Services Member" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsequentEventLineItems", "presentation": [ "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Events", "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event." } } }, "auth_ref": [ "r685", "r719" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsequentEventMember", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails", "http://vseehealth.com/role/LeasesDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event [Member]", "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r685", "r719" ] }, "us-gaap_SubsequentEventTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsequentEventTable", "presentation": [ "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Table]", "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued." } } }, "auth_ref": [ "r685", "r719" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails", "http://vseehealth.com/role/LeasesDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r685", "r719" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails", "http://vseehealth.com/role/LeasesDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Domain]", "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r685", "r719" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://vseehealth.com/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Events", "label": "Subsequent Events [Text Block]", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r718", "r720" ] }, "vsee_SubsequentSettlementAgreementPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "SubsequentSettlementAgreementPaid", "crdr": "credit", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent settlement agreement, paid", "documentation": "The value represents subsequent settlement agreement, paid.", "label": "Subsequent Settlement Agreement Paid" } } }, "auth_ref": [] }, "us-gaap_SubsidiarySaleOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SubsidiarySaleOfStockAxis", "presentation": [ "http://vseehealth.com/role/SubsequentEventsDetails" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Axis]", "documentation": "Information by type of sale of the entity's stock." } } }, "auth_ref": [] }, "vsee_SummaryOfRecapitalizationAndEquityImpactTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "SummaryOfRecapitalizationAndEquityImpactTableTextBlock", "presentation": [ "http://vseehealth.com/role/BusinessCombinationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of the Recapitalization and Net Equity Impact on Business Combination", "documentation": "Tabular disclosure of information relating to the recapitalization and its net equity impact.", "label": "Summary Of Recapitalization And Equity Impact Table Text Block" } } }, "auth_ref": [] }, "vsee_SummaryofSignificantAccountingPoliciesDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "SummaryofSignificantAccountingPoliciesDetailsLineItems", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies (Details) [Line Items]" } } }, "auth_ref": [] }, "vsee_SummaryofSignificantAccountingPoliciesDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "SummaryofSignificantAccountingPoliciesDetailsTable", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies (Details) [Table]" } } }, "auth_ref": [] }, "vsee_SummaryofSignificantAccountingPoliciesScheduleofFixedAssetsareDepreciatedUsingtheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "SummaryofSignificantAccountingPoliciesScheduleofFixedAssetsareDepreciatedUsingtheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsLineItems", "presentation": [ "http://vseehealth.com/role/ScheduleofFixedAssetsareDepreciatedUsingtheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable" ], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies - Schedule of Fixed Assets are Depreciated Using the Straight-Line Method Over the Estimated Useful Lives of the Assets (Details) [Line Items]" } } }, "auth_ref": [] }, "vsee_SummaryofSignificantAccountingPoliciesScheduleofFixedAssetsareDepreciatedUsingtheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "SummaryofSignificantAccountingPoliciesScheduleofFixedAssetsareDepreciatedUsingtheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsDetailsTable", "presentation": [ "http://vseehealth.com/role/ScheduleofFixedAssetsareDepreciatedUsingtheStraightLineMethodOvertheEstimatedUsefulLivesoftheAssetsTable" ], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies - Schedule of Fixed Assets are Depreciated Using the Straight-Line Method Over the Estimated Useful Lives of the Assets (Details) [Table]" } } }, "auth_ref": [] }, "vsee_SummaryofSignificantAccountingPoliciesScheduleofNetLossPerCommonShareDetailsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "SummaryofSignificantAccountingPoliciesScheduleofNetLossPerCommonShareDetailsLineItems", "presentation": [ "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable" ], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies - Schedule of Net Loss Per Common Share (Details) [Line Items]" } } }, "auth_ref": [] }, "vsee_SummaryofSignificantAccountingPoliciesScheduleofNetLossPerCommonShareDetailsTable": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "SummaryofSignificantAccountingPoliciesScheduleofNetLossPerCommonShareDetailsTable", "presentation": [ "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable" ], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies - Schedule of Net Loss Per Common Share (Details) [Table]" } } }, "auth_ref": [] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Supplemental disclosure of cash flow information:", "label": "Supplemental Cash Flow Information [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SupplierConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "SupplierConcentrationRiskMember", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Supplier Concentration Risk [Member]", "label": "Supplier Concentration Risk [Member]", "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services." } } }, "auth_ref": [ "r1383" ] }, "stpr_TX": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/stpr/2025", "localname": "TX", "presentation": [ "http://vseehealth.com/role/LeasesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "TEXAS", "label": "TEXAS" } } }, "auth_ref": [] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Tabular List [Table Text Block]", "terseLabel": "Tabular List, Table" } } }, "auth_ref": [ "r1226" ] }, "us-gaap_TaxPeriodAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TaxPeriodAxis", "presentation": [ "http://vseehealth.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Tax Period [Axis]", "documentation": "Information by period subject to enacted tax law." } } }, "auth_ref": [ "r1475" ] }, "us-gaap_TaxPeriodDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TaxPeriodDomain", "presentation": [ "http://vseehealth.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "label": "Tax Period [Domain]", "documentation": "Identified tax period." } } }, "auth_ref": [ "r1475" ] }, "us-gaap_TaxYear2017Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TaxYear2017Member", "presentation": [ "http://vseehealth.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax Year 2017 [Member]", "label": "Tax Year 2017 [Member]", "documentation": "Identified as tax year 2017." } } }, "auth_ref": [ "r1475" ] }, "vsee_TaxYear2030Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "TaxYear2030Member", "presentation": [ "http://vseehealth.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tax Year 2030 [Member]", "label": "Tax Year2030 Member" } } }, "auth_ref": [] }, "vsee_TechnicalEngineeringFeesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "TechnicalEngineeringFeesMember", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable" ], "lang": { "en-us": { "role": { "terseLabel": "Technical engineering fees [Member]", "label": "Technical Engineering Fees Member" } } }, "auth_ref": [] }, "us-gaap_TechnologyBasedIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TechnologyBasedIntangibleAssetsMember", "presentation": [ "http://vseehealth.com/role/ScheduleofIdentifiableIntangibleAssetsSubjecttoAmortizationTable" ], "lang": { "en-us": { "role": { "terseLabel": "Developed technology [Member]", "label": "Technology-Based Intangible Assets [Member]", "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights." } } }, "auth_ref": [ "r1083", "r1409", "r1410", "r1411", "r1412", "r1413", "r1415", "r1418", "r1419" ] }, "vsee_TechnologySegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "TechnologySegmentMember", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable", "http://vseehealth.com/role/ScheduleofReportableSegmentDepreciationandAmortizationandCapitalExpendituresTable", "http://vseehealth.com/role/ScheduleofTotalAssetsbySegmentTable" ], "lang": { "en-us": { "role": { "terseLabel": "Technology [Member]", "verboseLabel": "Technology Segment [Member]", "documentation": "Represents information pertaining to the technology segment.", "label": "Technology Segment Member" } } }, "auth_ref": [] }, "us-gaap_TechnologyServiceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TechnologyServiceMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement" ], "lang": { "en-us": { "role": { "terseLabel": "Technical engineering fees", "label": "Technology Service [Member]", "documentation": "Technology assistance, including but not limited to, training, installation, engineering, and software design." } } }, "auth_ref": [ "r1440", "r1441" ] }, "vsee_TelehealthAndInstitutionalServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "TelehealthAndInstitutionalServicesMember", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Telehealth and Institutional Services [Member]", "documentation": "Represents information pertaining to telehealth and institutional services.", "label": "Telehealth And Institutional Services Member" } } }, "auth_ref": [] }, "vsee_TelehealthFeesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "TelehealthFeesMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable" ], "lang": { "en-us": { "role": { "terseLabel": "Telehealth fees", "verboseLabel": "Telehealth fees [Member]", "netLabel": "Telehealth Fees [Member]", "documentation": "Represents fees relating to telehealth services.", "label": "Telehealth Fees Member" } } }, "auth_ref": [] }, "vsee_TelehealthSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "TelehealthSegmentMember", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable", "http://vseehealth.com/role/ScheduleofReportableSegmentDepreciationandAmortizationandCapitalExpendituresTable", "http://vseehealth.com/role/ScheduleofTotalAssetsbySegmentTable" ], "lang": { "en-us": { "role": { "terseLabel": "Telehealth [Member]", "verboseLabel": "Telehealth Segment [Member]", "documentation": "Represents information pertaining to the telehealth segment.", "label": "Telehealth Segment Member" } } }, "auth_ref": [] }, "vsee_ThisAmericanDocIncMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ThisAmericanDocIncMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow_Parentheticals", "http://vseehealth.com/role/ShareholdersEquityType2or3", "http://vseehealth.com/role/ShareholdersEquityType2or3_Parentheticals", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "This American Doc", "verboseLabel": "This American Doc, Inc [Member]", "documentation": "Represents the information pertaining to This American Doc, Inc.", "label": "This American Doc Inc Member" } } }, "auth_ref": [] }, "vsee_ThreeCustomersMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ThreeCustomersMember", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Three Customers [Member]", "label": "Three Customers Member" } } }, "auth_ref": [] }, "vsee_ThresholdBeneficialOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ThresholdBeneficialOwnershipPercentage", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Threshold beneficial ownership percentage", "documentation": "Represents the threshold percentage of beneficial ownership of the shares of common stock outstanding.", "label": "Threshold Beneficial Ownership Percentage" } } }, "auth_ref": [] }, "vsee_ThresholdGrossProceedsFromCapitalRaisingAsPercentageOfTotalEquityProceedsConsideredForAdjustmentOfExercisePriceOfWarrants": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ThresholdGrossProceedsFromCapitalRaisingAsPercentageOfTotalEquityProceedsConsideredForAdjustmentOfExercisePriceOfWarrants", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Threshold gross proceeds from capital raising as a percentage of total equity proceeds, considered for adjustment of exercise price of warrants", "documentation": "Represents the threshold gross proceeds from capital raising as a percentage of total equity proceeds, considered for adjustments of exercise price of warrants.", "label": "Threshold Gross Proceeds From Capital Raising As Percentage Of Total Equity Proceeds Considered For Adjustment Of Exercise Price Of Warrants" } } }, "auth_ref": [] }, "vsee_ThresholdIssuePriceForCapitalRaisingInConnectionWithClosingOfInitialBusinessCombinationConsideredForAdjustmentOfExercisePriceOfWarrants": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ThresholdIssuePriceForCapitalRaisingInConnectionWithClosingOfInitialBusinessCombinationConsideredForAdjustmentOfExercisePriceOfWarrants", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Threshold issue price for capital raising purposes in connection with the closing of the initial business combination, considered for adjustment of exercise price of warrants (in Dollars per share)", "documentation": "Represents the threshold issue price for capital raising in connection with the closing of a Initial Business Combination, considered for adjustments of exercise price of warrants.", "label": "Threshold Issue Price For Capital Raising In Connection With Closing Of Initial Business Combination Considered For Adjustment Of Exercise Price Of Warrants" } } }, "auth_ref": [] }, "vsee_ThresholdMaximumMarketValuePerShareConsideredForAdjustmentOfExercisePriceOfWarrants": { "xbrltype": "perShareItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ThresholdMaximumMarketValuePerShareConsideredForAdjustmentOfExercisePriceOfWarrants", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Threshold maximum market value per share, considered for adjustment of exercise price of warrants (in Dollars per share)", "documentation": "Represents the threshold maximum market value per share, considered for adjustments of exercise price of warrants.", "label": "Threshold Maximum Market Value Per Share Considered For Adjustment Of Exercise Price Of Warrants" } } }, "auth_ref": [] }, "vsee_ThresholdOwnershipPercentageEligibleToVote": { "xbrltype": "percentItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "ThresholdOwnershipPercentageEligibleToVote", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ownership percentage eligible to vote", "documentation": "Threshold ownership percentage eligible to vote.", "label": "Threshold Ownership Percentage Eligible To Vote" } } }, "auth_ref": [] }, "vsee_TidewaterMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "TidewaterMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Tidewater [Member]", "documentation": "Represents information pertaining to tidewater.", "label": "Tidewater Member" } } }, "auth_ref": [] }, "vsee_TimingOfRevenueRecognitionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "TimingOfRevenueRecognitionAbstract", "presentation": [ "http://vseehealth.com/role/ScheduleofDisaggregatedRevenuebyTimingofRevenueRecognitionTable" ], "lang": { "en-us": { "role": { "terseLabel": "Timing of revenue recognition", "label": "Timing Of Revenue Recognition Abstract" } } }, "auth_ref": [] }, "us-gaap_TimingOfTransferOfGoodOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TimingOfTransferOfGoodOrServiceAxis", "presentation": [ "http://vseehealth.com/role/ScheduleofDisaggregatedRevenuebyTimingofRevenueRecognitionTable" ], "lang": { "en-us": { "role": { "label": "Timing of Transfer of Good or Service [Axis]", "documentation": "Information by timing of transfer of good or service to customer." } } }, "auth_ref": [ "r447", "r1030", "r1037" ] }, "us-gaap_TimingOfTransferOfGoodOrServiceDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TimingOfTransferOfGoodOrServiceDomain", "presentation": [ "http://vseehealth.com/role/ScheduleofDisaggregatedRevenuebyTimingofRevenueRecognitionTable" ], "lang": { "en-us": { "role": { "label": "Timing of Transfer of Good or Service [Domain]", "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time." } } }, "auth_ref": [ "r447", "r1030", "r1037" ] }, "srt_TitleOfIndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "TitleOfIndividualAxis", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "label": "Title and Position [Axis]" } } }, "auth_ref": [ "r1393", "r1539" ] }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2025", "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "label": "Title and Position [Domain]" } } }, "auth_ref": [] }, "vsee_TotalNumberOfDeployedTelepresenceRobotsRightsConsideredForCalculatingPercentageOfMonthlyRevenueGeneration": { "xbrltype": "integerItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "TotalNumberOfDeployedTelepresenceRobotsRightsConsideredForCalculatingPercentageOfMonthlyRevenueGeneration", "presentation": [ "http://vseehealth.com/role/CommitmentsandContingenciesDetails", "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total number of deployed telepresence robots", "verboseLabel": "Total number of deployed telepresence robots (in robot)", "documentation": "Total number of deployed telepresence robots rights considered for calculating percentage of monthly revenue generation.", "label": "Total Number Of Deployed Telepresence Robots Rights Considered For Calculating Percentage Of Monthly Revenue Generation" } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount", "terseLabel": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r1218" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group [Text Block]", "terseLabel": "Total Shareholder Return Vs Peer Group" } } }, "auth_ref": [ "r1225" ] }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TradeAndOtherAccountsReceivablePolicy", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts Receivable and Credit Losses", "label": "Accounts Receivable [Policy Text Block]", "documentation": "Disclosure of accounting policy for accounts receivable." } } }, "auth_ref": [ "r1395", "r1396", "r1397" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement [Axis]", "terseLabel": "Trading Arrangement:" } } }, "auth_ref": [ "r1246" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangements, by Individual [Table]", "terseLabel": "Trading Arrangements, by Individual" } } }, "auth_ref": [ "r1248" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "TradingSymbol", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_TransferredAtPointInTimeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TransferredAtPointInTimeMember", "presentation": [ "http://vseehealth.com/role/ScheduleofDisaggregatedRevenuebyTimingofRevenueRecognitionTable" ], "lang": { "en-us": { "role": { "terseLabel": "Transferred at Point in Time [Member]", "label": "Transferred at Point in Time [Member]", "documentation": "Contract with customer in which good or service is transferred at point in time." } } }, "auth_ref": [ "r1030", "r1031", "r1037" ] }, "us-gaap_TransferredOverTimeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TransferredOverTimeMember", "presentation": [ "http://vseehealth.com/role/ScheduleofDisaggregatedRevenuebyTimingofRevenueRecognitionTable" ], "lang": { "en-us": { "role": { "terseLabel": "Transferred over Time [Member]", "label": "Transferred over Time [Member]", "documentation": "Contract with customer in which good or service is transferred over time." } } }, "auth_ref": [ "r1030", "r1031", "r1037" ] }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "presentation": [ "http://vseehealth.com/role/EquityDetails", "http://vseehealth.com/role/FairValueMeasurementsTables", "http://vseehealth.com/role/ScheduleofChangesintheFairValueofFinancialLiabilitiesTable" ], "lang": { "en-us": { "role": { "label": "Financial Instruments [Domain]", "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "auth_ref": [ "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r395", "r429", "r628", "r641", "r669", "r676", "r678", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r728", "r729", "r730", "r731", "r732", "r733", "r734", "r735", "r738", "r739", "r740", "r741", "r742", "r743", "r744", "r745", "r746", "r747", "r748", "r749", "r750", "r751", "r752", "r806", "r825", "r1096", "r1099", "r1100", "r1101", "r1102", "r1103", "r1104", "r1105", "r1106", "r1111", "r1294", "r1295", "r1296", "r1297", "r1298", "r1299", "r1300", "r1398", "r1399", "r1400", "r1401", "r1513", "r1516", "r1517", "r1518", "r1520", "r1522", "r1524", "r1525" ] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Adoption Date", "terseLabel": "Adoption Date" } } }, "auth_ref": [ "r1249" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Duration", "terseLabel": "Arrangement Duration" } } }, "auth_ref": [ "r1250" ] }, "ecd_TrdArrExpirationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrExpirationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Expiration Date", "terseLabel": "Expiration Date" } } }, "auth_ref": [ "r1250" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Name", "terseLabel": "Name" } } }, "auth_ref": [ "r1248" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Individual Title", "terseLabel": "Title" } } }, "auth_ref": [ "r1248" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement, Securities Aggregate Available Amount", "terseLabel": "Aggregate Available" } } }, "auth_ref": [ "r1251" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement Termination Date", "terseLabel": "Termination Date" } } }, "auth_ref": [ "r1249" ] }, "vsee_TwoCustomersMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "TwoCustomersMember", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Two Customers [Member]", "documentation": "Represents information relating to two customers.", "label": "Two Customers Member" } } }, "auth_ref": [] }, "vsee_TwoVendorsMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "TwoVendorsMember", "presentation": [ "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Two Vendors [Member]", "label": "Two Vendors Member" } } }, "auth_ref": [] }, "us-gaap_TypeOfArrangementAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "TypeOfArrangementAxis", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]", "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "auth_ref": [ "r613" ] }, "vsee_UnallocatedCorporateOverheadExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "UnallocatedCorporateOverheadExpenses", "crdr": "debit", "presentation": [ "http://vseehealth.com/role/ScheduleofReconciliationofConsolidatedSegmentTable" ], "lang": { "en-us": { "role": { "terseLabel": "Unallocated corporate overhead expenses", "documentation": "Unallocated corporate overhead expenses.", "label": "Unallocated Corporate Overhead Expenses" } } }, "auth_ref": [] }, "vsee_UncertainTaxPositionsExpectedToReverseDuration": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "UncertainTaxPositionsExpectedToReverseDuration", "presentation": [ "http://vseehealth.com/role/IncomeTaxesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Uncertain tax positions expected to reverse dyration", "documentation": "Uncertain tax positions are expected to reverse.", "label": "Uncertain Tax Positions Expected To Reverse Duration" } } }, "auth_ref": [] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change, Percent", "terseLabel": "Underlying Security Market Price Change" } } }, "auth_ref": [ "r1245" ] }, "vsee_UnsecuredPromissoryNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "UnsecuredPromissoryNoteMember", "presentation": [ "http://vseehealth.com/role/RelatedPartyDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unsecured Promissory Note [Member]", "documentation": "Represents the information pertaining to unsecured promissory note.", "label": "Unsecured Promissory Note Member" } } }, "auth_ref": [] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "UseOfEstimates", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Use of Estimates", "label": "Use of Estimates, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r111", "r112", "r214", "r217", "r218", "r219", "r798", "r800", "r1006" ] }, "us-gaap_VestingAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "VestingAxis", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "label": "Vesting [Axis]", "documentation": "Information by vesting schedule of award under share-based payment arrangement." } } }, "auth_ref": [ "r1442", "r1443", "r1444", "r1445", "r1446", "r1447", "r1448", "r1449", "r1450", "r1451", "r1452", "r1453", "r1454", "r1455", "r1456", "r1457", "r1458", "r1459", "r1460", "r1461", "r1462", "r1464", "r1465", "r1466", "r1467", "r1468" ] }, "us-gaap_VestingDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "VestingDomain", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails" ], "lang": { "en-us": { "role": { "label": "Vesting [Domain]", "documentation": "Vesting schedule of award under share-based payment arrangement." } } }, "auth_ref": [ "r1442", "r1443", "r1444", "r1445", "r1446", "r1447", "r1448", "r1449", "r1450", "r1451", "r1452", "r1453", "r1454", "r1455", "r1456", "r1457", "r1458", "r1459", "r1460", "r1461", "r1462", "r1464", "r1465", "r1466", "r1467", "r1468" ] }, "vsee_VseeLabIncMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "VseeLabIncMember", "presentation": [ "http://vseehealth.com/role/BusinessCombinationDetails", "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails", "http://vseehealth.com/role/RelatedPartyDetails", "http://vseehealth.com/role/ScheduleofCommonStockBusinessCombinationTable", "http://vseehealth.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "VSee Lab, Inc [Member]", "documentation": "Represents the information pertaining to VSee Lab, Inc.", "label": "Vsee Lab Inc Member" } } }, "auth_ref": [] }, "vsee_VseeLabStockholdersMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "VseeLabStockholdersMember", "presentation": [ "http://vseehealth.com/role/OrganizationandDescriptionofBusinessDetails" ], "lang": { "en-us": { "role": { "terseLabel": "VSee Lab Stockholders [Member]", "documentation": "Represents information pertaining to VSee Lab stockholders.", "label": "Vsee Lab Stockholders Member" } } }, "auth_ref": [] }, "vsee_VseeNoteMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "VseeNoteMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/ShareholdersEquityType2or3" ], "lang": { "en-us": { "role": { "terseLabel": "VSee Note", "verboseLabel": "Vsee Note [Member]", "documentation": "Represents information related to VSee Note.", "label": "Vsee Note Member" } } }, "auth_ref": [] }, "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]", "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year" } } }, "auth_ref": [ "r1214" ] }, "vsee_Warrant1Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "Warrant1Member", "presentation": [ "http://xbrl.sec.gov/dei/role/document/AuditInformation", "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Warrant [Member]", "label": "Warrant1 Member" } } }, "auth_ref": [] }, "vsee_WarrantExchangeAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "WarrantExchangeAgreementMember", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrant Exchange Agreement [Member]", "label": "Warrant Exchange Agreement Member" } } }, "auth_ref": [] }, "vsee_WarrantInstrumentsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "WarrantInstrumentsPolicyPolicyTextBlock", "presentation": [ "http://vseehealth.com/role/AccountingPoliciesByPolicy" ], "lang": { "en-us": { "role": { "terseLabel": "Warrant Instruments", "documentation": "Disclosure of accounting policy for warrant instruments.", "label": "Warrant Instruments Policy Policy Text Block" } } }, "auth_ref": [] }, "vsee_WarrantPeriodForExerciseAfterClosingOfInitialPublicOffering": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "WarrantPeriodForExerciseAfterClosingOfInitialPublicOffering", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrant, period for exercise after closing of initial public offering", "documentation": "Represents the period after closing of Initial Public Offering, that the warrants become exercisable.", "label": "Warrant Period For Exercise After Closing Of Initial Public Offering" } } }, "auth_ref": [] }, "vsee_WarrantPeriodForExerciseAfterCompletionOfInitialBusinessCombination": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "WarrantPeriodForExerciseAfterCompletionOfInitialBusinessCombination", "presentation": [ "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum notice period for redemption of warrants", "documentation": "Represents the period after completion of Initial Business Combination, that the warrants become exercisable.", "label": "Warrant Period For Exercise After Completion Of Initial Business Combination" } } }, "auth_ref": [] }, "vsee_Warrants1Member": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "Warrants1Member", "presentation": [ "http://vseehealth.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Warrants [Member]", "label": "Warrants1 Member" } } }, "auth_ref": [] }, "us-gaap_WarrantsAndRightsNoteDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "WarrantsAndRightsNoteDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Warrants and Rights Note Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "WarrantsAndRightsOutstandingTerm", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails", "http://vseehealth.com/role/WarrantsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise period", "verboseLabel": "Weighted Average remaining life in years", "label": "Warrants and Rights Outstanding, Term", "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r1516", "r1517", "r1518" ] }, "vsee_WarrantsAndRightsOutstandingWeightedAverageRemainingTerm": { "xbrltype": "durationItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "WarrantsAndRightsOutstandingWeightedAverageRemainingTerm", "presentation": [ "http://vseehealth.com/role/ScheduleofWarrantsIssuedandoutstandingTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Remaining Life in Years", "documentation": "Weighted average remaining term of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants And Rights Outstanding Weighted Average Remaining Term" } } }, "auth_ref": [] }, "vsee_WarrantsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "WarrantsTextBlock", "presentation": [ "http://vseehealth.com/role/Warrants" ], "lang": { "en-us": { "role": { "terseLabel": "Warrants", "documentation": "The entire disclosure of Warrants.", "label": "Warrants Text Block" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average number of common shares outstanding, diluted (in Shares)", "verboseLabel": "Weighted average shares outstanding diluted", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r200", "r206" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2025", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://vseehealth.com/role/ConsolidatedIncomeStatement", "http://vseehealth.com/role/ScheduleofNetLossPerCommonShareTable" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average number of common shares outstanding, basic (in Shares)", "verboseLabel": "Weighted average shares outstanding \u2013 basic", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r199", "r206" ] }, "vsee_WhackyMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "WhackyMember", "presentation": [ "http://vseehealth.com/role/LineofCreditandNotesPayablenetofdiscountDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Whacky [Member]", "documentation": "Represents information related to Whacky.", "label": "Whacky Member" } } }, "auth_ref": [] }, "vsee_WorkingCapitalFundsAdvancesMember": { "xbrltype": "domainItemType", "nsuri": "http://vseehealth.com/20251231", "localname": "WorkingCapitalFundsAdvancesMember", "presentation": [ "http://vseehealth.com/role/ConsolidatedCashFlow" ], "lang": { "en-us": { "role": { "terseLabel": "Working Capital Funds Advances", "label": "Working Capital Funds Advances Member" } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2025", "localname": "WrittenCommunications", "presentation": [ "http://xbrl.sec.gov/dei/role/document/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r1269" ] }, "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2025", "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]", "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested" } } }, "auth_ref": [ "r1212" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(g)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "470", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-1" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "SubTopic": "10", "Topic": "280", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-4" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-4" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "40", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-2" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "50", "Section": "40", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-4" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-11" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-15" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-16" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4I" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "250", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/250/tableOfContent" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/360/tableOfContent" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-2" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/470/tableOfContent" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-5" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/505/tableOfContent" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "4", "Subparagraph": "(SAB Topic 4.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-4" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(f)(2)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/810/tableOfContent" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "470", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "210", "Topic": "946", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-20" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org/606/tableOfContent" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "a", "Publisher": "SEC" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "9", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "9", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/205/tableOfContent" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481034/205-10-S45-5" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481003/205-10-S50-2" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480922/205-10-S99-3" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "7", "Subparagraph": "(SAB Topic 1.B.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480922/205-10-S99-7" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-2" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/235/tableOfContent" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-4" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(k)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(n))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-6" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/280/tableOfContent" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-24" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "36", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-36" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aa)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(aaa)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480265/350-10-S45-1" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/350-20/tableOfContent" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-2" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-4" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-6" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4.d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(f)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481679/480-10-45-2" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-1" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-2" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-3" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-1" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-2" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(01)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(01)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3A", "Subparagraph": "(24)(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-11" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-17" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-19" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-7" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/718/tableOfContent" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "17", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479983/718-10-S45-1" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-2" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-3" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-4" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479953/718-10-S50-5" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.C.Q3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.1.Q5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.3.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/740/tableOfContent" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12A", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.1.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478758/740-323-25-1" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/805-10/tableOfContent" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "05", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479515/805-10-05-4" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479405/805-10-25-1" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-4" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-5" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-7" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/805-20/tableOfContent" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-2" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-3" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/805-30/tableOfContent" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-2" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-3" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479326/805-40-45-1" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "808", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2AG", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-2AG" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/815/tableOfContent" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4F" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8A" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8C" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479693/815-10-S50-1" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "54B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2G", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2G" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-32" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483013/835-20-50-1" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2" }, "r688": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1" }, "r689": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8" }, "r690": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8" }, "r691": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "12A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A" }, "r692": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "40", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479092/842-20-40-1" }, "r693": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1" }, "r694": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1" }, "r695": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4" }, "r696": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5" }, "r697": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5" }, "r698": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-1" }, "r699": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3" }, "r700": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r701": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r702": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r703": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r704": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r705": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6" }, "r706": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A" }, "r707": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A" }, "r708": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r709": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/850/tableOfContent" }, "r710": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r711": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r712": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r713": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r714": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2" }, "r715": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r716": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6" }, "r717": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481435/852-10-45-14" }, "r718": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/855/tableOfContent" }, "r719": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2" }, "r720": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2" }, "r721": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r722": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r723": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r724": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r725": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r726": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r727": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r728": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r729": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r730": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r731": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r732": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r733": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r734": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481444/860-30-45-1" }, "r735": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7" }, "r736": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7" }, "r737": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-9" }, "r738": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3" }, "r739": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3" }, "r740": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3" }, "r741": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(4)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3" }, "r742": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r743": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r744": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r745": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r746": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r747": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r748": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r749": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r750": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r751": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r752": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4" }, "r753": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6" }, "r754": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "912", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478345/912-310-45-11" }, "r755": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478609/920-350-50-1" }, "r756": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478609/920-350-50-1" }, "r757": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "920", "SubTopic": "350", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478609/920-350-50-4" }, "r758": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1" }, "r759": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5" }, "r760": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1" }, "r761": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1" }, "r762": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18" }, "r763": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18" }, "r764": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18" }, "r765": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19" }, "r766": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-20" }, "r767": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-20" }, "r768": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r769": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r770": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r771": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r772": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r773": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23" }, "r774": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-28" }, "r775": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-28" }, "r776": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r777": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r778": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r779": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r780": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r781": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31" }, "r782": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r783": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r784": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r785": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r786": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r787": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5" }, "r788": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6" }, "r789": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7" }, "r790": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8" }, "r791": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8" }, "r792": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8" }, "r793": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "280", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1" }, "r794": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1" }, "r795": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "940", "SubTopic": "820", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1" }, "r796": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r797": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r798": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478671/942-235-S50-1" }, "r799": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1" }, "r800": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1" }, "r801": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1" }, "r802": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2" }, "r803": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1" }, "r804": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "470", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3" }, "r805": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "740", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477617/942-740-50-1" }, "r806": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1" }, "r807": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(1)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r808": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r809": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r810": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r811": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r812": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r813": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r814": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r815": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r816": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r817": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r818": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r819": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r820": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r821": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r822": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r823": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r824": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r825": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r826": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r827": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r828": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r829": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r830": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r831": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r832": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r833": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r834": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r835": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r836": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r837": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column J))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r838": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column K))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1" }, "r839": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r840": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r841": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r842": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r843": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r844": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r845": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E" }, "r846": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r847": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r848": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r849": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r850": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r851": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r852": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r853": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.W.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1" }, "r854": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "740", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478822/944-740-50-1" }, "r855": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "805", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478072/944-805-50-1" }, "r856": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B" }, "r857": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B" }, "r858": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-1" }, "r859": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-2" }, "r860": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r861": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(h)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r862": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r863": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r864": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r865": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r866": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11" }, "r867": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13" }, "r868": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2" }, "r869": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5" }, "r870": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6" }, "r871": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3" }, "r872": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3" }, "r873": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r874": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-6" }, "r875": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2" }, "r876": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27" }, "r877": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r878": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r879": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r880": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r881": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r882": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r883": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r884": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r885": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-21" }, "r886": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4" }, "r887": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r888": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2" }, "r889": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r890": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r891": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r892": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r893": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r894": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r895": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r896": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r897": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r898": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r899": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r900": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r901": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r902": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r903": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r904": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r905": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r906": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r907": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r908": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r909": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r910": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r911": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r912": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r913": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r914": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r915": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r916": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r917": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r918": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r919": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r920": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7" }, "r921": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3" }, "r922": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r923": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r924": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r925": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r926": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r927": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r928": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r929": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r930": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r931": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r932": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r933": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r934": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r935": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r936": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r937": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r938": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r939": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r940": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r941": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r942": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r943": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r944": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r945": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r946": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r947": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r948": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r949": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2" }, "r950": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r951": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r952": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r953": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r954": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r955": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r956": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r957": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r958": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r959": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r960": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1" }, "r961": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r962": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r963": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r964": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r965": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-3" }, "r966": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6" }, "r967": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477011/948-310-45-1" }, "r968": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478322/948-310-S50-2" }, "r969": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1" }, "r970": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1" }, "r971": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1" }, "r972": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1" }, "r973": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2" }, "r974": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r975": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r976": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r977": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r978": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r979": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r980": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r981": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r982": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r983": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1" }, "r984": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1" }, "r985": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1" }, "r986": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "985", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2" }, "r987": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4" }, "r988": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "SubTopic": "10", "Topic": "825", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-10" }, "r989": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H" }, "r990": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H" }, "r991": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "40", "SubTopic": "30", "Topic": "350", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40" }, "r992": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r993": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16" }, "r994": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-21" }, "r995": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22" }, "r996": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-12" }, "r997": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-11" }, "r998": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-14" }, "r999": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-18" }, "r1000": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-21" }, "r1001": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-24" }, "r1002": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-4" }, "r1003": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4" }, "r1004": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52" }, "r1005": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-18" }, "r1006": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-6" }, "r1007": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r1008": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r1009": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r1010": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r1011": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r1012": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r1013": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47" }, "r1014": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "48", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48" }, "r1015": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "49", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49" }, "r1016": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r1017": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r1018": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r1019": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "54", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54" }, "r1020": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A" }, "r1021": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "326", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479081/326-30-55-8" }, "r1022": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24" }, "r1023": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r1024": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B" }, "r1025": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C" }, "r1026": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E" }, "r1027": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F" }, "r1028": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "64", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481620/480-10-55-64" }, "r1029": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r1030": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r1031": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-7" }, "r1032": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r1033": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r1034": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r1035": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r1036": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r1037": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r1038": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r1039": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r1040": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r1041": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r1042": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5" }, "r1043": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17" }, "r1044": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11" }, "r1045": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6" }, "r1046": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8" }, "r1047": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1048": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "231", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231" }, "r1049": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-8" }, "r1050": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-29" }, "r1051": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-29" }, "r1052": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-38" }, "r1053": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "39", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-39" }, "r1054": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-41" }, "r1055": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-42" }, "r1056": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "43", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-43" }, "r1057": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "45", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-45" }, "r1058": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "46", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-46" }, "r1059": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "47", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-47" }, "r1060": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "49", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-49" }, "r1061": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-50" }, "r1062": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14" }, "r1063": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14" }, "r1064": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14" }, "r1065": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "14", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14" }, "r1066": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "14", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14" }, "r1067": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20" }, "r1068": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20" }, "r1069": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20" }, "r1070": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20" }, "r1071": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-29" }, "r1072": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-29" }, "r1073": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31" }, "r1074": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "31", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31" }, "r1075": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "31", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31" }, "r1076": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "31", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31" }, "r1077": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "31", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31" }, "r1078": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "31", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31" }, "r1079": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "31", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31" }, "r1080": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "31", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31" }, "r1081": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "31", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31" }, "r1082": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "31", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-31" }, "r1083": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38" }, "r1084": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38" }, "r1085": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38" }, "r1086": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38" }, "r1087": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38" }, "r1088": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38" }, "r1089": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r1090": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-2" }, "r1091": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479299/805-40-55-10" }, "r1092": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "805", "SubTopic": "740", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478064/805-740-55-13" }, "r1093": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J" }, "r1094": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K" }, "r1095": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r1096": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r1097": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r1098": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r1099": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "101", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101" }, "r1100": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "103", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103" }, "r1101": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r1102": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r1103": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r1104": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r1105": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r1106": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r1107": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-12" }, "r1108": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8" }, "r1109": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "53", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53" }, "r1110": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10" }, "r1111": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4" }, "r1112": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17" }, "r1113": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21" }, "r1114": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "29", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29" }, "r1115": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3" }, "r1116": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2" }, "r1117": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4" }, "r1118": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5" }, "r1119": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6" }, "r1120": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2" }, "r1121": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H" }, "r1122": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29E" }, "r1123": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F" }, "r1124": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r1125": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r1126": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r1127": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r1128": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E" }, "r1129": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-11" }, "r1130": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "605", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-14" }, "r1131": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18" }, "r1132": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r1133": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r1134": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1" }, "r1135": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r1136": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r1137": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r1138": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r1139": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r1140": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10" }, "r1141": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11" }, "r1142": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12" }, "r1143": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "Global LEI Foundation" }, "r1144": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1145": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1146": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r1147": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r1148": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r1149": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r1150": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r1151": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r1152": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r1153": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r1154": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r1155": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r1156": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r1157": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "249", "Section": "308", "Subsection": "a" }, "r1158": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r1159": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r1160": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K" }, "r1161": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "1" }, "r1162": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "1", "Subparagraph": "i" }, "r1163": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "1", "Subparagraph": "ii" }, "r1164": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "1", "Subparagraph": "iii" }, "r1165": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "b", "Paragraph": "2" }, "r1166": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16K", "Subsection": "c", "Paragraph": "1" }, "r1167": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r1168": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r1169": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r1170": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r1171": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r1172": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r1173": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r1174": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r1175": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r1176": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r1177": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r1178": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r1179": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r1180": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r1181": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r1182": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r1183": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r1184": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r1185": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r1186": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r1187": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r1188": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 8-K", "Number": "249", "Section": "308" }, "r1189": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form F-3" }, "r1190": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2" }, "r1191": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-3" }, "r1192": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-4" }, "r1193": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6" }, "r1194": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r1195": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r1196": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r1197": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r1198": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r1199": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r1200": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r1201": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r1202": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r1203": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r1204": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form S-3" }, "r1205": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r1206": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Investment Company Act", "Number": "270" }, "r1207": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r1208": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r1209": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r1210": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r1211": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Subclause": "ii" }, "r1212": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "i" }, "r1213": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "ii" }, "r1214": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "iii" }, "r1215": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "iv" }, "r1216": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "v" }, "r1217": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1", "Subclause": "vi" }, "r1218": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r1219": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r1220": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r1221": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r1222": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r1223": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r1224": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r1225": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r1226": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r1227": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r1228": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w" }, "r1229": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r1230": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r1231": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r1232": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r1233": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r1234": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r1235": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r1236": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r1237": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r1238": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r1239": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r1240": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r1241": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r1242": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r1243": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r1244": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r1245": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r1246": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r1247": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r1248": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r1249": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r1250": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r1251": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r1252": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r1253": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106" }, "r1254": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "1" }, "r1255": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "1", "Subparagraph": "i" }, "r1256": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "1", "Subparagraph": "ii" }, "r1257": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "1", "Subparagraph": "iii" }, "r1258": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "b", "Paragraph": "2" }, "r1259": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "106", "Subsection": "c", "Paragraph": "1" }, "r1260": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Number": "229", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "C", "Clause": "1" }, "r1261": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "A", "Number": "229" }, "r1262": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Number": "229" }, "r1263": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii", "Sentence": "B", "Clause": "1", "Subclause": "i", "Number": "229" }, "r1264": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "313" }, "r1265": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r1266": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-X", "Number": "210", "Section": "2", "Subsection": "2" }, "r1267": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r1268": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "413", "Subsection": "b" }, "r1269": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r1270": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "462", "Subsection": "b" }, "r1271": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "462", "Subsection": "c" }, "r1272": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "462", "Subsection": "d" }, "r1273": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "462", "Subsection": "e" }, "r1274": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "486", "Subsection": "a" }, "r1275": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "486", "Subsection": "b" }, "r1276": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r1277": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Section": "8", "Subsection": "c" }, "r1278": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3" }, "r1279": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-10" }, "r1280": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2" }, "r1281": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2" }, "r1282": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-2" }, "r1283": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-3" }, "r1284": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1" }, "r1285": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4" }, "r1286": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r1287": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(3)", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r1288": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1289": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r1290": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r1291": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9" }, "r1292": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(6))", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r1293": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Topic": "705", "Publisher": "FASB", "URI": "https://asc.fasb.org/705/tableOfContent" }, "r1294": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "a", "Publisher": "SEC" }, "r1295": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "b", "Subparagraph": "(1)", "Publisher": "SEC" }, "r1296": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "b", "Subparagraph": "(2)", "Publisher": "SEC" }, "r1297": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "b", "Subparagraph": "(3)", "Publisher": "SEC" }, "r1298": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "c", "Subparagraph": "(2)(i)", "Publisher": "SEC" }, "r1299": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "c", "Subparagraph": "(2)(ii)", "Publisher": "SEC" }, "r1300": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "c", "Subparagraph": "(2)(iii)", "Publisher": "SEC" }, "r1301": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1302": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1303": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(26)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1304": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1305": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1306": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r1307": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r1308": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r1309": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r1310": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r1311": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r1312": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r1313": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3" }, "r1314": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-10" }, "r1315": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-12" }, "r1316": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r1317": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r1318": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r1319": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21" }, "r1320": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21" }, "r1321": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21" }, "r1322": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21" }, "r1323": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21" }, "r1324": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21" }, "r1325": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21" }, "r1326": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21" }, "r1327": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21" }, "r1328": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21" }, "r1329": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(k)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21" }, "r1330": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21" }, "r1331": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(m)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21" }, "r1332": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1333": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1334": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1335": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1336": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1337": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1338": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1339": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1340": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1341": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(k)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1342": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1343": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(m)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1344": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1345": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(o)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1346": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(p)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1347": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(q)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1348": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(r)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1349": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(s)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1350": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(t)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1351": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(u)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22" }, "r1352": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-30" }, "r1353": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-31" }, "r1354": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-32" }, "r1355": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-33" }, "r1356": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6" }, "r1357": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6" }, "r1358": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6" }, "r1359": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6" }, "r1360": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6" }, "r1361": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14" }, "r1362": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r1363": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r1364": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2" }, "r1365": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1" }, "r1366": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1" }, "r1367": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-4" }, "r1368": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r1369": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r1370": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r1371": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r1372": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r1373": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r1374": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3" }, "r1375": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r1376": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r1377": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r1378": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r1379": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55" }, "r1380": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r1381": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r1382": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r1383": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r1384": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r1385": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r1386": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "275", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18" }, "r1387": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18" }, "r1388": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r1389": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r1390": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r1391": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r1392": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r1393": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r1394": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2" }, "r1395": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2" }, "r1396": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2" }, "r1397": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481569/310-20-50-1" }, "r1398": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9" }, "r1399": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3" }, "r1400": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3" }, "r1401": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3" }, "r1402": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r1403": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1" }, "r1404": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r1405": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5" }, "r1406": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r1407": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r1408": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/350-30/tableOfContent" }, "r1409": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1" }, "r1410": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r1411": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r1412": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r1413": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1" }, "r1414": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r1415": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r1416": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r1417": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r1418": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r1419": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r1420": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-2" }, "r1421": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r1422": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r1423": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r1424": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10" }, "r1425": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r1426": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r1427": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6" }, "r1428": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r1429": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r1430": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r1431": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r1432": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r1433": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r1434": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D" }, "r1435": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r1436": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481648/480-10-50-2" }, "r1437": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-1" }, "r1438": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r1439": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r1440": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r1441": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r1442": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1443": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1444": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1445": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1446": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1447": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1448": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1449": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1450": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1451": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1452": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1453": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1454": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1455": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1456": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1457": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1458": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1459": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1460": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1461": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1462": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1463": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1464": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1465": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1466": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1467": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1468": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1469": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r1470": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-4" }, "r1471": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "720", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483384/720-30-45-1" }, "r1472": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10" }, "r1473": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12" }, "r1474": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A" }, "r1475": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15" }, "r1476": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2" }, "r1477": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3" }, "r1478": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6" }, "r1479": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9" }, "r1480": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9" }, "r1481": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r1482": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A" }, "r1483": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A" }, "r1484": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A" }, "r1485": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478156/740-323-50-1A" }, "r1486": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479405/805-10-25-23" }, "r1487": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479405/805-10-25-9" }, "r1488": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2" }, "r1489": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3" }, "r1490": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-7" }, "r1491": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-8" }, "r1492": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-42" }, "r1493": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r1494": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r1495": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r1496": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-2" }, "r1497": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38" }, "r1498": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1" }, "r1499": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-2" }, "r1500": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4" }, "r1501": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "15", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480123/805-50-15-3" }, "r1502": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480060/805-50-25-1" }, "r1503": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480027/805-50-30-1" }, "r1504": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480027/805-50-30-2" }, "r1505": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r1506": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A" }, "r1507": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7A" }, "r1508": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8" }, "r1509": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8" }, "r1510": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8" }, "r1511": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "15", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481116/815-15-25-1" }, "r1512": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r1513": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "54B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B" }, "r1514": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1515": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1516": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1517": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1518": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1519": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r1520": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E" }, "r1521": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r1522": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A" }, "r1523": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1" }, "r1524": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10" }, "r1525": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11" }, "r1526": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11" }, "r1527": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r1528": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r1529": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-1A" }, "r1530": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2" }, "r1531": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-3" }, "r1532": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1" }, "r1533": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4" }, "r1534": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r1535": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6" }, "r1536": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r1537": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r1538": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r1539": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2" }, "r1540": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r1541": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-2" }, "r1542": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r1543": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r1544": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r1545": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r1546": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r1547": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r1548": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r1549": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r1550": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2" }, "r1551": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r1552": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r1553": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r1554": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r1555": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B" }, "r1556": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r1557": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r1558": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C" }, "r1559": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D" }, "r1560": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4G", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G" }, "r1561": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1562": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1563": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1564": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r1565": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1566": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1567": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1568": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1569": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1570": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1571": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1572": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r1573": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1574": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1575": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1576": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1577": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1578": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r1579": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1580": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1581": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r1582": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r1583": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r1584": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r1585": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r1586": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1587": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r1588": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3" }, "r1589": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3" }, "r1590": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(k)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3" }, "r1591": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r1592": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r1593": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r1594": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "985", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2" } } }